[
  {
    "nctId": "NCT03600883",
    "avg_inclusion_score": 1.0,
    "avg_exclusion_score": 1.0,
    "avg_overall_score": 1.0,
    "trial": {
      "clean_text": "#briefTitle\nA Phase 1/2, Study Evaluating the Safety, Tolerability, PK, and Efficacy of Sotorasib (AMG 510) in Subjects With Solid Tumors With a Specific KRAS Mutation (CodeBreaK 100)\n\n#officialTitle\nA Phase 1/2, Open-label Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of Sotorasib (AMG 510) Monotherapy in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation and Sotorasib (AMG 510) Combination Therapy in Subjects With Advanced NSCLC With KRAS p.G12C Mutation (CodeBreaK 100)\n\n#briefSummary\nEvaluate the safety and tolerability of sotorasib in adult subjects with KRAS p.G12C mutant advanced solid tumors.\n\nEstimate the maximum tolerated dose (MTD) and/or a recommended phase 2 dose (RP2D) in adult subjects with KRAS p.G12C mutant advanced solid tumors.\n\n#conditions\nKRAS p.G12C Mutant Advanced Solid Tumors\n\n",
      "briefTitle": "A Phase 1/2, Study Evaluating the Safety, Tolerability, PK, and Efficacy of Sotorasib (AMG 510) in Subjects With Solid Tumors With a Specific KRAS Mutation (CodeBreaK 100)",
      "officialTitle": "A Phase 1/2, Open-label Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of Sotorasib (AMG 510) Monotherapy in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation and Sotorasib (AMG 510) Combination Therapy in Subjects With Advanced NSCLC With KRAS p.G12C Mutation (CodeBreaK 100)",
      "briefSummary": "Evaluate the safety and tolerability of sotorasib in adult subjects with KRAS p.G12C mutant advanced solid tumors.\n\nEstimate the maximum tolerated dose (MTD) and/or a recommended phase 2 dose (RP2D) in adult subjects with KRAS p.G12C mutant advanced solid tumors.",
      "detailedDescription": null,
      "conditions": [
        "KRAS p.G12C Mutant Advanced Solid Tumors"
      ],
      "armGroups": [
        {
          "label": "Phase 1 Dose Exploration Part 1 monotherapy",
          "type": "EXPERIMENTAL",
          "description": "Cohorts with food effect and alternative dosing regimens\n\nEnrollment into the dose exploration cohorts may be from any eligible solid tumor type. Dose escalation will begin with 2-4 subjects treated at the lowest planned dose level of 180 mg. If no DLT is observed, dose escalation will continue to the next planned dose cohort",
          "interventionNames": [
            "Drug: sotorasib"
          ]
        },
        {
          "label": "Phase 1 Dose Expansion Part 2 monotherapy",
          "type": "EXPERIMENTAL",
          "description": "Upon completing the dose exploration part of the study, dose expansion may proceed with 3 groups consisting of subjects with KRAS p.G12C mutant advanced solid tumors. Dose expansion in these 3 groups may be done concurrently",
          "interventionNames": [
            "Drug: sotorasib"
          ]
        },
        {
          "label": "Phase 1 combination arm with sotorasib and anti PD-1/L1",
          "type": "EXPERIMENTAL",
          "description": "Additional subjects will be enrolled into the combination arm with sotorasib in combination with an anti (PD-1/L1)",
          "interventionNames": [
            "Drug: sotorasib",
            "Drug: Anti PD-1/L1"
          ]
        },
        {
          "label": "Phase 1 monotherapy treatment naive advanced NSCLC",
          "type": "EXPERIMENTAL",
          "description": "Separate cohort of part 1 dose expansion subjects to evaluate the safety and clinical activity of sotorasib administered orally once daily in subjects with previously untreated advanced non-small cell lung cancer (NSCLC). Drug-drug interaction will be evaluated in 6 of the subjects enrolled in the treatment naive cohort by adding Midazolam alone on Day -1 and in combination with sotorasib on Day 15 of Cycle 1, where each cycle is 21 days.",
          "interventionNames": [
            "Drug: sotorasib",
            "Drug: Midazolam"
          ]
        },
        {
          "label": "Phase 2 monotherapy dose comparison",
          "type": "EXPERIMENTAL",
          "description": "Subjects with NSCLC will be enrolled in a dose comparison study evaluating safety and efficacy",
          "interventionNames": [
            "Drug: sotorasib"
          ]
        },
        {
          "label": "Phase 1 Does escalation and Expansion monotherapy BID",
          "type": "EXPERIMENTAL",
          "description": "BID 2L+solid tumors (fed state)",
          "interventionNames": [
            "Drug: sotorasib"
          ]
        }
      ],
      "interventions": [
        {
          "type": "DRUG",
          "name": "sotorasib",
          "description": "Characterize the pharmacokinetics (PK) of sotorasib following administration as an oral Tablet formulation",
          "armGroupLabels": [
            "Phase 1 Does escalation and Expansion monotherapy BID",
            "Phase 1 Dose Expansion Part 2 monotherapy",
            "Phase 1 Dose Exploration Part 1 monotherapy",
            "Phase 1 combination arm with sotorasib and anti PD-1/L1",
            "Phase 1 monotherapy treatment naive advanced NSCLC",
            "Phase 2 monotherapy dose comparison"
          ]
        },
        {
          "type": "DRUG",
          "name": "Anti PD-1/L1",
          "description": "Administered as an intravenous (IV) infusion",
          "armGroupLabels": [
            "Phase 1 combination arm with sotorasib and anti PD-1/L1"
          ]
        },
        {
          "type": "DRUG",
          "name": "Midazolam",
          "description": "Administered as an oral hydrochloride (HCI) syrup",
          "armGroupLabels": [
            "Phase 1 monotherapy treatment naive advanced NSCLC"
          ]
        }
      ],
      "primaryOutcomes": [
        {
          "measure": "Primary: Number of subjects with treatment-emergent adverse events",
          "description": "Treatment-emergent adverse events will be a primary outcome measure for the following groups:\n\n* Phase 1 Dose Exploration Part 1 monotherapy\n* Phase 1 Dose Expansion Part 2 monotherapy\n* Phase 1 combination arm with sotorasib and anti PD-1/L1\n* Phase 1 monotherapy treatment na\u00efve advanced NSCLC\n* Phase 2 monotherapy dose comparison",
          "timeFrame": "24 Months"
        },
        {
          "measure": "Primary: Number of subjects with treatment-related adverse events",
          "description": "Treatment-related adverse events will be a primary outcome measure for the following groups:\n\n* Phase 1 Dose Exploration Part 1 monotherapy\n* Phase 1 Dose Expansion Part 2 monotherapy\n* Phase 1 combination arm with sotorasib and anti PD-1/L1\n* Phase 1 monotherapy treatment na\u00efve advanced NSCLC",
          "timeFrame": "24 Months"
        },
        {
          "measure": "Primary: Number of subjects with grade \u22653 treatment-emergent adverse events",
          "description": "Grade \u22653 treatment-emergent adverse events will be a primary outcome measure in the following group:\n\n- Phase 2 monotherapy dose comparison",
          "timeFrame": "24 Months"
        },
        {
          "measure": "Primary: Number of subjects with serious adverse events",
          "description": "Serious adverse events will be a primary outcome measure in the following group:\n\n- Phase 2 monotherapy dose comparison",
          "timeFrame": "24 Months"
        },
        {
          "measure": "Primary: Number of subjects with adverse events of interest",
          "description": "Adverse events of interest will be a primary outcome measure in the following group:\n\n- Phase 2 monotherapy dose comparison",
          "timeFrame": "24 Months"
        },
        {
          "measure": "Primary: Number of subjects with clinically significant changes in vital signs",
          "description": "Vital signs will be a primary outcome measure for the following groups:\n\n* Phase 1 Dose Exploration Part 1 monotherapy\n* Phase 1 Dose Expansion Part 2 monotherapy\n* Phase 1 combination arm with sotorasib and anti PD-1/L1\n* Phase 1 monotherapy treatment na\u00efve advanced NSCLC",
          "timeFrame": "Baseline to 24 Months"
        },
        {
          "measure": "Primary: Number of subjects with clinically significant changes in physical examination results",
          "description": "Physical examinations will be a primary outcome measure for the following groups:\n\n* Phase 1 Dose Exploration Part 1 monotherapy\n* Phase 1 Dose Expansion Part 2 monotherapy\n* Phase 1 combination arm with sotorasib and anti PD-1/L1",
          "timeFrame": "Baseline to 24 Months"
        },
        {
          "measure": "Primary: Number of subjects with clinically significant changes on electrocardiograms (ECGs)",
          "description": "ECGs will be a primary outcome measure for the following groups:\n\n* Phase 1 Dose Exploration Part 1 monotherapy\n* Phase 1 Dose Expansion Part 2 monotherapy\n* Phase 1 combination arm with sotorasib and anti PD-1/L1\n* Phase 1 monotherapy treatment na\u00efve advanced NSCLC",
          "timeFrame": "Baseline to 24 Months"
        },
        {
          "measure": "Primary: Number of subjects with clinically significant changes in clinical laboratory values",
          "description": "Abnormal clinical laboratory values will be a primary outcome measure for the following groups:\n\n* Phase 1 Dose Exploration Part 1 monotherapy\n* Phase 1 Dose Expansion Part 2 monotherapy\n* Phase 1 combination arm with sotorasib and anti PD-1/L1\n* Phase 1 monotherapy treatment na\u00efve advanced NSCLC",
          "timeFrame": "Baseline to 24 Months"
        },
        {
          "measure": "Primary: Number of subjects with dose-limiting toxicities (DLTs)",
          "description": "DLTs will be a primary outcome measure for the following groups:\n\n* Phase 1 Dose Exploration Part 1 monotherapy\n* Phase 1 Dose Expansion Part 2 monotherapy\n* Phase 1 combination arm with sotorasib and anti PD-1/L1\n* Phase 1 monotherapy treatment na\u00efve advanced NSCLC",
          "timeFrame": "21 Days"
        },
        {
          "measure": "Primary: Objective response rate (ORR) as assessed by RECIST 1.1 criteria",
          "description": "ORR will be a primary outcome measure in the following group:\n\n* Phase 1 monotherapy treatment na\u00efve advanced NSCLC\n* Phase 2 monotherapy\n* Phase 2 monotherapy dose comparison",
          "timeFrame": "24 Months"
        },
        {
          "measure": "Primary: Duration of response (DOR) as assessed by RECIST 1.1 criteria",
          "description": "DOR will be a primary outcome measure in the following group:\n\n- Phase 1 monotherapy treatment na\u00efve advanced NSCLC",
          "timeFrame": "24 Months"
        },
        {
          "measure": "Primary: Disease control as assessed by RECIST 1.1 criteria",
          "description": "Disease control will be a primary outcome measure in the following group:\n\n- Phase 1 monotherapy treatment na\u00efve advanced NSCLC",
          "timeFrame": "24 Months"
        },
        {
          "measure": "Primary: Duration of stable disease (SD) as assessed by RECIST 1.1 criteria",
          "description": "Duration of SD will be a primary outcome measure in the following group:\n\n- Phase 1 monotherapy treatment na\u00efve advanced NSCLC",
          "timeFrame": "24 Months"
        },
        {
          "measure": "Primary: Time to response (TTR) as assessed by RECIST 1.1 criteria",
          "description": "TTR will be a primary outcome measure in the following group:\n\n- Phase 1 monotherapy treatment na\u00efve advanced NSCLC",
          "timeFrame": "24 Months"
        }
      ],
      "secondaryOutcomes": [
        {
          "measure": "Secondary: Plasma concentration (Cmax) of sotorasib",
          "description": "Cmax will be a secondary outcome measure for the following groups:\n\n* Phase 1 Dose Exploration Part 1 monotherapy\n* Phase 1 Dose Expansion Part 2 monotherapy\n* Phase 2 monotherapy\n* Phase 1 combination arm with sotorasib and anti PD-1/L1\n* Phase 1 monotherapy treatment na\u00efve advanced NSCLC\n* Phase 2 monotherapy dose comparison",
          "timeFrame": "15 Weeks"
        },
        {
          "measure": "Secondary: Plasma concentration (Cmax) of midazolam",
          "description": "Cmax of midazolam will be a secondary outcome measure for the subgroup of subjects who were administered midazolam in the following group:\n\n- Phase 1 monotherapy treatment na\u00efve advanced NSCLC",
          "timeFrame": "16 Days"
        },
        {
          "measure": "Secondary: Time to achieve Cmax (Tmax) of sotorasib",
          "description": "Tmax will be a secondary outcome measure for the following groups:\n\n* Phase 1 Dose Exploration Part 1 monotherapy\n* Phase 1 Dose Expansion Part 2 monotherapy\n* Phase 2 monotherapy\n* Phase 1 combination arm with sotorasib and anti PD-1/L1\n* Phase 1 monotherapy treatment na\u00efve advanced NSCLC",
          "timeFrame": "15 Weeks"
        },
        {
          "measure": "Secondary: Area under the plasma concentration-time curve (AUC) of sotorasib",
          "description": "AUC will be a secondary outcome measure for the following groups:\n\n* Phase 1 Dose Exploration Part 1 monotherapy\n* Phase 1 Dose Expansion Part 2 monotherapy\n* Phase 2 monotherapy\n* Phase 1 combination arm with sotorasib and anti PD-1/L1\n* Phase 1 monotherapy treatment na\u00efve advanced NSCLC\n* Phase 2 monotherapy dose comparison",
          "timeFrame": "15 Weeks"
        },
        {
          "measure": "Secondary: Area under the plasma concentration-time curve (AUC) of midazolam",
          "description": "AUC of midazolam will be a secondary outcome measure for the subgroup of subjects who were administered midazolam in the following group:\n\n- Phase 1 monotherapy treatment na\u00efve advanced NSCLC",
          "timeFrame": "16 Days"
        },
        {
          "measure": "Secondary: Clearance of midazolam from the plasma",
          "description": "Clearance of midazolam from the plasma will be a secondary outcome measure for the subgroup of subjects who were administered midazolam in the following group:\n\n- Phase 1 monotherapy treatment na\u00efve advanced NSCLC",
          "timeFrame": "16 Days"
        },
        {
          "measure": "Secondary: Terminal half-life (t1/2) of midazolam",
          "description": "t1/2 of midazolam will be a secondary outcome measure for the subgroup of subjects who were administered midazolam in the following group:\n\n- Phase 1 monotherapy treatment na\u00efve advanced NSCLC",
          "timeFrame": "16 Days"
        },
        {
          "measure": "Secondary: Objective response rate (ORR) as assessed by RECIST 1.1 criteria",
          "description": "ORR will be a secondary outcome measure for the following groups:\n\n* Phase 1 Dose Exploration Part 1 monotherapy\n* Phase 1 Dose Expansion Part 2 monotherapy\n* Phase 1 combination arm with sotorasib and anti PD-1/L1",
          "timeFrame": "24 Months"
        },
        {
          "measure": "Secondary: Duration of response (DOR) as assessed by RECIST 1.1 criteria",
          "description": "DOR will be a secondary outcome measure for the following groups:\n\n* Phase 1 Dose Exploration Part 1 monotherapy\n* Phase 1 Dose Expansion Part 2 monotherapy\n* Phase 2 monotherapy\n* Phase 1 combination arm with sotorasib and anti PD-1/L1\n* Phase 2 monotherapy dose comparison",
          "timeFrame": "24 Months"
        },
        {
          "measure": "Secondary: Disease control as assessed by RECIST 1.1 criteria",
          "description": "DOR will be a secondary outcome measure for the following groups:\n\n* Phase 1 Dose Exploration Part 1 monotherapy\n* Phase 1 Dose Expansion Part 2 monotherapy\n* Phase 2 monotherapy\n* Phase 1 combination arm with sotorasib and anti PD-1/L1\n* Phase 2 monotherapy dose comparison",
          "timeFrame": "24 Months"
        },
        {
          "measure": "Secondary: Progression-free survival (PFS) as assessed by RECIST 1.1 criteria",
          "description": "PFS will be a secondary outcome measure for the following groups:\n\n* Phase 1 Dose Exploration Part 1 monotherapy\n* Phase 1 Dose Expansion Part 2 monotherapy\n* Phase 2 monotherapy\n* Phase 1 combination arm with sotorasib and anti PD-1/L1\n* Phase 2 monotherapy dose comparison\n* Phase 1 monotherapy treatment na\u00efve advanced NSCLC",
          "timeFrame": "24 Months"
        },
        {
          "measure": "Secondary: Duration of stable disease (SD) as assessed by RECIST 1.1 criteria",
          "description": "Duration of SD will be a secondary outcome measure for the following groups:\n\n* Phase 1 Dose Exploration Part 1 monotherapy\n* Phase 1 Dose Expansion Part 2 monotherapy\n* Phase 1 combination arm with sotorasib and anti PD-1/L1",
          "timeFrame": "24 Months"
        },
        {
          "measure": "Secondary: Depth of response (best percentage change from baseline in lesion sum diameters) as assessed by RECIST 1.1 criteria",
          "description": "Depth of response will be a secondary outcome measure for the following group:\n\n- Phase 2 monotherapy dose comparison",
          "timeFrame": "Baseline to 24 Months"
        },
        {
          "measure": "Secondary: Time to response (TTR) as assessed by RECIST 1.1 criteria",
          "description": "DOR will be a secondary outcome measure for the following groups:\n\n* Phase 1 Dose Exploration Part 1 monotherapy\n* Phase 1 Dose Expansion Part 2 monotherapy\n* Phase 2 monotherapy\n* Phase 1 combination arm with sotorasib and anti PD-1/L1\n* Phase 2 monotherapy dose comparison",
          "timeFrame": "24 Months"
        },
        {
          "measure": "Secondary: Overall survival (OS)",
          "description": "OS will be a secondary outcome measure for the following groups:\n\n* Phase 1 Dose Exploration Part 1 monotherapy\n* Phase 1 Dose Expansion Part 2 monotherapy\n* Phase 2 monotherapy\n* Phase 1 combination arm with sotorasib and anti PD-1/L1\n* Phase 2 monotherapy dose comparison\n* Phase 1 monotherapy treatment na\u00efve advanced NSCLC",
          "timeFrame": "24 Months"
        },
        {
          "measure": "Secondary: sotorasib exposure and QTc interval relationship",
          "description": "sotorasib exposure and QTc interval relationship will be a secondary outcome measure for the following groups:\n\n* Phase 1 Dose Exploration Part 1 monotherapy\n* Phase 1 Dose Expansion Part 2 monotherapy",
          "timeFrame": "24 Months"
        },
        {
          "measure": "Secondary: Progression-free survival (PFS) at 6 months",
          "description": "PFS at 6 months will be a secondary outcome measure for the following group:\n\n- Phase 2 monotherapy",
          "timeFrame": "6 Months"
        },
        {
          "measure": "Secondary: Progression-free survival (PFS) at 12 months",
          "description": "PFS at 12 months will be a secondary outcome measure for the following group:\n\n- Phase 2 monotherapy",
          "timeFrame": "12 Months"
        },
        {
          "measure": "Secondary: Overall survival (OS) at 12 months",
          "description": "OS at 12 months will be a secondary outcome measure for the following group:\n\n- Phase 2 monotherapy",
          "timeFrame": "12 Months"
        },
        {
          "measure": "Secondary: Number of subjects with treatment-emergent adverse events",
          "description": "Treatment-emergent adverse events will be a secondary outcome measure for the following group:\n\n- Phase 2 monotherapy",
          "timeFrame": "24 Months"
        },
        {
          "measure": "Secondary: Number of subjects with grade \u22653 treatment-emergent adverse events",
          "description": "Grade \u22653 treatment-emergent adverse events will be a secondary outcome measure for the following group:\n\n- Phase 2 monotherapy",
          "timeFrame": "24 Months"
        },
        {
          "measure": "Secondary: Impact of treatment on disease-related symptoms and health related quality of life (HRQOL) as assessed by EORTC QLQ-C30",
          "description": "Impact of treatment on disease-related symptoms and HRQOL will be a secondary outcome measure for the following group:\n\n- Phase 2 monotherapy dose comparison",
          "timeFrame": "24 Months"
        },
        {
          "measure": "Secondary: Impact of treatment on disease-related symptoms and HRQOL as assessed by disease-specific modules Quality-of-Life Questionnaire Lung Cancer Module (QLQ LC13)",
          "description": "Impact of treatment on disease-related symptoms and HRQOL will be a secondary outcome measure for the following group:\n\n- Phase 2 monotherapy dose comparison",
          "timeFrame": "24 Months"
        },
        {
          "measure": "Secondary: Impact of treatment on disease-related symptoms and HRQOL as assessed by non-small cell lung cancer symptom assessment questionnaire (NSCLC SAQ) for NSCLC",
          "description": "Impact of treatment on disease-related symptoms and HRQOL will be a secondary outcome measure for the following group:\n\n- Phase 2 monotherapy dose comparison",
          "timeFrame": "24 Months"
        },
        {
          "measure": "Secondary: Impact of treatment on disease-related symptoms and HRQOL as assessed by Patient Global Impression of Severity (PGIS)",
          "description": "Impact of treatment on disease-related symptoms and HRQOL will be a secondary outcome measure for the following group:\n\n- Phase 2 monotherapy dose comparison",
          "timeFrame": "24 Months"
        },
        {
          "measure": "Secondary: Impact of treatment on disease-related symptoms and HRQOL as assessed by Patient Global Impression of Change (PGIC) in cough, dyspnea and chest pain for NSCLC",
          "description": "Impact of treatment on disease-related symptoms and HRQOL will be a secondary outcome measure for the following group:\n\n- Phase 2 monotherapy dose comparison",
          "timeFrame": "24 Months"
        },
        {
          "measure": "Secondary: Treatment-related symptoms and impact on the subject as assessed by EORTC QLQ-C30",
          "description": "Treament related symptoms and impact on the subject will be a secondary outcome measure for the following group:\n\n- Phase 2 monotherapy dose comparison",
          "timeFrame": "24 Months"
        },
        {
          "measure": "Secondary: Treatment-related symptoms and impact on the subject as assessed by selected questions from the Patient-reported Outcome of the Common Terminology Criteria for Adverse Events (PRO-CTCAE library)",
          "description": "Treatment-related symptoms and impact on the subject will be a secondary outcome measure for the following group:\n\n- Phase 2 monotherapy dose comparison",
          "timeFrame": "24 Months"
        },
        {
          "measure": "Secondary: Treatment-related symptoms and impact on the subject as assessed by a single item about symptom bother, item GP5 of the Functional Assessment of Cancer Therapy - General (FACT-G)",
          "description": "Treatment-related symptoms and impact on the subject will be a secondary outcome measure for the following group:\n\n- Phase 2 monotherapy dose comparison",
          "timeFrame": "24 Months"
        },
        {
          "measure": "Secondary: Change from baseline in physical function as assessed by EORTC QLQ-C30",
          "description": "Treatment-related symptoms and impact on the subject will be a secondary outcome measure for the following group:\n\n- Phase 2 monotherapy dose comparison",
          "timeFrame": "Baseline to 24 Months"
        }
      ],
      "eligibilityCriteria": "Inclusion Criteria:\n\n* Men or women greater than or equal to 18 years old.\n* Pathologically documented, locally-advanced or metastatic malignancy with, KRAS p.G12C mutation identified through molecular testing.\n\nExclusion Criteria\n\n* Active brain metastases from non-brain tumors.\n* Myocardial infarction within 6 months of study day 1.\n* Gastrointestinal (GI) tract disease causing the inability to take oral medication.",
      "nctId": "NCT03600883",
      "overallStatus": "ACTIVE_NOT_RECRUITING",
      "keywords": null,
      "locations": [
        {
          "facility": "City of Hope National Medical Center",
          "city": "Duarte",
          "state": "California",
          "zip": "91010",
          "country": "United States",
          "geoPoint": {
            "lat": 34.13945,
            "lon": -117.97729
          }
        },
        {
          "facility": "University of California Los Angeles",
          "city": "Los Angeles",
          "state": "California",
          "zip": "90095",
          "country": "United States",
          "geoPoint": {
            "lat": 34.05223,
            "lon": -118.24368
          }
        },
        {
          "facility": "University of California at SF",
          "city": "San Francisco",
          "state": "California",
          "zip": "94115",
          "country": "United States",
          "geoPoint": {
            "lat": 37.77493,
            "lon": -122.41942
          }
        },
        {
          "facility": "Sarcoma Oncology Research Center LLC",
          "city": "Santa Monica",
          "state": "California",
          "zip": "90403",
          "country": "United States",
          "geoPoint": {
            "lat": 34.01945,
            "lon": -118.49119
          }
        },
        {
          "facility": "Rocky Mountain Cancer Centers",
          "city": "Denver",
          "state": "Colorado",
          "zip": "80218",
          "country": "United States",
          "geoPoint": {
            "lat": 39.73915,
            "lon": -104.9847
          }
        },
        {
          "facility": "Sarah Cannon Research Institute at HealthONE",
          "city": "Denver",
          "state": "Colorado",
          "zip": "80218",
          "country": "United States",
          "geoPoint": {
            "lat": 39.73915,
            "lon": -104.9847
          }
        },
        {
          "facility": "Smilow Cancer Hospital at Yale New Haven",
          "city": "New Haven",
          "state": "Connecticut",
          "zip": "06510",
          "country": "United States",
          "geoPoint": {
            "lat": 41.30815,
            "lon": -72.92816
          }
        },
        {
          "facility": "Medical Oncology Hematology Consultants Helen F Graham Cancer Center",
          "city": "Newark",
          "state": "Delaware",
          "zip": "19713",
          "country": "United States",
          "geoPoint": {
            "lat": 39.68372,
            "lon": -75.74966
          }
        },
        {
          "facility": "University of Florida Health",
          "city": "Gainesville",
          "state": "Florida",
          "zip": "32610",
          "country": "United States",
          "geoPoint": {
            "lat": 29.65163,
            "lon": -82.32483
          }
        },
        {
          "facility": "AdventHealth Orlando Infusion Center",
          "city": "Orlando",
          "state": "Florida",
          "zip": "32804",
          "country": "United States",
          "geoPoint": {
            "lat": 28.53834,
            "lon": -81.37924
          }
        },
        {
          "facility": "Moffitt Cancer Center",
          "city": "Tampa",
          "state": "Florida",
          "zip": "33612",
          "country": "United States",
          "geoPoint": {
            "lat": 27.94752,
            "lon": -82.45843
          }
        },
        {
          "facility": "Winship Cancer Institute",
          "city": "Atlanta",
          "state": "Georgia",
          "zip": "30322",
          "country": "United States",
          "geoPoint": {
            "lat": 33.749,
            "lon": -84.38798
          }
        },
        {
          "facility": "Indiana University",
          "city": "Indianapolis",
          "state": "Indiana",
          "zip": "46202",
          "country": "United States",
          "geoPoint": {
            "lat": 39.76838,
            "lon": -86.15804
          }
        },
        {
          "facility": "American Oncology Partners of Maryland, PA",
          "city": "Bethesda",
          "state": "Maryland",
          "zip": "20817",
          "country": "United States",
          "geoPoint": {
            "lat": 38.98067,
            "lon": -77.10026
          }
        },
        {
          "facility": "Massachusetts General Hospital",
          "city": "Boston",
          "state": "Massachusetts",
          "zip": "02114",
          "country": "United States",
          "geoPoint": {
            "lat": 42.35843,
            "lon": -71.05977
          }
        },
        {
          "facility": "Dana Farber Cancer Institute",
          "city": "Boston",
          "state": "Massachusetts",
          "zip": "02215",
          "country": "United States",
          "geoPoint": {
            "lat": 42.35843,
            "lon": -71.05977
          }
        },
        {
          "facility": "University of Michigan",
          "city": "Ann Arbor",
          "state": "Michigan",
          "zip": "48109",
          "country": "United States",
          "geoPoint": {
            "lat": 42.27756,
            "lon": -83.74088
          }
        },
        {
          "facility": "Henry Ford Health System",
          "city": "Detroit",
          "state": "Michigan",
          "zip": "48202",
          "country": "United States",
          "geoPoint": {
            "lat": 42.33143,
            "lon": -83.04575
          }
        },
        {
          "facility": "Washington University",
          "city": "Saint Louis",
          "state": "Missouri",
          "zip": "63110-1093",
          "country": "United States",
          "geoPoint": {
            "lat": 38.62727,
            "lon": -90.19789
          }
        },
        {
          "facility": "Roswell Park Cancer Institute",
          "city": "Buffalo",
          "state": "New York",
          "zip": "14263",
          "country": "United States",
          "geoPoint": {
            "lat": 42.88645,
            "lon": -78.87837
          }
        },
        {
          "facility": "Laura and Isaac Perlmutter Cancer Center at New York University Langone",
          "city": "New York",
          "state": "New York",
          "zip": "10016",
          "country": "United States",
          "geoPoint": {
            "lat": 40.71427,
            "lon": -74.00597
          }
        },
        {
          "facility": "Memorial Sloan Kettering Cancer Center",
          "city": "New York",
          "state": "New York",
          "zip": "10065",
          "country": "United States",
          "geoPoint": {
            "lat": 40.71427,
            "lon": -74.00597
          }
        },
        {
          "facility": "Duke University Medical Center, Morris Cancer Clinic",
          "city": "Durham",
          "state": "North Carolina",
          "zip": "27710",
          "country": "United States",
          "geoPoint": {
            "lat": 35.99403,
            "lon": -78.89862
          }
        },
        {
          "facility": "University Hospitals Cleveland Medical Center",
          "city": "Cleveland",
          "state": "Ohio",
          "zip": "44106",
          "country": "United States",
          "geoPoint": {
            "lat": 41.4995,
            "lon": -81.69541
          }
        },
        {
          "facility": "Cleveland Clinic",
          "city": "Cleveland",
          "state": "Ohio",
          "zip": "44195",
          "country": "United States",
          "geoPoint": {
            "lat": 41.4995,
            "lon": -81.69541
          }
        },
        {
          "facility": "University of Pennsylvania",
          "city": "Philadelphia",
          "state": "Pennsylvania",
          "zip": "19104",
          "country": "United States",
          "geoPoint": {
            "lat": 39.95233,
            "lon": -75.16379
          }
        },
        {
          "facility": "Fox Chase Cancer Center",
          "city": "Philadelphia",
          "state": "Pennsylvania",
          "zip": "19111",
          "country": "United States",
          "geoPoint": {
            "lat": 39.95233,
            "lon": -75.16379
          }
        },
        {
          "facility": "University of Pittsburgh Medical Center Cancer Pavillion",
          "city": "Pittsburgh",
          "state": "Pennsylvania",
          "zip": "15232",
          "country": "United States",
          "geoPoint": {
            "lat": 40.44062,
            "lon": -79.99589
          }
        },
        {
          "facility": "Gibbs Cancer Center and Research Institute - Spartanburg",
          "city": "Spartanburg",
          "state": "South Carolina",
          "zip": "29303",
          "country": "United States",
          "geoPoint": {
            "lat": 34.94957,
            "lon": -81.93205
          }
        },
        {
          "facility": "Vanderbilt University Ingram Cancer Center",
          "city": "Nashville",
          "state": "Tennessee",
          "zip": "37232",
          "country": "United States",
          "geoPoint": {
            "lat": 36.16589,
            "lon": -86.78444
          }
        },
        {
          "facility": "Texas Oncology - Austin Central",
          "city": "Austin",
          "state": "Texas",
          "zip": "78731",
          "country": "United States",
          "geoPoint": {
            "lat": 30.26715,
            "lon": -97.74306
          }
        },
        {
          "facility": "Texas Oncology - Baylor",
          "city": "Dallas",
          "state": "Texas",
          "zip": "75246",
          "country": "United States",
          "geoPoint": {
            "lat": 32.78306,
            "lon": -96.80667
          }
        },
        {
          "facility": "University of Texas Southwestern Medical Center",
          "city": "Dallas",
          "state": "Texas",
          "zip": "75390",
          "country": "United States",
          "geoPoint": {
            "lat": 32.78306,
            "lon": -96.80667
          }
        },
        {
          "facility": "University of Texas MD Anderson Cancer Center",
          "city": "Houston",
          "state": "Texas",
          "zip": "77030",
          "country": "United States",
          "geoPoint": {
            "lat": 29.76328,
            "lon": -95.36327
          }
        },
        {
          "facility": "Huntsman Cancer Institute",
          "city": "Salt Lake City",
          "state": "Utah",
          "zip": "84112",
          "country": "United States",
          "geoPoint": {
            "lat": 40.76078,
            "lon": -111.89105
          }
        },
        {
          "facility": "US Oncology Research Investigational Products Center",
          "city": "Fairfax",
          "state": "Virginia",
          "zip": "22031",
          "country": "United States",
          "geoPoint": {
            "lat": 38.84622,
            "lon": -77.30637
          }
        },
        {
          "facility": "Virginia Cancer Specialists PC",
          "city": "Fairfax",
          "state": "Virginia",
          "zip": "22031",
          "country": "United States",
          "geoPoint": {
            "lat": 38.84622,
            "lon": -77.30637
          }
        },
        {
          "facility": "Blue Ridge Cancer Care",
          "city": "Salem",
          "state": "Virginia",
          "zip": "24153",
          "country": "United States",
          "geoPoint": {
            "lat": 37.29347,
            "lon": -80.05476
          }
        },
        {
          "facility": "Seattle Cancer Care Alliance",
          "city": "Seattle",
          "state": "Washington",
          "zip": "98109",
          "country": "United States",
          "geoPoint": {
            "lat": 47.60621,
            "lon": -122.33207
          }
        },
        {
          "facility": "Scientia Clinical Research Ltd",
          "city": "Randwick",
          "state": "New South Wales",
          "zip": "2031",
          "country": "Australia",
          "geoPoint": {
            "lat": -33.91439,
            "lon": 151.24895
          }
        },
        {
          "facility": "Princess Alexandra Hospital",
          "city": "Woolloongabba",
          "state": "Queensland",
          "zip": "4102",
          "country": "Australia",
          "geoPoint": {
            "lat": -27.48855,
            "lon": 153.03655
          }
        },
        {
          "facility": "The Queen Elizabeth Hospital",
          "city": "Woodville South",
          "state": "South Australia",
          "zip": "5011",
          "country": "Australia",
          "geoPoint": {
            "lat": -34.88186,
            "lon": 138.53477
          }
        },
        {
          "facility": "Peter MacCallum Cancer Centre",
          "city": "Parkville",
          "state": "Victoria",
          "zip": "3050",
          "country": "Australia",
          "geoPoint": {
            "lat": -37.78333,
            "lon": 144.95
          }
        },
        {
          "facility": "Medizinische Universitaet Graz",
          "city": "Graz",
          "zip": "8036",
          "country": "Austria",
          "geoPoint": {
            "lat": 47.06667,
            "lon": 15.45
          }
        },
        {
          "facility": "Medizinische Universitaet Innsbruck",
          "city": "Innsbruck",
          "zip": "6020",
          "country": "Austria",
          "geoPoint": {
            "lat": 47.26266,
            "lon": 11.39454
          }
        },
        {
          "facility": "Universitaetsklinikum Krems",
          "city": "Krems",
          "zip": "3500",
          "country": "Austria",
          "geoPoint": {
            "lat": 48.40921,
            "lon": 15.61415
          }
        },
        {
          "facility": "Universitaetsklinikum Allgemeines Krankenhaus Wien",
          "city": "Wien",
          "zip": "1090",
          "country": "Austria",
          "geoPoint": {
            "lat": 48.20849,
            "lon": 16.37208
          }
        },
        {
          "facility": "Krankenhaus Nord - Klinik Floridsdorf",
          "city": "Wien",
          "zip": "1210",
          "country": "Austria",
          "geoPoint": {
            "lat": 48.20849,
            "lon": 16.37208
          }
        },
        {
          "facility": "Institut Jules Bordet",
          "city": "Brussels",
          "zip": "B-1070",
          "country": "Belgium",
          "geoPoint": {
            "lat": 50.85045,
            "lon": 4.34878
          }
        },
        {
          "facility": "Grand Hopital de Charleroi",
          "city": "Charleroi",
          "zip": "6000",
          "country": "Belgium",
          "geoPoint": {
            "lat": 50.41136,
            "lon": 4.44448
          }
        },
        {
          "facility": "Universitair Ziekenhuis Antwerpen",
          "city": "Edegem",
          "zip": "2650",
          "country": "Belgium",
          "geoPoint": {
            "lat": 51.15662,
            "lon": 4.44504
          }
        },
        {
          "facility": "Ziekenhuis Oost-Limburg",
          "city": "Genk",
          "zip": "3600",
          "country": "Belgium",
          "geoPoint": {
            "lat": 50.965,
            "lon": 5.50082
          }
        },
        {
          "facility": "Universitair Ziekenhuis Gent",
          "city": "Gent",
          "zip": "9000",
          "country": "Belgium",
          "geoPoint": {
            "lat": 51.05,
            "lon": 3.71667
          }
        },
        {
          "facility": "Jessa Ziekenhuis - Campus Virga Jesse",
          "city": "Hasselt",
          "zip": "3500",
          "country": "Belgium",
          "geoPoint": {
            "lat": 50.93106,
            "lon": 5.33781
          }
        },
        {
          "facility": "Universitair Ziekenhuis Leuven - Campus Gasthuisberg",
          "city": "Leuven",
          "zip": "3000",
          "country": "Belgium",
          "geoPoint": {
            "lat": 50.87959,
            "lon": 4.70093
          }
        },
        {
          "facility": "Centre Hospitalier Universitaire de Liege",
          "city": "Liege",
          "zip": "4000",
          "country": "Belgium",
          "geoPoint": {
            "lat": 50.63373,
            "lon": 5.56749
          }
        },
        {
          "facility": "AZ Delta Campus Rumbeke",
          "city": "Roeselare",
          "zip": "8800",
          "country": "Belgium",
          "geoPoint": {
            "lat": 50.94653,
            "lon": 3.12269
          }
        },
        {
          "facility": "Irmandade da Santa Casa de Misericordia de Porto Alegre, Nucleo de Novos Tratamentos em Cancer",
          "city": "Porto Alegre",
          "state": "Rio Grande Do Sul",
          "zip": "90050-170",
          "country": "Brazil",
          "geoPoint": {
            "lat": -30.03306,
            "lon": -51.23
          }
        },
        {
          "facility": "Hospital Sao Lucas da Pontificia Universidade Catolica do Rio Grande do Sul",
          "city": "Porto Alegre",
          "state": "Rio Grande Do Sul",
          "zip": "90610-000",
          "country": "Brazil",
          "geoPoint": {
            "lat": -30.03306,
            "lon": -51.23
          }
        },
        {
          "facility": "Sociedade Beneficente de Senhoras Hospital Sirio Libanes",
          "city": "Sao Paulo",
          "state": "S\u00e3o Paulo",
          "zip": "01308-050",
          "country": "Brazil",
          "geoPoint": {
            "lat": -23.5475,
            "lon": -46.63611
          }
        },
        {
          "facility": "Oncologia Rede D\u00b4Or",
          "city": "Sao Paulo",
          "state": "S\u00e3o Paulo",
          "zip": "04501-000",
          "country": "Brazil",
          "geoPoint": {
            "lat": -23.5475,
            "lon": -46.63611
          }
        },
        {
          "facility": "Hospital de Base de Sao Jose do Rio Preto",
          "city": "S\u00e3o Jos\u00e9 do Rio Preto",
          "state": "S\u00e3o Paulo",
          "zip": "15090-000",
          "country": "Brazil",
          "geoPoint": {
            "lat": -20.81972,
            "lon": -49.37944
          }
        },
        {
          "facility": "Instituto Coi",
          "city": "Rio de Janeiro",
          "zip": "20231-050",
          "country": "Brazil",
          "geoPoint": {
            "lat": -22.90278,
            "lon": -43.2075
          }
        },
        {
          "facility": "Tom Baker Cancer Centre",
          "city": "Calgary",
          "state": "Alberta",
          "zip": "T2N 4N2",
          "country": "Canada",
          "geoPoint": {
            "lat": 51.05011,
            "lon": -114.08529
          }
        },
        {
          "facility": "Cross Cancer Institute",
          "city": "Edmonton",
          "state": "Alberta",
          "zip": "T6G 1Z2",
          "country": "Canada",
          "geoPoint": {
            "lat": 53.55014,
            "lon": -113.46871
          }
        },
        {
          "facility": "London Regional Cancer Program, London Health Sciences Centre",
          "city": "London",
          "state": "Ontario",
          "zip": "N6A 5W9",
          "country": "Canada",
          "geoPoint": {
            "lat": 42.98339,
            "lon": -81.23304
          }
        },
        {
          "facility": "The Ottawa Hospital Cancer Centre",
          "city": "Ottawa",
          "state": "Ontario",
          "zip": "K1H 8L6",
          "country": "Canada",
          "geoPoint": {
            "lat": 45.41117,
            "lon": -75.69812
          }
        },
        {
          "facility": "Princess Margaret Cancer Centre",
          "city": "Toronto",
          "state": "Ontario",
          "zip": "M5G 2M9",
          "country": "Canada",
          "geoPoint": {
            "lat": 43.70011,
            "lon": -79.4163
          }
        },
        {
          "facility": "McGill University Health Centre Glen Site",
          "city": "Montreal",
          "state": "Quebec",
          "zip": "H4A 3J1",
          "country": "Canada",
          "geoPoint": {
            "lat": 45.50884,
            "lon": -73.58781
          }
        },
        {
          "facility": "Institut Bergonie",
          "city": "Bordeaux",
          "zip": "33076",
          "country": "France",
          "geoPoint": {
            "lat": 44.84044,
            "lon": -0.5805
          }
        },
        {
          "facility": "Centre Hospitalier Intercommunal de Cr\u00e9teil",
          "city": "Cr\u00e9teil",
          "zip": "94010",
          "country": "France",
          "geoPoint": {
            "lat": 48.78333,
            "lon": 2.46667
          }
        },
        {
          "facility": "Hopital de la Timone",
          "city": "Marseille cedex 5",
          "zip": "13385",
          "country": "France",
          "geoPoint": {
            "lat": 43.29551,
            "lon": 5.38958
          }
        },
        {
          "facility": "Institut Curie",
          "city": "Paris",
          "zip": "75005",
          "country": "France",
          "geoPoint": {
            "lat": 48.85341,
            "lon": 2.3488
          }
        },
        {
          "facility": "Institut Claudius Regaud",
          "city": "Toulouse cedex 9",
          "zip": "31059",
          "country": "France",
          "geoPoint": {
            "lat": 43.60426,
            "lon": 1.44367
          }
        },
        {
          "facility": "Gustave Roussy",
          "city": "Villejuif",
          "zip": "94805",
          "country": "France",
          "geoPoint": {
            "lat": 48.7939,
            "lon": 2.35992
          }
        },
        {
          "facility": "Universit\u00e4tsklinikum Essen",
          "city": "Essen",
          "zip": "45147",
          "country": "Germany",
          "geoPoint": {
            "lat": 51.45657,
            "lon": 7.01228
          }
        },
        {
          "facility": "Universitatsklinikum Koln",
          "city": "K\u00f6ln",
          "zip": "50937",
          "country": "Germany",
          "geoPoint": {
            "lat": 50.93333,
            "lon": 6.95
          }
        },
        {
          "facility": "Klinikum der Universit\u00e4t M\u00fcnchen Campus Grosshadern",
          "city": "M\u00fcnchen",
          "zip": "81377",
          "country": "Germany",
          "geoPoint": {
            "lat": 48.13743,
            "lon": 11.57549
          }
        },
        {
          "facility": "Henry Dunant Hospital Center",
          "city": "Athens",
          "zip": "11526",
          "country": "Greece",
          "geoPoint": {
            "lat": 37.97945,
            "lon": 23.71622
          }
        },
        {
          "facility": "Metropolitan Hospital",
          "city": "Athens",
          "zip": "18547",
          "country": "Greece",
          "geoPoint": {
            "lat": 37.97945,
            "lon": 23.71622
          }
        },
        {
          "facility": "University Hospital of Heraklion",
          "city": "Heraklion - Crete",
          "zip": "71500",
          "country": "Greece"
        },
        {
          "facility": "Theagenion Cancer Hospital",
          "city": "Thessaloniki",
          "zip": "54007",
          "country": "Greece",
          "geoPoint": {
            "lat": 40.64361,
            "lon": 22.93086
          }
        },
        {
          "facility": "Agios Loukas Clinic",
          "city": "Thessaloniki",
          "zip": "55236",
          "country": "Greece",
          "geoPoint": {
            "lat": 40.64361,
            "lon": 22.93086
          }
        },
        {
          "facility": "Semmelweis Egyetem",
          "city": "Budapest",
          "zip": "1083",
          "country": "Hungary",
          "geoPoint": {
            "lat": 47.49801,
            "lon": 19.03991
          }
        },
        {
          "facility": "Orszagos Koranyi Pulmonologiai Intezet",
          "city": "Budapest",
          "zip": "1121",
          "country": "Hungary",
          "geoPoint": {
            "lat": 47.49801,
            "lon": 19.03991
          }
        },
        {
          "facility": "Somogy Megyei Kaposi Mor Oktato Korhaz",
          "city": "Kaposvar",
          "zip": "7400",
          "country": "Hungary",
          "geoPoint": {
            "lat": 46.36667,
            "lon": 17.8
          }
        },
        {
          "facility": "Fejer Megyei Szent Gyorgy Egyetemi Oktato Korhaz",
          "city": "Szekesfehervar",
          "zip": "8000",
          "country": "Hungary",
          "geoPoint": {
            "lat": 47.18995,
            "lon": 18.41034
          }
        },
        {
          "facility": "Szent Borbala Korhaz",
          "city": "Tatabanya",
          "zip": "2800",
          "country": "Hungary",
          "geoPoint": {
            "lat": 47.58494,
            "lon": 18.39325
          }
        },
        {
          "facility": "Tudogyogyintezet Torokbalint",
          "city": "Torokbalint",
          "zip": "2045",
          "country": "Hungary",
          "geoPoint": {
            "lat": 47.42931,
            "lon": 18.91356
          }
        },
        {
          "facility": "Aichi Cancer Center",
          "city": "Nagoya-shi",
          "state": "Aichi",
          "zip": "464-8681",
          "country": "Japan",
          "geoPoint": {
            "lat": 35.18147,
            "lon": 136.90641
          }
        },
        {
          "facility": "National Cancer Center Hospital East",
          "city": "Kashiwa-shi",
          "state": "Chiba",
          "zip": "277-8577",
          "country": "Japan",
          "geoPoint": {
            "lat": 35.86224,
            "lon": 139.97732
          }
        },
        {
          "facility": "National Hospital Organization Shikoku Cancer Center",
          "city": "Matsuyama-shi",
          "state": "Ehime",
          "zip": "791-0280",
          "country": "Japan",
          "geoPoint": {
            "lat": 33.83916,
            "lon": 132.76574
          }
        },
        {
          "facility": "National Hospital Organization Kyushu Cancer Center",
          "city": "Fukuoka-shi",
          "state": "Fukuoka",
          "zip": "811-1395",
          "country": "Japan",
          "geoPoint": {
            "lat": 33.6,
            "lon": 130.41667
          }
        },
        {
          "facility": "National Hospital Organization Hokkaido Cancer Center",
          "city": "Sapporo-shi",
          "state": "Hokkaido",
          "zip": "003-0804",
          "country": "Japan",
          "geoPoint": {
            "lat": 43.06667,
            "lon": 141.35
          }
        },
        {
          "facility": "St Marianna University Hospital",
          "city": "Kawasaki-shi",
          "state": "Kanagawa",
          "zip": "216-8511",
          "country": "Japan",
          "geoPoint": {
            "lat": 35.52056,
            "lon": 139.71722
          }
        },
        {
          "facility": "Kanagawa Prefectural Hospital Organization Kanagawa Cancer Center",
          "city": "Yokohama-shi",
          "state": "Kanagawa",
          "zip": "241-8515",
          "country": "Japan",
          "geoPoint": {
            "lat": 35.43333,
            "lon": 139.65
          }
        },
        {
          "facility": "Sendai Kousei Hospital",
          "city": "Sendai-shi",
          "state": "Miyagi",
          "zip": "980-0873",
          "country": "Japan",
          "geoPoint": {
            "lat": 38.26667,
            "lon": 140.86667
          }
        },
        {
          "facility": "Niigata Cancer Center Hospital",
          "city": "Niigata-shi",
          "state": "Niigata",
          "zip": "951-8566",
          "country": "Japan",
          "geoPoint": {
            "lat": 37.88637,
            "lon": 139.00589
          }
        },
        {
          "facility": "Okayama University Hospital",
          "city": "Okayama-shi",
          "state": "Okayama",
          "zip": "700-8558",
          "country": "Japan",
          "geoPoint": {
            "lat": 34.65,
            "lon": 133.93333
          }
        },
        {
          "facility": "Kansai Medical University Hospital",
          "city": "Hirakata-shi",
          "state": "Osaka",
          "zip": "573-1191",
          "country": "Japan",
          "geoPoint": {
            "lat": 34.81352,
            "lon": 135.64914
          }
        },
        {
          "facility": "Osaka International Cancer Institute",
          "city": "Osaka-shi",
          "state": "Osaka",
          "zip": "541-8567",
          "country": "Japan",
          "geoPoint": {
            "lat": 34.69374,
            "lon": 135.50218
          }
        },
        {
          "facility": "Shizuoka Cancer Center",
          "city": "Sunto-gun",
          "state": "Shizuoka",
          "zip": "411-8777",
          "country": "Japan"
        },
        {
          "facility": "The Cancer Institute Hospital of Japanese Foundation for Cancer Research",
          "city": "Koto-ku",
          "state": "Tokyo",
          "zip": "135-8550",
          "country": "Japan",
          "geoPoint": {
            "lat": 35.66667,
            "lon": 139.81718
          }
        },
        {
          "facility": "Wakayama Medical University Hospital",
          "city": "Wakayama-shi",
          "state": "Wakayama",
          "zip": "641-8510",
          "country": "Japan",
          "geoPoint": {
            "lat": 34.23333,
            "lon": 135.16667
          }
        },
        {
          "facility": "National Cancer Center",
          "city": "Goyang-si Gyeonggi-do",
          "zip": "10408",
          "country": "Korea, Republic of"
        },
        {
          "facility": "Seoul National University Bundang Hospital",
          "city": "Seongnam-si, Gyeonggi-do",
          "zip": "13620",
          "country": "Korea, Republic of"
        },
        {
          "facility": "Seoul National University Hospital",
          "city": "Seoul",
          "zip": "03080",
          "country": "Korea, Republic of",
          "geoPoint": {
            "lat": 37.566,
            "lon": 126.9784
          }
        },
        {
          "facility": "Severance Hospital Yonsei University Health System",
          "city": "Seoul",
          "zip": "03722",
          "country": "Korea, Republic of",
          "geoPoint": {
            "lat": 37.566,
            "lon": 126.9784
          }
        },
        {
          "facility": "Asan Medical Center",
          "city": "Seoul",
          "zip": "05505",
          "country": "Korea, Republic of",
          "geoPoint": {
            "lat": 37.566,
            "lon": 126.9784
          }
        },
        {
          "facility": "Samsung Medical Center",
          "city": "Seoul",
          "zip": "06351",
          "country": "Korea, Republic of",
          "geoPoint": {
            "lat": 37.566,
            "lon": 126.9784
          }
        },
        {
          "facility": "The Catholic University of Korea Seoul St Marys Hospital",
          "city": "Seoul",
          "zip": "06591",
          "country": "Korea, Republic of",
          "geoPoint": {
            "lat": 37.566,
            "lon": 126.9784
          }
        },
        {
          "facility": "Fundacao Champalimaud",
          "city": "Lisboa",
          "zip": "1400-038",
          "country": "Portugal",
          "geoPoint": {
            "lat": 38.71667,
            "lon": -9.13333
          }
        },
        {
          "facility": "Centro Hospitalar Universitario de Lisboa Norte EPE - Hospital Pulido Valente",
          "city": "Lisboa",
          "zip": "1769-001",
          "country": "Portugal",
          "geoPoint": {
            "lat": 38.71667,
            "lon": -9.13333
          }
        },
        {
          "facility": "Unidade Local de Saude de Matosinhos, EPE - Hospital Pedro Hispano",
          "city": "Matosinhos",
          "zip": "4464-513",
          "country": "Portugal",
          "geoPoint": {
            "lat": 41.18207,
            "lon": -8.68908
          }
        },
        {
          "facility": "Centro Hospitalar Universitario do Porto EPE - Hospital de Santo Antonio",
          "city": "Porto",
          "zip": "4099-001",
          "country": "Portugal",
          "geoPoint": {
            "lat": 41.14961,
            "lon": -8.61099
          }
        },
        {
          "facility": "Hospital Cuf porto",
          "city": "Porto",
          "zip": "4100-180",
          "country": "Portugal",
          "geoPoint": {
            "lat": 41.14961,
            "lon": -8.61099
          }
        },
        {
          "facility": "Institutul Oncologic, Prof Dr Alexandru Trestioreanu",
          "city": "Bucuresti",
          "zip": "022328",
          "country": "Romania",
          "geoPoint": {
            "lat": 44.42802,
            "lon": 26.09665
          }
        },
        {
          "facility": "Institutul Oncologic Prof Dr Ion Chiricuta Cluj-Napoca",
          "city": "Cluj Napoca",
          "zip": "400015",
          "country": "Romania",
          "geoPoint": {
            "lat": 46.76667,
            "lon": 23.6
          }
        },
        {
          "facility": "SC Medisprof SRL",
          "city": "Cluj Napoca",
          "zip": "400641",
          "country": "Romania",
          "geoPoint": {
            "lat": 46.76667,
            "lon": 23.6
          }
        },
        {
          "facility": "Centrul de Radioterapie Amethyst Cluj",
          "city": "Cluj Napoca",
          "zip": "407280",
          "country": "Romania",
          "geoPoint": {
            "lat": 46.76667,
            "lon": 23.6
          }
        },
        {
          "facility": "Centrul de Oncologie Sf Nectarie SRL",
          "city": "Craiova",
          "zip": "200347",
          "country": "Romania",
          "geoPoint": {
            "lat": 44.31667,
            "lon": 23.8
          }
        },
        {
          "facility": "Institutul Regional de Oncologie Iasi",
          "city": "Iasi",
          "zip": "700483",
          "country": "Romania",
          "geoPoint": {
            "lat": 47.16667,
            "lon": 27.6
          }
        },
        {
          "facility": "Spitalul Municipal Ploiesti",
          "city": "Ploiesti",
          "zip": "100337",
          "country": "Romania",
          "geoPoint": {
            "lat": 44.95,
            "lon": 26.01667
          }
        },
        {
          "facility": "SC Oncomed SRL",
          "city": "Timisoara",
          "zip": "300239",
          "country": "Romania",
          "geoPoint": {
            "lat": 45.75372,
            "lon": 21.22571
          }
        },
        {
          "facility": "Hospital Universitari Germans Trias i Pujol",
          "city": "Badalona",
          "state": "Catalu\u00f1a",
          "zip": "08916",
          "country": "Spain",
          "geoPoint": {
            "lat": 41.45004,
            "lon": 2.24741
          }
        },
        {
          "facility": "Hospital General Universitario de Valencia",
          "city": "Valencia",
          "state": "Comunidad Valenciana",
          "zip": "46014",
          "country": "Spain",
          "geoPoint": {
            "lat": 39.46975,
            "lon": -0.37739
          }
        },
        {
          "facility": "Hospital General Universitario Gregorio Mara\u00f1on",
          "city": "Madrid",
          "zip": "28009",
          "country": "Spain",
          "geoPoint": {
            "lat": 40.4165,
            "lon": -3.70256
          }
        },
        {
          "facility": "Clinica Universidad de Navarra",
          "city": "Madrid",
          "zip": "28027",
          "country": "Spain",
          "geoPoint": {
            "lat": 40.4165,
            "lon": -3.70256
          }
        },
        {
          "facility": "Fundacion Jimenez Diaz",
          "city": "Madrid",
          "zip": "28040",
          "country": "Spain",
          "geoPoint": {
            "lat": 40.4165,
            "lon": -3.70256
          }
        },
        {
          "facility": "Hospital Universitario Madrid Sanchinarro",
          "city": "Madrid",
          "zip": "28050",
          "country": "Spain",
          "geoPoint": {
            "lat": 40.4165,
            "lon": -3.70256
          }
        },
        {
          "facility": "Universitaetsspital Basel",
          "city": "Basel",
          "zip": "4031",
          "country": "Switzerland",
          "geoPoint": {
            "lat": 47.55839,
            "lon": 7.57327
          }
        },
        {
          "facility": "Hopitaux Universitaires de Geneve",
          "city": "Geneve",
          "zip": "1211",
          "country": "Switzerland",
          "geoPoint": {
            "lat": 46.20222,
            "lon": 6.14569
          }
        },
        {
          "facility": "Universitaetsspital Zuerich",
          "city": "Zurich",
          "zip": "8091",
          "country": "Switzerland",
          "geoPoint": {
            "lat": 47.36667,
            "lon": 8.54999
          }
        }
      ],
      "eligibilityModule": {
        "eligibilityCriteria": "Inclusion Criteria:\n\n* Men or women greater than or equal to 18 years old.\n* Pathologically documented, locally-advanced or metastatic malignancy with, KRAS p.G12C mutation identified through molecular testing.\n\nExclusion Criteria\n\n* Active brain metastases from non-brain tumors.\n* Myocardial infarction within 6 months of study day 1.\n* Gastrointestinal (GI) tract disease causing the inability to take oral medication.",
        "healthyVolunteers": false,
        "sex": "ALL",
        "minimumAge": "18 Years",
        "maximumAge": "100 Years",
        "stdAges": [
          "ADULT",
          "OLDER_ADULT"
        ]
      },
      "studyType": "INTERVENTIONAL",
      "phases": [
        "PHASE1",
        "PHASE2"
      ]
    },
    "structured_criteria": {
      "inclusion": {
        "Inclusion Criteria:": [
          "Patients who meet all of the following criteria are eligible for trial participation: ",
          [
            "* Men or women greater than or equal to 18 years old.",
            "* Pathologically documented, locally-advanced or metastatic malignancy with, KRAS p.G12C mutation identified through molecular testing."
          ]
        ]
      },
      "exclusion": {
        "Exclusion Criteria": [
          "Patients who meet any of the following criteria are not eligible for trial participation: ",
          [
            "* Active brain metastases from non-brain tumors.",
            "* Myocardial infarction within 6 months of study day 1.",
            "* Gastrointestinal (GI) tract disease causing the inability to take oral medication."
          ]
        ]
      }
    },
    "results_inclusion": [
      [
        "Inclusion Criteria:",
        "Patients who meet all of the following criteria are eligible for trial participation: ",
        [
          "* Men or women greater than or equal to 18 years old.",
          "* Pathologically documented, locally-advanced or metastatic malignancy with, KRAS p.G12C mutation identified through molecular testing."
        ],
        {
          "reasoning": "Let's think step by step in order to produce the criteria_decision. We need to evaluate each inclusion criterion based on the patient information provided.\n\n### Step-by-Step Evaluation:\n\n1. **Criterion 1: Men or women greater than or equal to 18 years old.**\n   - The patient is a 59-year-old male.\n   - This criterion is met.\n   - **Decision: True**\n\n2. **Criterion 2: Pathologically documented, locally-advanced or metastatic malignancy with KRAS p.G12C mutation identified through molecular testing.**\n   - The patient has lung adenocarcinoma, stage 4 (which is metastatic).\n   - The molecular testing shows a KRAS p.G12C mutation.\n   - This criterion is met.\n   - **Decision: True**\n\n### Criteria Decision:\n\n```json\n{\n  \"explanation\": [\n    \"The patient is a 59-year-old male, which meets the criterion of being greater than or equal to 18 years old.\",\n    \"The patient has a stage 4 lung adenocarcinoma with a KRAS p.G12C mutation, which meets the criterion of having a pathologically documented, locally-advanced or metastatic malignancy with a KRAS p.G12C mutation.\"\n  ],\n  \"criteria_decision\": [true, true]\n}\n```",
          "criteria_decision": {
            "explanation": [
              "The patient is a 59-year-old male, which meets the criterion of being greater than or equal to 18 years old.",
              "The patient has a stage 4 lung adenocarcinoma with a KRAS p.G12C mutation, which meets the criterion of having a pathologically documented, locally-advanced or metastatic malignancy with a KRAS p.G12C mutation."
            ],
            "criteria_decision": [
              true,
              true
            ]
          }
        }
      ]
    ],
    "results_exclusion": [
      [
        "Exclusion Criteria",
        "Patients who meet any of the following criteria are not eligible for trial participation: ",
        [
          "* Active brain metastases from non-brain tumors.",
          "* Myocardial infarction within 6 months of study day 1.",
          "* Gastrointestinal (GI) tract disease causing the inability to take oral medication."
        ],
        {
          "reasoning": "```json\n{\n    \"explanation\": [\n        \"The patient information does not mention brain metastases. Therefore, we assume the patient does not have active brain metastases and is eligible for the trial based on this criterion.\",\n        \"The patient information does not mention a recent myocardial infarction. Therefore, we assume the patient has not had a myocardial infarction within the last 6 months and is eligible for the trial based on this criterion.\",\n        \"The patient information does not mention any gastrointestinal tract disease causing the inability to take oral medication. Therefore, we assume the patient does not have such a condition and is eligible for the trial based on this criterion.\"\n    ],\n    \"criteria_decision\": [true, true, true]\n}\n```",
          "criteria_decision": {
            "explanation": [
              "The patient information does not mention brain metastases. Therefore, we assume the patient does not have active brain metastases and is eligible for the trial based on this criterion.",
              "The patient information does not mention a recent myocardial infarction. Therefore, we assume the patient has not had a myocardial infarction within the last 6 months and is eligible for the trial based on this criterion.",
              "The patient information does not mention any gastrointestinal tract disease causing the inability to take oral medication. Therefore, we assume the patient does not have such a condition and is eligible for the trial based on this criterion."
            ],
            "criteria_decision": [
              true,
              true,
              true
            ]
          }
        }
      ]
    ],
    "subinstruction": "metastatic lung adenocarcinoma, KRAS p.G12C mutation",
    "patient_id": "p6",
    "patient_info": "\nPatient Information\n    Name: Doe, John\n    born: 18.08.1968\n    Address: Main Street 1, Berlin\n\nOverview of Tumor Diagnosis and Therapy\n    Tumor Diagnosis\n    Diagnosis: Metastatic KRAS G12C mutant non-small cell lung cancer (NSCLC)\n    Initial Detection: March 22, 2023, following symptoms of persistent cough and weight loss\n    Biopsy Date: April 15, 2023, adenocarcinoma of the lung\n    Molecular Profile: KRAS p.G12C (AF 18%), KEAP1 p.L276F (AF 45%), STK11 p.K83Tfs*13 (AF 38%).\n\nTherapy Overview\n    Initial Treatment:\n    Chemotherapy: Began May 5, 2022 in Berlin, with a platinum-based regimen (Cisplatin and\n    Pemetrexed), partial response noted after initial chemotherapy cycle completed by August 10, 2022, contunuation of therapy until october 2023 (progressive disease)\n    Subsequent Treatment: Immunotherapy with Prembolizumab at Charit\u00e9 Berlin initiated on October 25, 2023, with Pembrolizumab, staging CT shows disease progression after 3 months\n    Current Status:\n    Health Condition: Stable with an ECOG performance status of 1\n    Comorbidities: Well-managed and not contraindicating further treatment\n \nComorbidities\n    Former Smoker: 40py\n    Hypertension: Controlled with medication (Lisinopril 20 mg daily), current blood pressure 130/90mmHg\n    Type 2 Diabetes Mellitus: Controlled with Metformin 1000 mg twice daily\n    Hyperlipidemia: Managed with Atorvastatin 40 mg daily\n    Osteoarthritis: Managed with over-the-counter NSAIDs as needed\n    Chronic Obstructive Pulmonary Disease (COPD): Mild, managed with inhalers (Tiotropium)\n    Gastroesophageal Reflux Disease (GERD): Managed with Omeprazole 20 mg daily\n    Benign Prostatic Hyperplasia (BPH): Treated with Tamsulosin 0.4 mg daily\n\nPerformance Status: ECOG Performance Status 1\n \nChronological Medical Findings:\n    January 10, 2018: Routine annual physical examination. Blood pressure elevated, diagnosed with hypertension. Prescribed Lisinopril 10 mg daily.\n    March 15, 2018: Complained of heartburn and acid reflux. Diagnosed with GERD. Prescribed Omeprazole 20 mg daily.\n    February 25, 2019: Annual follow-up for hypertension. Blood pressure well-controlled. Lisinopril dosage maintained.\n    May 20, 2019: Complained of knee pain. Diagnosed with osteoarthritis. Recommended over-the-counter NSAIDs for pain management.\n    April 5, 2020: Routine check-up. Elevated blood glucose levels. Diagnosed with Type 2 Diabetes Mellitus. Prescribed Metformin 500 mg twice daily.\n    August 30, 2020: Routine cholesterol check. Diagnosed with hyperlipidemia. Prescribed Atorvastatin 20 mg daily.\n    November 10, 2020: Follow-up for diabetes and hyperlipidemia. Dosages adjusted: Metformin increased to 1000 mg twice daily, Atorvastatin increased to 40 mg daily.\n    February 12, 2021: Complained of shortness of breath and chronic cough. Diagnosed with mild COPD. Prescribed Tiotropium inhaler.\n    July 18, 2021: Routine follow-up. Stable condition with controlled comorbidities. Blood pressure, blood sugar, and cholesterol levels within target ranges.\n    March 22, 2023: Experienced persistent cough and weight loss. Chest X-ray and CT scan revealed a mass in the left lung. Referred to oncologist. CT Angiography, Pulmonary Arteries: Tumor Size: Approximately 4.5 cm in diameter. Bronchial Obstruction: Partial obstruction of the left main bronchus leading to atelectasis of the left upper lobe.\n    Urgent suspicion of a tumor-atelectasis complex in the left upper lobe of the lung. Mucus present in the lower lobe bronchi on the left. Suspicion of mediastinal lymph node metastases. No evidence of pulmonary artery embolism. Thrombus in the left atrium at the transition to the auricle. Emphysematous and fibrotic changes in the lung parenchyma. \n    Lymph Nodes: Enlarged, FDG-positive lymph nodes in the mediastinum, particularly in regions 4R and infracarinal. \n    April 15, 2023: Lung biopsy via bronchoscopy: Endobronchial tumor manifestation in the distal left main bronchus extending to the upper lobe. Acute and chronic atrophic tracheobronchitis. Collapsed bronchial system in the affected area. Biopsy taken. Diagnosed with non-small cell lung cancer (NSCLC), molecular diagnostics: KRAS G12C mutant. \n    April 27, 2022: Ventilation: Moderate obstruction, no restriction. Increased airway resistance and slight hyperinflation. Tiffeneau index (FEV1/FVC) at 42.34%, z-score -3.32. FEV1: 0.93 L (42% predicted), z-score -2.89.Total lung capacity (TLC): 5.86 L (103% predicted), z-score 0.22. Forced vital capacity (FVC): 2.19 L, z-score -1.5. Residual volume (RV): 3.67 L, z-score 2.44. RV/TLC: 62.68%, z-score -1.18.\n    May 5, 2022: Initiated on platinum-based chemotherapy regimen (Cisplatin and Pemetrexed).\n    August 10, 2023: Completed initial chemotherapy cycle. Partial response noted. \n    August-October: Continued chemotherapy with Cisplatin/Pemetrexed.\n    October 13, 2023: Follow-up CT (chest + abdomen): Moderate disease progression. New nodule in the right lung (1cm). Slight increase in the size of previously noted FDG-positive lymph nodes in the mediastinum. No additional metastatic lesions were detected. The patient has continued to tolerate the current treatment regimen well, with no significant adverse effects reported.\n    October 25, 2023: Started immune checkpoint inhibitor therapy (Pembrolizumab), good tolerability, no signs of autoimmunity.\n    March 12, 2024: Follow-up CT scan abdomen/lung: Progressive Disease with three new metastases in the right lung and additional enlarged FDG-positive lymph nodes in the mediastinum. MRI scan of the brain conducted; no evidence of metastatic disease. Incidental findings included mild age-related cerebral atrophy and scattered white matter hyperintensities consistent with chronic microvascular ischemic changes.\n    March 17, 2024: Tumorboard recommends considering clinical trial options due to limited response to standard therapies.\n    April 20, 2024: Detailed assessment of health status. ECOG performance status 1. All routine labs, including liver and renal function tests, within normal limits.\n",
    "instruction": "Please find a clincial trial targeting the patients tumor and alterations in Germany."
  },
  {
    "nctId": "NCT05054725",
    "avg_inclusion_score": 0.75,
    "avg_exclusion_score": 1.0,
    "avg_overall_score": 0.95,
    "trial": {
      "clean_text": "#briefTitle\nCombination Study of RMC-4630 and Sotorasib for NSCLC Subjects With KRASG12C Mutation After Failure of Prior Standard Therapies\n\n#officialTitle\nA Phase 2, Open-Label, Multicenter Study of the Combination of RMC-4630 and Sotorasib for Non-Small Cell Lung Cancer Subjects With KRASG12C Mutation After Failure of Prior Standard Therapies\n\n#briefSummary\nThe purpose of this study is to evaluate the antitumor effects of sotorasib and RMC-4630 in subjects with KRASG12C mutant NSCLC\n\n#detailedDescription\nThis is a phase 2 multicenter, open-label study evaluating the efficacy, safety, tolerability, and pharmacokinetics (PK) of RMC-4630 in combination with sotorasib in subjects with KRASG12C mutant NSCLC after failure of prior standard therapies.\n\n#conditions\nNon-Small Cell Lung Cancer\n\n",
      "briefTitle": "Combination Study of RMC-4630 and Sotorasib for NSCLC Subjects With KRASG12C Mutation After Failure of Prior Standard Therapies",
      "officialTitle": "A Phase 2, Open-Label, Multicenter Study of the Combination of RMC-4630 and Sotorasib for Non-Small Cell Lung Cancer Subjects With KRASG12C Mutation After Failure of Prior Standard Therapies",
      "briefSummary": "The purpose of this study is to evaluate the antitumor effects of sotorasib and RMC-4630 in subjects with KRASG12C mutant NSCLC",
      "detailedDescription": "This is a phase 2 multicenter, open-label study evaluating the efficacy, safety, tolerability, and pharmacokinetics (PK) of RMC-4630 in combination with sotorasib in subjects with KRASG12C mutant NSCLC after failure of prior standard therapies.",
      "conditions": [
        "Non-Small Cell Lung Cancer"
      ],
      "armGroups": [
        {
          "label": "RMC-4630 and sotorasib, Safety Run-in",
          "type": "EXPERIMENTAL",
          "description": "Safety Run-In:\n\nRMC-4630 and sotorasib",
          "interventionNames": [
            "Drug: RMC-4630",
            "Drug: Sotorasib"
          ]
        },
        {
          "label": "RMC-4630 and sotorasib, Expansion",
          "type": "EXPERIMENTAL",
          "description": "Dose Expansion:\n\nRMC-4630 and sotorasib",
          "interventionNames": [
            "Drug: RMC-4630",
            "Drug: Sotorasib"
          ]
        }
      ],
      "interventions": [
        {
          "type": "DRUG",
          "name": "RMC-4630",
          "description": "RMC-4630 administered orally as a capsule",
          "armGroupLabels": [
            "RMC-4630 and sotorasib, Expansion",
            "RMC-4630 and sotorasib, Safety Run-in"
          ],
          "otherNames": [
            "SAR442720"
          ]
        },
        {
          "type": "DRUG",
          "name": "Sotorasib",
          "description": "Sotorasib administered orally as a tablet",
          "armGroupLabels": [
            "RMC-4630 and sotorasib, Expansion",
            "RMC-4630 and sotorasib, Safety Run-in"
          ],
          "otherNames": [
            "AMG 510",
            "Lumakras"
          ]
        }
      ],
      "primaryOutcomes": [
        {
          "measure": "Objective response rate (ORR)",
          "description": "ORR as assessed per RECIST v1.1",
          "timeFrame": "approximately 12 months"
        }
      ],
      "secondaryOutcomes": [
        {
          "measure": "Adverse Events",
          "description": "Number of Participants with Adverse Events",
          "timeFrame": "approximately 12 months"
        },
        {
          "measure": "Serious Adverse Events",
          "description": "Number of Participants with Serious Adverse Events",
          "timeFrame": "approximately 12 months"
        },
        {
          "measure": "Vital signs",
          "description": "Number of subjects with clinically significant changes in vital signs",
          "timeFrame": "approximately 12 months"
        },
        {
          "measure": "Clinical laboratory test values",
          "description": "Number of subjects with clinically significant changes in clinical laboratory test values",
          "timeFrame": "approximately 12 months"
        },
        {
          "measure": "ECGs Measurements",
          "description": "Number of subjects with clinically significant changes in ECGs Measurements",
          "timeFrame": "approximately 12 months"
        },
        {
          "measure": "Concentration of RMC-4630",
          "description": "Trough Concentration of RMC-4630",
          "timeFrame": "approximately 12 months"
        },
        {
          "measure": "Concentration of sotorasib",
          "description": "Trough Concentration of sotorasib",
          "timeFrame": "approximately 12 months"
        },
        {
          "measure": "Duration of response (DOR)",
          "description": "DOR as assessed by RECIST v1.1",
          "timeFrame": "approximately 12 months"
        },
        {
          "measure": "Disease Control Rate (DCR)",
          "description": "DCR as assessed by RECIST v1.1",
          "timeFrame": "approximately 12 months"
        },
        {
          "measure": "Progression-free survival (PFS)",
          "description": "PFS as assessed by RECIST v1.1",
          "timeFrame": "approximately 12 months"
        },
        {
          "measure": "Overall survival (OS)",
          "description": "Overall survival (OS)",
          "timeFrame": "approximately 12 months"
        }
      ],
      "eligibilityCriteria": "Inclusion Criteria:\n\n* Subject must be \u226518 years of age.\n* Subject must have pathologically documented, locally advanced or metastatic KRASG12C NSCLC (not amenable to curative surgery) that has progressed on prior standard therapies (no more than 3 prior lines of therapies are allowed)\n\nExclusion Criteria\n\n* Primary central nervous system (CNS) tumors\n* Known or suspected leptomeningeal or brain metastases or spinal cord compression\n* Clinically significant cardiac disease\n* Known impairment of GI function that would alter the absorption\n* Active autoimmune disease requiring systemic treatment within past 2 years\n* History of severe allergic reactions to any of the study intervention components\n* Major surgical procedures within 28 days or non-study-related minor procedures within 7 days of treatment.\n* Prior therapy with KRASG12C inhibitor and/or SHP2 inhibitor",
      "nctId": "NCT05054725",
      "overallStatus": "ACTIVE_NOT_RECRUITING",
      "keywords": [
        "SHP2",
        "NSCLC",
        "KRAS G12C",
        "BRAF Class 1/2/unclassified",
        "KRAS amplification",
        "KRAS mutation",
        "STK11/LKB1",
        "KEAP1",
        "PIK3CA",
        "ATRX",
        "BRCA2",
        "carcinoma, non-small lung cancer",
        "bronchial neoplasms",
        "lung neoplasms",
        "respiratory tract neoplasms",
        "neoplasms by site",
        "neoplasms",
        "lung diseases",
        "respiratory tract diseases"
      ],
      "locations": [
        {
          "facility": "Florida Cancer Specialists",
          "city": "Fort Myers",
          "state": "Florida",
          "zip": "33901",
          "country": "United States",
          "geoPoint": {
            "lat": 26.62168,
            "lon": -81.84059
          }
        },
        {
          "facility": "BRCR Medical Center Inc.",
          "city": "Plantation",
          "state": "Florida",
          "zip": "33322",
          "country": "United States",
          "geoPoint": {
            "lat": 26.13421,
            "lon": -80.23184
          }
        },
        {
          "facility": "Cancer Specialists of North Florida",
          "city": "Saint Augustine",
          "state": "Florida",
          "zip": "32086",
          "country": "United States",
          "geoPoint": {
            "lat": 29.89469,
            "lon": -81.31452
          }
        },
        {
          "facility": "GenHarp Clinical Solutions",
          "city": "Evergreen Park",
          "state": "Illinois",
          "zip": "60805",
          "country": "United States",
          "geoPoint": {
            "lat": 41.72059,
            "lon": -87.70172
          }
        },
        {
          "facility": "Hematology Oncology Clinic",
          "city": "Baton Rouge",
          "state": "Louisiana",
          "zip": "70809",
          "country": "United States",
          "geoPoint": {
            "lat": 30.45075,
            "lon": -91.15455
          }
        },
        {
          "facility": "New England Cancer Specialists",
          "city": "Scarborough",
          "state": "Maine",
          "zip": "04074",
          "country": "United States",
          "geoPoint": {
            "lat": 43.57814,
            "lon": -70.32172
          }
        },
        {
          "facility": "American Oncology Partners of Maryland, PA",
          "city": "Bethesda",
          "state": "Maryland",
          "zip": "20817",
          "country": "United States",
          "geoPoint": {
            "lat": 38.98067,
            "lon": -77.10026
          }
        },
        {
          "facility": "Maryland Oncology Hematology, P.A.",
          "city": "Columbia",
          "state": "Maryland",
          "zip": "21044",
          "country": "United States",
          "geoPoint": {
            "lat": 39.24038,
            "lon": -76.83942
          }
        },
        {
          "facility": "Minnesota Oncology Hematology, P.A.",
          "city": "Minneapolis",
          "state": "Minnesota",
          "zip": "55404",
          "country": "United States",
          "geoPoint": {
            "lat": 44.97997,
            "lon": -93.26384
          }
        },
        {
          "facility": "Nebraska Cancer Specialists",
          "city": "Omaha",
          "state": "Nebraska",
          "zip": "68130",
          "country": "United States",
          "geoPoint": {
            "lat": 41.25626,
            "lon": -95.94043
          }
        },
        {
          "facility": "Comprehensive Cancer Centers of Nevada",
          "city": "Las Vegas",
          "state": "Nevada",
          "zip": "89169",
          "country": "United States",
          "geoPoint": {
            "lat": 36.17497,
            "lon": -115.13722
          }
        },
        {
          "facility": "New Jersey Center for Cancer Research",
          "city": "Brick",
          "state": "New Jersey",
          "zip": "08724",
          "country": "United States",
          "geoPoint": {
            "lat": 40.05928,
            "lon": -74.13708
          }
        },
        {
          "facility": "University of New Mexico Comprehensive Cancer Center",
          "city": "Albuquerque",
          "state": "New Mexico",
          "zip": "87131",
          "country": "United States",
          "geoPoint": {
            "lat": 35.08449,
            "lon": -106.65114
          }
        },
        {
          "facility": "Roswell Park cancer Institute",
          "city": "Buffalo",
          "state": "New York",
          "zip": "14263",
          "country": "United States",
          "geoPoint": {
            "lat": 42.88645,
            "lon": -78.87837
          }
        },
        {
          "facility": "Clinical Research Alliance, Inc.",
          "city": "New York",
          "state": "New York",
          "zip": "10021",
          "country": "United States",
          "geoPoint": {
            "lat": 40.71427,
            "lon": -74.00597
          }
        },
        {
          "facility": "Zangmeister Cancer Center",
          "city": "Columbus",
          "state": "Ohio",
          "zip": "43219",
          "country": "United States",
          "geoPoint": {
            "lat": 39.96118,
            "lon": -82.99879
          }
        },
        {
          "facility": "Charleston Oncology",
          "city": "Charleston",
          "state": "South Carolina",
          "zip": "29414",
          "country": "United States",
          "geoPoint": {
            "lat": 32.77657,
            "lon": -79.93092
          }
        },
        {
          "facility": "Tennessee Oncology",
          "city": "Chattanooga",
          "state": "Tennessee",
          "zip": "37404",
          "country": "United States",
          "geoPoint": {
            "lat": 35.04563,
            "lon": -85.30968
          }
        },
        {
          "facility": "Sarah Cannon Research Institute",
          "city": "Nashville",
          "state": "Tennessee",
          "zip": "37203",
          "country": "United States",
          "geoPoint": {
            "lat": 36.16589,
            "lon": -86.78444
          }
        },
        {
          "facility": "CHRISTUS St. Michael-Colom and Carney Clinic P.A",
          "city": "Texarkana",
          "state": "Texas",
          "zip": "75503",
          "country": "United States",
          "geoPoint": {
            "lat": 33.42513,
            "lon": -94.04769
          }
        },
        {
          "facility": "Virginia Cancer Specialists",
          "city": "Fairfax",
          "state": "Virginia",
          "zip": "22031",
          "country": "United States",
          "geoPoint": {
            "lat": 38.84622,
            "lon": -77.30637
          }
        },
        {
          "facility": "Virginia Oncology Associates",
          "city": "Norfolk",
          "state": "Virginia",
          "zip": "23502",
          "country": "United States",
          "geoPoint": {
            "lat": 36.84681,
            "lon": -76.28522
          }
        },
        {
          "facility": "Northwest Cancer specialists, P.C.",
          "city": "Vancouver",
          "state": "Washington",
          "zip": "98684",
          "country": "United States",
          "geoPoint": {
            "lat": 45.63873,
            "lon": -122.66149
          }
        },
        {
          "facility": "South West Oncology",
          "city": "Warrnambool",
          "state": "Victoria",
          "zip": "3280",
          "country": "Australia",
          "geoPoint": {
            "lat": -38.38176,
            "lon": 142.48799
          }
        },
        {
          "facility": "Blacktown Hospital",
          "city": "Blacktown",
          "zip": "2148",
          "country": "Australia",
          "geoPoint": {
            "lat": -33.76667,
            "lon": 150.91667
          }
        },
        {
          "facility": "Goulburn Valley Health",
          "city": "Shepparton",
          "zip": "3630",
          "country": "Australia",
          "geoPoint": {
            "lat": -36.38047,
            "lon": 145.39867
          }
        },
        {
          "facility": "Cross Cancer Institute",
          "city": "Edmonton",
          "state": "Alberta",
          "zip": "T6G 1Z2",
          "country": "Canada",
          "geoPoint": {
            "lat": 53.55014,
            "lon": -113.46871
          }
        },
        {
          "facility": "William Osler Health System",
          "city": "Mississauga",
          "state": "Ontario",
          "zip": "L5N 5M8",
          "country": "Canada",
          "geoPoint": {
            "lat": 43.5789,
            "lon": -79.6583
          }
        },
        {
          "facility": "APHM Hopital Nord, Service d'Oncologie Multidisciplinaire et innovations therapeutics",
          "city": "Marseille",
          "zip": "13015",
          "country": "France",
          "geoPoint": {
            "lat": 43.29551,
            "lon": 5.38958
          }
        },
        {
          "facility": "Hospital Larrey Universite Paul Sabatier",
          "city": "Toulouse",
          "zip": "31059",
          "country": "France",
          "geoPoint": {
            "lat": 43.60426,
            "lon": 1.44367
          }
        },
        {
          "facility": "Klinikum Esslingen GmbH",
          "city": "Esslingen",
          "state": "Baden-Wurttemberg",
          "zip": "73730",
          "country": "Germany",
          "geoPoint": {
            "lat": 48.73961,
            "lon": 9.30473
          }
        },
        {
          "facility": "Asklepios Fachkliniken Munchen",
          "city": "Gauting",
          "state": "Bavaria",
          "zip": "82131",
          "country": "Germany",
          "geoPoint": {
            "lat": 48.06919,
            "lon": 11.37703
          }
        },
        {
          "facility": "Lungenklinik Hemer",
          "city": "Hemer",
          "state": "North Rhine- Westphalia",
          "zip": "58675",
          "country": "Germany",
          "geoPoint": {
            "lat": 51.38707,
            "lon": 7.77019
          }
        },
        {
          "facility": "Bethanien Hospital Moers",
          "city": "Moers",
          "state": "North Rhine-Westphalia",
          "zip": "47441",
          "country": "Germany",
          "geoPoint": {
            "lat": 51.45342,
            "lon": 6.6326
          }
        },
        {
          "facility": "Comprehensive Cancer Center Mainfranken, University Wuerzburg",
          "city": "Homburg",
          "state": "Saarland",
          "zip": "66421",
          "country": "Germany",
          "geoPoint": {
            "lat": 49.32637,
            "lon": 7.33867
          }
        },
        {
          "facility": "Lung Cancer Center, University of Saarland",
          "city": "Homburg",
          "state": "Saarland",
          "zip": "66421",
          "country": "Germany",
          "geoPoint": {
            "lat": 49.32637,
            "lon": 7.33867
          }
        },
        {
          "facility": "POIS Sachsen GmbH",
          "city": "Leipzig",
          "state": "Sachsen",
          "zip": "04347",
          "country": "Germany",
          "geoPoint": {
            "lat": 51.33962,
            "lon": 12.37129
          }
        },
        {
          "facility": "Charite Benjamin Franklin Comprehensive Cancer center",
          "city": "Berlin",
          "zip": "12200",
          "country": "Germany",
          "geoPoint": {
            "lat": 52.52437,
            "lon": 13.41053
          }
        },
        {
          "facility": "Evangelische Lung Clinic",
          "city": "Berlin",
          "zip": "13125",
          "country": "Germany",
          "geoPoint": {
            "lat": 52.52437,
            "lon": 13.41053
          }
        },
        {
          "facility": "Hamato-Onkologie Hamburg",
          "city": "Hamburg",
          "zip": "20251",
          "country": "Germany",
          "geoPoint": {
            "lat": 53.57532,
            "lon": 10.01534
          }
        },
        {
          "facility": "Azienda Ospedaliera dei Colli",
          "city": "Napoli",
          "state": "Campania",
          "zip": "80131",
          "country": "Italy",
          "geoPoint": {
            "lat": 40.85216,
            "lon": 14.26811
          }
        },
        {
          "facility": "Azienda Sanitaria Ospedaliera S Luigi Gonzaga",
          "city": "Orbassano",
          "state": "Piedmont",
          "zip": "10043",
          "country": "Italy",
          "geoPoint": {
            "lat": 45.00547,
            "lon": 7.53813
          }
        },
        {
          "facility": "Istituto Europeo Di Oncologia",
          "city": "Milano",
          "zip": "20141",
          "country": "Italy",
          "geoPoint": {
            "lat": 45.46427,
            "lon": 9.18951
          }
        },
        {
          "facility": "Chungbuk National University Hospital",
          "city": "Cheongju-si",
          "zip": "28644",
          "country": "Korea, Republic of",
          "geoPoint": {
            "lat": 36.63722,
            "lon": 127.48972
          }
        },
        {
          "facility": "Seoul National University Hospital",
          "city": "Seoul",
          "zip": "03080",
          "country": "Korea, Republic of",
          "geoPoint": {
            "lat": 37.566,
            "lon": 126.9784
          }
        },
        {
          "facility": "Asan Medical Center",
          "city": "Seoul",
          "zip": "05505",
          "country": "Korea, Republic of",
          "geoPoint": {
            "lat": 37.566,
            "lon": 126.9784
          }
        },
        {
          "facility": "Samsung Medical Center",
          "city": "Seoul",
          "zip": "06351",
          "country": "Korea, Republic of",
          "geoPoint": {
            "lat": 37.566,
            "lon": 126.9784
          }
        },
        {
          "facility": "Hospital Universitario Virgen Macarena",
          "city": "Sevilla",
          "state": "Andalucia",
          "zip": "41009",
          "country": "Spain",
          "geoPoint": {
            "lat": 37.38283,
            "lon": -5.97317
          }
        },
        {
          "facility": "Hospital Clinic de Barcelona",
          "city": "Barcelona",
          "state": "Catalonia",
          "zip": "08036",
          "country": "Spain",
          "geoPoint": {
            "lat": 41.38879,
            "lon": 2.15899
          }
        },
        {
          "facility": "Complejo Hospitalario Universitario A Coru\u00f1a",
          "city": "A Coru\u00f1a",
          "state": "Galicia",
          "zip": "15006",
          "country": "Spain",
          "geoPoint": {
            "lat": 43.37135,
            "lon": -8.396
          }
        },
        {
          "facility": "Clinica Universidad de Navarra",
          "city": "Pamplona",
          "state": "Navarra",
          "zip": "31008",
          "country": "Spain",
          "geoPoint": {
            "lat": 42.81687,
            "lon": -1.64323
          }
        },
        {
          "facility": "Clinica Universidad de Navarra",
          "city": "Madrid",
          "zip": "28027",
          "country": "Spain",
          "geoPoint": {
            "lat": 40.4165,
            "lon": -3.70256
          }
        },
        {
          "facility": "Hospital Universitario y Politecnico La Fe",
          "city": "Valencia",
          "zip": "46026",
          "country": "Spain",
          "geoPoint": {
            "lat": 39.46975,
            "lon": -0.37739
          }
        },
        {
          "facility": "Kaohsiung Medical University Chung Ho Memorial Hospital",
          "city": "Kaohsiung",
          "zip": "807",
          "country": "Taiwan",
          "geoPoint": {
            "lat": 22.61626,
            "lon": 120.31333
          }
        },
        {
          "facility": "E-DA Hospital",
          "city": "Kaohsiung",
          "zip": "824",
          "country": "Taiwan",
          "geoPoint": {
            "lat": 22.61626,
            "lon": 120.31333
          }
        },
        {
          "facility": "Taichung Veterans General Hospital",
          "city": "Taichung",
          "zip": "40705",
          "country": "Taiwan",
          "geoPoint": {
            "lat": 24.1469,
            "lon": 120.6839
          }
        },
        {
          "facility": "National Cheng Kung University Hospital",
          "city": "Tainan",
          "zip": "704",
          "country": "Taiwan",
          "geoPoint": {
            "lat": 22.99083,
            "lon": 120.21333
          }
        },
        {
          "facility": "National Taiwan University Hospital",
          "city": "Taipei",
          "zip": "10002",
          "country": "Taiwan",
          "geoPoint": {
            "lat": 25.04776,
            "lon": 121.53185
          }
        },
        {
          "facility": "The Christie NHS Foundation Trust",
          "city": "Manchester",
          "state": "Greater Manchester",
          "zip": "M20 4BX",
          "country": "United Kingdom",
          "geoPoint": {
            "lat": 53.48095,
            "lon": -2.23743
          }
        },
        {
          "facility": "The Royal Marsden NHS Foundation Trust",
          "city": "Sutton",
          "state": "Surrey",
          "zip": "SM2 5PT",
          "country": "United Kingdom",
          "geoPoint": {
            "lat": 51.35,
            "lon": -0.2
          }
        }
      ],
      "eligibilityModule": {
        "eligibilityCriteria": "Inclusion Criteria:\n\n* Subject must be \u226518 years of age.\n* Subject must have pathologically documented, locally advanced or metastatic KRASG12C NSCLC (not amenable to curative surgery) that has progressed on prior standard therapies (no more than 3 prior lines of therapies are allowed)\n\nExclusion Criteria\n\n* Primary central nervous system (CNS) tumors\n* Known or suspected leptomeningeal or brain metastases or spinal cord compression\n* Clinically significant cardiac disease\n* Known impairment of GI function that would alter the absorption\n* Active autoimmune disease requiring systemic treatment within past 2 years\n* History of severe allergic reactions to any of the study intervention components\n* Major surgical procedures within 28 days or non-study-related minor procedures within 7 days of treatment.\n* Prior therapy with KRASG12C inhibitor and/or SHP2 inhibitor",
        "healthyVolunteers": false,
        "sex": "ALL",
        "minimumAge": "18 Years",
        "stdAges": [
          "ADULT",
          "OLDER_ADULT"
        ]
      },
      "studyType": "INTERVENTIONAL",
      "phases": [
        "PHASE2"
      ]
    },
    "structured_criteria": {
      "inclusion": {
        "Inclusion Criteria:": [
          "Patients who meet all of the following criteria are eligible for trial participation: ",
          [
            "* Subject must be \u226518 years of age.",
            "* Subject must have pathologically documented, locally advanced or metastatic KRASG12C NSCLC (not amenable to curative surgery) that has progressed on prior standard therapies (no more than 3 prior lines of therapies are allowed)"
          ]
        ]
      },
      "exclusion": {
        "Exclusion Criteria": [
          "Patients who meet any of the following criteria are not eligible for trial participation: ",
          [
            "* Primary central nervous system (CNS) tumors",
            "* Known or suspected leptomeningeal or brain metastases or spinal cord compression",
            "* Clinically significant cardiac disease",
            "* Known impairment of GI function that would alter the absorption",
            "* Active autoimmune disease requiring systemic treatment within past 2 years",
            "* History of severe allergic reactions to any of the study intervention components",
            "* Major surgical procedures within 28 days or non-study-related minor procedures within 7 days of treatment.",
            "* Prior therapy with KRASG12C inhibitor and/or SHP2 inhibitor"
          ]
        ]
      }
    },
    "results_inclusion": [
      [
        "Inclusion Criteria:",
        "Patients who meet all of the following criteria are eligible for trial participation: ",
        [
          "* Subject must be \u226518 years of age.",
          "* Subject must have pathologically documented, locally advanced or metastatic KRASG12C NSCLC (not amenable to curative surgery) that has progressed on prior standard therapies (no more than 3 prior lines of therapies are allowed)"
        ],
        {
          "reasoning": "Reasoning: Let's think step by step in order to produce the criteria_decision. We will evaluate each criterion independently based on the provided patient information.\n\n1. **Criterion 1: Subject must be \u226518 years of age.**\n   - The patient is 59 years old.\n   - Decision: True\n   - Explanation: The patient is 59 years old, which is greater than 18 years.\n\n2. **Criterion 2: Subject must have pathologically documented, locally advanced or metastatic KRASG12C NSCLC (not amenable to curative surgery) that has progressed on prior standard therapies (no more than 3 prior lines of therapies are allowed).**\n   - The patient has lung adenocarcinoma, stage 4, with a KRAS p.G12C mutation.\n   - There is no information provided about the number of prior lines of therapies or whether the cancer has progressed on prior standard therapies.\n   - Decision: ?\n   - Explanation: The patient has the required KRAS p.G12C mutation and stage 4 lung adenocarcinoma, but there is no information about the number of prior lines of therapies or progression on prior standard therapies.",
          "criteria_decision": {
            "explanation": [
              "The patient is 59 years old, which is greater than 18 years.",
              "The patient has the required KRAS p.G12C mutation and stage 4 lung adenocarcinoma, but there is no information about the number of prior lines of therapies or progression on prior standard therapies."
            ],
            "criteria_decision": [
              true,
              "?"
            ]
          }
        }
      ]
    ],
    "results_exclusion": [
      [
        "Exclusion Criteria",
        "Patients who meet any of the following criteria are not eligible for trial participation: ",
        [
          "* Primary central nervous system (CNS) tumors",
          "* Known or suspected leptomeningeal or brain metastases or spinal cord compression",
          "* Clinically significant cardiac disease",
          "* Known impairment of GI function that would alter the absorption",
          "* Active autoimmune disease requiring systemic treatment within past 2 years"
        ],
        {
          "reasoning": "Let's think step by step in order to produce the criteria_decision.\n\n1. **Primary central nervous system (CNS) tumors**:\n   - The patient information does not mention any primary CNS tumors.\n   - According to the guardrails, if a disease or condition is not explicitly mentioned, we assume it is not present.\n   - Therefore, the patient is eligible for this criterion.\n   - **Decision**: True\n\n2. **Known or suspected leptomeningeal or brain metastases or spinal cord compression**:\n   - The patient information does not mention leptomeningeal or brain metastases or spinal cord compression.\n   - According to the guardrails, if there is no information on brain metastases and no indication anywhere about brain metastases, we assume the patient does not have them.\n   - Therefore, the patient is eligible for this criterion.\n   - **Decision**: True\n\n3. **Clinically significant cardiac disease**:\n   - The patient information does not mention any cardiac disease.\n   - According to the guardrails, if a disease or condition is not explicitly mentioned, we assume it is not present.\n   - Therefore, the patient is eligible for this criterion.\n   - **Decision**: True\n\n4. **Known impairment of GI function that would alter the absorption**:\n   - The patient information does not mention any impairment of GI function.\n   - According to the guardrails, if a disease or condition is not explicitly mentioned, we assume it is not present.\n   - Therefore, the patient is eligible for this criterion.\n   - **Decision**: True\n\n5. **Active autoimmune disease requiring systemic treatment within past 2 years**:\n   - The patient information does not mention any autoimmune disease or systemic treatment for such a condition.\n   - According to the guardrails, if a disease or condition is not explicitly mentioned, we assume it is not present.\n   - Therefore, the patient is eligible for this criterion.\n   - **Decision**: True",
          "criteria_decision": {
            "explanation": [
              "The patient information does not mention any primary CNS tumors, so we assume the patient does not have them.",
              "The patient information does not mention leptomeningeal or brain metastases or spinal cord compression, so we assume the patient does not have them.",
              "The patient information does not mention any cardiac disease, so we assume the patient does not have it.",
              "The patient information does not mention any impairment of GI function, so we assume the patient does not have it.",
              "The patient information does not mention any autoimmune disease or systemic treatment for such a condition, so we assume the patient does not have it."
            ],
            "criteria_decision": [
              true,
              true,
              true,
              true,
              true
            ]
          }
        }
      ],
      [
        "Exclusion Criteria",
        "Patients who meet any of the following criteria are not eligible for trial participation: ",
        [
          "* History of severe allergic reactions to any of the study intervention components",
          "* Major surgical procedures within 28 days or non-study-related minor procedures within 7 days of treatment.",
          "* Prior therapy with KRASG12C inhibitor and/or SHP2 inhibitor"
        ],
        {
          "reasoning": "Reasoning: Let's think step by step in order to produce the criteria_decision. We will evaluate each criterion based on the patient information provided.\n\n1. **History of severe allergic reactions to any of the study intervention components**:\n   - The patient information does not mention any history of severe allergic reactions.\n   - According to the guardrails, if a condition is not explicitly mentioned, we assume it is not present.\n   - Therefore, the patient is eligible for this criterion.\n   - **Decision**: True\n\n2. **Major surgical procedures within 28 days or non-study-related minor procedures within 7 days of treatment**:\n   - The patient information does not mention any recent surgical procedures.\n   - According to the guardrails, if a condition is not explicitly mentioned, we assume it is not present.\n   - Therefore, the patient is eligible for this criterion.\n   - **Decision**: True\n\n3. **Prior therapy with KRASG12C inhibitor and/or SHP2 inhibitor**:\n   - The patient information does not mention any prior therapy with KRASG12C inhibitor or SHP2 inhibitor.\n   - According to the guardrails, if a condition is not explicitly mentioned, we assume it is not present.\n   - Therefore, the patient is eligible for this criterion.\n   - **Decision**: True",
          "criteria_decision": {
            "explanation": [
              "The patient information does not mention any history of severe allergic reactions, so we assume the patient does not have this condition.",
              "The patient information does not mention any recent surgical procedures, so we assume the patient has not undergone any.",
              "The patient information does not mention any prior therapy with KRASG12C inhibitor or SHP2 inhibitor, so we assume the patient has not received such therapy."
            ],
            "criteria_decision": [
              true,
              true,
              true
            ]
          }
        }
      ]
    ],
    "subinstruction": "metastatic lung adenocarcinoma, KRAS p.G12C mutation",
    "patient_id": "p6",
    "patient_info": "\nPatient Information\n    Name: Doe, John\n    born: 18.08.1968\n    Address: Main Street 1, Berlin\n\nOverview of Tumor Diagnosis and Therapy\n    Tumor Diagnosis\n    Diagnosis: Metastatic KRAS G12C mutant non-small cell lung cancer (NSCLC)\n    Initial Detection: March 22, 2023, following symptoms of persistent cough and weight loss\n    Biopsy Date: April 15, 2023, adenocarcinoma of the lung\n    Molecular Profile: KRAS p.G12C (AF 18%), KEAP1 p.L276F (AF 45%), STK11 p.K83Tfs*13 (AF 38%).\n\nTherapy Overview\n    Initial Treatment:\n    Chemotherapy: Began May 5, 2022 in Berlin, with a platinum-based regimen (Cisplatin and\n    Pemetrexed), partial response noted after initial chemotherapy cycle completed by August 10, 2022, contunuation of therapy until october 2023 (progressive disease)\n    Subsequent Treatment: Immunotherapy with Prembolizumab at Charit\u00e9 Berlin initiated on October 25, 2023, with Pembrolizumab, staging CT shows disease progression after 3 months\n    Current Status:\n    Health Condition: Stable with an ECOG performance status of 1\n    Comorbidities: Well-managed and not contraindicating further treatment\n \nComorbidities\n    Former Smoker: 40py\n    Hypertension: Controlled with medication (Lisinopril 20 mg daily), current blood pressure 130/90mmHg\n    Type 2 Diabetes Mellitus: Controlled with Metformin 1000 mg twice daily\n    Hyperlipidemia: Managed with Atorvastatin 40 mg daily\n    Osteoarthritis: Managed with over-the-counter NSAIDs as needed\n    Chronic Obstructive Pulmonary Disease (COPD): Mild, managed with inhalers (Tiotropium)\n    Gastroesophageal Reflux Disease (GERD): Managed with Omeprazole 20 mg daily\n    Benign Prostatic Hyperplasia (BPH): Treated with Tamsulosin 0.4 mg daily\n\nPerformance Status: ECOG Performance Status 1\n \nChronological Medical Findings:\n    January 10, 2018: Routine annual physical examination. Blood pressure elevated, diagnosed with hypertension. Prescribed Lisinopril 10 mg daily.\n    March 15, 2018: Complained of heartburn and acid reflux. Diagnosed with GERD. Prescribed Omeprazole 20 mg daily.\n    February 25, 2019: Annual follow-up for hypertension. Blood pressure well-controlled. Lisinopril dosage maintained.\n    May 20, 2019: Complained of knee pain. Diagnosed with osteoarthritis. Recommended over-the-counter NSAIDs for pain management.\n    April 5, 2020: Routine check-up. Elevated blood glucose levels. Diagnosed with Type 2 Diabetes Mellitus. Prescribed Metformin 500 mg twice daily.\n    August 30, 2020: Routine cholesterol check. Diagnosed with hyperlipidemia. Prescribed Atorvastatin 20 mg daily.\n    November 10, 2020: Follow-up for diabetes and hyperlipidemia. Dosages adjusted: Metformin increased to 1000 mg twice daily, Atorvastatin increased to 40 mg daily.\n    February 12, 2021: Complained of shortness of breath and chronic cough. Diagnosed with mild COPD. Prescribed Tiotropium inhaler.\n    July 18, 2021: Routine follow-up. Stable condition with controlled comorbidities. Blood pressure, blood sugar, and cholesterol levels within target ranges.\n    March 22, 2023: Experienced persistent cough and weight loss. Chest X-ray and CT scan revealed a mass in the left lung. Referred to oncologist. CT Angiography, Pulmonary Arteries: Tumor Size: Approximately 4.5 cm in diameter. Bronchial Obstruction: Partial obstruction of the left main bronchus leading to atelectasis of the left upper lobe.\n    Urgent suspicion of a tumor-atelectasis complex in the left upper lobe of the lung. Mucus present in the lower lobe bronchi on the left. Suspicion of mediastinal lymph node metastases. No evidence of pulmonary artery embolism. Thrombus in the left atrium at the transition to the auricle. Emphysematous and fibrotic changes in the lung parenchyma. \n    Lymph Nodes: Enlarged, FDG-positive lymph nodes in the mediastinum, particularly in regions 4R and infracarinal. \n    April 15, 2023: Lung biopsy via bronchoscopy: Endobronchial tumor manifestation in the distal left main bronchus extending to the upper lobe. Acute and chronic atrophic tracheobronchitis. Collapsed bronchial system in the affected area. Biopsy taken. Diagnosed with non-small cell lung cancer (NSCLC), molecular diagnostics: KRAS G12C mutant. \n    April 27, 2022: Ventilation: Moderate obstruction, no restriction. Increased airway resistance and slight hyperinflation. Tiffeneau index (FEV1/FVC) at 42.34%, z-score -3.32. FEV1: 0.93 L (42% predicted), z-score -2.89.Total lung capacity (TLC): 5.86 L (103% predicted), z-score 0.22. Forced vital capacity (FVC): 2.19 L, z-score -1.5. Residual volume (RV): 3.67 L, z-score 2.44. RV/TLC: 62.68%, z-score -1.18.\n    May 5, 2022: Initiated on platinum-based chemotherapy regimen (Cisplatin and Pemetrexed).\n    August 10, 2023: Completed initial chemotherapy cycle. Partial response noted. \n    August-October: Continued chemotherapy with Cisplatin/Pemetrexed.\n    October 13, 2023: Follow-up CT (chest + abdomen): Moderate disease progression. New nodule in the right lung (1cm). Slight increase in the size of previously noted FDG-positive lymph nodes in the mediastinum. No additional metastatic lesions were detected. The patient has continued to tolerate the current treatment regimen well, with no significant adverse effects reported.\n    October 25, 2023: Started immune checkpoint inhibitor therapy (Pembrolizumab), good tolerability, no signs of autoimmunity.\n    March 12, 2024: Follow-up CT scan abdomen/lung: Progressive Disease with three new metastases in the right lung and additional enlarged FDG-positive lymph nodes in the mediastinum. MRI scan of the brain conducted; no evidence of metastatic disease. Incidental findings included mild age-related cerebral atrophy and scattered white matter hyperintensities consistent with chronic microvascular ischemic changes.\n    March 17, 2024: Tumorboard recommends considering clinical trial options due to limited response to standard therapies.\n    April 20, 2024: Detailed assessment of health status. ECOG performance status 1. All routine labs, including liver and renal function tests, within normal limits.\n",
    "instruction": "Please find a clincial trial targeting the patients tumor and alterations in Germany."
  },
  {
    "nctId": "NCT04449874",
    "avg_inclusion_score": 0.8333333333333334,
    "avg_exclusion_score": 1.0,
    "avg_overall_score": 0.9166666666666666,
    "trial": {
      "clean_text": "#briefTitle\nA Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-6036 Alone or in Combination in Participants With Advanced or Metastatic Solid Tumors With a KRAS G12C Mutation\n\n#officialTitle\nA Phase Ia/Ib Dose-Escalation and Dose-Expansion Study Evaluating the Safety, Pharmacokinetics, and Activity of GDC-6036 as a Single Agent and in Combination With Other Anti-cancer Therapies in Patients With Advanced or Metastatic Solid Tumors With a KRAS G12C Mutation\n\n#briefSummary\nThis is a Phase I dose-escalation and dose-expansion study that will evaluate the safety, pharmacokinetics (PK), and preliminary activity of GDC-6036 in patients with advanced or metastatic solid tumors with a KRAS G12C mutation.\n\n#conditions\nNon-Small Cell Lung Cancer\nColorectal Cancer\nAdvanced Solid Tumors\n\n",
      "briefTitle": "A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-6036 Alone or in Combination in Participants With Advanced or Metastatic Solid Tumors With a KRAS G12C Mutation",
      "officialTitle": "A Phase Ia/Ib Dose-Escalation and Dose-Expansion Study Evaluating the Safety, Pharmacokinetics, and Activity of GDC-6036 as a Single Agent and in Combination With Other Anti-cancer Therapies in Patients With Advanced or Metastatic Solid Tumors With a KRAS G12C Mutation",
      "briefSummary": "This is a Phase I dose-escalation and dose-expansion study that will evaluate the safety, pharmacokinetics (PK), and preliminary activity of GDC-6036 in patients with advanced or metastatic solid tumors with a KRAS G12C mutation.",
      "detailedDescription": null,
      "conditions": [
        "Non-Small Cell Lung Cancer",
        "Colorectal Cancer",
        "Advanced Solid Tumors"
      ],
      "armGroups": [
        {
          "label": "Arm A: Dose-escalation (Stage I), Dose Expansion (Stage II)",
          "type": "EXPERIMENTAL",
          "description": "Participants in Stage I will receive GDC-6036 administered orally once daily (PO QD). The dose will be increased in successive cohorts until a study-specific threshold is reached.\n\nParticipants with select solid tumors will be treated with GDC-6036 PO QD in Stage II.",
          "interventionNames": [
            "Drug: GDC-6036"
          ]
        },
        {
          "label": "Arm B: GDC-6036 + Atezolizumab (Stage I and Stage II)",
          "type": "EXPERIMENTAL",
          "description": "Participants with non-small cell lung cancer will receive GDC-6036 in combination with atezolizumab.",
          "interventionNames": [
            "Drug: GDC-6036",
            "Drug: Atezolizumab"
          ]
        },
        {
          "label": "Arm C: GDC-6036 + Cetuximab (Stage I and Stage II)",
          "type": "EXPERIMENTAL",
          "description": "Participants with colorectal cancer will receive GDC-6036 in combination with cetuximab.",
          "interventionNames": [
            "Drug: GDC-6036",
            "Drug: Cetuximab"
          ]
        },
        {
          "label": "Arm D: GDC-6036 + Bevacizumab (Stage I and Stage II)",
          "type": "EXPERIMENTAL",
          "description": "Participants with solid tumors will receive GDC-6036 in combination with bevacizumab.",
          "interventionNames": [
            "Drug: GDC-6036",
            "Drug: Bevacizumab"
          ]
        },
        {
          "label": "Arm E: GDC-6036 + Erlotinib (Stage I and Stage II)",
          "type": "EXPERIMENTAL",
          "description": "Participants with non-small cell lung cancer will receive GDC-6036 in combination with erlotinib.",
          "interventionNames": [
            "Drug: GDC-6036",
            "Drug: Erlotinib"
          ]
        },
        {
          "label": "Arm F: GDC-6036 + GDC-1971 (Stage I and Stage II)",
          "type": "EXPERIMENTAL",
          "description": "Participants with solid tumors will receive GDC-6036 in combination with GDC-1971 PO in Stage I.\n\nParticipants with select solid tumors will be treated with GDC-6036 in combination with GDC-1971 PO in Stage II.",
          "interventionNames": [
            "Drug: GDC-6036",
            "Drug: GDC-1971"
          ]
        },
        {
          "label": "Arm G: GDC-6036 + Inavolisib (Stage I and Stage II)",
          "type": "EXPERIMENTAL",
          "description": "Participants with solid tumors will receive GDC-6036 in combination with inavolisib PO in Stage I.\n\nParticipants with select solid tumors will be treated with GDC-6036 in combination with inavolisib PO in Stage II.",
          "interventionNames": [
            "Drug: GDC-6036",
            "Drug: Inavolisib"
          ]
        }
      ],
      "interventions": [
        {
          "type": "DRUG",
          "name": "GDC-6036",
          "description": "The starting dose of GDC-6036 in the combination Arms B, C, D, E, F and G will be determined from Stage I Arm A (single-agent dose escalation).",
          "armGroupLabels": [
            "Arm A: Dose-escalation (Stage I), Dose Expansion (Stage II)",
            "Arm B: GDC-6036 + Atezolizumab (Stage I and Stage II)",
            "Arm C: GDC-6036 + Cetuximab (Stage I and Stage II)",
            "Arm D: GDC-6036 + Bevacizumab (Stage I and Stage II)",
            "Arm E: GDC-6036 + Erlotinib (Stage I and Stage II)",
            "Arm F: GDC-6036 + GDC-1971 (Stage I and Stage II)",
            "Arm G: GDC-6036 + Inavolisib (Stage I and Stage II)"
          ]
        },
        {
          "type": "DRUG",
          "name": "Atezolizumab",
          "description": "A 1200 milligram (mg) intravenous (IV) infusion of atezolizumab will be administered on Day 1 of 21 day cycles.",
          "armGroupLabels": [
            "Arm B: GDC-6036 + Atezolizumab (Stage I and Stage II)"
          ]
        },
        {
          "type": "DRUG",
          "name": "Cetuximab",
          "description": "Cetuximab will be administered at an initial dose of 400 milligram per square meter (mg/m\\^2) IV infusion followed by 250 mg/m\\^2 IV infusion weekly in 21 day cycles.",
          "armGroupLabels": [
            "Arm C: GDC-6036 + Cetuximab (Stage I and Stage II)"
          ]
        },
        {
          "type": "DRUG",
          "name": "Bevacizumab",
          "description": "A 15 milligram per kilogram (mg/kg) IV infusion of bevacizumab will be administered on Day 1 of 21 day cycles.",
          "armGroupLabels": [
            "Arm D: GDC-6036 + Bevacizumab (Stage I and Stage II)"
          ]
        },
        {
          "type": "DRUG",
          "name": "Erlotinib",
          "description": "150 mg of erlotinib will be administered PO QD in 21 day cycles.",
          "armGroupLabels": [
            "Arm E: GDC-6036 + Erlotinib (Stage I and Stage II)"
          ]
        },
        {
          "type": "DRUG",
          "name": "GDC-1971",
          "description": "The starting dose of GDC-1971 will be determined from its single-agent dose escalation.",
          "armGroupLabels": [
            "Arm F: GDC-6036 + GDC-1971 (Stage I and Stage II)"
          ]
        },
        {
          "type": "DRUG",
          "name": "Inavolisib",
          "description": "The starting dose of inavolisib will be determined from its single-agent dose escalation.",
          "armGroupLabels": [
            "Arm G: GDC-6036 + Inavolisib (Stage I and Stage II)"
          ]
        }
      ],
      "primaryOutcomes": [
        {
          "measure": "Percentage of Participants With Adverse Events (AEs)",
          "description": "Severity is determined according to National Cancer Institute Common Terminology Criteria for Adverse Events, Version 5.0 (NCI CTCAE v5.0)",
          "timeFrame": "From Cycle 1 Day 1 until 28 days after the final dose (or as specified in the protocol). A cycle is 21 days."
        },
        {
          "measure": "Percentage of Participants With Dose-Limiting Toxicities (DLTs)",
          "timeFrame": "From Cycle 1 Day 1 through Day 21. A cycle is 21 days."
        }
      ],
      "secondaryOutcomes": [
        {
          "measure": "Plasma Concentrations of GDC-6036",
          "timeFrame": "Various timepoints from Cycle 1 Day 1 through study treatment discontinuation (within 28 days after the final dose of study drug). A cycle is 21 days."
        },
        {
          "measure": "Plasma Concentrations of Erlotinib",
          "timeFrame": "Various timepoints from Cycle 1 Day 1 through study treatment discontinuation (within 28 days after the final dose of study drug). A cycle is 21 days."
        },
        {
          "measure": "Plasma Concentrations of GDC-1971",
          "timeFrame": "Various timepoints from Cycle 1 Day 1 through study treatment discontinuation (within 28 days after the final dose of study drug). A cycle is 21 days."
        },
        {
          "measure": "Plasma Concentrations of Inavolisib",
          "timeFrame": "Various timepoints from Cycle 1 Day 1 through study treatment discontinuation (within 28 days after the final dose of study drug). A cycle is 21 days."
        },
        {
          "measure": "Objective Response Rate (ORR) as Determined by the Investigator According to Response Evaluation Criteria in Solid Tumors, Version 1.1 (RECIST v1.1)",
          "timeFrame": "Every 6 weeks from Cycle 1 Day 1 until study treatment discontinuation (within 28 days after the final dose of study drug). A cycle is 21 days."
        },
        {
          "measure": "Duration of Response (DOR) as Determined by the Investigator According to RECIST v1.1",
          "timeFrame": "Every 6 weeks from Cycle 1 Day 1 until study treatment discontinuation (within 28 days after the final dose of study drug). A cycle is 21 days."
        },
        {
          "measure": "Progression-free survival (PFS) as determined by the investigator according to RECIST v1.1",
          "timeFrame": "Every 6 weeks from Cycle 1 Day 1 until study treatment discontinuation (within 28 days after the final dose of study drug). A cycle is 21 days."
        },
        {
          "measure": "Relationship Between GDC-6036 Exposure (Maximum Plasma Concentration Observed [Cmax])",
          "timeFrame": "Various timepoints from Cycle 1 Day 1 through study treatment discontinuation (within 28 days after the final dose of study drug). A cycle is 21 days."
        },
        {
          "measure": "Relationship Between GDC-6036 Exposure (Time to Maximum Plasma Concentration [Tmax])",
          "timeFrame": "Various timepoints from Cycle 1 Day 1 through study treatment discontinuation (within 28 days after the final dose of study drug). A cycle is 21 days."
        },
        {
          "measure": "Relationship Between GDC-6036 Exposure (Half-life [t1/2])",
          "timeFrame": "Various timepoints from Cycle 1 Day 1 through study treatment discontinuation (within 28 days after the final dose of study drug). A cycle is 21 days."
        },
        {
          "measure": "Relationship Between GDC-6036 Exposure (Area Under the Curve [AUC])",
          "timeFrame": "Various timepoints from Cycle 1 Day 1 through study treatment discontinuation (within 28 days after the final dose of study drug). A cycle is 21 days."
        },
        {
          "measure": "Relationship Between Tumor Pharmacodynamic Effects of GDC-6036",
          "timeFrame": "Various timepoints from Cycle 1 Day 1 through study treatment discontinuation (within 28 days after the final dose of study drug). A cycle is 21 days."
        }
      ],
      "eligibilityCriteria": "Inclusion Criteria:\n\n* Histologically documented advanced or metastatic solid tumor with KRAS G12C mutation.\n* Women of childbearing potential must agree to remain abstinent or use contraception, and agree to refrain from donating eggs during the treatment period and after the final dose of study treatment as specified in the protocol.\n* Men who are not surgically sterile must agree to remain abstinent or use a condom, and agreement to refrain from donating sperm during the treatment period and after the final dose of study treatment as specified in the protocol.\n\nExclusion Criteria:\n\n* Active brain metastases.\n* Malabsorption or other condition that interferes with enteral absorption.\n* Clinically significant cardiovascular dysfunction or liver disease.",
      "nctId": "NCT04449874",
      "overallStatus": "RECRUITING",
      "keywords": [
        "KRAS G12C",
        "Non-Small Cell Lung Cancer",
        "Colorectal Cancer",
        "GDC-6036",
        "Metastatic Solid Tumor",
        "Atezolizumab",
        "Bevacizumab",
        "Cetuximab",
        "Erlotinib",
        "Inavolisib",
        "GDC-1971",
        "SHP2"
      ],
      "locations": [
        {
          "facility": "City of Hope Comprehensive Cancer Center",
          "status": "RECRUITING",
          "city": "Duarte",
          "state": "California",
          "zip": "91010",
          "country": "United States",
          "geoPoint": {
            "lat": 34.13945,
            "lon": -117.97729
          }
        },
        {
          "facility": "UCSD Moores Cancer Center",
          "status": "RECRUITING",
          "city": "La Jolla",
          "state": "California",
          "zip": "92093",
          "country": "United States",
          "geoPoint": {
            "lat": 32.84727,
            "lon": -117.2742
          }
        },
        {
          "facility": "Chao Family Comprehensive Cancer Center UCI",
          "status": "RECRUITING",
          "city": "Orange",
          "state": "California",
          "zip": "92868",
          "country": "United States",
          "geoPoint": {
            "lat": 33.78779,
            "lon": -117.85311
          }
        },
        {
          "facility": "Univ of Calif, San Francisco; Breast Cancer Center",
          "status": "WITHDRAWN",
          "city": "San Francisco",
          "state": "California",
          "zip": "94115",
          "country": "United States",
          "geoPoint": {
            "lat": 37.77493,
            "lon": -122.41942
          }
        },
        {
          "facility": "Yale Cancer Center",
          "status": "RECRUITING",
          "city": "New Haven",
          "state": "Connecticut",
          "zip": "06520",
          "country": "United States",
          "geoPoint": {
            "lat": 41.30815,
            "lon": -72.92816
          }
        },
        {
          "facility": "Florida Cancer Specialists - Sarasota",
          "status": "RECRUITING",
          "city": "Sarasota",
          "state": "Florida",
          "zip": "34232",
          "country": "United States",
          "geoPoint": {
            "lat": 27.33643,
            "lon": -82.53065
          }
        },
        {
          "facility": "Dana Farber Cancer Institute",
          "status": "RECRUITING",
          "city": "Boston",
          "state": "Massachusetts",
          "zip": "02215",
          "country": "United States",
          "geoPoint": {
            "lat": 42.35843,
            "lon": -71.05977
          }
        },
        {
          "facility": "Memorial Sloan Kettering Cancer Center",
          "status": "RECRUITING",
          "city": "New York",
          "state": "New York",
          "zip": "11101",
          "country": "United States",
          "geoPoint": {
            "lat": 40.71427,
            "lon": -74.00597
          }
        },
        {
          "facility": "University of Oklahoma; Stephenson Oklahoma Canc Ctr",
          "status": "RECRUITING",
          "city": "Oklahoma City",
          "state": "Oklahoma",
          "zip": "73104",
          "country": "United States",
          "geoPoint": {
            "lat": 35.46756,
            "lon": -97.51643
          }
        },
        {
          "facility": "Abramson Cancer Center; Univ of Pennsylvania",
          "status": "RECRUITING",
          "city": "Philadelphia",
          "state": "Pennsylvania",
          "zip": "19104",
          "country": "United States",
          "geoPoint": {
            "lat": 39.95233,
            "lon": -75.16379
          }
        },
        {
          "facility": "UPMC - Hillman Cancer Center",
          "status": "RECRUITING",
          "city": "Pittsburgh",
          "state": "Pennsylvania",
          "zip": "15232",
          "country": "United States",
          "geoPoint": {
            "lat": 40.44062,
            "lon": -79.99589
          }
        },
        {
          "facility": "St Vincent's Hospital Sydney",
          "status": "RECRUITING",
          "city": "Darlinghurst",
          "state": "New South Wales",
          "zip": "2010",
          "country": "Australia",
          "geoPoint": {
            "lat": -33.87939,
            "lon": 151.21925
          }
        },
        {
          "facility": "Slade Health Inward goods",
          "status": "RECRUITING",
          "city": "Mount Kuring-gai",
          "state": "New South Wales",
          "zip": "2080",
          "country": "Australia",
          "geoPoint": {
            "lat": -33.64197,
            "lon": 151.12865
          }
        },
        {
          "facility": "Alfred Health",
          "status": "RECRUITING",
          "city": "Melbourne",
          "state": "Victoria",
          "zip": "3004",
          "country": "Australia",
          "geoPoint": {
            "lat": -37.814,
            "lon": 144.96332
          }
        },
        {
          "facility": "Peter MacCallum Cancer Center",
          "status": "RECRUITING",
          "city": "North Melbourne",
          "state": "Victoria",
          "zip": "3051",
          "country": "Australia",
          "geoPoint": {
            "lat": -37.80132,
            "lon": 144.95822
          }
        },
        {
          "facility": "Linear Clinical Research Limited",
          "status": "RECRUITING",
          "city": "Nedlands",
          "state": "Western Australia",
          "zip": "6009",
          "country": "Australia",
          "geoPoint": {
            "lat": -31.98184,
            "lon": 115.8073
          }
        },
        {
          "facility": "UZ Antwerpen",
          "status": "RECRUITING",
          "city": "Edegem",
          "zip": "2650",
          "country": "Belgium",
          "geoPoint": {
            "lat": 51.15662,
            "lon": 4.44504
          }
        },
        {
          "facility": "CHU de Li\u00e8ge",
          "status": "RECRUITING",
          "city": "Li\u00e8ge",
          "zip": "4000",
          "country": "Belgium",
          "geoPoint": {
            "lat": 50.63373,
            "lon": 5.56749
          }
        },
        {
          "facility": "AZ St Maarten Campus Leopoldstr",
          "status": "ACTIVE_NOT_RECRUITING",
          "city": "Mechelen",
          "zip": "2800",
          "country": "Belgium",
          "geoPoint": {
            "lat": 51.02574,
            "lon": 4.47762
          }
        },
        {
          "facility": "Santa Casa de Misericordia de Belo Horizonte - PPDS",
          "status": "RECRUITING",
          "city": "Belo Horizonte",
          "state": "MG",
          "zip": "30150-221",
          "country": "Brazil",
          "geoPoint": {
            "lat": -19.92083,
            "lon": -43.93778
          }
        },
        {
          "facility": "Hospital de Clinicas de Porto Alegre HCPA PPDS",
          "status": "RECRUITING",
          "city": "Porto Alegre",
          "state": "PA",
          "zip": "90035-903",
          "country": "Brazil",
          "geoPoint": {
            "lat": -30.03306,
            "lon": -51.23
          }
        },
        {
          "facility": "Hospital Erasto Gaertner",
          "status": "RECRUITING",
          "city": "Curitiba",
          "state": "PR",
          "zip": "81520-060",
          "country": "Brazil",
          "geoPoint": {
            "lat": -25.42778,
            "lon": -49.27306
          }
        },
        {
          "facility": "Instituto Nacional de C\u00e2ncer",
          "status": "RECRUITING",
          "city": "Rio de Janeiro",
          "state": "RJ",
          "zip": "20230-130",
          "country": "Brazil",
          "geoPoint": {
            "lat": -22.90278,
            "lon": -43.2075
          }
        },
        {
          "facility": "Universidade de Caxias do Sul",
          "status": "RECRUITING",
          "city": "Caxias Do Sul",
          "state": "RS",
          "zip": "95070-561",
          "country": "Brazil",
          "geoPoint": {
            "lat": -29.16806,
            "lon": -51.17944
          }
        },
        {
          "facility": "Hospital Sao Lucas Da Pontificia Universidade Catolica Do Rio Grande Do Sul (PUCRS)",
          "status": "RECRUITING",
          "city": "Porto Alegre",
          "state": "RS",
          "zip": "90610-000",
          "country": "Brazil",
          "geoPoint": {
            "lat": -30.03306,
            "lon": -51.23
          }
        },
        {
          "facility": "Hospital de Cancer de Barretos",
          "status": "RECRUITING",
          "city": "Barretos",
          "state": "SP",
          "zip": "14784-400",
          "country": "Brazil",
          "geoPoint": {
            "lat": -20.55722,
            "lon": -48.56778
          }
        },
        {
          "facility": "Fundacao Faculdade Regional de Medicina de Sao Jose Do Rio Preto Hospital de Base - PPDS",
          "status": "RECRUITING",
          "city": "Sao Jose Do Rio Preto",
          "state": "SP",
          "zip": "15090-000",
          "country": "Brazil",
          "geoPoint": {
            "lat": -20.81972,
            "lon": -49.37944
          }
        },
        {
          "facility": "Instituto do Cancer do Estado de Sao Paulo - ICESP",
          "status": "RECRUITING",
          "city": "Sao Paulo",
          "state": "SP",
          "zip": "01246-000",
          "country": "Brazil",
          "geoPoint": {
            "lat": -23.5475,
            "lon": -46.63611
          }
        },
        {
          "facility": "Ottawa Hospital",
          "status": "RECRUITING",
          "city": "Ottawa",
          "state": "Ontario",
          "zip": "K1H 8L6",
          "country": "Canada",
          "geoPoint": {
            "lat": 45.41117,
            "lon": -75.69812
          }
        },
        {
          "facility": "Princess Margaret Cancer Centre",
          "status": "RECRUITING",
          "city": "Toronto",
          "state": "Ontario",
          "zip": "M5G 1Z5",
          "country": "Canada",
          "geoPoint": {
            "lat": 43.70011,
            "lon": -79.4163
          }
        },
        {
          "facility": "Jewish General Hospital; Sir Mortimer B. Davis",
          "status": "RECRUITING",
          "city": "Montreal",
          "state": "Quebec",
          "zip": "H2W 1S6",
          "country": "Canada",
          "geoPoint": {
            "lat": 45.50884,
            "lon": -73.58781
          }
        },
        {
          "facility": "Universit\u00e4tsklinikum \"Carl Gustav Carus\" der Technischen Universit\u00e4t Dresden",
          "status": "WITHDRAWN",
          "city": "Dresden",
          "zip": "01307",
          "country": "Germany",
          "geoPoint": {
            "lat": 51.05089,
            "lon": 13.73832
          }
        },
        {
          "facility": "Semmelweis Egyetem; Belgyogyaszati es Hematologiai Klinika",
          "status": "WITHDRAWN",
          "city": "Budapest",
          "zip": "1088",
          "country": "Hungary",
          "geoPoint": {
            "lat": 47.49801,
            "lon": 19.03991
          }
        },
        {
          "facility": "Clinexpert Kft. - Gyongyos",
          "status": "RECRUITING",
          "city": "Gyongyos",
          "zip": "3200",
          "country": "Hungary",
          "geoPoint": {
            "lat": 47.78257,
            "lon": 19.928
          }
        },
        {
          "facility": "Rambam Medical Center",
          "status": "RECRUITING",
          "city": "Haifa",
          "zip": "3109601",
          "country": "Israel",
          "geoPoint": {
            "lat": 32.81841,
            "lon": 34.9885
          }
        },
        {
          "facility": "Sheba Medical Center - PPDS",
          "status": "RECRUITING",
          "city": "Ramat Gan",
          "zip": "5266202",
          "country": "Israel",
          "geoPoint": {
            "lat": 32.08227,
            "lon": 34.81065
          }
        },
        {
          "facility": "Tel-Aviv Sourasky Medical Center",
          "status": "RECRUITING",
          "city": "Tel Aviv",
          "zip": "6423906",
          "country": "Israel",
          "geoPoint": {
            "lat": 32.08088,
            "lon": 34.78057
          }
        },
        {
          "facility": "Istituto Scientifico Romagnolo Per Lo Studio E La Cura Dei Tumori IRST - PPDS",
          "status": "COMPLETED",
          "city": "Meldola",
          "state": "Emilia-Romagna",
          "zip": "47014",
          "country": "Italy",
          "geoPoint": {
            "lat": 44.12775,
            "lon": 12.0626
          }
        },
        {
          "facility": "Irccs Ospedale San Raffaele;Oncologia Medica",
          "status": "RECRUITING",
          "city": "Milano",
          "state": "Lombardia",
          "zip": "20132",
          "country": "Italy",
          "geoPoint": {
            "lat": 45.46427,
            "lon": 9.18951
          }
        },
        {
          "facility": "Asst Grande Ospedale Metropolitano Niguarda",
          "status": "RECRUITING",
          "city": "Milano",
          "state": "Lombardia",
          "zip": "20162",
          "country": "Italy",
          "geoPoint": {
            "lat": 45.46427,
            "lon": 9.18951
          }
        },
        {
          "facility": "Istituto Clinico Humanitas",
          "status": "RECRUITING",
          "city": "Rozzano (MI)",
          "state": "Lombardia",
          "zip": "20089",
          "country": "Italy",
          "geoPoint": {
            "lat": 45.38193,
            "lon": 9.1559
          }
        },
        {
          "facility": "Azienda Ospedaliero Universitaria Pisana",
          "status": "RECRUITING",
          "city": "Pisa",
          "state": "Toscana",
          "zip": "56126",
          "country": "Italy",
          "geoPoint": {
            "lat": 43.70853,
            "lon": 10.4036
          }
        },
        {
          "facility": "Aga Khan University Hospital",
          "status": "RECRUITING",
          "city": "Nairobi",
          "zip": "00100",
          "country": "Kenya",
          "geoPoint": {
            "lat": -1.28333,
            "lon": 36.81667
          }
        },
        {
          "facility": "Seoul National University Bundang Hospital",
          "status": "RECRUITING",
          "city": "Seongnam-si",
          "zip": "463-707",
          "country": "Korea, Republic of",
          "geoPoint": {
            "lat": 37.43861,
            "lon": 127.13778
          }
        },
        {
          "facility": "Seoul National University Hospital",
          "status": "RECRUITING",
          "city": "Seoul",
          "zip": "03080",
          "country": "Korea, Republic of",
          "geoPoint": {
            "lat": 37.566,
            "lon": 126.9784
          }
        },
        {
          "facility": "Asan Medical Center - PPDS",
          "status": "RECRUITING",
          "city": "Seoul",
          "zip": "05505",
          "country": "Korea, Republic of",
          "geoPoint": {
            "lat": 37.566,
            "lon": 126.9784
          }
        },
        {
          "facility": "Samsung Medical Center - PPDS",
          "status": "RECRUITING",
          "city": "Seoul",
          "zip": "06351",
          "country": "Korea, Republic of",
          "geoPoint": {
            "lat": 37.566,
            "lon": 126.9784
          }
        },
        {
          "facility": "Het Nederlands Kanker Instituut Antoni Van Leeuwenhoek Ziekenhuis",
          "status": "RECRUITING",
          "city": "Amsterdam",
          "zip": "1066 CX",
          "country": "Netherlands",
          "geoPoint": {
            "lat": 52.37403,
            "lon": 4.88969
          }
        },
        {
          "facility": "Leids Universitair Medisch Centrum",
          "status": "RECRUITING",
          "city": "Leiden",
          "zip": "2333 ZA",
          "country": "Netherlands",
          "geoPoint": {
            "lat": 52.15833,
            "lon": 4.49306
          }
        },
        {
          "facility": "Maastricht University Medical Center",
          "status": "RECRUITING",
          "city": "Maastricht",
          "zip": "6229 HX",
          "country": "Netherlands",
          "geoPoint": {
            "lat": 50.84833,
            "lon": 5.68889
          }
        },
        {
          "facility": "Universitair Medisch Centrum Utrecht",
          "status": "RECRUITING",
          "city": "Utrecht",
          "zip": "3584 CX",
          "country": "Netherlands",
          "geoPoint": {
            "lat": 52.09083,
            "lon": 5.12222
          }
        },
        {
          "facility": "Auckland City Hospital, Cancer and Blood Research",
          "status": "RECRUITING",
          "city": "Auckland",
          "zip": "1023",
          "country": "New Zealand",
          "geoPoint": {
            "lat": -36.84853,
            "lon": 174.76349
          }
        },
        {
          "facility": "Auckland City Hospital",
          "status": "RECRUITING",
          "city": "Auckland",
          "zip": "1023",
          "country": "New Zealand",
          "geoPoint": {
            "lat": -36.84853,
            "lon": 174.76349
          }
        },
        {
          "facility": "New Zealand Clinical Research - Christchurch",
          "status": "RECRUITING",
          "city": "Christchurch",
          "zip": "8011",
          "country": "New Zealand",
          "geoPoint": {
            "lat": -43.53333,
            "lon": 172.63333
          }
        },
        {
          "facility": "Haukeland University Hospital; Hospital Pharmacy",
          "status": "RECRUITING",
          "city": "Bergen",
          "zip": "5053",
          "country": "Norway",
          "geoPoint": {
            "lat": 60.39299,
            "lon": 5.32415
          }
        },
        {
          "facility": "Oslo university hospital Radiumhospitalet",
          "status": "RECRUITING",
          "city": "Oslo",
          "zip": "0424",
          "country": "Norway",
          "geoPoint": {
            "lat": 59.91273,
            "lon": 10.74609
          }
        },
        {
          "facility": "Medical University of Gdansk",
          "status": "RECRUITING",
          "city": "Gdansk",
          "zip": "80-952",
          "country": "Poland",
          "geoPoint": {
            "lat": 54.35205,
            "lon": 18.64637
          }
        },
        {
          "facility": "Biokinetica, Przychodnia Jozefow",
          "status": "RECRUITING",
          "city": "Jozefow",
          "zip": "05-410",
          "country": "Poland",
          "geoPoint": {
            "lat": 52.13707,
            "lon": 21.23589
          }
        },
        {
          "facility": "Uniwersytecki Szpital Kliniczny w Poznaniu",
          "status": "RECRUITING",
          "city": "Pozna?",
          "zip": "60-780",
          "country": "Poland",
          "geoPoint": {
            "lat": 51.84442,
            "lon": 14.61868
          }
        },
        {
          "facility": "Republican Clinical Oncology Dispensary of Ministry of Healthcare of Tatarstan Republic",
          "status": "WITHDRAWN",
          "city": "Kazan",
          "state": "Tatarstan",
          "zip": "420029",
          "country": "Russian Federation",
          "geoPoint": {
            "lat": 55.78874,
            "lon": 49.12214
          }
        },
        {
          "facility": "Hospital Universitari Vall d'Hebron",
          "status": "RECRUITING",
          "city": "Barcelona",
          "zip": "08035",
          "country": "Spain",
          "geoPoint": {
            "lat": 41.38879,
            "lon": 2.15899
          }
        },
        {
          "facility": "START Madrid-FJD, Hospital Fundacion Jimenez Diaz",
          "status": "RECRUITING",
          "city": "Madrid",
          "zip": "28040",
          "country": "Spain",
          "geoPoint": {
            "lat": 40.4165,
            "lon": -3.70256
          }
        },
        {
          "facility": "Hospital Universitario 12 de Octubre",
          "status": "RECRUITING",
          "city": "Madrid",
          "zip": "28041",
          "country": "Spain",
          "geoPoint": {
            "lat": 40.4165,
            "lon": -3.70256
          }
        },
        {
          "facility": "Hospital Universitario HM Sanchinarro-CIOCC",
          "status": "RECRUITING",
          "city": "Madrid",
          "zip": "28050",
          "country": "Spain",
          "geoPoint": {
            "lat": 40.4165,
            "lon": -3.70256
          }
        },
        {
          "facility": "Hospital Clinico Universitario Virgen de la Victoria",
          "status": "RECRUITING",
          "city": "Malaga",
          "zip": "29010",
          "country": "Spain",
          "geoPoint": {
            "lat": 36.72016,
            "lon": -4.42034
          }
        },
        {
          "facility": "Hospital Universitario Virgen del Roc\u00edo",
          "status": "RECRUITING",
          "city": "Sevilla",
          "zip": "41013",
          "country": "Spain",
          "geoPoint": {
            "lat": 37.38283,
            "lon": -5.97317
          }
        },
        {
          "facility": "Hospital Clinico Universitario de Valencia",
          "status": "RECRUITING",
          "city": "Valencia",
          "zip": "46010",
          "country": "Spain",
          "geoPoint": {
            "lat": 39.46975,
            "lon": -0.37739
          }
        },
        {
          "facility": "Universitaetsspital Basel; Onkologie",
          "status": "WITHDRAWN",
          "city": "Basel",
          "zip": "4031",
          "country": "Switzerland",
          "geoPoint": {
            "lat": 47.55839,
            "lon": 7.57327
          }
        },
        {
          "facility": "Inselspital",
          "status": "RECRUITING",
          "city": "Bern",
          "zip": "3010",
          "country": "Switzerland",
          "geoPoint": {
            "lat": 46.94809,
            "lon": 7.44744
          }
        },
        {
          "facility": "H\u00f4pitaux Universitaires de Gen\u00e8ve",
          "status": "RECRUITING",
          "city": "Gen\u00e8ve",
          "zip": "1211",
          "country": "Switzerland",
          "geoPoint": {
            "lat": 46.20222,
            "lon": 6.14569
          }
        },
        {
          "facility": "Unversit\u00e4tsspital Z\u00fcrich",
          "status": "WITHDRAWN",
          "city": "Z\u00fcrich",
          "zip": "8091",
          "country": "Switzerland",
          "geoPoint": {
            "lat": 47.36667,
            "lon": 8.54999
          }
        },
        {
          "facility": "Queen Elizabeth Hospital",
          "status": "RECRUITING",
          "city": "Birmingham",
          "zip": "B15 2TH",
          "country": "United Kingdom",
          "geoPoint": {
            "lat": 52.48142,
            "lon": -1.89983
          }
        },
        {
          "facility": "Velindre Cancer Centre",
          "status": "RECRUITING",
          "city": "Cardiff",
          "zip": "CF14 2TL",
          "country": "United Kingdom",
          "geoPoint": {
            "lat": 51.48,
            "lon": -3.18
          }
        },
        {
          "facility": "University College London Hospitals NHS Foundation Trust; NIHR UCLH Clinical Research Facility",
          "status": "RECRUITING",
          "city": "London",
          "zip": "W1T 7HA",
          "country": "United Kingdom",
          "geoPoint": {
            "lat": 51.50853,
            "lon": -0.12574
          }
        },
        {
          "facility": "The Christie NHS Foundation Trust",
          "status": "RECRUITING",
          "city": "Manchester",
          "zip": "M20 4BX",
          "country": "United Kingdom",
          "geoPoint": {
            "lat": 53.48095,
            "lon": -2.23743
          }
        }
      ],
      "eligibilityModule": {
        "eligibilityCriteria": "Inclusion Criteria:\n\n* Histologically documented advanced or metastatic solid tumor with KRAS G12C mutation.\n* Women of childbearing potential must agree to remain abstinent or use contraception, and agree to refrain from donating eggs during the treatment period and after the final dose of study treatment as specified in the protocol.\n* Men who are not surgically sterile must agree to remain abstinent or use a condom, and agreement to refrain from donating sperm during the treatment period and after the final dose of study treatment as specified in the protocol.\n\nExclusion Criteria:\n\n* Active brain metastases.\n* Malabsorption or other condition that interferes with enteral absorption.\n* Clinically significant cardiovascular dysfunction or liver disease.",
        "healthyVolunteers": false,
        "sex": "ALL",
        "minimumAge": "18 Years",
        "stdAges": [
          "ADULT",
          "OLDER_ADULT"
        ]
      },
      "studyType": "INTERVENTIONAL",
      "phases": [
        "PHASE1"
      ]
    },
    "structured_criteria": {
      "inclusion": {
        "Inclusion Criteria:": [
          "Patients who meet all of the following criteria are eligible for trial participation: ",
          [
            "* Histologically documented advanced or metastatic solid tumor with KRAS G12C mutation.",
            "* Women of childbearing potential must agree to remain abstinent or use contraception, and agree to refrain from donating eggs during the treatment period and after the final dose of study treatment as specified in the protocol.",
            "* Men who are not surgically sterile must agree to remain abstinent or use a condom, and agreement to refrain from donating sperm during the treatment period and after the final dose of study treatment as specified in the protocol."
          ]
        ]
      },
      "exclusion": {
        "Exclusion Criteria:": [
          "Patients who meet any of the following criteria are not eligible for trial participation: ",
          [
            "* Active brain metastases.",
            "* Malabsorption or other condition that interferes with enteral absorption.",
            "* Clinically significant cardiovascular dysfunction or liver disease."
          ]
        ]
      }
    },
    "results_inclusion": [
      [
        "Inclusion Criteria:",
        "Patients who meet all of the following criteria are eligible for trial participation: ",
        [
          "* Histologically documented advanced or metastatic solid tumor with KRAS G12C mutation.",
          "* Women of childbearing potential must agree to remain abstinent or use contraception, and agree to refrain from donating eggs during the treatment period and after the final dose of study treatment as specified in the protocol.",
          "* Men who are not surgically sterile must agree to remain abstinent or use a condom, and agreement to refrain from donating sperm during the treatment period and after the final dose of study treatment as specified in the protocol."
        ],
        {
          "reasoning": "Reasoning: Let's think step by step in order to produce the criteria_decision. We will evaluate each criterion independently based on the patient information provided.\n\n1. **Criterion 1: \u00ab* Histologically documented advanced or metastatic solid tumor with KRAS G12C mutation.\u00bb**\n   - The patient has lung adenocarcinoma, stage 4, which is an advanced solid tumor.\n   - The molecular alterations include KRAS p.G12C (AF 18%).\n   - Therefore, the patient meets this criterion.\n   - **Decision: True**\n\n2. **Criterion 2: \u00ab* Women of childbearing potential must agree to remain abstinent or use contraception, and agree to refrain from donating eggs during the treatment period and after the final dose of study treatment as specified in the protocol.\u00bb**\n   - The patient is a 59-year-old male.\n   - This criterion is not applicable to the patient.\n   - **Decision: True**\n\n3. **Criterion 3: \u00ab* Men who are not surgically sterile must agree to remain abstinent or use a condom, and agreement to refrain from donating sperm during the treatment period and after the final dose of study treatment as specified in the protocol.\u00bb**\n   - The patient is a 59-year-old male.\n   - There is no information provided about whether the patient is surgically sterile or not.\n   - Therefore, we cannot determine if the patient meets this criterion.\n   - **Decision: ?**",
          "criteria_decision": {
            "explanation": [
              "The patient has lung adenocarcinoma, stage 4, and a KRAS G12C mutation, meeting the criterion.",
              "The patient is a male, so this criterion is not applicable.",
              "There is no information about the patient's surgical sterility status, so we cannot determine if he meets this criterion."
            ],
            "criteria_decision": [
              true,
              true,
              "?"
            ]
          }
        }
      ]
    ],
    "results_exclusion": [
      [
        "Exclusion Criteria:",
        "Patients who meet any of the following criteria are not eligible for trial participation: ",
        [
          "* Active brain metastases.",
          "* Malabsorption or other condition that interferes with enteral absorption.",
          "* Clinically significant cardiovascular dysfunction or liver disease."
        ],
        {
          "reasoning": "Reasoning: Let's think step by step in order to produce the criteria_decision. We will evaluate each exclusion criterion based on the patient information provided.\n\n1. **Active brain metastases**:\n   - The patient information does not mention brain metastases.\n   - According to the guardrails, if there is no information on brain metastases and no indication anywhere about brain metastases, we assume the patient does not have brain metastases.\n   - Decision: True (The patient is eligible based on this criterion).\n\n2. **Malabsorption or other condition that interferes with enteral absorption**:\n   - The patient information does not mention any malabsorption or conditions that interfere with enteral absorption.\n   - According to the guardrails, if a condition is not explicitly mentioned, we assume it is not present.\n   - Decision: True (The patient is eligible based on this criterion).\n\n3. **Clinically significant cardiovascular dysfunction or liver disease**:\n   - The patient information does not mention any cardiovascular dysfunction or liver disease.\n   - According to the guardrails, if a condition is not explicitly mentioned, we assume it is not present.\n   - Decision: True (The patient is eligible based on this criterion).",
          "criteria_decision": {
            "explanation": [
              "The patient information does not mention brain metastases. We assume the patient does not have brain metastases.",
              "The patient information does not mention any malabsorption or conditions that interfere with enteral absorption. We assume the patient does not have such conditions.",
              "The patient information does not mention any cardiovascular dysfunction or liver disease. We assume the patient does not have such conditions."
            ],
            "criteria_decision": [
              true,
              true,
              true
            ]
          }
        }
      ]
    ],
    "subinstruction": "metastatic lung adenocarcinoma, KRAS p.G12C mutation",
    "patient_id": "p6",
    "patient_info": "\nPatient Information\n    Name: Doe, John\n    born: 18.08.1968\n    Address: Main Street 1, Berlin\n\nOverview of Tumor Diagnosis and Therapy\n    Tumor Diagnosis\n    Diagnosis: Metastatic KRAS G12C mutant non-small cell lung cancer (NSCLC)\n    Initial Detection: March 22, 2023, following symptoms of persistent cough and weight loss\n    Biopsy Date: April 15, 2023, adenocarcinoma of the lung\n    Molecular Profile: KRAS p.G12C (AF 18%), KEAP1 p.L276F (AF 45%), STK11 p.K83Tfs*13 (AF 38%).\n\nTherapy Overview\n    Initial Treatment:\n    Chemotherapy: Began May 5, 2022 in Berlin, with a platinum-based regimen (Cisplatin and\n    Pemetrexed), partial response noted after initial chemotherapy cycle completed by August 10, 2022, contunuation of therapy until october 2023 (progressive disease)\n    Subsequent Treatment: Immunotherapy with Prembolizumab at Charit\u00e9 Berlin initiated on October 25, 2023, with Pembrolizumab, staging CT shows disease progression after 3 months\n    Current Status:\n    Health Condition: Stable with an ECOG performance status of 1\n    Comorbidities: Well-managed and not contraindicating further treatment\n \nComorbidities\n    Former Smoker: 40py\n    Hypertension: Controlled with medication (Lisinopril 20 mg daily), current blood pressure 130/90mmHg\n    Type 2 Diabetes Mellitus: Controlled with Metformin 1000 mg twice daily\n    Hyperlipidemia: Managed with Atorvastatin 40 mg daily\n    Osteoarthritis: Managed with over-the-counter NSAIDs as needed\n    Chronic Obstructive Pulmonary Disease (COPD): Mild, managed with inhalers (Tiotropium)\n    Gastroesophageal Reflux Disease (GERD): Managed with Omeprazole 20 mg daily\n    Benign Prostatic Hyperplasia (BPH): Treated with Tamsulosin 0.4 mg daily\n\nPerformance Status: ECOG Performance Status 1\n \nChronological Medical Findings:\n    January 10, 2018: Routine annual physical examination. Blood pressure elevated, diagnosed with hypertension. Prescribed Lisinopril 10 mg daily.\n    March 15, 2018: Complained of heartburn and acid reflux. Diagnosed with GERD. Prescribed Omeprazole 20 mg daily.\n    February 25, 2019: Annual follow-up for hypertension. Blood pressure well-controlled. Lisinopril dosage maintained.\n    May 20, 2019: Complained of knee pain. Diagnosed with osteoarthritis. Recommended over-the-counter NSAIDs for pain management.\n    April 5, 2020: Routine check-up. Elevated blood glucose levels. Diagnosed with Type 2 Diabetes Mellitus. Prescribed Metformin 500 mg twice daily.\n    August 30, 2020: Routine cholesterol check. Diagnosed with hyperlipidemia. Prescribed Atorvastatin 20 mg daily.\n    November 10, 2020: Follow-up for diabetes and hyperlipidemia. Dosages adjusted: Metformin increased to 1000 mg twice daily, Atorvastatin increased to 40 mg daily.\n    February 12, 2021: Complained of shortness of breath and chronic cough. Diagnosed with mild COPD. Prescribed Tiotropium inhaler.\n    July 18, 2021: Routine follow-up. Stable condition with controlled comorbidities. Blood pressure, blood sugar, and cholesterol levels within target ranges.\n    March 22, 2023: Experienced persistent cough and weight loss. Chest X-ray and CT scan revealed a mass in the left lung. Referred to oncologist. CT Angiography, Pulmonary Arteries: Tumor Size: Approximately 4.5 cm in diameter. Bronchial Obstruction: Partial obstruction of the left main bronchus leading to atelectasis of the left upper lobe.\n    Urgent suspicion of a tumor-atelectasis complex in the left upper lobe of the lung. Mucus present in the lower lobe bronchi on the left. Suspicion of mediastinal lymph node metastases. No evidence of pulmonary artery embolism. Thrombus in the left atrium at the transition to the auricle. Emphysematous and fibrotic changes in the lung parenchyma. \n    Lymph Nodes: Enlarged, FDG-positive lymph nodes in the mediastinum, particularly in regions 4R and infracarinal. \n    April 15, 2023: Lung biopsy via bronchoscopy: Endobronchial tumor manifestation in the distal left main bronchus extending to the upper lobe. Acute and chronic atrophic tracheobronchitis. Collapsed bronchial system in the affected area. Biopsy taken. Diagnosed with non-small cell lung cancer (NSCLC), molecular diagnostics: KRAS G12C mutant. \n    April 27, 2022: Ventilation: Moderate obstruction, no restriction. Increased airway resistance and slight hyperinflation. Tiffeneau index (FEV1/FVC) at 42.34%, z-score -3.32. FEV1: 0.93 L (42% predicted), z-score -2.89.Total lung capacity (TLC): 5.86 L (103% predicted), z-score 0.22. Forced vital capacity (FVC): 2.19 L, z-score -1.5. Residual volume (RV): 3.67 L, z-score 2.44. RV/TLC: 62.68%, z-score -1.18.\n    May 5, 2022: Initiated on platinum-based chemotherapy regimen (Cisplatin and Pemetrexed).\n    August 10, 2023: Completed initial chemotherapy cycle. Partial response noted. \n    August-October: Continued chemotherapy with Cisplatin/Pemetrexed.\n    October 13, 2023: Follow-up CT (chest + abdomen): Moderate disease progression. New nodule in the right lung (1cm). Slight increase in the size of previously noted FDG-positive lymph nodes in the mediastinum. No additional metastatic lesions were detected. The patient has continued to tolerate the current treatment regimen well, with no significant adverse effects reported.\n    October 25, 2023: Started immune checkpoint inhibitor therapy (Pembrolizumab), good tolerability, no signs of autoimmunity.\n    March 12, 2024: Follow-up CT scan abdomen/lung: Progressive Disease with three new metastases in the right lung and additional enlarged FDG-positive lymph nodes in the mediastinum. MRI scan of the brain conducted; no evidence of metastatic disease. Incidental findings included mild age-related cerebral atrophy and scattered white matter hyperintensities consistent with chronic microvascular ischemic changes.\n    March 17, 2024: Tumorboard recommends considering clinical trial options due to limited response to standard therapies.\n    April 20, 2024: Detailed assessment of health status. ECOG performance status 1. All routine labs, including liver and renal function tests, within normal limits.\n",
    "instruction": "Please find a clincial trial targeting the patients tumor and alterations in Germany."
  },
  {
    "nctId": "NCT04933695",
    "avg_inclusion_score": 0.7857142857142857,
    "avg_exclusion_score": 1.0,
    "avg_overall_score": 0.8846153846153846,
    "trial": {
      "clean_text": "#briefTitle\nA Study of Sotorasib (AMG 510) in Participants With Stage IV NSCLC Whose Tumors Harbor a KRAS p.G12C Mutation in Need of First-line Treatment\n\n#officialTitle\nA Phase 2, Multicenter, Open-label Study of Sotorasib (AMG 510) in Subjects With Stage IV NSCLC Whose Tumors Harbor a KRAS G12C Mutation in Need of First-line Treatment (CodeBreaK 201)\n\n#briefSummary\nThe main objective of this study is to evaluate the tumor objective response rate (ORR) assessed by Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 criteria in participants who receive sotorasib at either 960 mg daily or 240 mg daily whose tumors are programmed death-ligand 1 (PD-L1) Tumor Proportion Score (TPS) \\< 1% and/or harbor a serine/threonine kinase 11 (STK11) co-mutation, in a subgroup of participants with PD-L1 \\< 1% and in a subgroup of participants with STK11 co-mutation.\n\n#conditions\nNon-small Cell Lung Cancer\n\n",
      "briefTitle": "A Study of Sotorasib (AMG 510) in Participants With Stage IV NSCLC Whose Tumors Harbor a KRAS p.G12C Mutation in Need of First-line Treatment",
      "officialTitle": "A Phase 2, Multicenter, Open-label Study of Sotorasib (AMG 510) in Subjects With Stage IV NSCLC Whose Tumors Harbor a KRAS G12C Mutation in Need of First-line Treatment (CodeBreaK 201)",
      "briefSummary": "The main objective of this study is to evaluate the tumor objective response rate (ORR) assessed by Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 criteria in participants who receive sotorasib at either 960 mg daily or 240 mg daily whose tumors are programmed death-ligand 1 (PD-L1) Tumor Proportion Score (TPS) \\< 1% and/or harbor a serine/threonine kinase 11 (STK11) co-mutation, in a subgroup of participants with PD-L1 \\< 1% and in a subgroup of participants with STK11 co-mutation.",
      "detailedDescription": null,
      "conditions": [
        "Non-small Cell Lung Cancer"
      ],
      "armGroups": [
        {
          "label": "Sotorasib: 960 mg Daily",
          "type": "EXPERIMENTAL",
          "description": "Participants with metastatic non-small cell lung cancer (NSCLC) with Kirsten rat sarcoma (KRAS) p.G12C mutation whose tumors express \\< 1% programmed death-ligand 1 (PD-L1) and/or serine/threonine kinase 11 (STK11) mutation in need of first line treatment will be administered sotorasib 960 mg daily. Participants will be stratified by known presence of STK11 mutation.",
          "interventionNames": [
            "Drug: Sotorasib"
          ]
        },
        {
          "label": "Sotorasib: 240 mg Daily",
          "type": "EXPERIMENTAL",
          "description": "Participants with metastatic non-small cell lung cancer (NSCLC) with Kirsten rat sarcoma (KRAS) p.G12C mutation whose tumors express \\< 1% programmed death-ligand 1 (PD-L1) and/or serine/threonine kinase 11 (STK11) mutation in need of first line treatment will be administered sotorasib 240 mg daily. Participants will be stratified by known presence of STK11 mutation.",
          "interventionNames": [
            "Drug: Sotorasib"
          ]
        }
      ],
      "interventions": [
        {
          "type": "DRUG",
          "name": "Sotorasib",
          "description": "Oral tablet",
          "armGroupLabels": [
            "Sotorasib: 240 mg Daily",
            "Sotorasib: 960 mg Daily"
          ],
          "otherNames": [
            "AMG 510",
            "LUMYKRAS",
            "LUMAKRAS"
          ]
        }
      ],
      "primaryOutcomes": [
        {
          "measure": "Objective Response Rate (OR)",
          "description": "OR is defined as the total of Complete Response (CR) and Partial Response (PR).",
          "timeFrame": "Up to 6 years"
        }
      ],
      "secondaryOutcomes": [
        {
          "measure": "Disease Control Rate",
          "timeFrame": "Up to 6 years"
        },
        {
          "measure": "Duration of Reponse (DOR)",
          "timeFrame": "Up to 6 years"
        },
        {
          "measure": "Time to Response (TTR)",
          "timeFrame": "Up to 6 years"
        },
        {
          "measure": "Progression-free Survival (PFS)",
          "timeFrame": "Up to 6 years"
        },
        {
          "measure": "Overall Survival (OS)",
          "timeFrame": "Up to 6 years"
        },
        {
          "measure": "Number of Participants with a Treatment-emergent Adverse Event (TEAE)",
          "timeFrame": "Day 1 up to Month 13"
        },
        {
          "measure": "Number of Participants with a Treatment-related Adverse Event",
          "timeFrame": "Day 1 up to Month 13"
        },
        {
          "measure": "Number of Participants with a Clinically Significant Change from Baseline in Vital Signs",
          "timeFrame": "Baseline (Screening; up to 28 days pre-dose) up to Month 13"
        },
        {
          "measure": "Number of Participants with a Clinically Significant Change from Baseline in Electrocardiograms (ECGs)",
          "timeFrame": "Baseline (Screening; up to 28 days pre-dose) up to Month 13"
        },
        {
          "measure": "Number of Participants with a Clinically Significant Change from Baseline in Clinical Laboratory Tests",
          "timeFrame": "Baseline (Screening; up to 28 days pre-dose) up to Month 13"
        },
        {
          "measure": "Maximum Plasma Concentration (Cmax) of Sotorasib",
          "timeFrame": "Day 1 up to Month 3"
        },
        {
          "measure": "Time to Reach Maximum Plasma Concentration (tmax) of Sotorasib",
          "timeFrame": "Day 1 up to Month 3"
        },
        {
          "measure": "Area Under the Plasma Concentration-time Curve (AUC) of Sotorasib",
          "timeFrame": "Day 1 up to Month 3"
        }
      ],
      "eligibilityCriteria": "Inclusion Criteria:\n\n* Adult (= or \\> 18 years old) with NSCLC\n* Untreated Stage IV metastatic disease. Participants who received adjuvant or neoadjuvant anti-tumor therapy are eligible if the adjuvant/neoadjuvant therapy was completed greater than 12 months prior to the development of metastatic stage IV disease\n* Pathologically documented metastatic NSCLC with KRAS G12C mutation (local confirmation)\n* Programmed death-ligand 1 (PD-L1) TPS Score \\< 1% and/or serine/threonine kinase 11 (STK11) co-mutation (local confirmation)\n* Eastern Cooperative Oncology Group (ECOG) score of 0 or 1\n* No active brain metastases\n* Measurable disease per investigator interpretation using Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 criteria\n\nExclusion Criteria:\n\n* Mixed small-cell lung cancer and NSCLC histology\n* Myocardial Infarction within 6 months of study Day 1\n* Use of proton-pump inhibitors (PPIs), histamine (H2) receptor antagonists (H2RA), strong inducers of cytochrome P450 (CYP) 3A4 (CYP3A4) or known CYP3A4 sensitive substrates or P-gp substrates\n* Therapeutic or palliative radiation therapy within 2 weeks of study day 1\n* Unable to take oral medication\n* Unable to receive both iodinated contrast for computed tomography (CT) scans and gadolinium contrast for magnetic resonance imagine (MRI) scans",
      "nctId": "NCT04933695",
      "overallStatus": "ACTIVE_NOT_RECRUITING",
      "keywords": [
        "Non-small cell lung cancer",
        "KRAS p.G12C",
        "Sotorasib",
        "AMG 510"
      ],
      "locations": [
        {
          "facility": "Alabama Oncology",
          "city": "Birmingham",
          "state": "Alabama",
          "zip": "35243",
          "country": "United States",
          "geoPoint": {
            "lat": 33.52066,
            "lon": -86.80249
          }
        },
        {
          "facility": "Arizona Oncology Associates Professional Corporation",
          "city": "Tucson",
          "state": "Arizona",
          "zip": "85711",
          "country": "United States",
          "geoPoint": {
            "lat": 32.22174,
            "lon": -110.92648
          }
        },
        {
          "facility": "City of Hope at Long Beach Elm",
          "city": "Duarte",
          "state": "California",
          "zip": "91010",
          "country": "United States",
          "geoPoint": {
            "lat": 34.13945,
            "lon": -117.97729
          }
        },
        {
          "facility": "City of Hope National Medical Center",
          "city": "Duarte",
          "state": "California",
          "zip": "91010",
          "country": "United States",
          "geoPoint": {
            "lat": 34.13945,
            "lon": -117.97729
          }
        },
        {
          "facility": "Baptist MD Anderson Cancer Center",
          "city": "Jacksonville",
          "state": "Florida",
          "zip": "32207",
          "country": "United States",
          "geoPoint": {
            "lat": 30.33218,
            "lon": -81.65565
          }
        },
        {
          "facility": "Northwest Georgia Oncology Centers PC",
          "city": "Marietta",
          "state": "Georgia",
          "zip": "30060",
          "country": "United States",
          "geoPoint": {
            "lat": 33.9526,
            "lon": -84.54993
          }
        },
        {
          "facility": "Indiana University Melvin and Bren Simon Cancer Center",
          "city": "Indianapolis",
          "state": "Indiana",
          "zip": "46202",
          "country": "United States",
          "geoPoint": {
            "lat": 39.76838,
            "lon": -86.15804
          }
        },
        {
          "facility": "Baptist Health Lexington",
          "city": "Lexington",
          "state": "Kentucky",
          "zip": "40503",
          "country": "United States",
          "geoPoint": {
            "lat": 37.98869,
            "lon": -84.47772
          }
        },
        {
          "facility": "Frederick Memorial Hospital",
          "city": "Frederick",
          "state": "Maryland",
          "zip": "21702",
          "country": "United States",
          "geoPoint": {
            "lat": 39.41427,
            "lon": -77.41054
          }
        },
        {
          "facility": "Englewood Hospital and Medical Center",
          "city": "Englewood",
          "state": "New Jersey",
          "zip": "07631",
          "country": "United States",
          "geoPoint": {
            "lat": 40.89288,
            "lon": -73.97264
          }
        },
        {
          "facility": "Rutgers Cancer Institute of New Jersey",
          "city": "New Brunswick",
          "state": "New Jersey",
          "zip": "08901",
          "country": "United States",
          "geoPoint": {
            "lat": 40.48622,
            "lon": -74.45182
          }
        },
        {
          "facility": "James J Peters VA Medical Center",
          "city": "Bronx",
          "state": "New York",
          "zip": "10468",
          "country": "United States",
          "geoPoint": {
            "lat": 40.84985,
            "lon": -73.86641
          }
        },
        {
          "facility": "Laura and Isaac Perlmutter Cancer Center at New York University Langone",
          "city": "New York",
          "state": "New York",
          "zip": "10016",
          "country": "United States",
          "geoPoint": {
            "lat": 40.71427,
            "lon": -74.00597
          }
        },
        {
          "facility": "Northport Veterans Affairs Medical Center",
          "city": "Northport",
          "state": "New York",
          "zip": "11768",
          "country": "United States",
          "geoPoint": {
            "lat": 40.90093,
            "lon": -73.34317
          }
        },
        {
          "facility": "State University of New York Upstate Medical University",
          "city": "Syracuse",
          "state": "New York",
          "zip": "13210",
          "country": "United States",
          "geoPoint": {
            "lat": 43.04812,
            "lon": -76.14742
          }
        },
        {
          "facility": "Duke University Medical Center, Morris Cancer Clinic",
          "city": "Durham",
          "state": "North Carolina",
          "zip": "27710",
          "country": "United States",
          "geoPoint": {
            "lat": 35.99403,
            "lon": -78.89862
          }
        },
        {
          "facility": "Allegheny Health Network Cancer Institute at Allegheny General Hospital",
          "city": "Pittsburgh",
          "state": "Pennsylvania",
          "zip": "15212",
          "country": "United States",
          "geoPoint": {
            "lat": 40.44062,
            "lon": -79.99589
          }
        },
        {
          "facility": "University of Pittsburgh Medical Center Cancer Pavillion",
          "city": "Pittsburgh",
          "state": "Pennsylvania",
          "zip": "15232",
          "country": "United States",
          "geoPoint": {
            "lat": 40.44062,
            "lon": -79.99589
          }
        },
        {
          "facility": "Medical University of South Carolina, Hollings Cancer Center",
          "city": "Charleston",
          "state": "South Carolina",
          "zip": "29425",
          "country": "United States",
          "geoPoint": {
            "lat": 32.77657,
            "lon": -79.93092
          }
        },
        {
          "facility": "Texas Oncology - Medical City Dallas",
          "city": "Dallas",
          "state": "Texas",
          "zip": "75230-2510",
          "country": "United States",
          "geoPoint": {
            "lat": 32.78306,
            "lon": -96.80667
          }
        },
        {
          "facility": "Texas Oncology - Plano East",
          "city": "Dallas",
          "state": "Texas",
          "zip": "75230-2510",
          "country": "United States",
          "geoPoint": {
            "lat": 32.78306,
            "lon": -96.80667
          }
        },
        {
          "facility": "Texas Oncology-Dallas Presbyterian Hospital",
          "city": "Dallas",
          "state": "Texas",
          "zip": "75231",
          "country": "United States",
          "geoPoint": {
            "lat": 32.78306,
            "lon": -96.80667
          }
        },
        {
          "facility": "Texas Oncology - Flower Mound",
          "city": "Dallas",
          "state": "Texas",
          "zip": "75234",
          "country": "United States",
          "geoPoint": {
            "lat": 32.78306,
            "lon": -96.80667
          }
        },
        {
          "facility": "Texas Oncology - Baylor",
          "city": "Dallas",
          "state": "Texas",
          "zip": "75246",
          "country": "United States",
          "geoPoint": {
            "lat": 32.78306,
            "lon": -96.80667
          }
        },
        {
          "facility": "Texas Oncology-Denton",
          "city": "Denton",
          "state": "Texas",
          "zip": "76201",
          "country": "United States",
          "geoPoint": {
            "lat": 33.21484,
            "lon": -97.13307
          }
        },
        {
          "facility": "Oncology Consultants PA",
          "city": "Houston",
          "state": "Texas",
          "zip": "77030",
          "country": "United States",
          "geoPoint": {
            "lat": 29.76328,
            "lon": -95.36327
          }
        },
        {
          "facility": "University of Texas MD Anderson Cancer Center",
          "city": "Houston",
          "state": "Texas",
          "zip": "77030",
          "country": "United States",
          "geoPoint": {
            "lat": 29.76328,
            "lon": -95.36327
          }
        },
        {
          "facility": "Texas Oncology- Mckinney",
          "city": "McKinney",
          "state": "Texas",
          "zip": "75071",
          "country": "United States",
          "geoPoint": {
            "lat": 33.19762,
            "lon": -96.61527
          }
        },
        {
          "facility": "Texas Oncology - Northeast Texas",
          "city": "Paris",
          "state": "Texas",
          "zip": "75460-5004",
          "country": "United States",
          "geoPoint": {
            "lat": 33.66094,
            "lon": -95.55551
          }
        },
        {
          "facility": "Gundersen Health System",
          "city": "La Crosse",
          "state": "Wisconsin",
          "zip": "54601",
          "country": "United States",
          "geoPoint": {
            "lat": 43.80136,
            "lon": -91.23958
          }
        },
        {
          "facility": "Universite Catholique de Louvain Cliniques Universitaires Saint Luc",
          "city": "Bruxelles",
          "zip": "1200",
          "country": "Belgium",
          "geoPoint": {
            "lat": 50.85045,
            "lon": 4.34878
          }
        },
        {
          "facility": "Universitair Ziekenhuis Antwerpen",
          "city": "Edegem",
          "zip": "2650",
          "country": "Belgium",
          "geoPoint": {
            "lat": 51.15662,
            "lon": 4.44504
          }
        },
        {
          "facility": "Jessa Ziekenhuis - Campus Virga Jesse",
          "city": "Hasselt",
          "zip": "3500",
          "country": "Belgium",
          "geoPoint": {
            "lat": 50.93106,
            "lon": 5.33781
          }
        },
        {
          "facility": "Centre Hospitalier Universitaire de Liege - Sart Tilman",
          "city": "Liege",
          "zip": "4000",
          "country": "Belgium",
          "geoPoint": {
            "lat": 50.63373,
            "lon": 5.56749
          }
        },
        {
          "facility": "Odense Universitetshospital",
          "city": "Odense C",
          "zip": "5000",
          "country": "Denmark",
          "geoPoint": {
            "lat": 55.39594,
            "lon": 10.38831
          }
        },
        {
          "facility": "Institut Sainte Catherine",
          "city": "Avignon cedex 9",
          "zip": "84918",
          "country": "France",
          "geoPoint": {
            "lat": 43.94834,
            "lon": 4.80892
          }
        },
        {
          "facility": "Centre Hospitalier Universitaire R\u00e9gional de Lille - H\u00f4pital Albert Calmette",
          "city": "Lille Cedex",
          "zip": "59037",
          "country": "France",
          "geoPoint": {
            "lat": 50.63297,
            "lon": 3.05858
          }
        },
        {
          "facility": "Centre Hospitalier Universitaire de Limoges - Hopital Dupuytren",
          "city": "Limoges Cedex",
          "zip": "87042",
          "country": "France",
          "geoPoint": {
            "lat": 45.83153,
            "lon": 1.25781
          }
        },
        {
          "facility": "Centre Hospitalier Universitaire de Montpellier - Val d Aurelle",
          "city": "Montpellier Cedex 5",
          "zip": "34298",
          "country": "France",
          "geoPoint": {
            "lat": 43.61092,
            "lon": 3.87723
          }
        },
        {
          "facility": "Hopital Cochin",
          "city": "Paris",
          "zip": "75014",
          "country": "France",
          "geoPoint": {
            "lat": 48.85341,
            "lon": 2.3488
          }
        },
        {
          "facility": "Centre Hospitalier Universitaire de Bordeaux - Hopital Haut Leveque",
          "city": "Pessac Cedex",
          "zip": "33604",
          "country": "France",
          "geoPoint": {
            "lat": 44.81011,
            "lon": -0.64129
          }
        },
        {
          "facility": "Centre Hospitalier Universitaire de Rennes - Hopital Pontchaillou",
          "city": "Rennes",
          "zip": "35033",
          "country": "France",
          "geoPoint": {
            "lat": 48.11198,
            "lon": -1.67429
          }
        },
        {
          "facility": "Centre Hospitalier de Nantes - H\u00f4pital Nord La\u00ebnnec",
          "city": "Saint Herblain",
          "zip": "44800",
          "country": "France",
          "geoPoint": {
            "lat": 47.21765,
            "lon": -1.64841
          }
        },
        {
          "facility": "H\u00f4pital Sainte Musse",
          "city": "Toulon Cedex",
          "zip": "83056",
          "country": "France",
          "geoPoint": {
            "lat": 43.12442,
            "lon": 5.92836
          }
        },
        {
          "facility": "Centre Hospitalier Universitaire de Toulouse - Hopital Larrey",
          "city": "Toulouse Cedex 9",
          "zip": "31059",
          "country": "France",
          "geoPoint": {
            "lat": 43.60426,
            "lon": 1.44367
          }
        },
        {
          "facility": "Klinikum und Fachbereich Medizin Johann Wolfgang Goethe-Universit\u00e4t Frankfurt am Main",
          "city": "Frankfurt am Main",
          "zip": "60590",
          "country": "Germany",
          "geoPoint": {
            "lat": 50.11552,
            "lon": 8.68417
          }
        },
        {
          "facility": "Asklepios - Fachkliniken M\u00fcnchen-Gauting",
          "city": "Gauting",
          "zip": "82130",
          "country": "Germany",
          "geoPoint": {
            "lat": 48.06919,
            "lon": 11.37703
          }
        },
        {
          "facility": "Universit\u00e4tsklinikum K\u00f6ln",
          "city": "Koeln",
          "zip": "50937",
          "country": "Germany",
          "geoPoint": {
            "lat": 50.93333,
            "lon": 6.95
          }
        },
        {
          "facility": "Azienda Socio Sanitaria Territoriale di Monza Ospedale San Gerardo",
          "city": "Monza (MB)",
          "zip": "20900",
          "country": "Italy"
        },
        {
          "facility": "Azienda Ospedaliera di Rilievo Nazionale Specialistica dei Colli Monaldi",
          "city": "Napoli",
          "zip": "80131",
          "country": "Italy",
          "geoPoint": {
            "lat": 40.85216,
            "lon": 14.26811
          }
        },
        {
          "facility": "Azienda Ospedaliera Universitaria San Luigi Gonzaga",
          "city": "Orbassano (TO)",
          "zip": "10043",
          "country": "Italy",
          "geoPoint": {
            "lat": 45.00547,
            "lon": 7.53813
          }
        },
        {
          "facility": "Istituti Fisioterapici Ospitalieri Regina Elena San Gallicano",
          "city": "Rome",
          "zip": "00144",
          "country": "Italy",
          "geoPoint": {
            "lat": 41.89193,
            "lon": 12.51133
          }
        },
        {
          "facility": "Nederlands Kanker Instituut Antoni van Leeuwenhoekziekenhuis",
          "city": "Amsterdam",
          "zip": "1066 CX",
          "country": "Netherlands",
          "geoPoint": {
            "lat": 52.37403,
            "lon": 4.88969
          }
        },
        {
          "facility": "Hospital del Mar",
          "city": "Barcelona",
          "state": "Catalu\u00f1a",
          "zip": "08003",
          "country": "Spain",
          "geoPoint": {
            "lat": 41.38879,
            "lon": 2.15899
          }
        },
        {
          "facility": "Hospital de la Santa Creu i Sant Pau",
          "city": "Barcelona",
          "state": "Catalu\u00f1a",
          "zip": "08041",
          "country": "Spain",
          "geoPoint": {
            "lat": 41.38879,
            "lon": 2.15899
          }
        },
        {
          "facility": "Hospital Universitari i Politecnic La Fe",
          "city": "Valencia",
          "state": "Comunidad Valenciana",
          "zip": "46026",
          "country": "Spain",
          "geoPoint": {
            "lat": 39.46975,
            "lon": -0.37739
          }
        },
        {
          "facility": "Hospital Clinico Universitario de Santiago",
          "city": "Santiago de Compostela",
          "state": "Galicia",
          "zip": "15706",
          "country": "Spain",
          "geoPoint": {
            "lat": 42.88052,
            "lon": -8.54569
          }
        },
        {
          "facility": "Hospital Universitario Puerta de Hierro Majadahonda",
          "city": "Majadahonda",
          "state": "Madrid",
          "zip": "28222",
          "country": "Spain",
          "geoPoint": {
            "lat": 40.47353,
            "lon": -3.87182
          }
        },
        {
          "facility": "Hospital Universitario La Paz",
          "city": "Madrid",
          "zip": "28046",
          "country": "Spain",
          "geoPoint": {
            "lat": 40.4165,
            "lon": -3.70256
          }
        },
        {
          "facility": "Gavle Sjukhus",
          "city": "Gavle",
          "zip": "801 87",
          "country": "Sweden",
          "geoPoint": {
            "lat": 60.67452,
            "lon": 17.14174
          }
        },
        {
          "facility": "Sahlgrenska Universitetssjukhuset",
          "city": "Goteborg",
          "zip": "413 45",
          "country": "Sweden",
          "geoPoint": {
            "lat": 57.70716,
            "lon": 11.96679
          }
        },
        {
          "facility": "Universitetssjukhuset i Linkoping",
          "city": "Linkoping",
          "zip": "581 85",
          "country": "Sweden",
          "geoPoint": {
            "lat": 58.41086,
            "lon": 15.62157
          }
        },
        {
          "facility": "Skanes Universitetssjukhus",
          "city": "Lund",
          "zip": "221 85",
          "country": "Sweden",
          "geoPoint": {
            "lat": 55.70584,
            "lon": 13.19321
          }
        },
        {
          "facility": "Norrlands Universitetssjukhus",
          "city": "Umea",
          "zip": "901 85",
          "country": "Sweden",
          "geoPoint": {
            "lat": 63.82842,
            "lon": 20.25972
          }
        },
        {
          "facility": "Gazi Universitesi Saglik Arastirma ve Uygulama Merkezi Gazi Hastanesi",
          "city": "Ankara",
          "zip": "06560",
          "country": "Turkey",
          "geoPoint": {
            "lat": 39.91987,
            "lon": 32.85427
          }
        },
        {
          "facility": "Trakya Universitesi Saglik Arastirma ve Uygulama Merkezi",
          "city": "Edirne",
          "zip": "22030",
          "country": "Turkey",
          "geoPoint": {
            "lat": 41.67719,
            "lon": 26.55597
          }
        },
        {
          "facility": "Koc Universitesi Hastanesi",
          "city": "Istanbul",
          "zip": "34010",
          "country": "Turkey",
          "geoPoint": {
            "lat": 41.01384,
            "lon": 28.94966
          }
        }
      ],
      "eligibilityModule": {
        "eligibilityCriteria": "Inclusion Criteria:\n\n* Adult (= or \\> 18 years old) with NSCLC\n* Untreated Stage IV metastatic disease. Participants who received adjuvant or neoadjuvant anti-tumor therapy are eligible if the adjuvant/neoadjuvant therapy was completed greater than 12 months prior to the development of metastatic stage IV disease\n* Pathologically documented metastatic NSCLC with KRAS G12C mutation (local confirmation)\n* Programmed death-ligand 1 (PD-L1) TPS Score \\< 1% and/or serine/threonine kinase 11 (STK11) co-mutation (local confirmation)\n* Eastern Cooperative Oncology Group (ECOG) score of 0 or 1\n* No active brain metastases\n* Measurable disease per investigator interpretation using Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 criteria\n\nExclusion Criteria:\n\n* Mixed small-cell lung cancer and NSCLC histology\n* Myocardial Infarction within 6 months of study Day 1\n* Use of proton-pump inhibitors (PPIs), histamine (H2) receptor antagonists (H2RA), strong inducers of cytochrome P450 (CYP) 3A4 (CYP3A4) or known CYP3A4 sensitive substrates or P-gp substrates\n* Therapeutic or palliative radiation therapy within 2 weeks of study day 1\n* Unable to take oral medication\n* Unable to receive both iodinated contrast for computed tomography (CT) scans and gadolinium contrast for magnetic resonance imagine (MRI) scans",
        "healthyVolunteers": false,
        "sex": "ALL",
        "minimumAge": "18 Years",
        "stdAges": [
          "ADULT",
          "OLDER_ADULT"
        ]
      },
      "studyType": "INTERVENTIONAL",
      "phases": [
        "PHASE2"
      ]
    },
    "structured_criteria": {
      "inclusion": {
        "Inclusion Criteria:": [
          "Patients who meet all of the following criteria are eligible for trial participation: ",
          [
            "* Adult (= or \\> 18 years old) with NSCLC",
            "* Untreated Stage IV metastatic disease. Participants who received adjuvant or neoadjuvant anti-tumor therapy are eligible if the adjuvant/neoadjuvant therapy was completed greater than 12 months prior to the development of metastatic stage IV disease",
            "* Pathologically documented metastatic NSCLC with KRAS G12C mutation (local confirmation)",
            "* Programmed death-ligand 1 (PD-L1) TPS Score \\< 1% and/or serine/threonine kinase 11 (STK11) co-mutation (local confirmation)",
            "* Eastern Cooperative Oncology Group (ECOG) score of 0 or 1",
            "* No active brain metastases",
            "* Measurable disease per investigator interpretation using Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 criteria"
          ]
        ]
      },
      "exclusion": {
        "Exclusion Criteria:": [
          "Patients who meet any of the following criteria are not eligible for trial participation: ",
          [
            "* Mixed small-cell lung cancer and NSCLC histology",
            "* Myocardial Infarction within 6 months of study Day 1",
            "* Use of proton-pump inhibitors (PPIs), histamine (H2) receptor antagonists (H2RA), strong inducers of cytochrome P450 (CYP) 3A4 (CYP3A4) or known CYP3A4 sensitive substrates or P-gp substrates",
            "* Therapeutic or palliative radiation therapy within 2 weeks of study day 1",
            "* Unable to take oral medication",
            "* Unable to receive both iodinated contrast for computed tomography (CT) scans and gadolinium contrast for magnetic resonance imagine (MRI) scans"
          ]
        ]
      }
    },
    "results_inclusion": [
      [
        "Inclusion Criteria:",
        "Patients who meet all of the following criteria are eligible for trial participation: ",
        [
          "* Adult (= or \\> 18 years old) with NSCLC",
          "* Untreated Stage IV metastatic disease. Participants who received adjuvant or neoadjuvant anti-tumor therapy are eligible if the adjuvant/neoadjuvant therapy was completed greater than 12 months prior to the development of metastatic stage IV disease",
          "* Pathologically documented metastatic NSCLC with KRAS G12C mutation (local confirmation)",
          "* Programmed death-ligand 1 (PD-L1) TPS Score \\< 1% and/or serine/threonine kinase 11 (STK11) co-mutation (local confirmation)",
          "* Eastern Cooperative Oncology Group (ECOG) score of 0 or 1"
        ],
        {
          "reasoning": "Reasoning: Let's think step by step in order to produce the criteria_decision. We will evaluate each criterion based on the provided patient information.\n\n1. **Criterion**: \u00ab* Adult (= or \\> 18 years old) with NSCLC\u00bb\n   - **Patient Info**: 59-year-old male patient with lung adenocarcinoma, stage 4.\n   - **Decision**: True. The patient is an adult (59 years old) with NSCLC.\n\n2. **Criterion**: \u00ab* Untreated Stage IV metastatic disease. Participants who received adjuvant or neoadjuvant anti-tumor therapy are eligible if the adjuvant/neoadjuvant therapy was completed greater than 12 months prior to the development of metastatic stage IV disease\u00bb\n   - **Patient Info**: Stage 4 lung adenocarcinoma. No information on prior treatments.\n   - **Decision**: ?. There is no information provided about whether the patient received adjuvant or neoadjuvant therapy and if so, when it was completed.\n\n3. **Criterion**: \u00ab* Pathologically documented metastatic NSCLC with KRAS G12C mutation (local confirmation)\u00bb\n   - **Patient Info**: Molecular alterations include KRAS p.G12C (AF 18%).\n   - **Decision**: True. The patient has a KRAS G12C mutation.\n\n4. **Criterion**: \u00ab* Programmed death-ligand 1 (PD-L1) TPS Score \\< 1% and/or serine/threonine kinase 11 (STK11) co-mutation (local confirmation)\u00bb\n   - **Patient Info**: Molecular alterations include STK11 p.K83Tfs*13 (AF 38%).\n   - **Decision**: True. The patient has an STK11 co-mutation.\n\n5. **Criterion**: \u00ab* Eastern Cooperative Oncology Group (ECOG) score of 0 or 1\u00bb\n   - **Patient Info**: No information on ECOG score.\n   - **Decision**: ?. There is no information provided about the patient's ECOG score.",
          "criteria_decision": {
            "explanation": [
              "The patient is an adult (59 years old) with NSCLC.",
              "There is no information provided about whether the patient received adjuvant or neoadjuvant therapy and if so, when it was completed.",
              "The patient has a KRAS G12C mutation.",
              "The patient has an STK11 co-mutation.",
              "There is no information provided about the patient's ECOG score."
            ],
            "criteria_decision": [
              true,
              "?",
              true,
              true,
              "?"
            ]
          }
        }
      ],
      [
        "Inclusion Criteria:",
        "Patients who meet all of the following criteria are eligible for trial participation: ",
        [
          "* No active brain metastases",
          "* Measurable disease per investigator interpretation using Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 criteria"
        ],
        {
          "reasoning": "Reasoning: Let's think step by step in order to produce the criteria_decision. We need to evaluate each inclusion criterion based on the provided patient information.\n\n1. **Criterion 1: No active brain metastases**\n   - The patient information does not mention brain metastases.\n   - According to the guardrails, if a disease or condition is not explicitly mentioned, we assume it is not present.\n   - Therefore, the patient is eligible based on this criterion.\n   - **Explanation**: The patient information does not mention brain metastases, so we assume the patient does not have active brain metastases.\n\n2. **Criterion 2: Measurable disease per investigator interpretation using Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 criteria**\n   - The patient has lung adenocarcinoma, stage 4, which typically involves measurable disease.\n   - However, the patient information does not explicitly state that the disease is measurable per RECIST 1.1 criteria.\n   - Therefore, the information is not sufficient to make a decision.\n   - **Explanation**: The patient has lung adenocarcinoma, stage 4, but it is not explicitly stated that the disease is measurable per RECIST 1.1 criteria.",
          "criteria_decision": {
            "explanation": [
              "The patient information does not mention brain metastases, so we assume the patient does not have active brain metastases.",
              "The patient has lung adenocarcinoma, stage 4, but it is not explicitly stated that the disease is measurable per RECIST 1.1 criteria."
            ],
            "criteria_decision": [
              true,
              "?"
            ]
          }
        }
      ]
    ],
    "results_exclusion": [
      [
        "Exclusion Criteria:",
        "Patients who meet any of the following criteria are not eligible for trial participation: ",
        [
          "* Mixed small-cell lung cancer and NSCLC histology",
          "* Myocardial Infarction within 6 months of study Day 1",
          "* Use of proton-pump inhibitors (PPIs), histamine (H2) receptor antagonists (H2RA), strong inducers of cytochrome P450 (CYP) 3A4 (CYP3A4) or known CYP3A4 sensitive substrates or P-gp substrates",
          "* Therapeutic or palliative radiation therapy within 2 weeks of study day 1",
          "* Unable to take oral medication"
        ],
        {
          "reasoning": "Reasoning: Let's think step by step in order to produce the criteria_decision. We will evaluate each exclusion criterion based on the patient information provided.\n\n1. **Mixed small-cell lung cancer and NSCLC histology**:\n   - The patient information mentions lung adenocarcinoma, which is a type of NSCLC. There is no mention of mixed small-cell lung cancer.\n   - Decision: True (The patient does not have mixed small-cell lung cancer and NSCLC histology).\n\n2. **Myocardial Infarction within 6 months of study Day 1**:\n   - There is no mention of a myocardial infarction in the patient information.\n   - Decision: True (Assume the patient did not have a myocardial infarction within the last 6 months).\n\n3. **Use of proton-pump inhibitors (PPIs), histamine (H2) receptor antagonists (H2RA), strong inducers of cytochrome P450 (CYP) 3A4 (CYP3A4) or known CYP3A4 sensitive substrates or P-gp substrates**:\n   - The patient information does not mention the use of any of these medications.\n   - Decision: True (Assume the patient is not using these medications).\n\n4. **Therapeutic or palliative radiation therapy within 2 weeks of study day 1**:\n   - The patient information does not mention recent radiation therapy.\n   - Decision: True (Assume the patient did not receive radiation therapy within the last 2 weeks).\n\n5. **Unable to take oral medication**:\n   - The patient information does not mention any issues with taking oral medication.\n   - Decision: True (Assume the patient is able to take oral medication).",
          "criteria_decision": {
            "explanation": [
              "The patient has lung adenocarcinoma, which is a type of NSCLC, and there is no mention of mixed small-cell lung cancer.",
              "There is no mention of a myocardial infarction in the patient information, so we assume the patient did not have one within the last 6 months.",
              "The patient information does not mention the use of PPIs, H2RAs, CYP3A4 inducers, or P-gp substrates, so we assume the patient is not using these medications.",
              "The patient information does not mention recent radiation therapy, so we assume the patient did not receive radiation therapy within the last 2 weeks.",
              "The patient information does not mention any issues with taking oral medication, so we assume the patient is able to take oral medication."
            ],
            "criteria_decision": [
              true,
              true,
              true,
              true,
              true
            ]
          }
        }
      ],
      [
        "Exclusion Criteria:",
        "Patients who meet any of the following criteria are not eligible for trial participation: ",
        [
          "* Unable to receive both iodinated contrast for computed tomography (CT) scans and gadolinium contrast for magnetic resonance imagine (MRI) scans"
        ],
        {
          "reasoning": "Reasoning: Let's think step by step in order to produce the criteria_decision. We need to determine if the patient is eligible based on the exclusion criterion provided. The criterion states that the patient should not be \"unable to receive both iodinated contrast for CT scans and gadolinium contrast for MRI scans.\" \n\n1. The patient information does not mention any issues with receiving iodinated contrast for CT scans.\n2. The patient information does not mention any issues with receiving gadolinium contrast for MRI scans.\n\nSince there is no information indicating that the patient is unable to receive these contrasts, we assume the patient can receive both types of contrast agents. Therefore, the patient is eligible based on this criterion.",
          "criteria_decision": {
            "explanation": [
              "The patient information does not mention any issues with receiving iodinated contrast for CT scans or gadolinium contrast for MRI scans. Therefore, the patient is eligible based on this criterion."
            ],
            "criteria_decision": [
              true
            ]
          }
        }
      ]
    ],
    "subinstruction": "metastatic lung adenocarcinoma, KRAS p.G12C mutation",
    "patient_id": "p6",
    "patient_info": "\nPatient Information\n    Name: Doe, John\n    born: 18.08.1968\n    Address: Main Street 1, Berlin\n\nOverview of Tumor Diagnosis and Therapy\n    Tumor Diagnosis\n    Diagnosis: Metastatic KRAS G12C mutant non-small cell lung cancer (NSCLC)\n    Initial Detection: March 22, 2023, following symptoms of persistent cough and weight loss\n    Biopsy Date: April 15, 2023, adenocarcinoma of the lung\n    Molecular Profile: KRAS p.G12C (AF 18%), KEAP1 p.L276F (AF 45%), STK11 p.K83Tfs*13 (AF 38%).\n\nTherapy Overview\n    Initial Treatment:\n    Chemotherapy: Began May 5, 2022 in Berlin, with a platinum-based regimen (Cisplatin and\n    Pemetrexed), partial response noted after initial chemotherapy cycle completed by August 10, 2022, contunuation of therapy until october 2023 (progressive disease)\n    Subsequent Treatment: Immunotherapy with Prembolizumab at Charit\u00e9 Berlin initiated on October 25, 2023, with Pembrolizumab, staging CT shows disease progression after 3 months\n    Current Status:\n    Health Condition: Stable with an ECOG performance status of 1\n    Comorbidities: Well-managed and not contraindicating further treatment\n \nComorbidities\n    Former Smoker: 40py\n    Hypertension: Controlled with medication (Lisinopril 20 mg daily), current blood pressure 130/90mmHg\n    Type 2 Diabetes Mellitus: Controlled with Metformin 1000 mg twice daily\n    Hyperlipidemia: Managed with Atorvastatin 40 mg daily\n    Osteoarthritis: Managed with over-the-counter NSAIDs as needed\n    Chronic Obstructive Pulmonary Disease (COPD): Mild, managed with inhalers (Tiotropium)\n    Gastroesophageal Reflux Disease (GERD): Managed with Omeprazole 20 mg daily\n    Benign Prostatic Hyperplasia (BPH): Treated with Tamsulosin 0.4 mg daily\n\nPerformance Status: ECOG Performance Status 1\n \nChronological Medical Findings:\n    January 10, 2018: Routine annual physical examination. Blood pressure elevated, diagnosed with hypertension. Prescribed Lisinopril 10 mg daily.\n    March 15, 2018: Complained of heartburn and acid reflux. Diagnosed with GERD. Prescribed Omeprazole 20 mg daily.\n    February 25, 2019: Annual follow-up for hypertension. Blood pressure well-controlled. Lisinopril dosage maintained.\n    May 20, 2019: Complained of knee pain. Diagnosed with osteoarthritis. Recommended over-the-counter NSAIDs for pain management.\n    April 5, 2020: Routine check-up. Elevated blood glucose levels. Diagnosed with Type 2 Diabetes Mellitus. Prescribed Metformin 500 mg twice daily.\n    August 30, 2020: Routine cholesterol check. Diagnosed with hyperlipidemia. Prescribed Atorvastatin 20 mg daily.\n    November 10, 2020: Follow-up for diabetes and hyperlipidemia. Dosages adjusted: Metformin increased to 1000 mg twice daily, Atorvastatin increased to 40 mg daily.\n    February 12, 2021: Complained of shortness of breath and chronic cough. Diagnosed with mild COPD. Prescribed Tiotropium inhaler.\n    July 18, 2021: Routine follow-up. Stable condition with controlled comorbidities. Blood pressure, blood sugar, and cholesterol levels within target ranges.\n    March 22, 2023: Experienced persistent cough and weight loss. Chest X-ray and CT scan revealed a mass in the left lung. Referred to oncologist. CT Angiography, Pulmonary Arteries: Tumor Size: Approximately 4.5 cm in diameter. Bronchial Obstruction: Partial obstruction of the left main bronchus leading to atelectasis of the left upper lobe.\n    Urgent suspicion of a tumor-atelectasis complex in the left upper lobe of the lung. Mucus present in the lower lobe bronchi on the left. Suspicion of mediastinal lymph node metastases. No evidence of pulmonary artery embolism. Thrombus in the left atrium at the transition to the auricle. Emphysematous and fibrotic changes in the lung parenchyma. \n    Lymph Nodes: Enlarged, FDG-positive lymph nodes in the mediastinum, particularly in regions 4R and infracarinal. \n    April 15, 2023: Lung biopsy via bronchoscopy: Endobronchial tumor manifestation in the distal left main bronchus extending to the upper lobe. Acute and chronic atrophic tracheobronchitis. Collapsed bronchial system in the affected area. Biopsy taken. Diagnosed with non-small cell lung cancer (NSCLC), molecular diagnostics: KRAS G12C mutant. \n    April 27, 2022: Ventilation: Moderate obstruction, no restriction. Increased airway resistance and slight hyperinflation. Tiffeneau index (FEV1/FVC) at 42.34%, z-score -3.32. FEV1: 0.93 L (42% predicted), z-score -2.89.Total lung capacity (TLC): 5.86 L (103% predicted), z-score 0.22. Forced vital capacity (FVC): 2.19 L, z-score -1.5. Residual volume (RV): 3.67 L, z-score 2.44. RV/TLC: 62.68%, z-score -1.18.\n    May 5, 2022: Initiated on platinum-based chemotherapy regimen (Cisplatin and Pemetrexed).\n    August 10, 2023: Completed initial chemotherapy cycle. Partial response noted. \n    August-October: Continued chemotherapy with Cisplatin/Pemetrexed.\n    October 13, 2023: Follow-up CT (chest + abdomen): Moderate disease progression. New nodule in the right lung (1cm). Slight increase in the size of previously noted FDG-positive lymph nodes in the mediastinum. No additional metastatic lesions were detected. The patient has continued to tolerate the current treatment regimen well, with no significant adverse effects reported.\n    October 25, 2023: Started immune checkpoint inhibitor therapy (Pembrolizumab), good tolerability, no signs of autoimmunity.\n    March 12, 2024: Follow-up CT scan abdomen/lung: Progressive Disease with three new metastases in the right lung and additional enlarged FDG-positive lymph nodes in the mediastinum. MRI scan of the brain conducted; no evidence of metastatic disease. Incidental findings included mild age-related cerebral atrophy and scattered white matter hyperintensities consistent with chronic microvascular ischemic changes.\n    March 17, 2024: Tumorboard recommends considering clinical trial options due to limited response to standard therapies.\n    April 20, 2024: Detailed assessment of health status. ECOG performance status 1. All routine labs, including liver and renal function tests, within normal limits.\n",
    "instruction": "Please find a clincial trial targeting the patients tumor and alterations in Germany."
  },
  {
    "nctId": "NCT04303780",
    "avg_inclusion_score": 0.6666666666666666,
    "avg_exclusion_score": 1.0,
    "avg_overall_score": 0.8333333333333334,
    "trial": {
      "clean_text": "#briefTitle\nStudy to Compare AMG 510 \"Proposed INN Sotorasib\" With Docetaxel in Non Small Cell Lung Cancer (NSCLC) (CodeBreak 200).\n\n#officialTitle\nA Phase 3 Multicenter, Randomized, Open Label, Active-controlled, Study of AMG 510 Versus Docetaxel for the Treatment of Previously Treated Locally Advanced and Unresectable or Metastatic NSCLC Subjects With Mutated KRAS p.G12C\n\n#briefSummary\nA Phase 3 Study to Compare AMG 510 with Docetaxel in Non Small Cell Lung Cancer (NSCLC) subjects with KRAS p. G12c mutation\n\n#conditions\nKRAS p, G12c Mutated /Advanced Metastatic NSCLC\n\n",
      "briefTitle": "Study to Compare AMG 510 \"Proposed INN Sotorasib\" With Docetaxel in Non Small Cell Lung Cancer (NSCLC) (CodeBreak 200).",
      "officialTitle": "A Phase 3 Multicenter, Randomized, Open Label, Active-controlled, Study of AMG 510 Versus Docetaxel for the Treatment of Previously Treated Locally Advanced and Unresectable or Metastatic NSCLC Subjects With Mutated KRAS p.G12C",
      "briefSummary": "A Phase 3 Study to Compare AMG 510 with Docetaxel in Non Small Cell Lung Cancer (NSCLC) subjects with KRAS p. G12c mutation",
      "detailedDescription": null,
      "conditions": [
        "KRAS p, G12c Mutated /Advanced Metastatic NSCLC"
      ],
      "armGroups": [
        {
          "label": "AMG 510",
          "type": "EXPERIMENTAL",
          "interventionNames": [
            "Drug: AMG 510"
          ]
        },
        {
          "label": "Docetaxel",
          "type": "ACTIVE_COMPARATOR",
          "interventionNames": [
            "Drug: Docetaxel"
          ]
        }
      ],
      "interventions": [
        {
          "type": "DRUG",
          "name": "AMG 510",
          "description": "21 day cycles",
          "armGroupLabels": [
            "AMG 510"
          ]
        },
        {
          "type": "DRUG",
          "name": "Docetaxel",
          "description": "21 day cycles",
          "armGroupLabels": [
            "Docetaxel"
          ]
        }
      ],
      "primaryOutcomes": [
        {
          "measure": "Progression-free Survival (PFS)",
          "description": "PFS was defined as the time from randomization (baseline) until disease progression or death from any cause, whichever occurred first for all participants. Progression was based on blinded independent central review (BICR) of disease response per Response Evaluation Criteria in Solid Tumors version 1.1 (RECIST v1.1).\n\nAs pre-specified in the statistical analysis plan, for participants who crossed over from docetaxel to AMG 510, the participant's response post first progression or post crossover was not used for the primary analyses. Data are presented per original treatment randomized.",
          "timeFrame": "Baseline up to primary analysis data cut-off date (02 August 2022); max time on study as of primary analysis data cut off was 24.3 months"
        }
      ],
      "secondaryOutcomes": null,
      "eligibilityCriteria": "Inclusion Criteria:\n\n* Men or women greater than or equal to 18 years old.\n* ECOG \u2264 1\n* Pathologically documented, previously treated, locally-advanced and unresectable or metastatic NSCLC with KRAS p.G12C mutation confirmed through central testing or have documentation of KRAS p.G12C mutation through Amgen Study 20190294 prior to enrollment\n\nExclusion Criteria:\n\n* Active brain metastases\n* Myocardial infarction within 6 months of study day 1\n* Gastrointestinal (GI) tract disease causing the inability to take oral medication",
      "nctId": "NCT04303780",
      "overallStatus": "ACTIVE_NOT_RECRUITING",
      "keywords": null,
      "locations": [
        {
          "facility": "Pacific Cancer Medical Center Inc",
          "city": "Anaheim",
          "state": "California",
          "zip": "92801",
          "country": "United States",
          "geoPoint": {
            "lat": 33.83529,
            "lon": -117.9145
          }
        },
        {
          "facility": "City of Hope National Medical Center",
          "city": "Duarte",
          "state": "California",
          "zip": "91010",
          "country": "United States",
          "geoPoint": {
            "lat": 34.13945,
            "lon": -117.97729
          }
        },
        {
          "facility": "Pacific Shores Medical Group Long Beach",
          "city": "Long Beach",
          "state": "California",
          "zip": "90813",
          "country": "United States",
          "geoPoint": {
            "lat": 33.76696,
            "lon": -118.18923
          }
        },
        {
          "facility": "University of California Los Angeles",
          "city": "Los Angeles",
          "state": "California",
          "zip": "90095-1772",
          "country": "United States",
          "geoPoint": {
            "lat": 34.05223,
            "lon": -118.24368
          }
        },
        {
          "facility": "University of California Los Angeles",
          "city": "Los Angeles",
          "state": "California",
          "zip": "90095",
          "country": "United States",
          "geoPoint": {
            "lat": 34.05223,
            "lon": -118.24368
          }
        },
        {
          "facility": "University of California at Davis Medical Center",
          "city": "Sacramento",
          "state": "California",
          "zip": "95817",
          "country": "United States",
          "geoPoint": {
            "lat": 38.58157,
            "lon": -121.4944
          }
        },
        {
          "facility": "Ridley Tree Cancer Center",
          "city": "Santa Barbara",
          "state": "California",
          "zip": "93105",
          "country": "United States",
          "geoPoint": {
            "lat": 34.42083,
            "lon": -119.69819
          }
        },
        {
          "facility": "University of California San Francisco Mission Hall",
          "city": "Stanford",
          "state": "California",
          "zip": "94305",
          "country": "United States",
          "geoPoint": {
            "lat": 37.42411,
            "lon": -122.16608
          }
        },
        {
          "facility": "Harbor University of California Los Angeles Medical Center",
          "city": "Torrance",
          "state": "California",
          "zip": "90502",
          "country": "United States",
          "geoPoint": {
            "lat": 33.83585,
            "lon": -118.34063
          }
        },
        {
          "facility": "Rocky Mountain Cancer Centers",
          "city": "Denver",
          "state": "Colorado",
          "zip": "80218",
          "country": "United States",
          "geoPoint": {
            "lat": 39.73915,
            "lon": -104.9847
          }
        },
        {
          "facility": "Danbury Hospital",
          "city": "Norwalk",
          "state": "Connecticut",
          "zip": "06856",
          "country": "United States",
          "geoPoint": {
            "lat": 41.1176,
            "lon": -73.4079
          }
        },
        {
          "facility": "Medical Oncology Hematology Consultants Helen F Graham Cancer Center",
          "city": "Newark",
          "state": "Delaware",
          "zip": "19713",
          "country": "United States",
          "geoPoint": {
            "lat": 39.68372,
            "lon": -75.74966
          }
        },
        {
          "facility": "Washington Cancer Institute at MedStar Washington Hospital",
          "city": "Washington",
          "state": "District of Columbia",
          "zip": "20010",
          "country": "United States",
          "geoPoint": {
            "lat": 38.89511,
            "lon": -77.03637
          }
        },
        {
          "facility": "Florida Cancer Specialists - Fort Myers",
          "city": "Fort Myers",
          "state": "Florida",
          "zip": "33901",
          "country": "United States",
          "geoPoint": {
            "lat": 26.62168,
            "lon": -81.84059
          }
        },
        {
          "facility": "Memorial Regional Hospital",
          "city": "Hollywood",
          "state": "Florida",
          "zip": "33021",
          "country": "United States",
          "geoPoint": {
            "lat": 26.0112,
            "lon": -80.14949
          }
        },
        {
          "facility": "Florida Cancer Specialists Research North",
          "city": "Saint Petersburg",
          "state": "Florida",
          "zip": "33705",
          "country": "United States",
          "geoPoint": {
            "lat": 27.77086,
            "lon": -82.67927
          }
        },
        {
          "facility": "Florida Cancer Specialists Research Panhandle",
          "city": "Tallahassee",
          "state": "Florida",
          "zip": "32308",
          "country": "United States",
          "geoPoint": {
            "lat": 30.43826,
            "lon": -84.28073
          }
        },
        {
          "facility": "Emory University",
          "city": "Atlanta",
          "state": "Georgia",
          "zip": "30332",
          "country": "United States",
          "geoPoint": {
            "lat": 33.749,
            "lon": -84.38798
          }
        },
        {
          "facility": "Northside Hospital, Incorporated",
          "city": "Atlanta",
          "state": "Georgia",
          "zip": "30341",
          "country": "United States",
          "geoPoint": {
            "lat": 33.749,
            "lon": -84.38798
          }
        },
        {
          "facility": "Affiliated Oncologists, LLC",
          "city": "North Chicago",
          "state": "Illinois",
          "zip": "60064",
          "country": "United States",
          "geoPoint": {
            "lat": 42.32558,
            "lon": -87.84118
          }
        },
        {
          "facility": "Fort Wayne Medical Oncology and Hematology",
          "city": "Fort Wayne",
          "state": "Indiana",
          "zip": "46804",
          "country": "United States",
          "geoPoint": {
            "lat": 41.1306,
            "lon": -85.12886
          }
        },
        {
          "facility": "Willis Knighton Cancer Center",
          "city": "Shreveport",
          "state": "Louisiana",
          "zip": "71103",
          "country": "United States",
          "geoPoint": {
            "lat": 32.52515,
            "lon": -93.75018
          }
        },
        {
          "facility": "Maryland Oncology Hematology PA",
          "city": "Clinton",
          "state": "Maryland",
          "zip": "20735",
          "country": "United States",
          "geoPoint": {
            "lat": 38.76511,
            "lon": -76.89831
          }
        },
        {
          "facility": "New York Cancer and Blood Specialists",
          "city": "Lowell",
          "state": "Massachusetts",
          "zip": "01854",
          "country": "United States",
          "geoPoint": {
            "lat": 42.63342,
            "lon": -71.31617
          }
        },
        {
          "facility": "University of Michigan",
          "city": "Ann Arbor",
          "state": "Michigan",
          "zip": "48109-1274",
          "country": "United States",
          "geoPoint": {
            "lat": 42.27756,
            "lon": -83.74088
          }
        },
        {
          "facility": "Center for Oncology Clinical Trials",
          "city": "Grand Rapids",
          "state": "Michigan",
          "zip": "49503",
          "country": "United States",
          "geoPoint": {
            "lat": 42.96336,
            "lon": -85.66809
          }
        },
        {
          "facility": "Minnesota Oncology Hematology PA",
          "city": "Minneapolis",
          "state": "Minnesota",
          "zip": "55404",
          "country": "United States",
          "geoPoint": {
            "lat": 44.97997,
            "lon": -93.26384
          }
        },
        {
          "facility": "HCA Midwest Health Kansas City",
          "city": "Kansas City",
          "state": "Missouri",
          "zip": "64132",
          "country": "United States",
          "geoPoint": {
            "lat": 39.09973,
            "lon": -94.57857
          }
        },
        {
          "facility": "Comprehensive Cancer Centers of Nevada",
          "city": "Las Vegas",
          "state": "Nevada",
          "zip": "89169",
          "country": "United States",
          "geoPoint": {
            "lat": 36.17497,
            "lon": -115.13722
          }
        },
        {
          "facility": "Summit Medical Group",
          "city": "Florham Park",
          "state": "New Jersey",
          "zip": "07932",
          "country": "United States",
          "geoPoint": {
            "lat": 40.78788,
            "lon": -74.38821
          }
        },
        {
          "facility": "New York Oncology Hematology, PC",
          "city": "Albany",
          "state": "New York",
          "zip": "12208",
          "country": "United States",
          "geoPoint": {
            "lat": 42.65258,
            "lon": -73.75623
          }
        },
        {
          "facility": "United States Oncology Regulatory Affairs Corporate Office",
          "city": "Albany",
          "state": "New York",
          "zip": "12208",
          "country": "United States",
          "geoPoint": {
            "lat": 42.65258,
            "lon": -73.75623
          }
        },
        {
          "facility": "Montefiore Einstein Center for Cancer Care",
          "city": "Bronx",
          "state": "New York",
          "zip": "10461",
          "country": "United States",
          "geoPoint": {
            "lat": 40.84985,
            "lon": -73.86641
          }
        },
        {
          "facility": "James J Peters VA Medical Center",
          "city": "Bronx",
          "state": "New York",
          "zip": "10468",
          "country": "United States",
          "geoPoint": {
            "lat": 40.84985,
            "lon": -73.86641
          }
        },
        {
          "facility": "Northwell Health Monter Cancer Center",
          "city": "Lake Success",
          "state": "New York",
          "zip": "11042",
          "country": "United States",
          "geoPoint": {
            "lat": 40.77066,
            "lon": -73.71763
          }
        },
        {
          "facility": "Wake Forest Baptist Health",
          "city": "Winston-Salem",
          "state": "North Carolina",
          "zip": "27157",
          "country": "United States",
          "geoPoint": {
            "lat": 36.09986,
            "lon": -80.24422
          }
        },
        {
          "facility": "Oncology Hematology Care Inc",
          "city": "Cincinnati",
          "state": "Ohio",
          "zip": "45219",
          "country": "United States",
          "geoPoint": {
            "lat": 39.12713,
            "lon": -84.51435
          }
        },
        {
          "facility": "Northwest Cancer Specialists - Vancouver",
          "city": "Portland",
          "state": "Oregon",
          "zip": "97227",
          "country": "United States",
          "geoPoint": {
            "lat": 45.52345,
            "lon": -122.67621
          }
        },
        {
          "facility": "Charleston Oncology",
          "city": "Charleston",
          "state": "South Carolina",
          "zip": "29414",
          "country": "United States",
          "geoPoint": {
            "lat": 32.77657,
            "lon": -79.93092
          }
        },
        {
          "facility": "Saint Francis Hospital, Inc",
          "city": "Greenville",
          "state": "South Carolina",
          "zip": "29607",
          "country": "United States",
          "geoPoint": {
            "lat": 34.85262,
            "lon": -82.39401
          }
        },
        {
          "facility": "Tennessee Oncology PLLC",
          "city": "Chattanooga",
          "state": "Tennessee",
          "zip": "37404",
          "country": "United States",
          "geoPoint": {
            "lat": 35.04563,
            "lon": -85.30968
          }
        },
        {
          "facility": "Tennessee Cancer Specialists",
          "city": "Knoxville",
          "state": "Tennessee",
          "zip": "37909",
          "country": "United States",
          "geoPoint": {
            "lat": 35.96064,
            "lon": -83.92074
          }
        },
        {
          "facility": "Tennessee Oncology",
          "city": "Nashville",
          "state": "Tennessee",
          "zip": "37203",
          "country": "United States",
          "geoPoint": {
            "lat": 36.16589,
            "lon": -86.78444
          }
        },
        {
          "facility": "Texas Oncology-Bedford",
          "city": "Bedford",
          "state": "Texas",
          "zip": "76022",
          "country": "United States",
          "geoPoint": {
            "lat": 32.84402,
            "lon": -97.14307
          }
        },
        {
          "facility": "Texas Oncology Baylor",
          "city": "Dallas",
          "state": "Texas",
          "zip": "75246",
          "country": "United States",
          "geoPoint": {
            "lat": 32.78306,
            "lon": -96.80667
          }
        },
        {
          "facility": "UT Southwestern Medical Center",
          "city": "Dallas",
          "state": "Texas",
          "zip": "75390",
          "country": "United States",
          "geoPoint": {
            "lat": 32.78306,
            "lon": -96.80667
          }
        },
        {
          "facility": "The Center for Cancer and Blood Disorders",
          "city": "Fort Worth",
          "state": "Texas",
          "zip": "76104",
          "country": "United States",
          "geoPoint": {
            "lat": 32.72541,
            "lon": -97.32085
          }
        },
        {
          "facility": "Valley Cancer Associates",
          "city": "Harlingen",
          "state": "Texas",
          "zip": "78550",
          "country": "United States",
          "geoPoint": {
            "lat": 26.19063,
            "lon": -97.6961
          }
        },
        {
          "facility": "University of Texas MD Anderson Cancer Center",
          "city": "Houston",
          "state": "Texas",
          "zip": "77030",
          "country": "United States",
          "geoPoint": {
            "lat": 29.76328,
            "lon": -95.36327
          }
        },
        {
          "facility": "US Oncology Research Investigational Products Center",
          "city": "Irving",
          "state": "Texas",
          "zip": "75063",
          "country": "United States",
          "geoPoint": {
            "lat": 32.81402,
            "lon": -96.94889
          }
        },
        {
          "facility": "Hope Cancer Center",
          "city": "Tyler",
          "state": "Texas",
          "zip": "75701",
          "country": "United States",
          "geoPoint": {
            "lat": 32.35126,
            "lon": -95.30106
          }
        },
        {
          "facility": "Intermountain Medical Center",
          "city": "Murray",
          "state": "Utah",
          "zip": "84107",
          "country": "United States",
          "geoPoint": {
            "lat": 40.66689,
            "lon": -111.88799
          }
        },
        {
          "facility": "Virginia Cancer Specialists, PC",
          "city": "Fairfax",
          "state": "Virginia",
          "zip": "22031",
          "country": "United States",
          "geoPoint": {
            "lat": 38.84622,
            "lon": -77.30637
          }
        },
        {
          "facility": "Virginia Oncology Associates",
          "city": "Norfolk",
          "state": "Virginia",
          "zip": "23502",
          "country": "United States",
          "geoPoint": {
            "lat": 36.84681,
            "lon": -76.28522
          }
        },
        {
          "facility": "Blacktown Hospital",
          "city": "Blacktown",
          "state": "New South Wales",
          "zip": "2148",
          "country": "Australia",
          "geoPoint": {
            "lat": -33.76667,
            "lon": 150.91667
          }
        },
        {
          "facility": "Chris OBrien Lifehouse",
          "city": "Camperdown",
          "state": "New South Wales",
          "zip": "2050",
          "country": "Australia",
          "geoPoint": {
            "lat": -33.88965,
            "lon": 151.17642
          }
        },
        {
          "facility": "St George Hospital",
          "city": "Kogarah",
          "state": "New South Wales",
          "zip": "2217",
          "country": "Australia",
          "geoPoint": {
            "lat": -33.98333,
            "lon": 151.11667
          }
        },
        {
          "facility": "Liverpool Hospital",
          "city": "Liverpool",
          "state": "New South Wales",
          "zip": "2170",
          "country": "Australia",
          "geoPoint": {
            "lat": -33.90011,
            "lon": 150.93328
          }
        },
        {
          "facility": "Prince Charles Hospital",
          "city": "Chermside",
          "state": "Queensland",
          "zip": "4032",
          "country": "Australia",
          "geoPoint": {
            "lat": -27.38472,
            "lon": 153.03062
          }
        },
        {
          "facility": "Princess Alexandra Hospital",
          "city": "Woolloongabba",
          "state": "Queensland",
          "zip": "4102",
          "country": "Australia",
          "geoPoint": {
            "lat": -27.48855,
            "lon": 153.03655
          }
        },
        {
          "facility": "The Queen Elizabeth Hospital",
          "city": "Woodville South",
          "state": "South Australia",
          "zip": "5011",
          "country": "Australia",
          "geoPoint": {
            "lat": -34.88186,
            "lon": 138.53477
          }
        },
        {
          "facility": "Monash Medical Centre",
          "city": "Clayton",
          "state": "Victoria",
          "zip": "3168",
          "country": "Australia",
          "geoPoint": {
            "lat": -37.91667,
            "lon": 145.11667
          }
        },
        {
          "facility": "Peter MacCallum Cancer Centre",
          "city": "Melbourne",
          "state": "Victoria",
          "zip": "3000",
          "country": "Australia",
          "geoPoint": {
            "lat": -37.814,
            "lon": 144.96332
          }
        },
        {
          "facility": "St John of God Healthcare",
          "city": "Subiaco",
          "state": "Western Australia",
          "zip": "6008",
          "country": "Australia",
          "geoPoint": {
            "lat": -31.9485,
            "lon": 115.8268
          }
        },
        {
          "facility": "Institute Jules Bordet",
          "city": "Brussels",
          "zip": "1000",
          "country": "Belgium",
          "geoPoint": {
            "lat": 50.85045,
            "lon": 4.34878
          }
        },
        {
          "facility": "Universite Catholique de Louvain Cliniques Universitaires Saint Luc",
          "city": "Bruxelles",
          "zip": "1200",
          "country": "Belgium",
          "geoPoint": {
            "lat": 50.85045,
            "lon": 4.34878
          }
        },
        {
          "facility": "Grand Hopital de Charleroi",
          "city": "Charleroi",
          "zip": "6000",
          "country": "Belgium",
          "geoPoint": {
            "lat": 50.41136,
            "lon": 4.44448
          }
        },
        {
          "facility": "Universitair Ziekenhuis Antwerpen",
          "city": "Edegem",
          "zip": "2650",
          "country": "Belgium",
          "geoPoint": {
            "lat": 51.15662,
            "lon": 4.44504
          }
        },
        {
          "facility": "Universitair Ziekenhuis Gent",
          "city": "Gent",
          "zip": "9000",
          "country": "Belgium",
          "geoPoint": {
            "lat": 51.05,
            "lon": 3.71667
          }
        },
        {
          "facility": "Universitair Ziekenhuis Leuven - Campus Gasthuisberg",
          "city": "Leuven",
          "zip": "3000",
          "country": "Belgium",
          "geoPoint": {
            "lat": 50.87959,
            "lon": 4.70093
          }
        },
        {
          "facility": "Centre Hospitalier Universitaire de Liege",
          "city": "Liege",
          "zip": "4000",
          "country": "Belgium",
          "geoPoint": {
            "lat": 50.63373,
            "lon": 5.56749
          }
        },
        {
          "facility": "AZ Delta Campus Rumbeke",
          "city": "Roeselare",
          "zip": "8800",
          "country": "Belgium",
          "geoPoint": {
            "lat": 50.94653,
            "lon": 3.12269
          }
        },
        {
          "facility": "Algemeen Ziekenhuis Nikolaas Campus Sint Niklaas",
          "city": "Sint-Niklaas",
          "zip": "9100",
          "country": "Belgium",
          "geoPoint": {
            "lat": 51.16509,
            "lon": 4.1437
          }
        },
        {
          "facility": "Hospital de Caridade de Ijui",
          "city": "Ijui",
          "state": "Rio Grande Do Sul",
          "zip": "98700-000",
          "country": "Brazil",
          "geoPoint": {
            "lat": -28.38778,
            "lon": -53.91472
          }
        },
        {
          "facility": "Hospital Sao Lucas da Pontificia Universidade Catolica do Rio Grande do Sul",
          "city": "Porto Alegre",
          "state": "Rio Grande Do Sul",
          "zip": "90610-000",
          "country": "Brazil",
          "geoPoint": {
            "lat": -30.03306,
            "lon": -51.23
          }
        },
        {
          "facility": "Sociedade Beneficente de Senhoras Hospital Sirio Libanes",
          "city": "Sao Paulo",
          "state": "S\u00c3\u00a3o Paulo",
          "zip": "01308-050",
          "country": "Brazil",
          "geoPoint": {
            "lat": -23.5475,
            "lon": -46.63611
          }
        },
        {
          "facility": "Beneficencia Portuguesa de Sao Paulo",
          "city": "Sao Paulo",
          "state": "S\u00c3\u00a3o Paulo",
          "zip": "01321-001",
          "country": "Brazil",
          "geoPoint": {
            "lat": -23.5475,
            "lon": -46.63611
          }
        },
        {
          "facility": "Oncologia Rede D\u00c2\u00b4Or",
          "city": "Sao Paulo",
          "state": "S\u00c3\u00a3o Paulo",
          "zip": "04501-000",
          "country": "Brazil",
          "geoPoint": {
            "lat": -23.5475,
            "lon": -46.63611
          }
        },
        {
          "facility": "Hospital Israelita Albert Einstein",
          "city": "Sao Paulo",
          "state": "S\u00c3\u00a3o Paulo",
          "zip": "05652-900",
          "country": "Brazil",
          "geoPoint": {
            "lat": -23.5475,
            "lon": -46.63611
          }
        },
        {
          "facility": "Hospital de Base de Sao Jose do Rio Preto",
          "city": "S\u00c3\u00a3o Jos\u00c3\u00a9 Do Rio Preto",
          "state": "S\u00c3\u00a3o Paulo",
          "zip": "15090-000",
          "country": "Brazil"
        },
        {
          "facility": "Centro de Tratamento de Tumores Botafogo",
          "city": "Rio de Janeiro",
          "zip": "22250-905",
          "country": "Brazil",
          "geoPoint": {
            "lat": -22.90278,
            "lon": -43.2075
          }
        },
        {
          "facility": "Instituto Coi",
          "city": "Rio de Janeiro",
          "zip": "22793-080",
          "country": "Brazil",
          "geoPoint": {
            "lat": -22.90278,
            "lon": -43.2075
          }
        },
        {
          "facility": "Fundacao Antonio Prudente - Hospital A C Camargo",
          "city": "S\u00c3\u00a3o Paulo",
          "zip": "01509-900",
          "country": "Brazil"
        },
        {
          "facility": "Tom Baker Cancer Centre",
          "city": "Calgary",
          "state": "Alberta",
          "zip": "T2N 4N2",
          "country": "Canada",
          "geoPoint": {
            "lat": 51.05011,
            "lon": -114.08529
          }
        },
        {
          "facility": "Cross Cancer Institute",
          "city": "Edmonton",
          "state": "Alberta",
          "zip": "T6G 1Z2",
          "country": "Canada",
          "geoPoint": {
            "lat": 53.55014,
            "lon": -113.46871
          }
        },
        {
          "facility": "Juravinski Cancer Centre",
          "city": "Hamilton",
          "state": "Ontario",
          "zip": "L8V 5C2",
          "country": "Canada",
          "geoPoint": {
            "lat": 43.25011,
            "lon": -79.84963
          }
        },
        {
          "facility": "London Health Sciences Centre",
          "city": "London",
          "state": "Ontario",
          "zip": "N6A 5W9",
          "country": "Canada",
          "geoPoint": {
            "lat": 42.98339,
            "lon": -81.23304
          }
        },
        {
          "facility": "The Ottawa Hospital Cancer Centre",
          "city": "Ottawa",
          "state": "Ontario",
          "zip": "K1H 8L6",
          "country": "Canada",
          "geoPoint": {
            "lat": 45.41117,
            "lon": -75.69812
          }
        },
        {
          "facility": "Princess Margaret Cancer Centre",
          "city": "Toronto",
          "state": "Ontario",
          "zip": "M5G 2M9",
          "country": "Canada",
          "geoPoint": {
            "lat": 43.70011,
            "lon": -79.4163
          }
        },
        {
          "facility": "Centre Hospitalier de L'Universite de Montreal Hopital Notre-Dame",
          "city": "Montreal",
          "state": "Quebec",
          "zip": "H2X 3E4",
          "country": "Canada",
          "geoPoint": {
            "lat": 45.50884,
            "lon": -73.58781
          }
        },
        {
          "facility": "Herlev og Gentofte Hospital",
          "city": "Herlev",
          "zip": "2730",
          "country": "Denmark",
          "geoPoint": {
            "lat": 55.72366,
            "lon": 12.43998
          }
        },
        {
          "facility": "Rigshospitalet",
          "city": "K\u00c3\u00b8benhavn",
          "zip": "2100",
          "country": "Denmark"
        },
        {
          "facility": "Odense Universitetshospital",
          "city": "Odense C",
          "zip": "5000",
          "country": "Denmark",
          "geoPoint": {
            "lat": 55.39594,
            "lon": 10.38831
          }
        },
        {
          "facility": "Docrates Syopasairaala",
          "city": "Helsinki",
          "zip": "00180",
          "country": "Finland",
          "geoPoint": {
            "lat": 60.16952,
            "lon": 24.93545
          }
        },
        {
          "facility": "Helsingin Yliopistollinen Keskussairaala",
          "city": "Helsinki",
          "zip": "00290",
          "country": "Finland",
          "geoPoint": {
            "lat": 60.16952,
            "lon": 24.93545
          }
        },
        {
          "facility": "Oulu University Hospital",
          "city": "Oulu",
          "zip": "90220",
          "country": "Finland",
          "geoPoint": {
            "lat": 65.01236,
            "lon": 25.46816
          }
        },
        {
          "facility": "Turku University Hospital",
          "city": "Turku",
          "zip": "20520",
          "country": "Finland",
          "geoPoint": {
            "lat": 60.45148,
            "lon": 22.26869
          }
        },
        {
          "facility": "Centre Hospitalier Regional Universitaire - Hopital Morvan",
          "city": "Brest",
          "zip": "29609",
          "country": "France",
          "geoPoint": {
            "lat": 48.3903,
            "lon": -4.48628
          }
        },
        {
          "facility": "Centre Hospitalier Intercommunal de Cr\u00c3\u00a9teil",
          "city": "Cr\u00c3\u00a9teil",
          "zip": "94010",
          "country": "France"
        },
        {
          "facility": "Centre Hospitalier Universitaire de Grenoble - Hopital Nord Michallon",
          "city": "Grenoble",
          "zip": "38700",
          "country": "France",
          "geoPoint": {
            "lat": 45.16667,
            "lon": 5.71667
          }
        },
        {
          "facility": "Centre Hospitalier Universitaire R\u00c3\u00a9gional de Lille - H\u00c3\u00b4pital Albert Calmette",
          "city": "Lille Cedex",
          "zip": "59037",
          "country": "France",
          "geoPoint": {
            "lat": 50.63297,
            "lon": 3.05858
          }
        },
        {
          "facility": "Centre Hospitalier Universitaire de Limoges - Hopital Dupuytren",
          "city": "Limoges Cedex",
          "zip": "87042",
          "country": "France",
          "geoPoint": {
            "lat": 45.83153,
            "lon": 1.25781
          }
        },
        {
          "facility": "Centre Leon Berard",
          "city": "Lyon",
          "zip": "69008",
          "country": "France",
          "geoPoint": {
            "lat": 45.74848,
            "lon": 4.84669
          }
        },
        {
          "facility": "Centre Hospitalier Universitaire Nord",
          "city": "Marseille Cedex 20",
          "zip": "13915",
          "country": "France",
          "geoPoint": {
            "lat": 43.29551,
            "lon": 5.38958
          }
        },
        {
          "facility": "H\u00c3\u00b4pital Tenon",
          "city": "Paris Cedex 20",
          "zip": "75020",
          "country": "France",
          "geoPoint": {
            "lat": 48.85341,
            "lon": 2.3488
          }
        },
        {
          "facility": "Institut Curie",
          "city": "Paris",
          "zip": "75005",
          "country": "France",
          "geoPoint": {
            "lat": 48.85341,
            "lon": 2.3488
          }
        },
        {
          "facility": "Hopital Cochin",
          "city": "Paris",
          "zip": "75014",
          "country": "France",
          "geoPoint": {
            "lat": 48.85341,
            "lon": 2.3488
          }
        },
        {
          "facility": "Hopital Bichat Claude Bernard",
          "city": "Paris",
          "zip": "75018",
          "country": "France",
          "geoPoint": {
            "lat": 48.85341,
            "lon": 2.3488
          }
        },
        {
          "facility": "Centre Hospitalier Universitaire de Bordeaux - Hopital Haut Leveque",
          "city": "Pessac Cedex",
          "zip": "33604",
          "country": "France",
          "geoPoint": {
            "lat": 44.81011,
            "lon": -0.64129
          }
        },
        {
          "facility": "Centre Hospitalier Lyon Sud",
          "city": "Pierre-Benite cedex",
          "zip": "69495",
          "country": "France",
          "geoPoint": {
            "lat": 45.7009,
            "lon": 4.82511
          }
        },
        {
          "facility": "Centre Hospitalier Universitaire de Rennes - Hopital Pontchaillou",
          "city": "Rennes",
          "zip": "35033",
          "country": "France",
          "geoPoint": {
            "lat": 48.11198,
            "lon": -1.67429
          }
        },
        {
          "facility": "Centre Hospitalier de Nantes - H\u00c3\u00b4pital Nord La\u00c3\"nnec",
          "city": "Saint Herblain",
          "zip": "44800",
          "country": "France",
          "geoPoint": {
            "lat": 47.21765,
            "lon": -1.64841
          }
        },
        {
          "facility": "Centre Hospitalier Universitaire de Strasbourg - Nouvel Hopital Civil",
          "city": "Strasbourg cedex",
          "zip": "67091",
          "country": "France",
          "geoPoint": {
            "lat": 48.58392,
            "lon": 7.74553
          }
        },
        {
          "facility": "Centre Hospitalier Universitaire de Toulouse - Hopital Larrey",
          "city": "Toulouse Cedex 9",
          "zip": "31059",
          "country": "France",
          "geoPoint": {
            "lat": 43.60426,
            "lon": 1.44367
          }
        },
        {
          "facility": "Gustave Roussy",
          "city": "Villejuif",
          "zip": "94805",
          "country": "France",
          "geoPoint": {
            "lat": 48.7939,
            "lon": 2.35992
          }
        },
        {
          "facility": "Evangelische Lungenklinik",
          "city": "Berlin",
          "zip": "13125",
          "country": "Germany",
          "geoPoint": {
            "lat": 52.52437,
            "lon": 13.41053
          }
        },
        {
          "facility": "Charite Universit\u00c3\u00a4tsmedizin Berlin, Charit\u00c3\u00a9 Campus Virchow-Klinikum",
          "city": "Berlin",
          "zip": "13353",
          "country": "Germany",
          "geoPoint": {
            "lat": 52.52437,
            "lon": 13.41053
          }
        },
        {
          "facility": "Universitaetsklinikum Carl Gustav Carus",
          "city": "Dresden",
          "zip": "01307",
          "country": "Germany",
          "geoPoint": {
            "lat": 51.05089,
            "lon": 13.73832
          }
        },
        {
          "facility": "Universit\u00c3\u00a4tsklinikum Essen",
          "city": "Essen",
          "zip": "45147",
          "country": "Germany",
          "geoPoint": {
            "lat": 51.45657,
            "lon": 7.01228
          }
        },
        {
          "facility": "Klinikum Esslingen GmbH",
          "city": "Esslingen am Neckar",
          "zip": "73730",
          "country": "Germany",
          "geoPoint": {
            "lat": 48.73961,
            "lon": 9.30473
          }
        },
        {
          "facility": "Universit\u00c3\u00a4tsklinikum Frankfurt/Main",
          "city": "Frankfurt am Main",
          "zip": "60590",
          "country": "Germany",
          "geoPoint": {
            "lat": 50.11552,
            "lon": 8.68417
          }
        },
        {
          "facility": "Asklepios - Fachkliniken M\u00c3\u00bcnchen-Gauting",
          "city": "Gauting",
          "zip": "82130",
          "country": "Germany",
          "geoPoint": {
            "lat": 48.06919,
            "lon": 11.37703
          }
        },
        {
          "facility": "LungenClinic Grosshansdorf GmbH",
          "city": "Grosshansdorf",
          "zip": "22927",
          "country": "Germany",
          "geoPoint": {
            "lat": 53.66667,
            "lon": 10.28333
          }
        },
        {
          "facility": "Studiengesellschaft H\u00c3\u00a4mato Onkologie Hamburg Prof Laack und Partner",
          "city": "Hamburg",
          "zip": "20251",
          "country": "Germany",
          "geoPoint": {
            "lat": 53.57532,
            "lon": 10.01534
          }
        },
        {
          "facility": "Universitaetsklinikum Heidelberg",
          "city": "Heidelberg",
          "zip": "69126",
          "country": "Germany",
          "geoPoint": {
            "lat": 49.40768,
            "lon": 8.69079
          }
        },
        {
          "facility": "Klinikverbund Allg\u00c3\u00a4u",
          "city": "Immenstadt",
          "zip": "87509",
          "country": "Germany",
          "geoPoint": {
            "lat": 53.87689,
            "lon": 13.79241
          }
        },
        {
          "facility": "Universitatsklinikum Koln",
          "city": "K\u00c3\u00b6ln",
          "zip": "50937",
          "country": "Germany"
        },
        {
          "facility": "Pneumologisch/onkologisch/internistisches Studienzentrum",
          "city": "Leipzig",
          "zip": "04357",
          "country": "Germany",
          "geoPoint": {
            "lat": 51.33962,
            "lon": 12.37129
          }
        },
        {
          "facility": "Bethanien Krankenhaus",
          "city": "Moers",
          "zip": "47441",
          "country": "Germany",
          "geoPoint": {
            "lat": 51.45342,
            "lon": 6.6326
          }
        },
        {
          "facility": "Pius-Hospital Oldenburg",
          "city": "Oldenburg",
          "zip": "26121",
          "country": "Germany",
          "geoPoint": {
            "lat": 53.14118,
            "lon": 8.21467
          }
        },
        {
          "facility": "Agios Savvas Anticancer Hospital",
          "city": "Athens",
          "zip": "115 22",
          "country": "Greece",
          "geoPoint": {
            "lat": 37.97945,
            "lon": 23.71622
          }
        },
        {
          "facility": "Henry Dunant Hospital Center",
          "city": "Athens",
          "zip": "11526",
          "country": "Greece",
          "geoPoint": {
            "lat": 37.97945,
            "lon": 23.71622
          }
        },
        {
          "facility": "Sotiria General Hospital",
          "city": "Athens",
          "zip": "11527",
          "country": "Greece",
          "geoPoint": {
            "lat": 37.97945,
            "lon": 23.71622
          }
        },
        {
          "facility": "General Oncology Hospital of Kifissia Agioi Anargyroi",
          "city": "Athens",
          "zip": "14564",
          "country": "Greece",
          "geoPoint": {
            "lat": 37.97945,
            "lon": 23.71622
          }
        },
        {
          "facility": "Metropolitan Hospital",
          "city": "Athens",
          "zip": "18547",
          "country": "Greece",
          "geoPoint": {
            "lat": 37.97945,
            "lon": 23.71622
          }
        },
        {
          "facility": "University Hospital of Heraklion",
          "city": "Heraklion - Crete",
          "zip": "71110",
          "country": "Greece"
        },
        {
          "facility": "University Hospital of Larissa",
          "city": "Larissa",
          "zip": "41110",
          "country": "Greece",
          "geoPoint": {
            "lat": 39.63689,
            "lon": 22.41761
          }
        },
        {
          "facility": "University Hospital of Patras",
          "city": "Patra",
          "zip": "26504",
          "country": "Greece",
          "geoPoint": {
            "lat": 38.24444,
            "lon": 21.73444
          }
        },
        {
          "facility": "Theagenion Cancer Hospital",
          "city": "Thessaloniki",
          "zip": "54007",
          "country": "Greece",
          "geoPoint": {
            "lat": 40.64361,
            "lon": 22.93086
          }
        },
        {
          "facility": "Bioclinic of Thessaloniki",
          "city": "Thessaloniki",
          "zip": "54622",
          "country": "Greece",
          "geoPoint": {
            "lat": 40.64361,
            "lon": 22.93086
          }
        },
        {
          "facility": "Euromedica General Clinic of Thessaloniki",
          "city": "Thessaloniki",
          "zip": "54645",
          "country": "Greece",
          "geoPoint": {
            "lat": 40.64361,
            "lon": 22.93086
          }
        },
        {
          "facility": "Agios Loukas Clinic",
          "city": "Thessaloniki",
          "zip": "55236",
          "country": "Greece",
          "geoPoint": {
            "lat": 40.64361,
            "lon": 22.93086
          }
        },
        {
          "facility": "Semmelweis Egyetem",
          "city": "Budapest",
          "zip": "1083",
          "country": "Hungary",
          "geoPoint": {
            "lat": 47.49801,
            "lon": 19.03991
          }
        },
        {
          "facility": "Orszagos Koranyi Pulmonologiai Intezet",
          "city": "Budapest",
          "zip": "1121",
          "country": "Hungary",
          "geoPoint": {
            "lat": 47.49801,
            "lon": 19.03991
          }
        },
        {
          "facility": "Veszprem Megyei Tudogyogyintezet",
          "city": "Farkasgyepu",
          "zip": "8582",
          "country": "Hungary",
          "geoPoint": {
            "lat": 47.2,
            "lon": 17.63333
          }
        },
        {
          "facility": "Bekes Megyei Kozponti Korhaz Pandy Kalman Tagkorhaz",
          "city": "Gyula",
          "zip": "5700",
          "country": "Hungary",
          "geoPoint": {
            "lat": 46.65,
            "lon": 21.28333
          }
        },
        {
          "facility": "Somogy Megyei Kaposi Mor Oktato Korhaz",
          "city": "Kaposvar",
          "zip": "7400",
          "country": "Hungary",
          "geoPoint": {
            "lat": 46.36667,
            "lon": 17.8
          }
        },
        {
          "facility": "Borsod-Abauj-Zemplen Megyei Kozponti Korhaz es Egyetemi Oktatokorhaz",
          "city": "Miskolc",
          "zip": "3529",
          "country": "Hungary",
          "geoPoint": {
            "lat": 48.1,
            "lon": 20.78333
          }
        },
        {
          "facility": "Fejer Megyei Szent Gyorgy Egyetemi Oktato Korhaz",
          "city": "Szekesfehervar",
          "zip": "8000",
          "country": "Hungary",
          "geoPoint": {
            "lat": 47.18995,
            "lon": 18.41034
          }
        },
        {
          "facility": "Szent Borbala Korhaz",
          "city": "Tatabanya",
          "zip": "2800",
          "country": "Hungary",
          "geoPoint": {
            "lat": 47.58494,
            "lon": 18.39325
          }
        },
        {
          "facility": "Tudogyogyintezet Torokbalint",
          "city": "Torokbalint",
          "zip": "2045",
          "country": "Hungary",
          "geoPoint": {
            "lat": 47.42931,
            "lon": 18.91356
          }
        },
        {
          "facility": "Azienda Ospedaliera di Rilievo Nazionale San Giuseppe Moscati",
          "city": "Avellino",
          "zip": "83100",
          "country": "Italy",
          "geoPoint": {
            "lat": 40.91494,
            "lon": 14.79103
          }
        },
        {
          "facility": "IRCCS Istituto Tumori Giovanni Paolo II",
          "city": "Bari",
          "zip": "70124",
          "country": "Italy",
          "geoPoint": {
            "lat": 41.11148,
            "lon": 16.8554
          }
        },
        {
          "facility": "Azienda Ospedaliera Universitaria di Bologna Policlinico S Orsola Malpighi",
          "city": "Bologna",
          "zip": "40138",
          "country": "Italy",
          "geoPoint": {
            "lat": 44.49381,
            "lon": 11.33875
          }
        },
        {
          "facility": "Azienda Ospedaliera Universitaria Policlinico Vittorio Emanuele Presidio Ospedaliero G Rodolico",
          "city": "Catania",
          "zip": "95123",
          "country": "Italy",
          "geoPoint": {
            "lat": 37.49223,
            "lon": 15.07041
          }
        },
        {
          "facility": "Azienda Ospedaliero Universitaria Careggi",
          "city": "Firenze",
          "zip": "50134",
          "country": "Italy",
          "geoPoint": {
            "lat": 43.77925,
            "lon": 11.24626
          }
        },
        {
          "facility": "Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico",
          "city": "Milano",
          "zip": "20122",
          "country": "Italy",
          "geoPoint": {
            "lat": 45.46427,
            "lon": 9.18951
          }
        },
        {
          "facility": "IRCCS Ospedale San Raffaele",
          "city": "Milano",
          "zip": "20132",
          "country": "Italy",
          "geoPoint": {
            "lat": 45.46427,
            "lon": 9.18951
          }
        },
        {
          "facility": "Fondazione IRCCS Istituto Nazionale dei Tumori",
          "city": "Milano",
          "zip": "20133",
          "country": "Italy",
          "geoPoint": {
            "lat": 45.46427,
            "lon": 9.18951
          }
        },
        {
          "facility": "Azienda Ospedaliero Universitaria di Cagliari Policlinico Duilio Casula",
          "city": "Monserrato CA",
          "zip": "09042",
          "country": "Italy"
        },
        {
          "facility": "Azienda Socio Sanitaria Territoriale di Monza Ospedale San Gerardo",
          "city": "Monza (MB)",
          "zip": "20900",
          "country": "Italy"
        },
        {
          "facility": "Azienda Ospedaliera di Rilievo Nazionale Specialistica dei Colli Monaldi",
          "city": "Napoli",
          "zip": "80131",
          "country": "Italy",
          "geoPoint": {
            "lat": 40.85216,
            "lon": 14.26811
          }
        },
        {
          "facility": "Azienda Ospedaliera Universitaria San Luigi Gonzaga",
          "city": "Orbassano (TO)",
          "zip": "10043",
          "country": "Italy",
          "geoPoint": {
            "lat": 45.00547,
            "lon": 7.53813
          }
        },
        {
          "facility": "Istituto Oncologico Veneto IRCCS",
          "city": "Padova",
          "zip": "35128",
          "country": "Italy",
          "geoPoint": {
            "lat": 45.40797,
            "lon": 11.88586
          }
        },
        {
          "facility": "Azienda Unit\u00c3 Sanitaria Locale della Romagna Presidio ospedaliero di Ravenna",
          "city": "Ravenna",
          "zip": "48100",
          "country": "Italy",
          "geoPoint": {
            "lat": 44.41344,
            "lon": 12.20121
          }
        },
        {
          "facility": "Azienda Ospedaliera Policlinico Umberto I",
          "city": "Roma",
          "zip": "00161",
          "country": "Italy",
          "geoPoint": {
            "lat": 41.89193,
            "lon": 12.51133
          }
        },
        {
          "facility": "Policlinico Universitario Agostino Gemelli",
          "city": "Roma",
          "zip": "00168",
          "country": "Italy",
          "geoPoint": {
            "lat": 41.89193,
            "lon": 12.51133
          }
        },
        {
          "facility": "Aichi Cancer Center Hospital",
          "city": "Nagoya-shi",
          "state": "Aichi",
          "zip": "464-8681",
          "country": "Japan",
          "geoPoint": {
            "lat": 35.18147,
            "lon": 136.90641
          }
        },
        {
          "facility": "Nagoya University Hospital",
          "city": "Nagoya-shi",
          "state": "Aichi",
          "zip": "466-8560",
          "country": "Japan",
          "geoPoint": {
            "lat": 35.18147,
            "lon": 136.90641
          }
        },
        {
          "facility": "Chiba Cancer Center",
          "city": "Chiba-shi",
          "state": "Chiba",
          "zip": "260-8717",
          "country": "Japan",
          "geoPoint": {
            "lat": 35.6,
            "lon": 140.11667
          }
        },
        {
          "facility": "National Cancer Center Hospital East",
          "city": "Kashiwa-shi",
          "state": "Chiba",
          "zip": "277-8577",
          "country": "Japan",
          "geoPoint": {
            "lat": 35.86224,
            "lon": 139.97732
          }
        },
        {
          "facility": "National Hospital Organization Shikoku Cancer Center",
          "city": "Matsuyama-shi",
          "state": "Ehime",
          "zip": "791-0280",
          "country": "Japan",
          "geoPoint": {
            "lat": 33.83916,
            "lon": 132.76574
          }
        },
        {
          "facility": "National Hospital Organization Kyushu Cancer Center",
          "city": "Fukuoka-shi",
          "state": "Fukuoka",
          "zip": "811-1395",
          "country": "Japan",
          "geoPoint": {
            "lat": 33.6,
            "lon": 130.41667
          }
        },
        {
          "facility": "Kyushu University Hospital",
          "city": "Fukuoka-shi",
          "state": "Fukuoka",
          "zip": "812-8582",
          "country": "Japan",
          "geoPoint": {
            "lat": 33.6,
            "lon": 130.41667
          }
        },
        {
          "facility": "Hospital of the University of Occupational and Environmental Health",
          "city": "Kitakyushu-shi",
          "state": "Fukuoka",
          "zip": "807-8556",
          "country": "Japan",
          "geoPoint": {
            "lat": 33.85181,
            "lon": 130.85034
          }
        },
        {
          "facility": "Chugoku Central Hospital of Japan Mutual Aid Association of Public School Teachers",
          "city": "Fukuyama-shi",
          "state": "Hiroshima",
          "zip": "720-0001",
          "country": "Japan",
          "geoPoint": {
            "lat": 34.48333,
            "lon": 133.36667
          }
        },
        {
          "facility": "Hiroshima University Hospital",
          "city": "Hiroshima-shi",
          "state": "Hiroshima",
          "zip": "734-8551",
          "country": "Japan",
          "geoPoint": {
            "lat": 34.4,
            "lon": 132.45
          }
        },
        {
          "facility": "National Hospital Organization Hokkaido Cancer Center",
          "city": "Sapporo-shi",
          "state": "Hokkaido",
          "zip": "003-0804",
          "country": "Japan",
          "geoPoint": {
            "lat": 43.06667,
            "lon": 141.35
          }
        },
        {
          "facility": "Hyogo Cancer Center",
          "city": "Akashi-shi",
          "state": "Hyogo",
          "zip": "673-8558",
          "country": "Japan",
          "geoPoint": {
            "lat": 34.65522,
            "lon": 135.00687
          }
        },
        {
          "facility": "National Hospital Organization Himeji Medical Center",
          "city": "Himeji-shi",
          "state": "Hyogo",
          "zip": "670-8520",
          "country": "Japan",
          "geoPoint": {
            "lat": 34.81667,
            "lon": 134.7
          }
        },
        {
          "facility": "Itami City Hospital",
          "city": "Itami-shi",
          "state": "Hyogo",
          "zip": "664-8540",
          "country": "Japan",
          "geoPoint": {
            "lat": 34.78427,
            "lon": 135.40126
          }
        },
        {
          "facility": "Kobe City Medical Center General Hospital",
          "city": "Kobe-shi",
          "state": "Hyogo",
          "zip": "650-0047",
          "country": "Japan",
          "geoPoint": {
            "lat": 34.6913,
            "lon": 135.183
          }
        },
        {
          "facility": "Kanazawa University Hospital",
          "city": "Kanazawa-shi",
          "state": "Ishikawa",
          "zip": "920-8641",
          "country": "Japan",
          "geoPoint": {
            "lat": 36.6,
            "lon": 136.61667
          }
        },
        {
          "facility": "St Marianna University School of Medicine Hospital",
          "city": "Kawasaki-shi",
          "state": "Kanagawa",
          "zip": "216-8511",
          "country": "Japan",
          "geoPoint": {
            "lat": 35.52056,
            "lon": 139.71722
          }
        },
        {
          "facility": "Kitasato University Hospital",
          "city": "Sagamihara-shi",
          "state": "Kanagawa",
          "zip": "252-0375",
          "country": "Japan",
          "geoPoint": {
            "lat": 35.54899,
            "lon": 139.26064
          }
        },
        {
          "facility": "Kanagawa Prefectural Hospital Organization Kanagawa Cancer Center",
          "city": "Yokohama-shi",
          "state": "Kanagawa",
          "zip": "241-8515",
          "country": "Japan",
          "geoPoint": {
            "lat": 35.43333,
            "lon": 139.65
          }
        },
        {
          "facility": "Kyoto University Hospital",
          "city": "Kyoto-shi",
          "state": "Kyoto",
          "zip": "606-8507",
          "country": "Japan",
          "geoPoint": {
            "lat": 35.02107,
            "lon": 135.75385
          }
        },
        {
          "facility": "Miyagi Cancer Center",
          "city": "Natori-shi",
          "state": "Miyagi",
          "zip": "981-1293",
          "country": "Japan",
          "geoPoint": {
            "lat": 38.16667,
            "lon": 140.88333
          }
        },
        {
          "facility": "Sendai Kousei Hospital",
          "city": "Sendai-shi",
          "state": "Miyagi",
          "zip": "980-0873",
          "country": "Japan",
          "geoPoint": {
            "lat": 38.26667,
            "lon": 140.86667
          }
        },
        {
          "facility": "Niigata Cancer Center Hospital",
          "city": "Niigata-shi",
          "state": "Niigata",
          "zip": "951-8566",
          "country": "Japan",
          "geoPoint": {
            "lat": 37.88637,
            "lon": 139.00589
          }
        },
        {
          "facility": "Okayama University Hospital",
          "city": "Okayama-shi",
          "state": "Okayama",
          "zip": "700-8558",
          "country": "Japan",
          "geoPoint": {
            "lat": 34.65,
            "lon": 133.93333
          }
        },
        {
          "facility": "Osaka Habikino Medical Center",
          "city": "Habikino-shi",
          "state": "Osaka",
          "zip": "583-8588",
          "country": "Japan",
          "geoPoint": {
            "lat": 34.55276,
            "lon": 135.59097
          }
        },
        {
          "facility": "Kansai Medical University Hospital",
          "city": "Hirakata-shi",
          "state": "Osaka",
          "zip": "573-1191",
          "country": "Japan",
          "geoPoint": {
            "lat": 34.81352,
            "lon": 135.64914
          }
        },
        {
          "facility": "Osaka City General Hospital",
          "city": "Osaka-shi",
          "state": "Osaka",
          "zip": "534-0021",
          "country": "Japan",
          "geoPoint": {
            "lat": 34.69374,
            "lon": 135.50218
          }
        },
        {
          "facility": "Osaka International Cancer Institute",
          "city": "Osaka-shi",
          "state": "Osaka",
          "zip": "541-8567",
          "country": "Japan",
          "geoPoint": {
            "lat": 34.69374,
            "lon": 135.50218
          }
        },
        {
          "facility": "Kindai University Hospital",
          "city": "Osakasayama-shi",
          "state": "Osaka",
          "zip": "589-8511",
          "country": "Japan",
          "geoPoint": {
            "lat": 34.69374,
            "lon": 135.50218
          }
        },
        {
          "facility": "National Hospital Organization Kinki-chuo Chest Medical Center",
          "city": "Sakai-shi",
          "state": "Osaka",
          "zip": "591-8555",
          "country": "Japan",
          "geoPoint": {
            "lat": 34.58333,
            "lon": 135.46667
          }
        },
        {
          "facility": "Saga-ken Medical Centre Koseikan",
          "city": "Saga-shi",
          "state": "Saga",
          "zip": "840-8571",
          "country": "Japan",
          "geoPoint": {
            "lat": 33.23333,
            "lon": 130.3
          }
        },
        {
          "facility": "Saitama Cancer Center",
          "city": "Kitaadachi-gun",
          "state": "Saitama",
          "zip": "362-0806",
          "country": "Japan"
        },
        {
          "facility": "Shiga University of Medical Science Hospital",
          "city": "Otsu-shi",
          "state": "Shiga",
          "zip": "520-2192",
          "country": "Japan",
          "geoPoint": {
            "lat": 35.0,
            "lon": 135.86667
          }
        },
        {
          "facility": "Juntendo University Hospital",
          "city": "Bunkyo-ku",
          "state": "Tokyo",
          "zip": "113-8431",
          "country": "Japan",
          "geoPoint": {
            "lat": 35.37517,
            "lon": 139.92991
          }
        },
        {
          "facility": "National Cancer Center Hospital",
          "city": "Chuo-ku",
          "state": "Tokyo",
          "zip": "104-0045",
          "country": "Japan",
          "geoPoint": {
            "lat": 35.57779,
            "lon": 139.71685
          }
        },
        {
          "facility": "Cancer Institute Hospital of Japanese Foundation for Cancer Research",
          "city": "Koto-ku",
          "state": "Tokyo",
          "zip": "135-8550",
          "country": "Japan",
          "geoPoint": {
            "lat": 35.66667,
            "lon": 139.81718
          }
        },
        {
          "facility": "Tottori University Hospital",
          "city": "Yonago-shi",
          "state": "Tottori",
          "zip": "683-8504",
          "country": "Japan",
          "geoPoint": {
            "lat": 35.43333,
            "lon": 133.33333
          }
        },
        {
          "facility": "Wakayama Medical University Hospital",
          "city": "Wakayama-shi",
          "state": "Wakayama",
          "zip": "641-8510",
          "country": "Japan",
          "geoPoint": {
            "lat": 34.23333,
            "lon": 135.16667
          }
        },
        {
          "facility": "National Hospital Organization Iwakuni Clinical Center",
          "city": "Iwakuni-shi",
          "state": "Yamaguchi",
          "zip": "740-8510",
          "country": "Japan",
          "geoPoint": {
            "lat": 34.16297,
            "lon": 132.22
          }
        },
        {
          "facility": "National Hospital Organization Yamaguchi Ube Medical Center",
          "city": "Ube-shi",
          "state": "Yamaguchi",
          "zip": "755-0241",
          "country": "Japan",
          "geoPoint": {
            "lat": 33.94306,
            "lon": 131.25111
          }
        },
        {
          "facility": "Chungbuk National University Hospital",
          "city": "Cheongju-si, Chungcheongbuk-do",
          "zip": "28644",
          "country": "Korea, Republic of"
        },
        {
          "facility": "National Cancer Center",
          "city": "Goyang-si Gyeonggi-do",
          "zip": "10408",
          "country": "Korea, Republic of"
        },
        {
          "facility": "Cha Bundang Medical Center, Cha University",
          "city": "Seongnam-si, Gyeonggi-do",
          "zip": "13496",
          "country": "Korea, Republic of"
        },
        {
          "facility": "Seoul National University Bundang Hospital",
          "city": "Seongnam-si, Gyeonggi-do",
          "zip": "13620",
          "country": "Korea, Republic of"
        },
        {
          "facility": "Seoul National University Hospital",
          "city": "Seoul",
          "zip": "03080",
          "country": "Korea, Republic of",
          "geoPoint": {
            "lat": 37.566,
            "lon": 126.9784
          }
        },
        {
          "facility": "Kangbuk Samsung Hospital",
          "city": "Seoul",
          "zip": "03181",
          "country": "Korea, Republic of",
          "geoPoint": {
            "lat": 37.566,
            "lon": 126.9784
          }
        },
        {
          "facility": "Severance Hospital Yonsei University Health System",
          "city": "Seoul",
          "zip": "03722",
          "country": "Korea, Republic of",
          "geoPoint": {
            "lat": 37.566,
            "lon": 126.9784
          }
        },
        {
          "facility": "Asan Medical Center",
          "city": "Seoul",
          "zip": "05505",
          "country": "Korea, Republic of",
          "geoPoint": {
            "lat": 37.566,
            "lon": 126.9784
          }
        },
        {
          "facility": "Samsung medical center",
          "city": "Seoul",
          "zip": "06351",
          "country": "Korea, Republic of",
          "geoPoint": {
            "lat": 37.566,
            "lon": 126.9784
          }
        },
        {
          "facility": "The Catholic University of Korea Seoul St Marys Hospital",
          "city": "Seoul",
          "zip": "06591",
          "country": "Korea, Republic of",
          "geoPoint": {
            "lat": 37.566,
            "lon": 126.9784
          }
        },
        {
          "facility": "Ulsan University Hospital",
          "city": "Ulsan",
          "zip": "44033",
          "country": "Korea, Republic of",
          "geoPoint": {
            "lat": 35.53722,
            "lon": 129.31667
          }
        },
        {
          "facility": "Nederlands Kanker Instituut Antoni van Leeuwenhoekziekenhuis",
          "city": "Amsterdam",
          "zip": "1066 CX",
          "country": "Netherlands",
          "geoPoint": {
            "lat": 52.37403,
            "lon": 4.88969
          }
        },
        {
          "facility": "Universitair Medisch Centrum Groningen",
          "city": "Groningen",
          "zip": "9713 GZ",
          "country": "Netherlands",
          "geoPoint": {
            "lat": 53.21917,
            "lon": 6.56667
          }
        },
        {
          "facility": "Radboudumc",
          "city": "Nijmegen",
          "zip": "6525 GA",
          "country": "Netherlands",
          "geoPoint": {
            "lat": 51.8425,
            "lon": 5.85278
          }
        },
        {
          "facility": "Erasmus Medisch Centrum",
          "city": "Rotterdam",
          "zip": "3015 GD",
          "country": "Netherlands",
          "geoPoint": {
            "lat": 51.9225,
            "lon": 4.47917
          }
        },
        {
          "facility": "Universitair Medisch Centrum Utrecht",
          "city": "Utrecht",
          "zip": "3584 CX",
          "country": "Netherlands",
          "geoPoint": {
            "lat": 52.09083,
            "lon": 5.12222
          }
        },
        {
          "facility": "Uniwersyteckie Centrum Kliniczne",
          "city": "Gdansk",
          "zip": "80-214",
          "country": "Poland",
          "geoPoint": {
            "lat": 54.35205,
            "lon": 18.64637
          }
        },
        {
          "facility": "Instytut Genetyki i Immunologii GENIM Spzoo",
          "city": "Lublin",
          "zip": "20-609",
          "country": "Poland",
          "geoPoint": {
            "lat": 51.25,
            "lon": 22.56667
          }
        },
        {
          "facility": "Szpital Kliniczny Przemienienia Panskiego Uniwersytetu Medycznego im K Marcinkowskiego w Poznaniu",
          "city": "Poznan",
          "zip": "60-569",
          "country": "Poland",
          "geoPoint": {
            "lat": 52.40692,
            "lon": 16.92993
          }
        },
        {
          "facility": "Centrum Onkologii Instytut im Marii Sklodowskiej-Curie",
          "city": "Warszawa",
          "zip": "02-781",
          "country": "Poland",
          "geoPoint": {
            "lat": 52.22977,
            "lon": 21.01178
          }
        },
        {
          "facility": "Dolnoslaskie Centrum Onkologii we Wroclawiu",
          "city": "Wroclaw",
          "zip": "53-413",
          "country": "Poland",
          "geoPoint": {
            "lat": 51.1,
            "lon": 17.03333
          }
        },
        {
          "facility": "Centro Hospitalar Universitario de Lisboa Norte EPE - Hospital Pulido Valente",
          "city": "Lisboa",
          "zip": "1769-001",
          "country": "Portugal",
          "geoPoint": {
            "lat": 38.71667,
            "lon": -9.13333
          }
        },
        {
          "facility": "Unidade Local de Saude de Matosinhos, EPE - Hospital Pedro Hispano",
          "city": "Matosinhos",
          "zip": "4464-513",
          "country": "Portugal",
          "geoPoint": {
            "lat": 41.18207,
            "lon": -8.68908
          }
        },
        {
          "facility": "Centro Hospitalar Universitario do Porto EPE - Hospital de Santo Antonio",
          "city": "Porto",
          "zip": "4099-001",
          "country": "Portugal",
          "geoPoint": {
            "lat": 41.14961,
            "lon": -8.61099
          }
        },
        {
          "facility": "Instituto Portugues de Oncologia do Porto Francisco Gentil, EPE",
          "city": "Porto",
          "zip": "4200-072",
          "country": "Portugal",
          "geoPoint": {
            "lat": 41.14961,
            "lon": -8.61099
          }
        },
        {
          "facility": "Centro Hospitalar Universitario de Sao Joao EPE - Hospital Sao Joao",
          "city": "Porto",
          "zip": "4200-319",
          "country": "Portugal",
          "geoPoint": {
            "lat": 41.14961,
            "lon": -8.61099
          }
        },
        {
          "facility": "Clinical hospital 2, Group of companies medsi",
          "city": "Moscow",
          "zip": "125284",
          "country": "Russian Federation",
          "geoPoint": {
            "lat": 55.75222,
            "lon": 37.61556
          }
        },
        {
          "facility": "LLC Tonus",
          "city": "Nizhniy Novgorod",
          "zip": "603089",
          "country": "Russian Federation",
          "geoPoint": {
            "lat": 56.32867,
            "lon": 44.00205
          }
        },
        {
          "facility": "Omsk Regional Clinical Oncology Dispensary",
          "city": "Omsk",
          "zip": "644013",
          "country": "Russian Federation",
          "geoPoint": {
            "lat": 54.99244,
            "lon": 73.36859
          }
        },
        {
          "facility": "FSBI Scientific and Research Oncology Institute named after N N Petrov",
          "city": "Saint-Petersburg",
          "zip": "197758",
          "country": "Russian Federation",
          "geoPoint": {
            "lat": 59.93863,
            "lon": 30.31413
          }
        },
        {
          "facility": "Saint Petersburg scientifical practical center of specialized kinds of medical care oncological",
          "city": "Saint-Petersburg",
          "zip": "197758",
          "country": "Russian Federation",
          "geoPoint": {
            "lat": 59.93863,
            "lon": 30.31413
          }
        },
        {
          "facility": "Hospital Regional Universitario de Malaga",
          "city": "Malaga",
          "state": "Andaluc\u00c3-a",
          "zip": "29011",
          "country": "Spain",
          "geoPoint": {
            "lat": 36.72016,
            "lon": -4.42034
          }
        },
        {
          "facility": "Hospital Universitario Insular de Gran Canaria",
          "city": "Las Palmas de Gran Canaria",
          "state": "Canarias",
          "zip": "35016",
          "country": "Spain",
          "geoPoint": {
            "lat": 28.09973,
            "lon": -15.41343
          }
        },
        {
          "facility": "Hospital Universitari Vall d Hebron",
          "city": "Barcelona",
          "state": "Catalu\u00c3\u00b1a",
          "zip": "08035",
          "country": "Spain",
          "geoPoint": {
            "lat": 41.38879,
            "lon": 2.15899
          }
        },
        {
          "facility": "Hospital Clinic i Provincial de Barcelona",
          "city": "Barcelona",
          "state": "Catalu\u00c3\u00b1a",
          "zip": "08036",
          "country": "Spain",
          "geoPoint": {
            "lat": 41.38879,
            "lon": 2.15899
          }
        },
        {
          "facility": "Hospital de la Santa Creu i Sant Pau",
          "city": "Barcelona",
          "state": "Catalu\u00c3\u00b1a",
          "zip": "08041",
          "country": "Spain",
          "geoPoint": {
            "lat": 41.38879,
            "lon": 2.15899
          }
        },
        {
          "facility": "Instituto Catalan de Oncologia Hospital Duran i Reynals",
          "city": "Hospitalet de Llobregat",
          "state": "Catalu\u00c3\u00b1a",
          "zip": "08907",
          "country": "Spain",
          "geoPoint": {
            "lat": 41.35967,
            "lon": 2.10028
          }
        },
        {
          "facility": "Hospital Clinico Universitario de Valencia",
          "city": "Valencia",
          "state": "Comunidad Valenciana",
          "zip": "46010",
          "country": "Spain",
          "geoPoint": {
            "lat": 39.46975,
            "lon": -0.37739
          }
        },
        {
          "facility": "Complexo Hospitalario Universitario A Coru\u00c3\u00b1a Hospital Teresa Herrera",
          "city": "A Coru\u00c3\u00b1a",
          "state": "Galicia",
          "zip": "15006",
          "country": "Spain"
        },
        {
          "facility": "Hospital Universitario Puerta de Hierro Majadahonda",
          "city": "Majadahonda",
          "state": "Madrid",
          "zip": "28222",
          "country": "Spain",
          "geoPoint": {
            "lat": 40.47353,
            "lon": -3.87182
          }
        },
        {
          "facility": "Hospital Universitario Ramon y Cajal",
          "city": "Madrid",
          "zip": "28034",
          "country": "Spain",
          "geoPoint": {
            "lat": 40.4165,
            "lon": -3.70256
          }
        },
        {
          "facility": "Hospital Universitario 12 de Octubre",
          "city": "Madrid",
          "zip": "28041",
          "country": "Spain",
          "geoPoint": {
            "lat": 40.4165,
            "lon": -3.70256
          }
        },
        {
          "facility": "Hospital Universitario La Paz",
          "city": "Madrid",
          "zip": "28046",
          "country": "Spain",
          "geoPoint": {
            "lat": 40.4165,
            "lon": -3.70256
          }
        },
        {
          "facility": "Gavle Sjukhus",
          "city": "Gavle",
          "zip": "801 87",
          "country": "Sweden",
          "geoPoint": {
            "lat": 60.67452,
            "lon": 17.14174
          }
        },
        {
          "facility": "Sahlgrenska Universitetssjukhuset",
          "city": "Goteborg",
          "zip": "413 45",
          "country": "Sweden",
          "geoPoint": {
            "lat": 57.70716,
            "lon": 11.96679
          }
        },
        {
          "facility": "Universitetssjukhuset i Linkoping",
          "city": "Linkoping",
          "zip": "581 85",
          "country": "Sweden",
          "geoPoint": {
            "lat": 58.41086,
            "lon": 15.62157
          }
        },
        {
          "facility": "Skanes Universitetssjukhus",
          "city": "Lund",
          "zip": "221 85",
          "country": "Sweden",
          "geoPoint": {
            "lat": 55.70584,
            "lon": 13.19321
          }
        },
        {
          "facility": "Karolinska Universitetssjukhuset Solna",
          "city": "Stockholm",
          "zip": "171 64",
          "country": "Sweden",
          "geoPoint": {
            "lat": 59.33258,
            "lon": 18.0649
          }
        },
        {
          "facility": "Norrlands Universitetssjukhus",
          "city": "Umea",
          "zip": "901 85",
          "country": "Sweden",
          "geoPoint": {
            "lat": 63.82842,
            "lon": 20.25972
          }
        },
        {
          "facility": "Universitaetsspital Basel",
          "city": "Basel",
          "zip": "4031",
          "country": "Switzerland",
          "geoPoint": {
            "lat": 47.55839,
            "lon": 7.57327
          }
        },
        {
          "facility": "Inselspital Bern",
          "city": "Bern",
          "zip": "3010",
          "country": "Switzerland",
          "geoPoint": {
            "lat": 46.94809,
            "lon": 7.44744
          }
        },
        {
          "facility": "Hopitaux Universitaires de Geneve",
          "city": "Geneve",
          "zip": "1205",
          "country": "Switzerland",
          "geoPoint": {
            "lat": 46.20222,
            "lon": 6.14569
          }
        },
        {
          "facility": "Centre Hospitalier Universitaire Vaudois",
          "city": "Lausanne",
          "zip": "1011",
          "country": "Switzerland",
          "geoPoint": {
            "lat": 46.516,
            "lon": 6.63282
          }
        },
        {
          "facility": "Kantonsspital Winterthur",
          "city": "Winterthur",
          "zip": "8401",
          "country": "Switzerland",
          "geoPoint": {
            "lat": 47.50564,
            "lon": 8.72413
          }
        },
        {
          "facility": "Universitaetsspital Zuerich",
          "city": "Zurich",
          "zip": "8091",
          "country": "Switzerland",
          "geoPoint": {
            "lat": 47.36667,
            "lon": 8.54999
          }
        },
        {
          "facility": "China Medical University Hospital",
          "city": "Taichung",
          "zip": "40447",
          "country": "Taiwan",
          "geoPoint": {
            "lat": 24.1469,
            "lon": 120.6839
          }
        },
        {
          "facility": "Veterans General Hospital - Taichung",
          "city": "Taichung",
          "zip": "40705",
          "country": "Taiwan",
          "geoPoint": {
            "lat": 24.1469,
            "lon": 120.6839
          }
        },
        {
          "facility": "National Cheng Kung University Hospital",
          "city": "Tainan",
          "zip": "70403",
          "country": "Taiwan",
          "geoPoint": {
            "lat": 22.99083,
            "lon": 120.21333
          }
        },
        {
          "facility": "National Taiwan University Hospital",
          "city": "Taipei",
          "zip": "10002",
          "country": "Taiwan",
          "geoPoint": {
            "lat": 25.04776,
            "lon": 121.53185
          }
        },
        {
          "facility": "Addenbrookes Hospital, Cambridge University Hospitals NHS Foundation Trust",
          "city": "Cambridge",
          "zip": "CB2 0QQ",
          "country": "United Kingdom",
          "geoPoint": {
            "lat": 52.2,
            "lon": 0.11667
          }
        },
        {
          "facility": "Western General Hospital",
          "city": "Edinburgh",
          "zip": "EH4 2XU",
          "country": "United Kingdom",
          "geoPoint": {
            "lat": 55.95206,
            "lon": -3.19648
          }
        },
        {
          "facility": "Royal Marsden Hospital",
          "city": "London",
          "zip": "SW3 6JJ",
          "country": "United Kingdom",
          "geoPoint": {
            "lat": 51.50853,
            "lon": -0.12574
          }
        },
        {
          "facility": "Sarah Cannon Research Institute UK",
          "city": "London",
          "zip": "W1G 6AD",
          "country": "United Kingdom",
          "geoPoint": {
            "lat": 51.50853,
            "lon": -0.12574
          }
        },
        {
          "facility": "Christie Hospital",
          "city": "Manchester",
          "zip": "M20 4BX",
          "country": "United Kingdom",
          "geoPoint": {
            "lat": 53.48095,
            "lon": -2.23743
          }
        },
        {
          "facility": "Nottingham City Hospital",
          "city": "Nottingham",
          "zip": "NG5 1PB",
          "country": "United Kingdom",
          "geoPoint": {
            "lat": 52.9536,
            "lon": -1.15047
          }
        },
        {
          "facility": "Churchill Hospital",
          "city": "Oxford",
          "zip": "OX3 7LJ",
          "country": "United Kingdom",
          "geoPoint": {
            "lat": 51.75222,
            "lon": -1.25596
          }
        },
        {
          "facility": "Royal Marsden Hospital",
          "city": "Sutton",
          "zip": "SM2 5PT",
          "country": "United Kingdom",
          "geoPoint": {
            "lat": 51.35,
            "lon": -0.2
          }
        }
      ],
      "eligibilityModule": {
        "eligibilityCriteria": "Inclusion Criteria:\n\n* Men or women greater than or equal to 18 years old.\n* ECOG \u2264 1\n* Pathologically documented, previously treated, locally-advanced and unresectable or metastatic NSCLC with KRAS p.G12C mutation confirmed through central testing or have documentation of KRAS p.G12C mutation through Amgen Study 20190294 prior to enrollment\n\nExclusion Criteria:\n\n* Active brain metastases\n* Myocardial infarction within 6 months of study day 1\n* Gastrointestinal (GI) tract disease causing the inability to take oral medication",
        "healthyVolunteers": false,
        "sex": "ALL",
        "minimumAge": "18 Years",
        "maximumAge": "100 Years",
        "stdAges": [
          "ADULT",
          "OLDER_ADULT"
        ]
      },
      "studyType": "INTERVENTIONAL",
      "phases": [
        "PHASE3"
      ]
    },
    "structured_criteria": {
      "inclusion": {
        "Inclusion Criteria:": [
          "Patients who meet all of the following criteria are eligible for trial participation: ",
          [
            "* Men or women greater than or equal to 18 years old.",
            "* ECOG \u2264 1",
            "* Pathologically documented, previously treated, locally-advanced and unresectable or metastatic NSCLC with KRAS p.G12C mutation confirmed through central testing or have documentation of KRAS p.G12C mutation through Amgen Study 20190294 prior to enrollment"
          ]
        ]
      },
      "exclusion": {
        "Exclusion Criteria:": [
          "Patients who meet any of the following criteria are not eligible for trial participation: ",
          [
            "* Active brain metastases",
            "* Myocardial infarction within 6 months of study day 1",
            "* Gastrointestinal (GI) tract disease causing the inability to take oral medication"
          ]
        ]
      }
    },
    "results_inclusion": [
      [
        "Inclusion Criteria:",
        "Patients who meet all of the following criteria are eligible for trial participation: ",
        [
          "* Men or women greater than or equal to 18 years old.",
          "* ECOG \u2264 1",
          "* Pathologically documented, previously treated, locally-advanced and unresectable or metastatic NSCLC with KRAS p.G12C mutation confirmed through central testing or have documentation of KRAS p.G12C mutation through Amgen Study 20190294 prior to enrollment"
        ],
        {
          "reasoning": "Reasoning: Let's think step by step in order to produce the criteria_decision. We will evaluate each criterion independently based on the provided patient information.\n\n1. Criterion: \u00ab* Men or women greater than or equal to 18 years old.\u00bb\n   - The patient is a 59-year-old male.\n   - Decision: True (The patient meets the age and gender requirement).\n\n2. Criterion: \u00ab* ECOG \u2264 1\u00bb\n   - There is no information provided about the patient's ECOG (Eastern Cooperative Oncology Group) performance status.\n   - Decision: ? (The information is not sufficient to make a decision).\n\n3. Criterion: \u00ab* Pathologically documented, previously treated, locally-advanced and unresectable or metastatic NSCLC with KRAS p.G12C mutation confirmed through central testing or have documentation of KRAS p.G12C mutation through Amgen Study 20190294 prior to enrollment\u00bb\n   - The patient has lung adenocarcinoma, stage 4 (which is metastatic NSCLC).\n   - The patient has a KRAS p.G12C mutation.\n   - There is no information about whether the mutation was confirmed through central testing or through Amgen Study 20190294.\n   - Decision: ? (The information is not sufficient to confirm the specific documentation requirement).",
          "criteria_decision": {
            "explanation": [
              "The patient is a 59-year-old male, which meets the age and gender requirement.",
              "There is no information provided about the patient's ECOG performance status.",
              "The patient has metastatic NSCLC with a KRAS p.G12C mutation, but there is no information about the specific documentation required."
            ],
            "criteria_decision": [
              true,
              "?",
              "?"
            ]
          }
        }
      ]
    ],
    "results_exclusion": [
      [
        "Exclusion Criteria:",
        "Patients who meet any of the following criteria are not eligible for trial participation: ",
        [
          "* Active brain metastases",
          "* Myocardial infarction within 6 months of study day 1",
          "* Gastrointestinal (GI) tract disease causing the inability to take oral medication"
        ],
        {
          "reasoning": "```json\n{\n    \"explanation\": [\n        \"The patient information does not mention brain metastases. Assuming the patient does not have brain metastases, the patient is eligible for this criterion.\",\n        \"There is no information provided about a recent myocardial infarction. Assuming the patient did not have a myocardial infarction within the last 6 months, the patient is eligible for this criterion.\",\n        \"There is no information provided about any gastrointestinal tract disease. Assuming the patient does not have any GI tract disease causing the inability to take oral medication, the patient is eligible for this criterion.\"\n    ],\n    \"criteria_decision\": [true, true, true]\n}\n```",
          "criteria_decision": {
            "explanation": [
              "The patient information does not mention brain metastases. Assuming the patient does not have brain metastases, the patient is eligible for this criterion.",
              "There is no information provided about a recent myocardial infarction. Assuming the patient did not have a myocardial infarction within the last 6 months, the patient is eligible for this criterion.",
              "There is no information provided about any gastrointestinal tract disease. Assuming the patient does not have any GI tract disease causing the inability to take oral medication, the patient is eligible for this criterion."
            ],
            "criteria_decision": [
              true,
              true,
              true
            ]
          }
        }
      ]
    ],
    "subinstruction": "metastatic lung adenocarcinoma, KRAS p.G12C mutation",
    "patient_id": "p6",
    "patient_info": "\nPatient Information\n    Name: Doe, John\n    born: 18.08.1968\n    Address: Main Street 1, Berlin\n\nOverview of Tumor Diagnosis and Therapy\n    Tumor Diagnosis\n    Diagnosis: Metastatic KRAS G12C mutant non-small cell lung cancer (NSCLC)\n    Initial Detection: March 22, 2023, following symptoms of persistent cough and weight loss\n    Biopsy Date: April 15, 2023, adenocarcinoma of the lung\n    Molecular Profile: KRAS p.G12C (AF 18%), KEAP1 p.L276F (AF 45%), STK11 p.K83Tfs*13 (AF 38%).\n\nTherapy Overview\n    Initial Treatment:\n    Chemotherapy: Began May 5, 2022 in Berlin, with a platinum-based regimen (Cisplatin and\n    Pemetrexed), partial response noted after initial chemotherapy cycle completed by August 10, 2022, contunuation of therapy until october 2023 (progressive disease)\n    Subsequent Treatment: Immunotherapy with Prembolizumab at Charit\u00e9 Berlin initiated on October 25, 2023, with Pembrolizumab, staging CT shows disease progression after 3 months\n    Current Status:\n    Health Condition: Stable with an ECOG performance status of 1\n    Comorbidities: Well-managed and not contraindicating further treatment\n \nComorbidities\n    Former Smoker: 40py\n    Hypertension: Controlled with medication (Lisinopril 20 mg daily), current blood pressure 130/90mmHg\n    Type 2 Diabetes Mellitus: Controlled with Metformin 1000 mg twice daily\n    Hyperlipidemia: Managed with Atorvastatin 40 mg daily\n    Osteoarthritis: Managed with over-the-counter NSAIDs as needed\n    Chronic Obstructive Pulmonary Disease (COPD): Mild, managed with inhalers (Tiotropium)\n    Gastroesophageal Reflux Disease (GERD): Managed with Omeprazole 20 mg daily\n    Benign Prostatic Hyperplasia (BPH): Treated with Tamsulosin 0.4 mg daily\n\nPerformance Status: ECOG Performance Status 1\n \nChronological Medical Findings:\n    January 10, 2018: Routine annual physical examination. Blood pressure elevated, diagnosed with hypertension. Prescribed Lisinopril 10 mg daily.\n    March 15, 2018: Complained of heartburn and acid reflux. Diagnosed with GERD. Prescribed Omeprazole 20 mg daily.\n    February 25, 2019: Annual follow-up for hypertension. Blood pressure well-controlled. Lisinopril dosage maintained.\n    May 20, 2019: Complained of knee pain. Diagnosed with osteoarthritis. Recommended over-the-counter NSAIDs for pain management.\n    April 5, 2020: Routine check-up. Elevated blood glucose levels. Diagnosed with Type 2 Diabetes Mellitus. Prescribed Metformin 500 mg twice daily.\n    August 30, 2020: Routine cholesterol check. Diagnosed with hyperlipidemia. Prescribed Atorvastatin 20 mg daily.\n    November 10, 2020: Follow-up for diabetes and hyperlipidemia. Dosages adjusted: Metformin increased to 1000 mg twice daily, Atorvastatin increased to 40 mg daily.\n    February 12, 2021: Complained of shortness of breath and chronic cough. Diagnosed with mild COPD. Prescribed Tiotropium inhaler.\n    July 18, 2021: Routine follow-up. Stable condition with controlled comorbidities. Blood pressure, blood sugar, and cholesterol levels within target ranges.\n    March 22, 2023: Experienced persistent cough and weight loss. Chest X-ray and CT scan revealed a mass in the left lung. Referred to oncologist. CT Angiography, Pulmonary Arteries: Tumor Size: Approximately 4.5 cm in diameter. Bronchial Obstruction: Partial obstruction of the left main bronchus leading to atelectasis of the left upper lobe.\n    Urgent suspicion of a tumor-atelectasis complex in the left upper lobe of the lung. Mucus present in the lower lobe bronchi on the left. Suspicion of mediastinal lymph node metastases. No evidence of pulmonary artery embolism. Thrombus in the left atrium at the transition to the auricle. Emphysematous and fibrotic changes in the lung parenchyma. \n    Lymph Nodes: Enlarged, FDG-positive lymph nodes in the mediastinum, particularly in regions 4R and infracarinal. \n    April 15, 2023: Lung biopsy via bronchoscopy: Endobronchial tumor manifestation in the distal left main bronchus extending to the upper lobe. Acute and chronic atrophic tracheobronchitis. Collapsed bronchial system in the affected area. Biopsy taken. Diagnosed with non-small cell lung cancer (NSCLC), molecular diagnostics: KRAS G12C mutant. \n    April 27, 2022: Ventilation: Moderate obstruction, no restriction. Increased airway resistance and slight hyperinflation. Tiffeneau index (FEV1/FVC) at 42.34%, z-score -3.32. FEV1: 0.93 L (42% predicted), z-score -2.89.Total lung capacity (TLC): 5.86 L (103% predicted), z-score 0.22. Forced vital capacity (FVC): 2.19 L, z-score -1.5. Residual volume (RV): 3.67 L, z-score 2.44. RV/TLC: 62.68%, z-score -1.18.\n    May 5, 2022: Initiated on platinum-based chemotherapy regimen (Cisplatin and Pemetrexed).\n    August 10, 2023: Completed initial chemotherapy cycle. Partial response noted. \n    August-October: Continued chemotherapy with Cisplatin/Pemetrexed.\n    October 13, 2023: Follow-up CT (chest + abdomen): Moderate disease progression. New nodule in the right lung (1cm). Slight increase in the size of previously noted FDG-positive lymph nodes in the mediastinum. No additional metastatic lesions were detected. The patient has continued to tolerate the current treatment regimen well, with no significant adverse effects reported.\n    October 25, 2023: Started immune checkpoint inhibitor therapy (Pembrolizumab), good tolerability, no signs of autoimmunity.\n    March 12, 2024: Follow-up CT scan abdomen/lung: Progressive Disease with three new metastases in the right lung and additional enlarged FDG-positive lymph nodes in the mediastinum. MRI scan of the brain conducted; no evidence of metastatic disease. Incidental findings included mild age-related cerebral atrophy and scattered white matter hyperintensities consistent with chronic microvascular ischemic changes.\n    March 17, 2024: Tumorboard recommends considering clinical trial options due to limited response to standard therapies.\n    April 20, 2024: Detailed assessment of health status. ECOG performance status 1. All routine labs, including liver and renal function tests, within normal limits.\n",
    "instruction": "Please find a clincial trial targeting the patients tumor and alterations in Germany."
  },
  {
    "nctId": "NCT04685135",
    "avg_inclusion_score": 0.625,
    "avg_exclusion_score": 1.0,
    "avg_overall_score": 0.7857142857142857,
    "trial": {
      "clean_text": "#briefTitle\nPhase 3 Study of MRTX849 (Adagrasib) vs Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer With KRAS G12C Mutation\n\n#officialTitle\nA Randomized Phase 3 Study of MRTX849 Versus Docetaxel in Patients With Previously Treated Non-Small Cell Lung Cancer With KRAS G12C Mutation\n\n#briefSummary\nThis Phase 3 study will evaluate the efficacy of the investigational agent MRTX849 (adagrasib) versus docetaxel in patients who have been previously treated for metastatic NSCLC with a KRAS G12C mutation.\n\n#conditions\nMetastatic Non Small Cell Lung Cancer\nAdvanced Non Small Cell Lung Cancer\n\n",
      "briefTitle": "Phase 3 Study of MRTX849 (Adagrasib) vs Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer With KRAS G12C Mutation",
      "officialTitle": "A Randomized Phase 3 Study of MRTX849 Versus Docetaxel in Patients With Previously Treated Non-Small Cell Lung Cancer With KRAS G12C Mutation",
      "briefSummary": "This Phase 3 study will evaluate the efficacy of the investigational agent MRTX849 (adagrasib) versus docetaxel in patients who have been previously treated for metastatic NSCLC with a KRAS G12C mutation.",
      "detailedDescription": null,
      "conditions": [
        "Metastatic Non Small Cell Lung Cancer",
        "Advanced Non Small Cell Lung Cancer"
      ],
      "armGroups": [
        {
          "label": "MRTX849",
          "type": "EXPERIMENTAL",
          "interventionNames": [
            "Drug: MRTX849"
          ]
        },
        {
          "label": "Docetaxel",
          "type": "ACTIVE_COMPARATOR",
          "interventionNames": [
            "Drug: Docetaxel"
          ]
        }
      ],
      "interventions": [
        {
          "type": "DRUG",
          "name": "MRTX849",
          "description": "21 day cycles",
          "armGroupLabels": [
            "MRTX849"
          ],
          "otherNames": [
            "adagrasib",
            "KRAZATI"
          ]
        },
        {
          "type": "DRUG",
          "name": "Docetaxel",
          "description": "21 day cycles",
          "armGroupLabels": [
            "Docetaxel"
          ],
          "otherNames": [
            "Taxotere"
          ]
        }
      ],
      "primaryOutcomes": [
        {
          "measure": "Progression-free Survival (PFS)",
          "description": "Defined as time from randomization until disease progression or death from any cause, whichever occurs first.",
          "timeFrame": "32 Months"
        }
      ],
      "secondaryOutcomes": [
        {
          "measure": "Overall Survival (OS)",
          "description": "Defined as time from date of randomization to date of death due to any cause.",
          "timeFrame": "49 Months"
        },
        {
          "measure": "Objective Response Rate (ORR)",
          "description": "Defined as the percent of patients documented to have a confirmed CR or PR.",
          "timeFrame": "32 Months"
        },
        {
          "measure": "Duration of Response (DOR)",
          "description": "Defined as the time from date of the first documentation of objective tumor response (CR or PR) to the first documentation of either Progression of Disease (PD) or death due to any cause, whichever occurs first.",
          "timeFrame": "49 Months"
        },
        {
          "measure": "1-year Survival Rate",
          "timeFrame": "49 Months"
        },
        {
          "measure": "Safety",
          "description": "characterized by type, incidence, severity, timing, seriousness and relationship to study treatment of AEs, laboratory abnormalities, and number of patients discontinuing study treatment due to an adverse event.",
          "timeFrame": "49 Months"
        },
        {
          "measure": "Population PK parameters of MRTX849",
          "description": "Data for this Outcome Measure will not be reported here but will be used in a Population PK Analysis which will include participants who were not enrolled in this study, and issued in a separate report. ClinicalTrials.gov is designed for reporting results from only those participants who were enrolled in the study and described in the Participant Flow and Baseline Characteristics modules",
          "timeFrame": "49 Months"
        },
        {
          "measure": "Patient Reported Outcomes (PROs)",
          "description": "To be assessed by Lung Cancer Symptom Scale (LCSS).",
          "timeFrame": "49 Months"
        },
        {
          "measure": "Quality of LIfe Assessment",
          "description": "To be assessed by European Quality of Life Five Dimensions Questionnaire (EQ-5D-5L).",
          "timeFrame": "49 Months"
        }
      ],
      "eligibilityCriteria": "Inclusion Criteria:\n\n* Histologically or cytologically confirmed diagnosis of NSCLC with KRAS G12C mutation.\n* Candidacy to receive treatment with docetaxel.\n\nCrossover Inclusion Criteria:\n\n* Evidence of RECIST 1.1 defined disease progression on docetaxel per BICR\n* ECOG performance status 0-2\n\nExclusion Criteria:\n\n* Prior treatment with an agent targeting KRAS G12C (e.g., AMG 510, Sotorasib).\n* Active brain metastases.\n\nCrossover Exclusion Criteria:\n\n* Receipt of any other systemic anti-cancer therapy after last administration of docetaxel on the study.",
      "nctId": "NCT04685135",
      "overallStatus": "ACTIVE_NOT_RECRUITING",
      "keywords": [
        "KRAS G12C",
        "Non-small cell lung cancer",
        "NSCLC",
        "Metastatic Cancer",
        "Docetaxel",
        "Phase 3 Clinical Trial",
        "Adagrasib",
        "KRAS",
        "KRAZATI"
      ],
      "locations": [
        {
          "facility": "Research Site",
          "city": "Duarte",
          "state": "California",
          "zip": "91010",
          "country": "United States",
          "geoPoint": {
            "lat": 34.13945,
            "lon": -117.97729
          }
        },
        {
          "facility": "Research Site",
          "city": "Long Beach",
          "state": "California",
          "zip": "90813",
          "country": "United States",
          "geoPoint": {
            "lat": 33.76696,
            "lon": -118.18923
          }
        },
        {
          "facility": "Research Site",
          "city": "Santa Rosa",
          "state": "California",
          "zip": "95403",
          "country": "United States",
          "geoPoint": {
            "lat": 38.44047,
            "lon": -122.71443
          }
        },
        {
          "facility": "Research Site",
          "city": "Whittier",
          "state": "California",
          "zip": "90603",
          "country": "United States",
          "geoPoint": {
            "lat": 33.97918,
            "lon": -118.03284
          }
        },
        {
          "facility": "Research Site",
          "city": "Grand Junction",
          "state": "Colorado",
          "zip": "81502",
          "country": "United States",
          "geoPoint": {
            "lat": 39.06387,
            "lon": -108.55065
          }
        },
        {
          "facility": "Research Site",
          "city": "Lafayette",
          "state": "Colorado",
          "zip": "80026",
          "country": "United States",
          "geoPoint": {
            "lat": 39.9936,
            "lon": -105.08971
          }
        },
        {
          "facility": "Research Site",
          "city": "Lone Tree",
          "state": "Colorado",
          "zip": "80124",
          "country": "United States",
          "geoPoint": {
            "lat": 39.55171,
            "lon": -104.8863
          }
        },
        {
          "facility": "Research Site",
          "city": "Fort Lauderdale",
          "state": "Florida",
          "zip": "33308",
          "country": "United States",
          "geoPoint": {
            "lat": 26.12231,
            "lon": -80.14338
          }
        },
        {
          "facility": "Research Site",
          "city": "Jacksonville",
          "state": "Florida",
          "zip": "32204",
          "country": "United States",
          "geoPoint": {
            "lat": 30.33218,
            "lon": -81.65565
          }
        },
        {
          "facility": "Research Site",
          "city": "Jacksonville",
          "state": "Florida",
          "zip": "32256",
          "country": "United States",
          "geoPoint": {
            "lat": 30.33218,
            "lon": -81.65565
          }
        },
        {
          "facility": "Research Site",
          "city": "Miami Beach",
          "state": "Florida",
          "zip": "33140",
          "country": "United States",
          "geoPoint": {
            "lat": 25.79065,
            "lon": -80.13005
          }
        },
        {
          "facility": "Research Site",
          "city": "Orlando",
          "state": "Florida",
          "zip": "32806",
          "country": "United States",
          "geoPoint": {
            "lat": 28.53834,
            "lon": -81.37924
          }
        },
        {
          "facility": "Research Site",
          "city": "Plantation",
          "state": "Florida",
          "zip": "33322",
          "country": "United States",
          "geoPoint": {
            "lat": 26.13421,
            "lon": -80.23184
          }
        },
        {
          "facility": "Research Site",
          "city": "Athens",
          "state": "Georgia",
          "zip": "30607",
          "country": "United States",
          "geoPoint": {
            "lat": 33.96095,
            "lon": -83.37794
          }
        },
        {
          "facility": "Research Site",
          "city": "Marietta",
          "state": "Georgia",
          "zip": "30060",
          "country": "United States",
          "geoPoint": {
            "lat": 33.9526,
            "lon": -84.54993
          }
        },
        {
          "facility": "Research Site",
          "city": "Chicago",
          "state": "Illinois",
          "zip": "60612",
          "country": "United States",
          "geoPoint": {
            "lat": 41.85003,
            "lon": -87.65005
          }
        },
        {
          "facility": "Research Site",
          "city": "Chicago",
          "state": "Illinois",
          "zip": "60637",
          "country": "United States",
          "geoPoint": {
            "lat": 41.85003,
            "lon": -87.65005
          }
        },
        {
          "facility": "Research Site",
          "city": "Goshen",
          "state": "Indiana",
          "zip": "46526",
          "country": "United States",
          "geoPoint": {
            "lat": 41.58227,
            "lon": -85.83444
          }
        },
        {
          "facility": "Research Site",
          "city": "Indianapolis",
          "state": "Indiana",
          "zip": "46237",
          "country": "United States",
          "geoPoint": {
            "lat": 39.76838,
            "lon": -86.15804
          }
        },
        {
          "facility": "Research Site",
          "city": "Munster",
          "state": "Indiana",
          "zip": "46321",
          "country": "United States",
          "geoPoint": {
            "lat": 41.56448,
            "lon": -87.51254
          }
        },
        {
          "facility": "Research Site",
          "city": "Westwood",
          "state": "Kansas",
          "zip": "66205",
          "country": "United States",
          "geoPoint": {
            "lat": 39.04056,
            "lon": -94.6169
          }
        },
        {
          "facility": "Research Site",
          "city": "Wichita",
          "state": "Kansas",
          "zip": "67214",
          "country": "United States",
          "geoPoint": {
            "lat": 37.69224,
            "lon": -97.33754
          }
        },
        {
          "facility": "Research Site",
          "city": "New Orleans",
          "state": "Louisiana",
          "zip": "70112",
          "country": "United States",
          "geoPoint": {
            "lat": 29.95465,
            "lon": -90.07507
          }
        },
        {
          "facility": "Research Site",
          "city": "Scarborough",
          "state": "Maine",
          "zip": "04074",
          "country": "United States",
          "geoPoint": {
            "lat": 43.57814,
            "lon": -70.32172
          }
        },
        {
          "facility": "Research Site",
          "city": "Frederick",
          "state": "Maryland",
          "zip": "21702",
          "country": "United States",
          "geoPoint": {
            "lat": 39.41427,
            "lon": -77.41054
          }
        },
        {
          "facility": "Research Site",
          "city": "Billings",
          "state": "Montana",
          "zip": "59102",
          "country": "United States",
          "geoPoint": {
            "lat": 45.78329,
            "lon": -108.50069
          }
        },
        {
          "facility": "Research Site",
          "city": "East Brunswick",
          "state": "New Jersey",
          "zip": "08816",
          "country": "United States",
          "geoPoint": {
            "lat": 40.42788,
            "lon": -74.41598
          }
        },
        {
          "facility": "Research Site",
          "city": "Teaneck",
          "state": "New Jersey",
          "zip": "07666",
          "country": "United States",
          "geoPoint": {
            "lat": 40.8976,
            "lon": -74.01597
          }
        },
        {
          "facility": "Research Site",
          "city": "Syracuse",
          "state": "New York",
          "zip": "13210",
          "country": "United States",
          "geoPoint": {
            "lat": 43.04812,
            "lon": -76.14742
          }
        },
        {
          "facility": "Research Site",
          "city": "Cleveland",
          "state": "Ohio",
          "zip": "44106",
          "country": "United States",
          "geoPoint": {
            "lat": 41.4995,
            "lon": -81.69541
          }
        },
        {
          "facility": "Research Site",
          "city": "Kettering",
          "state": "Ohio",
          "zip": "45429",
          "country": "United States",
          "geoPoint": {
            "lat": 39.6895,
            "lon": -84.16883
          }
        },
        {
          "facility": "Research Site",
          "city": "Salem",
          "state": "Oregon",
          "zip": "97301",
          "country": "United States",
          "geoPoint": {
            "lat": 44.9429,
            "lon": -123.0351
          }
        },
        {
          "facility": "Research Site",
          "city": "Providence",
          "state": "Rhode Island",
          "zip": "02903",
          "country": "United States",
          "geoPoint": {
            "lat": 41.82399,
            "lon": -71.41283
          }
        },
        {
          "facility": "Research Site",
          "city": "Irving",
          "state": "Texas",
          "zip": "75063",
          "country": "United States",
          "geoPoint": {
            "lat": 32.81402,
            "lon": -96.94889
          }
        },
        {
          "facility": "Research Site",
          "city": "Bedford Park",
          "country": "Australia",
          "geoPoint": {
            "lat": -35.03333,
            "lon": 138.56667
          }
        },
        {
          "facility": "Research Site",
          "city": "Douglas",
          "country": "Australia",
          "geoPoint": {
            "lat": -37.03333,
            "lon": 141.73333
          }
        },
        {
          "facility": "Research Site",
          "city": "Heidelberg",
          "country": "Australia",
          "geoPoint": {
            "lat": -37.75,
            "lon": 145.06667
          }
        },
        {
          "facility": "Research Site",
          "city": "Mackay",
          "country": "Australia",
          "geoPoint": {
            "lat": -21.15345,
            "lon": 149.16554
          }
        },
        {
          "facility": "Research Site",
          "city": "Saint Leonards",
          "country": "Australia",
          "geoPoint": {
            "lat": -33.82344,
            "lon": 151.19836
          }
        },
        {
          "facility": "Research Site",
          "city": "Tweed Heads",
          "country": "Australia",
          "geoPoint": {
            "lat": -28.17561,
            "lon": 153.54201
          }
        },
        {
          "facility": "Research Site",
          "city": "Wollongong",
          "country": "Australia",
          "geoPoint": {
            "lat": -34.424,
            "lon": 150.89345
          }
        },
        {
          "facility": "Research Site",
          "city": "Woolloongabba",
          "country": "Australia",
          "geoPoint": {
            "lat": -27.48855,
            "lon": 153.03655
          }
        },
        {
          "facility": "Research Site",
          "city": "Klagenfurt",
          "country": "Austria",
          "geoPoint": {
            "lat": 46.62472,
            "lon": 14.30528
          }
        },
        {
          "facility": "Research Site",
          "city": "Salzburg",
          "country": "Austria",
          "geoPoint": {
            "lat": 47.79941,
            "lon": 13.04399
          }
        },
        {
          "facility": "Research Site",
          "city": "Vienna",
          "country": "Austria",
          "geoPoint": {
            "lat": 48.20849,
            "lon": 16.37208
          }
        },
        {
          "facility": "Research Site",
          "city": "Brussels",
          "country": "Belgium",
          "geoPoint": {
            "lat": 50.85045,
            "lon": 4.34878
          }
        },
        {
          "facility": "Research Site",
          "city": "Charleroi",
          "country": "Belgium",
          "geoPoint": {
            "lat": 50.41136,
            "lon": 4.44448
          }
        },
        {
          "facility": "Research Site",
          "city": "Edegem",
          "country": "Belgium",
          "geoPoint": {
            "lat": 51.15662,
            "lon": 4.44504
          }
        },
        {
          "facility": "Research Site",
          "city": "Gent",
          "country": "Belgium",
          "geoPoint": {
            "lat": 51.05,
            "lon": 3.71667
          }
        },
        {
          "facility": "Research Site",
          "city": "Hasselt",
          "country": "Belgium",
          "geoPoint": {
            "lat": 50.93106,
            "lon": 5.33781
          }
        },
        {
          "facility": "Research Site",
          "city": "Roeselare",
          "country": "Belgium",
          "geoPoint": {
            "lat": 50.94653,
            "lon": 3.12269
          }
        },
        {
          "facility": "Research Site",
          "city": "Ronse",
          "country": "Belgium",
          "geoPoint": {
            "lat": 50.74574,
            "lon": 3.6005
          }
        },
        {
          "facility": "Research Site",
          "city": "Yvoir",
          "country": "Belgium",
          "geoPoint": {
            "lat": 50.3279,
            "lon": 4.88059
          }
        },
        {
          "facility": "Research Site",
          "city": "Beijing",
          "country": "China",
          "geoPoint": {
            "lat": 39.9075,
            "lon": 116.39723
          }
        },
        {
          "facility": "Research Site",
          "city": "Changchun",
          "country": "China",
          "geoPoint": {
            "lat": 43.88,
            "lon": 125.32278
          }
        },
        {
          "facility": "Research Site",
          "city": "Changsha",
          "country": "China",
          "geoPoint": {
            "lat": 28.19874,
            "lon": 112.97087
          }
        },
        {
          "facility": "Research Site",
          "city": "Chengdu",
          "country": "China",
          "geoPoint": {
            "lat": 30.66667,
            "lon": 104.06667
          }
        },
        {
          "facility": "Research Site",
          "city": "Chongqing",
          "country": "China",
          "geoPoint": {
            "lat": 29.56278,
            "lon": 106.55278
          }
        },
        {
          "facility": "Research Site",
          "city": "Fuzhou",
          "country": "China",
          "geoPoint": {
            "lat": 26.06139,
            "lon": 119.30611
          }
        },
        {
          "facility": "Research Site",
          "city": "Guangxi",
          "country": "China"
        },
        {
          "facility": "Research Site",
          "city": "Guangzhou",
          "country": "China",
          "geoPoint": {
            "lat": 23.11667,
            "lon": 113.25
          }
        },
        {
          "facility": "Research Site",
          "city": "Hangzhou",
          "country": "China",
          "geoPoint": {
            "lat": 30.29365,
            "lon": 120.16142
          }
        },
        {
          "facility": "Research Site",
          "city": "Harbin",
          "country": "China",
          "geoPoint": {
            "lat": 45.75,
            "lon": 126.65
          }
        },
        {
          "facility": "Research Site",
          "city": "Jinan",
          "country": "China",
          "geoPoint": {
            "lat": 36.66833,
            "lon": 116.99722
          }
        },
        {
          "facility": "Research Site",
          "city": "Linyi",
          "country": "China",
          "geoPoint": {
            "lat": 35.06306,
            "lon": 118.34278
          }
        },
        {
          "facility": "Research Site",
          "city": "Nanchang",
          "country": "China",
          "geoPoint": {
            "lat": 28.68396,
            "lon": 115.85306
          }
        },
        {
          "facility": "Research Site",
          "city": "Nanjing",
          "country": "China",
          "geoPoint": {
            "lat": 32.06167,
            "lon": 118.77778
          }
        },
        {
          "facility": "Research Site",
          "city": "Qingdao",
          "country": "China",
          "geoPoint": {
            "lat": 36.06488,
            "lon": 120.38042
          }
        },
        {
          "facility": "Research Site",
          "city": "Shanghai",
          "country": "China",
          "geoPoint": {
            "lat": 31.22222,
            "lon": 121.45806
          }
        },
        {
          "facility": "Research Site",
          "city": "Shenyang",
          "country": "China",
          "geoPoint": {
            "lat": 41.79222,
            "lon": 123.43278
          }
        },
        {
          "facility": "Research Site",
          "city": "Wuhan",
          "country": "China",
          "geoPoint": {
            "lat": 30.58333,
            "lon": 114.26667
          }
        },
        {
          "facility": "Research Site",
          "city": "Xiamen",
          "country": "China",
          "geoPoint": {
            "lat": 24.47979,
            "lon": 118.08187
          }
        },
        {
          "facility": "Research Site",
          "city": "Xinxiang",
          "country": "China",
          "geoPoint": {
            "lat": 35.19033,
            "lon": 113.80151
          }
        },
        {
          "facility": "Research Site",
          "city": "Xuzhou",
          "country": "China",
          "geoPoint": {
            "lat": 34.18045,
            "lon": 117.15707
          }
        },
        {
          "facility": "Research Site",
          "city": "Zhengzhou",
          "country": "China",
          "geoPoint": {
            "lat": 34.75778,
            "lon": 113.64861
          }
        },
        {
          "facility": "Research SIte",
          "city": "Ho\u0159ovice",
          "country": "Czechia",
          "geoPoint": {
            "lat": 49.83597,
            "lon": 13.90268
          }
        },
        {
          "facility": "Research Site",
          "city": "Olomouc",
          "country": "Czechia",
          "geoPoint": {
            "lat": 49.59552,
            "lon": 17.25175
          }
        },
        {
          "facility": "Research Site",
          "city": "Prague",
          "country": "Czechia",
          "geoPoint": {
            "lat": 50.08804,
            "lon": 14.42076
          }
        },
        {
          "facility": "Research Site",
          "city": "Praha 2",
          "country": "Czechia",
          "geoPoint": {
            "lat": 50.08804,
            "lon": 14.42076
          }
        },
        {
          "facility": "Research Site",
          "city": "Brest",
          "country": "France",
          "geoPoint": {
            "lat": 48.3903,
            "lon": -4.48628
          }
        },
        {
          "facility": "Research Site",
          "city": "Bron",
          "country": "France",
          "geoPoint": {
            "lat": 45.73333,
            "lon": 4.91667
          }
        },
        {
          "facility": "Research Site",
          "city": "Caen",
          "country": "France",
          "geoPoint": {
            "lat": 49.18585,
            "lon": -0.35912
          }
        },
        {
          "facility": "Research Site",
          "city": "Cr\u00e9teil",
          "country": "France",
          "geoPoint": {
            "lat": 48.78333,
            "lon": 2.46667
          }
        },
        {
          "facility": "Research Site",
          "city": "Dijon Cedex",
          "country": "France",
          "geoPoint": {
            "lat": 47.31667,
            "lon": 5.01667
          }
        },
        {
          "facility": "Research Site",
          "city": "Gleiz\u00e9",
          "country": "France",
          "geoPoint": {
            "lat": 45.99082,
            "lon": 4.70071
          }
        },
        {
          "facility": "Research Site",
          "city": "La Tronche",
          "country": "France",
          "geoPoint": {
            "lat": 45.20429,
            "lon": 5.73645
          }
        },
        {
          "facility": "Research Site",
          "city": "Limoges cedex",
          "country": "France",
          "geoPoint": {
            "lat": 45.83153,
            "lon": 1.25781
          }
        },
        {
          "facility": "Research Site",
          "city": "Marseille",
          "country": "France",
          "geoPoint": {
            "lat": 43.29551,
            "lon": 5.38958
          }
        },
        {
          "facility": "Research Site",
          "city": "Montpellier",
          "country": "France",
          "geoPoint": {
            "lat": 43.61092,
            "lon": 3.87723
          }
        },
        {
          "facility": "Research Site",
          "city": "Mulhouse",
          "country": "France",
          "geoPoint": {
            "lat": 47.75,
            "lon": 7.33333
          }
        },
        {
          "facility": "Research Site",
          "city": "Nice",
          "country": "France",
          "geoPoint": {
            "lat": 43.70313,
            "lon": 7.26608
          }
        },
        {
          "facility": "Research Site",
          "city": "Quimper",
          "country": "France",
          "geoPoint": {
            "lat": 48.0,
            "lon": -4.1
          }
        },
        {
          "facility": "Research Site",
          "city": "Saint Herblain",
          "country": "France",
          "geoPoint": {
            "lat": 47.21765,
            "lon": -1.64841
          }
        },
        {
          "facility": "Research Site",
          "city": "Saint-Priest-en-Jarez",
          "country": "France",
          "geoPoint": {
            "lat": 45.47501,
            "lon": 4.37614
          }
        },
        {
          "facility": "Research Site",
          "city": "Strasbourg",
          "country": "France",
          "geoPoint": {
            "lat": 48.58392,
            "lon": 7.74553
          }
        },
        {
          "facility": "Research Site",
          "city": "Tours Cedex 9",
          "country": "France",
          "geoPoint": {
            "lat": 47.38333,
            "lon": 0.68333
          }
        },
        {
          "facility": "Research Site",
          "city": "Villejuif",
          "country": "France",
          "geoPoint": {
            "lat": 48.7939,
            "lon": 2.35992
          }
        },
        {
          "facility": "Research Site",
          "city": "M\u00fcnchen",
          "state": "Bayern",
          "country": "Germany",
          "geoPoint": {
            "lat": 48.13743,
            "lon": 11.57549
          }
        },
        {
          "facility": "Research Site",
          "city": "Bad Berka",
          "country": "Germany",
          "geoPoint": {
            "lat": 50.89982,
            "lon": 11.28245
          }
        },
        {
          "facility": "Research Site",
          "city": "Bonn",
          "country": "Germany",
          "geoPoint": {
            "lat": 50.73438,
            "lon": 7.09549
          }
        },
        {
          "facility": "Research Site",
          "city": "Essen",
          "country": "Germany",
          "geoPoint": {
            "lat": 51.45657,
            "lon": 7.01228
          }
        },
        {
          "facility": "Research site",
          "city": "Gauting",
          "country": "Germany",
          "geoPoint": {
            "lat": 48.06919,
            "lon": 11.37703
          }
        },
        {
          "facility": "Research Site",
          "city": "Gie\u00dfen",
          "country": "Germany",
          "geoPoint": {
            "lat": 50.58727,
            "lon": 8.67554
          }
        },
        {
          "facility": "Research Site",
          "city": "Gro\u00dfhansdorf",
          "country": "Germany",
          "geoPoint": {
            "lat": 53.66667,
            "lon": 10.28333
          }
        },
        {
          "facility": "Research Site",
          "city": "Halle (Saale)",
          "country": "Germany",
          "geoPoint": {
            "lat": 51.48159,
            "lon": 11.97948
          }
        },
        {
          "facility": "Research Site",
          "city": "Jena",
          "country": "Germany",
          "geoPoint": {
            "lat": 50.92878,
            "lon": 11.5899
          }
        },
        {
          "facility": "Research Site",
          "city": "Kassel",
          "country": "Germany",
          "geoPoint": {
            "lat": 51.31667,
            "lon": 9.5
          }
        },
        {
          "facility": "Research Site",
          "city": "K\u00f6ln",
          "country": "Germany",
          "geoPoint": {
            "lat": 50.93333,
            "lon": 6.95
          }
        },
        {
          "facility": "Research Site",
          "city": "L\u00f6wenstein",
          "country": "Germany",
          "geoPoint": {
            "lat": 49.0954,
            "lon": 9.38069
          }
        },
        {
          "facility": "Research Site",
          "city": "L\u00fcbeck",
          "country": "Germany",
          "geoPoint": {
            "lat": 53.86893,
            "lon": 10.68729
          }
        },
        {
          "facility": "Research Site",
          "city": "Offenbach",
          "country": "Germany",
          "geoPoint": {
            "lat": 50.10061,
            "lon": 8.76647
          }
        },
        {
          "facility": "Research Site",
          "city": "Oldenburg",
          "country": "Germany",
          "geoPoint": {
            "lat": 53.14118,
            "lon": 8.21467
          }
        },
        {
          "facility": "Research Site",
          "city": "Athens",
          "country": "Greece",
          "geoPoint": {
            "lat": 37.97945,
            "lon": 23.71622
          }
        },
        {
          "facility": "Research Site",
          "city": "Heraklion",
          "country": "Greece",
          "geoPoint": {
            "lat": 35.32787,
            "lon": 25.14341
          }
        },
        {
          "facility": "Research Site",
          "city": "Larissa",
          "country": "Greece",
          "geoPoint": {
            "lat": 39.63689,
            "lon": 22.41761
          }
        },
        {
          "facility": "Research Site",
          "city": "N\u00e9a Kifisi\u00e1",
          "country": "Greece",
          "geoPoint": {
            "lat": 38.09282,
            "lon": 23.80192
          }
        },
        {
          "facility": "Research Site",
          "city": "N\u00e9o F\u00e1liro",
          "country": "Greece",
          "geoPoint": {
            "lat": 37.9464,
            "lon": 23.66736
          }
        },
        {
          "facility": "Research Site",
          "city": "Thessalon\u00edki",
          "country": "Greece",
          "geoPoint": {
            "lat": 40.64361,
            "lon": 22.93086
          }
        },
        {
          "facility": "Research Site",
          "city": "Volos",
          "country": "Greece",
          "geoPoint": {
            "lat": 39.36103,
            "lon": 22.94248
          }
        },
        {
          "facility": "Research Site",
          "city": "Hong Kong",
          "country": "Hong Kong",
          "geoPoint": {
            "lat": 22.27832,
            "lon": 114.17469
          }
        },
        {
          "facility": "Research Site",
          "city": "Kowloon",
          "country": "Hong Kong",
          "geoPoint": {
            "lat": 22.31667,
            "lon": 114.18333
          }
        },
        {
          "facility": "Research Site",
          "city": "Shatin",
          "country": "Hong Kong",
          "geoPoint": {
            "lat": 22.38333,
            "lon": 114.18333
          }
        },
        {
          "facility": "Research Site",
          "city": "Budapest",
          "country": "Hungary",
          "geoPoint": {
            "lat": 47.49801,
            "lon": 19.03991
          }
        },
        {
          "facility": "Research Site",
          "city": "Gyula",
          "country": "Hungary",
          "geoPoint": {
            "lat": 46.65,
            "lon": 21.28333
          }
        },
        {
          "facility": "Research Site",
          "city": "Gy\u00f6ngy\u00f6s",
          "country": "Hungary",
          "geoPoint": {
            "lat": 47.78257,
            "lon": 19.928
          }
        },
        {
          "facility": "Research Site",
          "city": "Sz\u00e9kesfeh\u00e9rv\u00e1r",
          "country": "Hungary",
          "geoPoint": {
            "lat": 47.18995,
            "lon": 18.41034
          }
        },
        {
          "facility": "Research Site",
          "city": "T\u00f6r\u00f6kb\u00e1lint",
          "country": "Hungary",
          "geoPoint": {
            "lat": 47.42931,
            "lon": 18.91356
          }
        },
        {
          "facility": "Research Site",
          "city": "Dublin",
          "country": "Ireland",
          "geoPoint": {
            "lat": 53.33306,
            "lon": -6.24889
          }
        },
        {
          "facility": "Research Site",
          "city": "Galway",
          "country": "Ireland",
          "geoPoint": {
            "lat": 53.27194,
            "lon": -9.04889
          }
        },
        {
          "facility": "Research Site",
          "city": "Limerick",
          "country": "Ireland",
          "geoPoint": {
            "lat": 52.66472,
            "lon": -8.62306
          }
        },
        {
          "facility": "Research Site",
          "city": "Alessandria",
          "country": "Italy",
          "geoPoint": {
            "lat": 44.90924,
            "lon": 8.61007
          }
        },
        {
          "facility": "Research Site",
          "city": "Avellino",
          "country": "Italy",
          "geoPoint": {
            "lat": 40.91494,
            "lon": 14.79103
          }
        },
        {
          "facility": "Research Site",
          "city": "Aviano",
          "country": "Italy",
          "geoPoint": {
            "lat": 46.07056,
            "lon": 12.59472
          }
        },
        {
          "facility": "Research Site",
          "city": "Bari",
          "country": "Italy",
          "geoPoint": {
            "lat": 41.11148,
            "lon": 16.8554
          }
        },
        {
          "facility": "Research Site",
          "city": "Brescia",
          "country": "Italy",
          "geoPoint": {
            "lat": 45.53558,
            "lon": 10.21472
          }
        },
        {
          "facility": "Research Site",
          "city": "Candiolo",
          "country": "Italy",
          "geoPoint": {
            "lat": 44.95858,
            "lon": 7.59812
          }
        },
        {
          "facility": "Research Site",
          "city": "Catania",
          "country": "Italy",
          "geoPoint": {
            "lat": 37.49223,
            "lon": 15.07041
          }
        },
        {
          "facility": "Research Site",
          "city": "Firenze",
          "country": "Italy",
          "geoPoint": {
            "lat": 43.77925,
            "lon": 11.24626
          }
        },
        {
          "facility": "Research Site",
          "city": "Genova",
          "country": "Italy",
          "geoPoint": {
            "lat": 44.40478,
            "lon": 8.94438
          }
        },
        {
          "facility": "Research Site",
          "city": "Lecce",
          "country": "Italy",
          "geoPoint": {
            "lat": 40.35481,
            "lon": 18.17244
          }
        },
        {
          "facility": "Research Site",
          "city": "Meldola",
          "country": "Italy",
          "geoPoint": {
            "lat": 44.12775,
            "lon": 12.0626
          }
        },
        {
          "facility": "Research Site",
          "city": "Milano",
          "country": "Italy",
          "geoPoint": {
            "lat": 45.46427,
            "lon": 9.18951
          }
        },
        {
          "facility": "Research Site",
          "city": "Milan",
          "country": "Italy",
          "geoPoint": {
            "lat": 45.46427,
            "lon": 9.18951
          }
        },
        {
          "facility": "Research Site",
          "city": "Napoli",
          "country": "Italy",
          "geoPoint": {
            "lat": 40.85216,
            "lon": 14.26811
          }
        },
        {
          "facility": "Research Site",
          "city": "Novara",
          "country": "Italy",
          "geoPoint": {
            "lat": 45.44694,
            "lon": 8.62118
          }
        },
        {
          "facility": "Research Site",
          "city": "Parma",
          "country": "Italy",
          "geoPoint": {
            "lat": 44.79935,
            "lon": 10.32618
          }
        },
        {
          "facility": "Research Site",
          "city": "Perugia",
          "country": "Italy",
          "geoPoint": {
            "lat": 43.1122,
            "lon": 12.38878
          }
        },
        {
          "facility": "Research Site",
          "city": "Pesaro",
          "country": "Italy",
          "geoPoint": {
            "lat": 43.90921,
            "lon": 12.9164
          }
        },
        {
          "facility": "Research Site",
          "city": "Ravenna",
          "country": "Italy",
          "geoPoint": {
            "lat": 44.41344,
            "lon": 12.20121
          }
        },
        {
          "facility": "Research Site",
          "city": "Roma",
          "country": "Italy",
          "geoPoint": {
            "lat": 41.89193,
            "lon": 12.51133
          }
        },
        {
          "facility": "Research Site",
          "city": "Busan",
          "country": "Korea, Republic of",
          "geoPoint": {
            "lat": 35.10278,
            "lon": 129.04028
          }
        },
        {
          "facility": "Research Site",
          "city": "Cheongju-si",
          "country": "Korea, Republic of",
          "geoPoint": {
            "lat": 36.63722,
            "lon": 127.48972
          }
        },
        {
          "facility": "Research Site",
          "city": "Daegu",
          "country": "Korea, Republic of",
          "geoPoint": {
            "lat": 35.87028,
            "lon": 128.59111
          }
        },
        {
          "facility": "Research Site",
          "city": "Hwasun",
          "country": "Korea, Republic of",
          "geoPoint": {
            "lat": 35.06125,
            "lon": 126.98746
          }
        },
        {
          "facility": "Research Site",
          "city": "Incheon",
          "country": "Korea, Republic of",
          "geoPoint": {
            "lat": 37.45646,
            "lon": 126.70515
          }
        },
        {
          "facility": "Research Site",
          "city": "Seongnam-si",
          "country": "Korea, Republic of",
          "geoPoint": {
            "lat": 37.43861,
            "lon": 127.13778
          }
        },
        {
          "facility": "Research Site",
          "city": "Seoul",
          "country": "Korea, Republic of",
          "geoPoint": {
            "lat": 37.566,
            "lon": 126.9784
          }
        },
        {
          "facility": "Research Site",
          "city": "Suwon-si",
          "country": "Korea, Republic of",
          "geoPoint": {
            "lat": 37.29111,
            "lon": 127.00889
          }
        },
        {
          "facility": "Research Site",
          "city": "Amsterdam",
          "country": "Netherlands",
          "geoPoint": {
            "lat": 52.37403,
            "lon": 4.88969
          }
        },
        {
          "facility": "Research Site",
          "city": "Breda",
          "country": "Netherlands",
          "geoPoint": {
            "lat": 51.58656,
            "lon": 4.77596
          }
        },
        {
          "facility": "Research Site",
          "city": "Den Haag",
          "country": "Netherlands",
          "geoPoint": {
            "lat": 52.07667,
            "lon": 4.29861
          }
        },
        {
          "facility": "Research Site",
          "city": "Maastricht",
          "country": "Netherlands",
          "geoPoint": {
            "lat": 50.84833,
            "lon": 5.68889
          }
        },
        {
          "facility": "Research Site",
          "city": "Nieuwegein",
          "country": "Netherlands",
          "geoPoint": {
            "lat": 52.02917,
            "lon": 5.08056
          }
        },
        {
          "facility": "Research Site",
          "city": "Nijmegen",
          "country": "Netherlands",
          "geoPoint": {
            "lat": 51.8425,
            "lon": 5.85278
          }
        },
        {
          "facility": "Research Site",
          "city": "Utrecht",
          "country": "Netherlands",
          "geoPoint": {
            "lat": 52.09083,
            "lon": 5.12222
          }
        },
        {
          "facility": "Research Site",
          "city": "Lublin",
          "state": "Lubelskie",
          "country": "Poland",
          "geoPoint": {
            "lat": 51.25,
            "lon": 22.56667
          }
        },
        {
          "facility": "Research Site",
          "city": "Lublin",
          "country": "Poland",
          "geoPoint": {
            "lat": 51.25,
            "lon": 22.56667
          }
        },
        {
          "facility": "Research Site",
          "city": "Otwock",
          "country": "Poland",
          "geoPoint": {
            "lat": 52.10577,
            "lon": 21.26129
          }
        },
        {
          "facility": "Research Site",
          "city": "Rzesz\u00f3w",
          "country": "Poland",
          "geoPoint": {
            "lat": 50.04132,
            "lon": 21.99901
          }
        },
        {
          "facility": "Research Site",
          "city": "Skorzewo",
          "country": "Poland"
        },
        {
          "facility": "Research Site",
          "city": "Toru\u0144",
          "country": "Poland",
          "geoPoint": {
            "lat": 53.01375,
            "lon": 18.59814
          }
        },
        {
          "facility": "Research Site",
          "city": "Warszawa",
          "country": "Poland",
          "geoPoint": {
            "lat": 52.22977,
            "lon": 21.01178
          }
        },
        {
          "facility": "Research Site",
          "city": "\u0141\u00f3d\u017a",
          "country": "Poland",
          "geoPoint": {
            "lat": 51.75,
            "lon": 19.46667
          }
        },
        {
          "facility": "Research Site",
          "city": "Almada",
          "country": "Portugal",
          "geoPoint": {
            "lat": 38.67902,
            "lon": -9.1569
          }
        },
        {
          "facility": "Research Site",
          "city": "Braga",
          "country": "Portugal",
          "geoPoint": {
            "lat": 41.55032,
            "lon": -8.42005
          }
        },
        {
          "facility": "Research Site",
          "city": "Coimbra",
          "country": "Portugal",
          "geoPoint": {
            "lat": 40.20564,
            "lon": -8.41955
          }
        },
        {
          "facility": "Research Site",
          "city": "Guimar\u00e3es",
          "country": "Portugal",
          "geoPoint": {
            "lat": 41.44443,
            "lon": -8.29619
          }
        },
        {
          "facility": "Research Site",
          "city": "Lisboa",
          "country": "Portugal",
          "geoPoint": {
            "lat": 38.71667,
            "lon": -9.13333
          }
        },
        {
          "facility": "Research Site",
          "city": "Lisbon",
          "country": "Portugal",
          "geoPoint": {
            "lat": 38.71667,
            "lon": -9.13333
          }
        },
        {
          "facility": "Research Site",
          "city": "Loures",
          "country": "Portugal",
          "geoPoint": {
            "lat": 38.83091,
            "lon": -9.16845
          }
        },
        {
          "facility": "Research Site",
          "city": "Porto",
          "country": "Portugal",
          "geoPoint": {
            "lat": 41.14961,
            "lon": -8.61099
          }
        },
        {
          "facility": "Research Site",
          "city": "Santa Maria Da Feira",
          "country": "Portugal",
          "geoPoint": {
            "lat": 40.92726,
            "lon": -8.54839
          }
        },
        {
          "facility": "Research Site",
          "city": "Set\u00fabal",
          "country": "Portugal",
          "geoPoint": {
            "lat": 38.5244,
            "lon": -8.8882
          }
        },
        {
          "facility": "Research Site",
          "city": "Vila Nova De Gaia",
          "country": "Portugal",
          "geoPoint": {
            "lat": 41.13363,
            "lon": -8.61742
          }
        },
        {
          "facility": "Research Site",
          "city": "Baia Mare",
          "country": "Romania",
          "geoPoint": {
            "lat": 47.65529,
            "lon": 23.57381
          }
        },
        {
          "facility": "Research Site",
          "city": "Bra\u015fov",
          "country": "Romania",
          "geoPoint": {
            "lat": 45.64861,
            "lon": 25.60613
          }
        },
        {
          "facility": "Research Site",
          "city": "Bucharest",
          "country": "Romania",
          "geoPoint": {
            "lat": 44.43225,
            "lon": 26.10626
          }
        },
        {
          "facility": "Research Site",
          "city": "Bucuresti",
          "country": "Romania",
          "geoPoint": {
            "lat": 44.42802,
            "lon": 26.09665
          }
        },
        {
          "facility": "Research Site",
          "city": "Cluj-Napoca",
          "country": "Romania",
          "geoPoint": {
            "lat": 46.76667,
            "lon": 23.6
          }
        },
        {
          "facility": "Research Site",
          "city": "Constan\u0163a",
          "country": "Romania",
          "geoPoint": {
            "lat": 44.18073,
            "lon": 28.63432
          }
        },
        {
          "facility": "Research Site",
          "city": "Craiova",
          "country": "Romania",
          "geoPoint": {
            "lat": 44.31667,
            "lon": 23.8
          }
        },
        {
          "facility": "Research Site",
          "city": "Ia\u015fi",
          "country": "Romania",
          "geoPoint": {
            "lat": 47.16667,
            "lon": 27.6
          }
        },
        {
          "facility": "Research Site",
          "city": "Timi\u015foara",
          "country": "Romania",
          "geoPoint": {
            "lat": 45.75372,
            "lon": 21.22571
          }
        },
        {
          "facility": "Research Site",
          "city": "Chelyabinsk",
          "country": "Russian Federation",
          "geoPoint": {
            "lat": 55.15402,
            "lon": 61.42915
          }
        },
        {
          "facility": "Research Site",
          "city": "Izhevsk",
          "country": "Russian Federation",
          "geoPoint": {
            "lat": 56.84976,
            "lon": 53.20448
          }
        },
        {
          "facility": "Research Site",
          "city": "Kursk",
          "country": "Russian Federation",
          "geoPoint": {
            "lat": 51.73733,
            "lon": 36.18735
          }
        },
        {
          "facility": "Research Site",
          "city": "Moscow",
          "country": "Russian Federation",
          "geoPoint": {
            "lat": 55.75222,
            "lon": 37.61556
          }
        },
        {
          "facility": "Research Site",
          "city": "Nizhniy Novgorod",
          "country": "Russian Federation",
          "geoPoint": {
            "lat": 56.32867,
            "lon": 44.00205
          }
        },
        {
          "facility": "Research Site",
          "city": "Novosibirsk",
          "country": "Russian Federation",
          "geoPoint": {
            "lat": 55.0415,
            "lon": 82.9346
          }
        },
        {
          "facility": "Research Site",
          "city": "Omsk",
          "country": "Russian Federation",
          "geoPoint": {
            "lat": 54.99244,
            "lon": 73.36859
          }
        },
        {
          "facility": "Research Site",
          "city": "Saint Petersburg",
          "country": "Russian Federation",
          "geoPoint": {
            "lat": 59.93863,
            "lon": 30.31413
          }
        },
        {
          "facility": "Research Site",
          "city": "Saint-Petersburg",
          "country": "Russian Federation",
          "geoPoint": {
            "lat": 59.93863,
            "lon": 30.31413
          }
        },
        {
          "facility": "Research Site",
          "city": "Singapore",
          "country": "Singapore",
          "geoPoint": {
            "lat": 1.28967,
            "lon": 103.85007
          }
        },
        {
          "facility": "Research Site",
          "city": "A Coru\u00f1a",
          "country": "Spain",
          "geoPoint": {
            "lat": 43.37135,
            "lon": -8.396
          }
        },
        {
          "facility": "Research Site",
          "city": "Alicante",
          "country": "Spain",
          "geoPoint": {
            "lat": 38.34517,
            "lon": -0.48149
          }
        },
        {
          "facility": "Research Site",
          "city": "Badalona",
          "country": "Spain",
          "geoPoint": {
            "lat": 41.45004,
            "lon": 2.24741
          }
        },
        {
          "facility": "Research Site",
          "city": "Barakaldo",
          "country": "Spain",
          "geoPoint": {
            "lat": 43.29639,
            "lon": -2.98813
          }
        },
        {
          "facility": "Research Site",
          "city": "Barcelona",
          "country": "Spain",
          "geoPoint": {
            "lat": 41.38879,
            "lon": 2.15899
          }
        },
        {
          "facility": "Research Site",
          "city": "Cordoba",
          "country": "Spain",
          "geoPoint": {
            "lat": 37.89155,
            "lon": -4.77275
          }
        },
        {
          "facility": "Research Site",
          "city": "Girona",
          "country": "Spain",
          "geoPoint": {
            "lat": 41.98311,
            "lon": 2.82493
          }
        },
        {
          "facility": "Research Site",
          "city": "Granada",
          "country": "Spain",
          "geoPoint": {
            "lat": 37.18817,
            "lon": -3.60667
          }
        },
        {
          "facility": "Research Site",
          "city": "Le\u00f3n",
          "country": "Spain",
          "geoPoint": {
            "lat": 42.60003,
            "lon": -5.57032
          }
        },
        {
          "facility": "Research Site",
          "city": "Lugo",
          "country": "Spain",
          "geoPoint": {
            "lat": 43.00992,
            "lon": -7.55602
          }
        },
        {
          "facility": "Research Site",
          "city": "Madrid",
          "country": "Spain",
          "geoPoint": {
            "lat": 40.4165,
            "lon": -3.70256
          }
        },
        {
          "facility": "Research Site",
          "city": "Malaga",
          "country": "Spain",
          "geoPoint": {
            "lat": 36.72016,
            "lon": -4.42034
          }
        },
        {
          "facility": "Research Site",
          "city": "Palma De Mallorca",
          "country": "Spain",
          "geoPoint": {
            "lat": 39.56939,
            "lon": 2.65024
          }
        },
        {
          "facility": "Research Site",
          "city": "Santander",
          "country": "Spain",
          "geoPoint": {
            "lat": 43.46472,
            "lon": -3.80444
          }
        },
        {
          "facility": "Research Site",
          "city": "Sevilla",
          "country": "Spain",
          "geoPoint": {
            "lat": 37.38283,
            "lon": -5.97317
          }
        },
        {
          "facility": "Research Site",
          "city": "Valencia",
          "country": "Spain",
          "geoPoint": {
            "lat": 39.46975,
            "lon": -0.37739
          }
        },
        {
          "facility": "Research Site",
          "city": "Zaragoza",
          "country": "Spain",
          "geoPoint": {
            "lat": 41.65606,
            "lon": -0.87734
          }
        },
        {
          "facility": "Research Site",
          "city": "Basel",
          "country": "Switzerland",
          "geoPoint": {
            "lat": 47.55839,
            "lon": 7.57327
          }
        },
        {
          "facility": "Research Site",
          "city": "Thun",
          "country": "Switzerland",
          "geoPoint": {
            "lat": 46.75118,
            "lon": 7.62166
          }
        },
        {
          "facility": "Research Site",
          "city": "Winterthur",
          "country": "Switzerland",
          "geoPoint": {
            "lat": 47.50564,
            "lon": 8.72413
          }
        },
        {
          "facility": "Research Site",
          "city": "Birmingham",
          "country": "United Kingdom",
          "geoPoint": {
            "lat": 52.48142,
            "lon": -1.89983
          }
        },
        {
          "facility": "Research Site",
          "city": "Edinburgh",
          "country": "United Kingdom",
          "geoPoint": {
            "lat": 55.95206,
            "lon": -3.19648
          }
        },
        {
          "facility": "Research Site",
          "city": "Glasgow",
          "country": "United Kingdom",
          "geoPoint": {
            "lat": 55.86515,
            "lon": -4.25763
          }
        },
        {
          "facility": "Research Site",
          "city": "Leicester",
          "country": "United Kingdom",
          "geoPoint": {
            "lat": 52.6386,
            "lon": -1.13169
          }
        },
        {
          "facility": "Research Site",
          "city": "Manchester",
          "country": "United Kingdom",
          "geoPoint": {
            "lat": 53.48095,
            "lon": -2.23743
          }
        }
      ],
      "eligibilityModule": {
        "eligibilityCriteria": "Inclusion Criteria:\n\n* Histologically or cytologically confirmed diagnosis of NSCLC with KRAS G12C mutation.\n* Candidacy to receive treatment with docetaxel.\n\nCrossover Inclusion Criteria:\n\n* Evidence of RECIST 1.1 defined disease progression on docetaxel per BICR\n* ECOG performance status 0-2\n\nExclusion Criteria:\n\n* Prior treatment with an agent targeting KRAS G12C (e.g., AMG 510, Sotorasib).\n* Active brain metastases.\n\nCrossover Exclusion Criteria:\n\n* Receipt of any other systemic anti-cancer therapy after last administration of docetaxel on the study.",
        "healthyVolunteers": false,
        "sex": "ALL",
        "minimumAge": "18 Years",
        "stdAges": [
          "ADULT",
          "OLDER_ADULT"
        ]
      },
      "studyType": "INTERVENTIONAL",
      "phases": [
        "PHASE3"
      ]
    },
    "structured_criteria": {
      "inclusion": {
        "Inclusion Criteria:": [
          "Patients who meet all of the following criteria are eligible for trial participation: ",
          [
            "* Histologically or cytologically confirmed diagnosis of NSCLC with KRAS G12C mutation.",
            "* Candidacy to receive treatment with docetaxel."
          ]
        ],
        "Crossover Inclusion Criteria:": [
          "Patients who meet all of the following criteria are eligible for trial participation: ",
          [
            "* Evidence of RECIST 1.1 defined disease progression on docetaxel per BICR",
            "* ECOG performance status 0-2"
          ]
        ]
      },
      "exclusion": {
        "Exclusion Criteria:": [
          "Patients who meet any of the following criteria are not eligible for trial participation: ",
          [
            "* Prior treatment with an agent targeting KRAS G12C (e.g., AMG 510, Sotorasib).",
            "* Active brain metastases."
          ]
        ],
        "Crossover Exclusion Criteria:": [
          "Patients who meet any of the following criteria are not eligible for trial participation: ",
          [
            "* Receipt of any other systemic anti-cancer therapy after last administration of docetaxel on the study."
          ]
        ]
      }
    },
    "results_inclusion": [
      [
        "Inclusion Criteria:",
        "Patients who meet all of the following criteria are eligible for trial participation: ",
        [
          "* Histologically or cytologically confirmed diagnosis of NSCLC with KRAS G12C mutation.",
          "* Candidacy to receive treatment with docetaxel."
        ],
        {
          "reasoning": "Reasoning: Let's think step by step in order to produce the criteria_decision. We will evaluate each criterion independently based on the provided patient information.\n\n1. **Criterion 1: \u00ab* Histologically or cytologically confirmed diagnosis of NSCLC with KRAS G12C mutation.\u00bb**\n   - The patient information states that the patient has lung adenocarcinoma, which is a type of non-small cell lung cancer (NSCLC).\n   - The molecular alterations include a KRAS p.G12C mutation.\n   - Therefore, the patient meets this criterion.\n\n2. **Criterion 2: \u00ab* Candidacy to receive treatment with docetaxel.\u00bb**\n   - The patient information does not provide any details about the patient's candidacy to receive treatment with docetaxel.\n   - Since there is no information about the patient's treatment history or any contraindications for docetaxel, we cannot determine if the patient is a candidate for this treatment.\n   - Therefore, the information is not sufficient to make a decision for this criterion.",
          "criteria_decision": {
            "explanation": [
              "The patient has a histologically confirmed diagnosis of NSCLC with a KRAS G12C mutation, meeting the criterion.",
              "There is no information provided about the patient's candidacy to receive treatment with docetaxel, so the decision is '?'."
            ],
            "criteria_decision": [
              true,
              "?"
            ]
          }
        }
      ],
      [
        "Crossover Inclusion Criteria:",
        "Patients who meet all of the following criteria are eligible for trial participation: ",
        [
          "* Evidence of RECIST 1.1 defined disease progression on docetaxel per BICR",
          "* ECOG performance status 0-2"
        ],
        {
          "reasoning": "Reasoning: Let's think step by step in order to produce the criteria_decision. We need to evaluate each criterion independently based on the provided patient information.\n\n1. **Criterion 1: Evidence of RECIST 1.1 defined disease progression on docetaxel per BICR**\n   - The patient information does not mention any evidence of RECIST 1.1 defined disease progression on docetaxel per BICR.\n   - Since there is no information provided about disease progression on docetaxel, we cannot determine if this criterion is met.\n   - Decision: `?`\n\n2. **Criterion 2: ECOG performance status 0-2**\n   - The patient information does not mention the ECOG performance status.\n   - Without this information, we cannot determine if the patient meets this criterion.\n   - Decision: `?`",
          "criteria_decision": {
            "explanation": [
              "The patient information does not mention any evidence of RECIST 1.1 defined disease progression on docetaxel per BICR, so we cannot determine if this criterion is met.",
              "The patient information does not mention the ECOG performance status, so we cannot determine if the patient meets this criterion."
            ],
            "criteria_decision": [
              "?",
              "?"
            ]
          }
        }
      ]
    ],
    "results_exclusion": [
      [
        "Exclusion Criteria:",
        "Patients who meet any of the following criteria are not eligible for trial participation: ",
        [
          "* Prior treatment with an agent targeting KRAS G12C (e.g., AMG 510, Sotorasib).",
          "* Active brain metastases."
        ],
        {
          "reasoning": "Reasoning: Let's think step by step in order to produce the criteria_decision. We will evaluate each exclusion criterion based on the provided patient information.\n\n1. **Prior treatment with an agent targeting KRAS G12C (e.g., AMG 510, Sotorasib):**\n   - The patient information does not mention any prior treatment with an agent targeting KRAS G12C.\n   - Therefore, we assume the patient has not received such treatment.\n   - Decision: True (The patient is eligible based on this criterion).\n\n2. **Active brain metastases:**\n   - The patient information does not mention brain metastases.\n   - According to the guardrails, if there is no information on brain metastases and no indication anywhere about brain metastases, we assume the patient does not have brain metastases.\n   - Decision: True (The patient is eligible based on this criterion).",
          "criteria_decision": {
            "explanation": [
              "The patient information does not mention any prior treatment with an agent targeting KRAS G12C, so we assume the patient has not received such treatment.",
              "The patient information does not mention brain metastases, so we assume the patient does not have brain metastases."
            ],
            "criteria_decision": [
              true,
              true
            ]
          }
        }
      ],
      [
        "Crossover Exclusion Criteria:",
        "Patients who meet any of the following criteria are not eligible for trial participation: ",
        [
          "* Receipt of any other systemic anti-cancer therapy after last administration of docetaxel on the study."
        ],
        {
          "reasoning": "Reasoning: Let's think step by step in order to produce the criteria_decision. We need to determine if the patient has received any other systemic anti-cancer therapy after the last administration of docetaxel on the study. \n\n1. The patient information provided does not mention any details about the receipt of other systemic anti-cancer therapies after the last administration of docetaxel.\n2. Since there is no explicit mention of the patient receiving any other systemic anti-cancer therapy, we assume the patient has not received any such therapy.\n3. Therefore, based on the given information, the patient is eligible for the trial according to this criterion.",
          "criteria_decision": {
            "explanation": [
              "The patient information does not mention any receipt of other systemic anti-cancer therapy after the last administration of docetaxel. Therefore, we assume the patient has not received any such therapy and is eligible for the trial based on this criterion."
            ],
            "criteria_decision": [
              true
            ]
          }
        }
      ]
    ],
    "subinstruction": "metastatic lung adenocarcinoma, KRAS p.G12C mutation",
    "patient_id": "p6",
    "patient_info": "\nPatient Information\n    Name: Doe, John\n    born: 18.08.1968\n    Address: Main Street 1, Berlin\n\nOverview of Tumor Diagnosis and Therapy\n    Tumor Diagnosis\n    Diagnosis: Metastatic KRAS G12C mutant non-small cell lung cancer (NSCLC)\n    Initial Detection: March 22, 2023, following symptoms of persistent cough and weight loss\n    Biopsy Date: April 15, 2023, adenocarcinoma of the lung\n    Molecular Profile: KRAS p.G12C (AF 18%), KEAP1 p.L276F (AF 45%), STK11 p.K83Tfs*13 (AF 38%).\n\nTherapy Overview\n    Initial Treatment:\n    Chemotherapy: Began May 5, 2022 in Berlin, with a platinum-based regimen (Cisplatin and\n    Pemetrexed), partial response noted after initial chemotherapy cycle completed by August 10, 2022, contunuation of therapy until october 2023 (progressive disease)\n    Subsequent Treatment: Immunotherapy with Prembolizumab at Charit\u00e9 Berlin initiated on October 25, 2023, with Pembrolizumab, staging CT shows disease progression after 3 months\n    Current Status:\n    Health Condition: Stable with an ECOG performance status of 1\n    Comorbidities: Well-managed and not contraindicating further treatment\n \nComorbidities\n    Former Smoker: 40py\n    Hypertension: Controlled with medication (Lisinopril 20 mg daily), current blood pressure 130/90mmHg\n    Type 2 Diabetes Mellitus: Controlled with Metformin 1000 mg twice daily\n    Hyperlipidemia: Managed with Atorvastatin 40 mg daily\n    Osteoarthritis: Managed with over-the-counter NSAIDs as needed\n    Chronic Obstructive Pulmonary Disease (COPD): Mild, managed with inhalers (Tiotropium)\n    Gastroesophageal Reflux Disease (GERD): Managed with Omeprazole 20 mg daily\n    Benign Prostatic Hyperplasia (BPH): Treated with Tamsulosin 0.4 mg daily\n\nPerformance Status: ECOG Performance Status 1\n \nChronological Medical Findings:\n    January 10, 2018: Routine annual physical examination. Blood pressure elevated, diagnosed with hypertension. Prescribed Lisinopril 10 mg daily.\n    March 15, 2018: Complained of heartburn and acid reflux. Diagnosed with GERD. Prescribed Omeprazole 20 mg daily.\n    February 25, 2019: Annual follow-up for hypertension. Blood pressure well-controlled. Lisinopril dosage maintained.\n    May 20, 2019: Complained of knee pain. Diagnosed with osteoarthritis. Recommended over-the-counter NSAIDs for pain management.\n    April 5, 2020: Routine check-up. Elevated blood glucose levels. Diagnosed with Type 2 Diabetes Mellitus. Prescribed Metformin 500 mg twice daily.\n    August 30, 2020: Routine cholesterol check. Diagnosed with hyperlipidemia. Prescribed Atorvastatin 20 mg daily.\n    November 10, 2020: Follow-up for diabetes and hyperlipidemia. Dosages adjusted: Metformin increased to 1000 mg twice daily, Atorvastatin increased to 40 mg daily.\n    February 12, 2021: Complained of shortness of breath and chronic cough. Diagnosed with mild COPD. Prescribed Tiotropium inhaler.\n    July 18, 2021: Routine follow-up. Stable condition with controlled comorbidities. Blood pressure, blood sugar, and cholesterol levels within target ranges.\n    March 22, 2023: Experienced persistent cough and weight loss. Chest X-ray and CT scan revealed a mass in the left lung. Referred to oncologist. CT Angiography, Pulmonary Arteries: Tumor Size: Approximately 4.5 cm in diameter. Bronchial Obstruction: Partial obstruction of the left main bronchus leading to atelectasis of the left upper lobe.\n    Urgent suspicion of a tumor-atelectasis complex in the left upper lobe of the lung. Mucus present in the lower lobe bronchi on the left. Suspicion of mediastinal lymph node metastases. No evidence of pulmonary artery embolism. Thrombus in the left atrium at the transition to the auricle. Emphysematous and fibrotic changes in the lung parenchyma. \n    Lymph Nodes: Enlarged, FDG-positive lymph nodes in the mediastinum, particularly in regions 4R and infracarinal. \n    April 15, 2023: Lung biopsy via bronchoscopy: Endobronchial tumor manifestation in the distal left main bronchus extending to the upper lobe. Acute and chronic atrophic tracheobronchitis. Collapsed bronchial system in the affected area. Biopsy taken. Diagnosed with non-small cell lung cancer (NSCLC), molecular diagnostics: KRAS G12C mutant. \n    April 27, 2022: Ventilation: Moderate obstruction, no restriction. Increased airway resistance and slight hyperinflation. Tiffeneau index (FEV1/FVC) at 42.34%, z-score -3.32. FEV1: 0.93 L (42% predicted), z-score -2.89.Total lung capacity (TLC): 5.86 L (103% predicted), z-score 0.22. Forced vital capacity (FVC): 2.19 L, z-score -1.5. Residual volume (RV): 3.67 L, z-score 2.44. RV/TLC: 62.68%, z-score -1.18.\n    May 5, 2022: Initiated on platinum-based chemotherapy regimen (Cisplatin and Pemetrexed).\n    August 10, 2023: Completed initial chemotherapy cycle. Partial response noted. \n    August-October: Continued chemotherapy with Cisplatin/Pemetrexed.\n    October 13, 2023: Follow-up CT (chest + abdomen): Moderate disease progression. New nodule in the right lung (1cm). Slight increase in the size of previously noted FDG-positive lymph nodes in the mediastinum. No additional metastatic lesions were detected. The patient has continued to tolerate the current treatment regimen well, with no significant adverse effects reported.\n    October 25, 2023: Started immune checkpoint inhibitor therapy (Pembrolizumab), good tolerability, no signs of autoimmunity.\n    March 12, 2024: Follow-up CT scan abdomen/lung: Progressive Disease with three new metastases in the right lung and additional enlarged FDG-positive lymph nodes in the mediastinum. MRI scan of the brain conducted; no evidence of metastatic disease. Incidental findings included mild age-related cerebral atrophy and scattered white matter hyperintensities consistent with chronic microvascular ischemic changes.\n    March 17, 2024: Tumorboard recommends considering clinical trial options due to limited response to standard therapies.\n    April 20, 2024: Detailed assessment of health status. ECOG performance status 1. All routine labs, including liver and renal function tests, within normal limits.\n",
    "instruction": "Please find a clincial trial targeting the patients tumor and alterations in Germany."
  },
  {
    "nctId": "NCT06119581",
    "avg_inclusion_score": 0.6818181818181818,
    "avg_exclusion_score": 0.8333333333333334,
    "avg_overall_score": 0.7352941176470589,
    "trial": {
      "clean_text": "#briefTitle\nA Study of LY3537982 Plus Immunotherapy With or Without Chemotherapy in Participants With Non-Small Cell Lung Cancer (NSCLC) With a Change in a Gene Called KRAS G12C\n\n#officialTitle\nSUNRAY-01, A Global Pivotal Study in Participants With KRAS G12C-Mutant, Locally Advanced or Metastatic Non-Small Cell Lung Cancer Comparing First-Line Treatment of LY3537982 and Pembrolizumab vs Placebo and Pembrolizumab in Those With PD-L1 Expression \u226550% or LY3537982 and Pembrolizumab, Pemetrexed, Platinum vs Placebo and Pembrolizumab, Pemetrexed, Platinum Regardless of PD-L1 Expression\n\n#briefSummary\nThe purpose of this study is to assess if adding LY3537982 in combination with standard of care anti-cancer drugs is more effective than standard of care in participants with untreated advanced NSCLC. NSCLC must have a change in a gene called KRAS G12C. Study participation, including follow-up, could last up to 3 years, depending on how you and your lung cancer are doing.\n\n#detailedDescription\nDose Optimization, Part A, and Part B are randomized. Safety Lead-In for Part B is single arm, non-randomized.\n\n#conditions\nCarcinoma, Non-Small-Cell Lung\nNeoplasm Metastasis\n\n",
      "briefTitle": "A Study of LY3537982 Plus Immunotherapy With or Without Chemotherapy in Participants With Non-Small Cell Lung Cancer (NSCLC) With a Change in a Gene Called KRAS G12C",
      "officialTitle": "SUNRAY-01, A Global Pivotal Study in Participants With KRAS G12C-Mutant, Locally Advanced or Metastatic Non-Small Cell Lung Cancer Comparing First-Line Treatment of LY3537982 and Pembrolizumab vs Placebo and Pembrolizumab in Those With PD-L1 Expression \u226550% or LY3537982 and Pembrolizumab, Pemetrexed, Platinum vs Placebo and Pembrolizumab, Pemetrexed, Platinum Regardless of PD-L1 Expression",
      "briefSummary": "The purpose of this study is to assess if adding LY3537982 in combination with standard of care anti-cancer drugs is more effective than standard of care in participants with untreated advanced NSCLC. NSCLC must have a change in a gene called KRAS G12C. Study participation, including follow-up, could last up to 3 years, depending on how you and your lung cancer are doing.",
      "detailedDescription": "Dose Optimization, Part A, and Part B are randomized. Safety Lead-In for Part B is single arm, non-randomized.",
      "conditions": [
        "Carcinoma, Non-Small-Cell Lung",
        "Neoplasm Metastasis"
      ],
      "armGroups": [
        {
          "label": "Dose Optimization: LY3537982 Dose Level 1 plus Pembrolizumab",
          "type": "EXPERIMENTAL",
          "description": "LY3537982 Dose level 1 administered orally in combination with pembrolizumab administered intravenously (IV) in 21-day cycles. Participants may continue to receive treatment until discontinuation criteria are met.",
          "interventionNames": [
            "Drug: LY3537982",
            "Drug: Pembrolizumab"
          ]
        },
        {
          "label": "Dose Optimization: LY3537982 Dose Level 2 plus Pembrolizumab",
          "type": "EXPERIMENTAL",
          "description": "LY3537982 Dose level 2 administered orally in combination with pembrolizumab administered IV in 21-day cycles. Participants may continue to receive treatment until discontinuation criteria are met.",
          "interventionNames": [
            "Drug: LY3537982",
            "Drug: Pembrolizumab"
          ]
        },
        {
          "label": "Safety Lead In: LY3537982 plus Pembrolizumab, Pemetrexed and Platinum",
          "type": "EXPERIMENTAL",
          "description": "LY3537982 administered orally in combination with pembrolizumab, pemetrexed, and platinum (cisplatin or carboplatin) administered IV in 21-day cycles. Participants may continue to receive treatment until discontinuation criteria are met.",
          "interventionNames": [
            "Drug: LY3537982",
            "Drug: Pembrolizumab",
            "Drug: Cisplatin",
            "Drug: Carboplatin",
            "Drug: Pemetrexed"
          ]
        },
        {
          "label": "Part A: LY3537982 plus Pembrolizumab",
          "type": "EXPERIMENTAL",
          "description": "LY3537982 administered orally in combination with pembrolizumab administered IV in 21-day cycles. Participants may continue to receive treatment until discontinuation criteria are met.",
          "interventionNames": [
            "Drug: LY3537982",
            "Drug: Pembrolizumab"
          ]
        },
        {
          "label": "Part A: Placebo plus Pembrolizumab",
          "type": "PLACEBO_COMPARATOR",
          "description": "Placebo administered orally in combination with pembrolizumab administered IV in 21-day cycles. Participants may continue to receive treatment until discontinuation criteria are met.",
          "interventionNames": [
            "Drug: Pembrolizumab",
            "Drug: Placebo"
          ]
        },
        {
          "label": "Part B: LY3537982 plus Pembrolizumab, Pemetrexed, and Platinum",
          "type": "EXPERIMENTAL",
          "description": "LY3537982 administered orally in combination with pembrolizumab, pemetrexed, and platinum (cisplatin or carboplatin) administered IV in 21-day cycles. Participants may continue to receive treatment until discontinuation criteria are met.",
          "interventionNames": [
            "Drug: LY3537982",
            "Drug: Pembrolizumab",
            "Drug: Cisplatin",
            "Drug: Carboplatin",
            "Drug: Pemetrexed"
          ]
        },
        {
          "label": "Part B: Placebo plus Pembrolizumab, Pemetrexed, and Platinum",
          "type": "PLACEBO_COMPARATOR",
          "description": "Placebo administered orally in combination with pembrolizumab, pemetrexed, and platinum (cisplatin or carboplatin) administered IV in 21-day cycles. Participants may continue to receive treatment until discontinuation criteria are met.",
          "interventionNames": [
            "Drug: Pembrolizumab",
            "Drug: Placebo",
            "Drug: Cisplatin",
            "Drug: Carboplatin",
            "Drug: Pemetrexed"
          ]
        }
      ],
      "interventions": [
        {
          "type": "DRUG",
          "name": "LY3537982",
          "description": "Administered orally.",
          "armGroupLabels": [
            "Dose Optimization: LY3537982 Dose Level 1 plus Pembrolizumab",
            "Dose Optimization: LY3537982 Dose Level 2 plus Pembrolizumab",
            "Part A: LY3537982 plus Pembrolizumab",
            "Part B: LY3537982 plus Pembrolizumab, Pemetrexed, and Platinum",
            "Safety Lead In: LY3537982 plus Pembrolizumab, Pemetrexed and Platinum"
          ]
        },
        {
          "type": "DRUG",
          "name": "Pembrolizumab",
          "description": "Administered IV.",
          "armGroupLabels": [
            "Dose Optimization: LY3537982 Dose Level 1 plus Pembrolizumab",
            "Dose Optimization: LY3537982 Dose Level 2 plus Pembrolizumab",
            "Part A: LY3537982 plus Pembrolizumab",
            "Part A: Placebo plus Pembrolizumab",
            "Part B: LY3537982 plus Pembrolizumab, Pemetrexed, and Platinum",
            "Part B: Placebo plus Pembrolizumab, Pemetrexed, and Platinum",
            "Safety Lead In: LY3537982 plus Pembrolizumab, Pemetrexed and Platinum"
          ]
        },
        {
          "type": "DRUG",
          "name": "Placebo",
          "description": "Administered orally.",
          "armGroupLabels": [
            "Part A: Placebo plus Pembrolizumab",
            "Part B: Placebo plus Pembrolizumab, Pemetrexed, and Platinum"
          ]
        },
        {
          "type": "DRUG",
          "name": "Cisplatin",
          "description": "Administered IV.",
          "armGroupLabels": [
            "Part B: LY3537982 plus Pembrolizumab, Pemetrexed, and Platinum",
            "Part B: Placebo plus Pembrolizumab, Pemetrexed, and Platinum",
            "Safety Lead In: LY3537982 plus Pembrolizumab, Pemetrexed and Platinum"
          ]
        },
        {
          "type": "DRUG",
          "name": "Carboplatin",
          "description": "Administered IV.",
          "armGroupLabels": [
            "Part B: LY3537982 plus Pembrolizumab, Pemetrexed, and Platinum",
            "Part B: Placebo plus Pembrolizumab, Pemetrexed, and Platinum",
            "Safety Lead In: LY3537982 plus Pembrolizumab, Pemetrexed and Platinum"
          ]
        },
        {
          "type": "DRUG",
          "name": "Pemetrexed",
          "description": "Administered IV.",
          "armGroupLabels": [
            "Part B: LY3537982 plus Pembrolizumab, Pemetrexed, and Platinum",
            "Part B: Placebo plus Pembrolizumab, Pemetrexed, and Platinum",
            "Safety Lead In: LY3537982 plus Pembrolizumab, Pemetrexed and Platinum"
          ]
        }
      ],
      "primaryOutcomes": [
        {
          "measure": "Dose Optimization and Safety Lead-In Part B: Number of Participants with a Treatment Emergent Adverse Event(s) (TEAE)",
          "description": "Dose Optimization and Safety Lead-In Part B: Number of Participants with a TEAE",
          "timeFrame": "Randomization to first documented progression of disease or death from any cause. (Estimated as approximately 1 year)"
        },
        {
          "measure": "Part A and Part B: Progression-Free Survival (PFS)",
          "description": "PFS per Response Evaluation Criteria in Solid Tumors (RECIST) v1.1 by blinded independent central review (BICR)",
          "timeFrame": "Randomization to first documented progression of disease or death from any cause. (Estimated as approximately 1 year)"
        }
      ],
      "secondaryOutcomes": [
        {
          "measure": "Part A and Part B: Overall Survival (OS)",
          "description": "Part A and Part B: OS",
          "timeFrame": "Randomization to date of death from any cause. (Estimated as up to 3 years)"
        },
        {
          "measure": "Part A and Part B: Overall Response Rate (ORR): Percentage of Participants who Achieve a Best Overall Response (BOR) of Complete Response (CR) or Partial Response (PR)",
          "description": "ORR per RECIST v1.1 by BICR",
          "timeFrame": "Randomization to disease progression or death. (Estimated as approximately 1 year)"
        },
        {
          "measure": "Part A and Part B: Duration of Response (DOR)",
          "description": "DOR per RECIST v1.1 by BICR",
          "timeFrame": "Date of first evidence of CR or PR to date of disease progression or death from any cause. (Estimated as approximately 1 year)"
        },
        {
          "measure": "Part A and Part B: Disease Control Rate (DCR): Percentage of Participants who Achieve a BOR of CR, PR, or Stable Disease (SD)",
          "description": "DCR per RECIST v1.1 by BICR",
          "timeFrame": "Randomization to disease progression or death from any cause. (Estimated as approximately 1 year)"
        },
        {
          "measure": "Part A and Part B: Time to Response (TTR)",
          "description": "TTR per RECIST v1.1 by BICR",
          "timeFrame": "Time from randomization until the date that measurement criteria for CR or PR (whichever is first recorded) are first met (Estimated as approximately 1 year)"
        },
        {
          "measure": "Part A and Part B: PFS2",
          "description": "Part A and Part B: PFS2 by Investigator",
          "timeFrame": "Randomization to disease progression on next line of treatment or death from any cause (Estimated as approximately 1 year"
        },
        {
          "measure": "Part A and Part B: Time to Worsening of NSCLC-related Symptoms as Measured by NSCLC Symptom Assessment Questionnaire (NSCLC-SAQ)",
          "description": "NSCLC symptoms will be assessed using the 7-item NSCLC-SAQ. The NSCLC-SAQ measures overall symptom severity of NSCLC, including cough, pain, dyspnea, fatigue, and poor appetite. Response options range from 0) \"Not at all\" to 4) \"Always\" or from 0) \"Never\" to 4) \"Always.\" The total score ranges from 0-20. Higher scores represent worse symptoms.",
          "timeFrame": "Randomization through end of treatment (Estimated as approximately 1 year)"
        },
        {
          "measure": "Part A and Part B: Time to Deterioration in Physical Function, as Measured by the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Core Questionnaire (EORTC QLQ-C30) Physical Functioning Subscale",
          "description": "The EORTC QLQ-C30 is a 30-question patient-reported instrument used to assess multidimensional health-related quality of life (HRQoL) in cancer patients. Physical functioning is measured by the EORTC-QLQ-30 Physical Function Scale (five items). Response options range from 1) \"Not at all\" to 4) \"Very much.\" The sum score is linearly transformed to the range 0 - 100. Higher scores represent better physical function.",
          "timeFrame": "Randomization through end of treatment (Estimated as approximately 1 year)"
        },
        {
          "measure": "Part A and Part B: Proportion of Time with High Side-Effect Burden, as Measured by Functional Assessment of Cancer Therapy - General Item 5 (FACT-GP5)",
          "description": "FACT-GP5 is a single-item, patient-reported instrument for assessing overall treatment side-effect burden. Response options range from 0) \"Not at all\" to 4) \"Very much.\" Higher scores represent higher symptom burden.",
          "timeFrame": "Randomization through end of treatment (Estimated as approximately 1 year)"
        },
        {
          "measure": "Part A and Part B: Change from Baseline in Overall Health-related Quality of Life, as Measured by the EORTC QLQ-C30 Global Health Status/Quality of Life Subscale",
          "description": "The EORTC QLQ-C30 is a 30-question patient-reported instrument used to assess multidimensional HRQoL in cancer patients. Overall HRQoL is measured by the EORTC QLQ-30 Global Health Status/Quality of Life Subscale (two items). Response options range from 1) \"very poor\" to 7) \"excellent.\" Scores are linearly transformed to the range 0 - 100. Higher scores represent better overall HRQoL.",
          "timeFrame": "Randomization through end of treatment (Estimated as approximately 1 year)"
        }
      ],
      "eligibilityCriteria": "Inclusion Criteria:\n\n* Histologically or cytologically confirmed NSCLC with Stage IIIB-IIIC or Stage IV disease, not suitable for curative intent radical surgery or radiation therapy.\n* Part B and Safety Lead-In Part B: the histology of the tumor must be predominantly non-squamous (in line with pemetrexed label).\n* Must have disease with evidence of KRAS G12C mutation.\n* Must have known programmed death-ligand 1 (PD-L1) expression\n\n  * Part A: Greater than or equal to (\u2265)50 percent (%).\n  * Part B: 0% to 100%.\n* Must have measurable disease per RECIST v1.1.\n* Must have an ECOG performance status of 0 or 1.\n* Estimated life expectancy \u226512 weeks.\n* Ability to swallow capsules.\n* Must have adequate laboratory parameters.\n* Contraceptive use should be consistent with local regulations for those participating in clinical studies.\n* Women of childbearing potential must\n\n  * Have a negative pregnancy test.\n  * Not be breastfeeding during treatment and after study intervention for at least 180 days.\n\nExclusion Criteria:\n\n* Have a documented additional validated targetable oncogenic driver mutation or alteration in genes such as epidermal growth factor receptor (EGFR), anaplastic lymphoma kinase (ALK), BRAF (V600E), human epidermal growth factor receptor 2 (HER2), MET (exon 14), ROS1, rearranged during transfection (RET), or neurotrophic tyrosine receptor kinase (NTRK)1/2/3.\n* Have had any of the following prior to randomization:\n\n  -- Prior systemic therapy (chemotherapy, immunotherapy, targeted therapy, or biological therapy) for advanced or metastatic NSCLC.\n\n  --- 1 cycle of standard-of-care treatment prior to study enrollment will be allowed for cases where immediate treatment is clinically indicated:\n* Have known active central nervous system metastases and/or carcinomatous meningitis.\n\nExclusion Criteria for Participants receiving Pemetrexed and Platinum (Part B and Safety Lead-In Part B)\n\n* Squamous cell and/or mixed small cell/nonsmall cell histology is not permitted.\n* Is unable to interrupt aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs)\n* Is unable or unwilling to take folic acid or vitamin B12 supplementation.",
      "nctId": "NCT06119581",
      "overallStatus": "RECRUITING",
      "keywords": null,
      "locations": [
        {
          "facility": "Clearview Cancer Institute",
          "status": "RECRUITING",
          "city": "Huntsville",
          "state": "Alabama",
          "zip": "35805",
          "country": "United States",
          "contacts": [
            {
              "name": "Marshall Schreeder",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 34.7304,
            "lon": -86.58594
          }
        },
        {
          "facility": "The University of Arizona Cancer Center - North Campus",
          "status": "NOT_YET_RECRUITING",
          "city": "Tucson",
          "state": "Arizona",
          "zip": "85719",
          "country": "United States",
          "contacts": [
            {
              "name": "Linda Garland",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 32.22174,
            "lon": -110.92648
          }
        },
        {
          "facility": "Mercy UC Davis Cancer Center",
          "status": "RECRUITING",
          "city": "Merced",
          "state": "California",
          "zip": "95340",
          "country": "United States",
          "contacts": [
            {
              "name": "Parminder Sidhu",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 37.30216,
            "lon": -120.48297
          }
        },
        {
          "facility": "Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center",
          "status": "RECRUITING",
          "city": "Torrance",
          "state": "California",
          "zip": "90502",
          "country": "United States",
          "contacts": [
            {
              "name": "Charity Huang",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 33.83585,
            "lon": -118.34063
          }
        },
        {
          "facility": "Yale University School of Medicine",
          "status": "NOT_YET_RECRUITING",
          "city": "New Haven",
          "state": "Connecticut",
          "zip": "06510",
          "country": "United States",
          "contacts": [
            {
              "name": "So Yeon Kim",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 41.30815,
            "lon": -72.92816
          }
        },
        {
          "facility": "Sibley Memorial Hospital",
          "status": "NOT_YET_RECRUITING",
          "city": "Washington",
          "state": "District of Columbia",
          "zip": "20016",
          "country": "United States",
          "contacts": [
            {
              "name": "Kristen Marrone",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 38.89511,
            "lon": -77.03637
          }
        },
        {
          "facility": "Millennium Oncology - Hollywood",
          "status": "RECRUITING",
          "city": "Hollywood",
          "state": "Florida",
          "zip": "33024",
          "country": "United States",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "954-450-1808"
            },
            {
              "name": "Isaac Levy",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 26.0112,
            "lon": -80.14949
          }
        },
        {
          "facility": "Miami Cancer Institute at Baptist Health, Inc.",
          "status": "RECRUITING",
          "city": "Miami",
          "state": "Florida",
          "zip": "33176",
          "country": "United States",
          "contacts": [
            {
              "name": "Paul Kaywin",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 25.77427,
            "lon": -80.19366
          }
        },
        {
          "facility": "Ocala Oncology Center PL DBA Florida Cancer Affiliates - Ocala",
          "status": "RECRUITING",
          "city": "Ocala",
          "state": "Florida",
          "zip": "34474",
          "country": "United States",
          "contacts": [
            {
              "name": "Ketan D. Doshi",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 29.1872,
            "lon": -82.14009
          }
        },
        {
          "facility": "Comprehensive Hematology Oncology",
          "status": "RECRUITING",
          "city": "Saint Petersburg",
          "state": "Florida",
          "zip": "33709",
          "country": "United States",
          "contacts": [
            {
              "name": "Neeharika Srivastava Makani",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 27.77086,
            "lon": -82.67927
          }
        },
        {
          "facility": "Tampa General Hospital",
          "status": "RECRUITING",
          "city": "Tampa",
          "state": "Florida",
          "zip": "33606",
          "country": "United States",
          "contacts": [
            {
              "name": "Noman Ashraf",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 27.94752,
            "lon": -82.45843
          }
        },
        {
          "facility": "University of Illinois at Chicago",
          "status": "NOT_YET_RECRUITING",
          "city": "Chicago",
          "state": "Illinois",
          "zip": "60612",
          "country": "United States",
          "contacts": [
            {
              "name": "Frank Weinberg",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 41.85003,
            "lon": -87.65005
          }
        },
        {
          "facility": "University of Chicago Hospital",
          "status": "NOT_YET_RECRUITING",
          "city": "Chicago",
          "state": "Illinois",
          "zip": "60637",
          "country": "United States",
          "contacts": [
            {
              "name": "Marina Garassino",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 41.85003,
            "lon": -87.65005
          }
        },
        {
          "facility": "Springfield Clinic Main Campus",
          "status": "RECRUITING",
          "city": "Springfield",
          "state": "Illinois",
          "zip": "62702",
          "country": "United States",
          "contacts": [
            {
              "name": "Preet Singh",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 39.80172,
            "lon": -89.64371
          }
        },
        {
          "facility": "Indiana University Melvin and Bren Simon Cancer Center",
          "status": "NOT_YET_RECRUITING",
          "city": "Indianapolis",
          "state": "Indiana",
          "zip": "46202",
          "country": "United States",
          "contacts": [
            {
              "name": "Gregory Durm",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 39.76838,
            "lon": -86.15804
          }
        },
        {
          "facility": "Community Cancer Center North",
          "status": "RECRUITING",
          "city": "Indianapolis",
          "state": "Indiana",
          "zip": "46250",
          "country": "United States",
          "contacts": [
            {
              "name": "Natraj Ammakkanavar",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 39.76838,
            "lon": -86.15804
          }
        },
        {
          "facility": "The University of Kansas Cancer Center - Westwood",
          "status": "NOT_YET_RECRUITING",
          "city": "Westwood",
          "state": "Kansas",
          "zip": "66205",
          "country": "United States",
          "contacts": [
            {
              "name": "Jun Zhang",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 39.04056,
            "lon": -94.6169
          }
        },
        {
          "facility": "University of Kentucky Chandler Medical Center",
          "status": "NOT_YET_RECRUITING",
          "city": "Lexington",
          "state": "Kentucky",
          "zip": "40536",
          "country": "United States",
          "contacts": [
            {
              "name": "Susanne Markesbery Arnold",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 37.98869,
            "lon": -84.47772
          }
        },
        {
          "facility": "Johns Hopkins Bayview Medical Center",
          "status": "NOT_YET_RECRUITING",
          "city": "Baltimore",
          "state": "Maryland",
          "zip": "21224",
          "country": "United States",
          "contacts": [
            {
              "name": "Kristen Marrone",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 39.29038,
            "lon": -76.61219
          }
        },
        {
          "facility": "Boston Medical Center",
          "status": "RECRUITING",
          "city": "Boston",
          "state": "Massachusetts",
          "zip": "02118",
          "country": "United States",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "617-638-7584"
            },
            {
              "name": "Umit Tapan",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 42.35843,
            "lon": -71.05977
          }
        },
        {
          "facility": "Lahey Hospital & Medical Center",
          "status": "RECRUITING",
          "city": "Burlington",
          "state": "Massachusetts",
          "zip": "01805",
          "country": "United States",
          "contacts": [
            {
              "name": "Andrew Piper-Vallillo",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 42.50482,
            "lon": -71.19561
          }
        },
        {
          "facility": "University of Michigan",
          "status": "NOT_YET_RECRUITING",
          "city": "Ann Arbor",
          "state": "Michigan",
          "zip": "48109",
          "country": "United States",
          "contacts": [
            {
              "name": "Angel Qin",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 42.27756,
            "lon": -83.74088
          }
        },
        {
          "facility": "Karmanos Cancer Institute",
          "status": "RECRUITING",
          "city": "Detroit",
          "state": "Michigan",
          "zip": "48201",
          "country": "United States",
          "contacts": [
            {
              "name": "Dipesh Uprety",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 42.33143,
            "lon": -83.04575
          }
        },
        {
          "facility": "Cancer and Hematology Centers of Western Michigan",
          "status": "RECRUITING",
          "city": "Grand Rapids",
          "state": "Michigan",
          "zip": "49503",
          "country": "United States",
          "contacts": [
            {
              "name": "Yuanbin Chen",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 42.96336,
            "lon": -85.66809
          }
        },
        {
          "facility": "Allina Health Cancer Institute",
          "status": "RECRUITING",
          "city": "Minneapolis",
          "state": "Minnesota",
          "zip": "55407",
          "country": "United States",
          "contacts": [
            {
              "name": "Charlene Marie Fares",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 44.97997,
            "lon": -93.26384
          }
        },
        {
          "facility": "HealthPartners Cancer Research Center",
          "status": "RECRUITING",
          "city": "Saint Paul",
          "state": "Minnesota",
          "zip": "55101",
          "country": "United States",
          "contacts": [
            {
              "name": "Kurt Demel",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 44.94441,
            "lon": -93.09327
          }
        },
        {
          "facility": "Saint Louis University Cancer Center",
          "status": "RECRUITING",
          "city": "Saint Louis",
          "state": "Missouri",
          "zip": "63110",
          "country": "United States",
          "contacts": [
            {
              "name": "Maurice Willis",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 38.62727,
            "lon": -90.19789
          }
        },
        {
          "facility": "Dartmouth-Hitchcock Medical Center",
          "status": "NOT_YET_RECRUITING",
          "city": "Lebanon",
          "state": "New Hampshire",
          "zip": "03756",
          "country": "United States",
          "contacts": [
            {
              "name": "Konstantin Dragnev",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 43.64229,
            "lon": -72.25176
          }
        },
        {
          "facility": "Summit Health",
          "status": "RECRUITING",
          "city": "Florham Park",
          "state": "New Jersey",
          "zip": "07932",
          "country": "United States",
          "contacts": [
            {
              "name": "Sarada Gurubhagavatula",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 40.78788,
            "lon": -74.38821
          }
        },
        {
          "facility": "The Valley Hospital",
          "status": "RECRUITING",
          "city": "Paramus",
          "state": "New Jersey",
          "zip": "07652",
          "country": "United States",
          "contacts": [
            {
              "name": "Eli Kirschner",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 40.94454,
            "lon": -74.07542
          }
        },
        {
          "facility": "Capital Health Medical Center - Hopewell",
          "status": "RECRUITING",
          "city": "Pennington",
          "state": "New Jersey",
          "zip": "08534",
          "country": "United States",
          "contacts": [
            {
              "name": "Arturo Loaiza-Bonilla",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 40.32844,
            "lon": -74.79072
          }
        },
        {
          "facility": "University of New Mexico Comprehensive Cancer Center",
          "status": "NOT_YET_RECRUITING",
          "city": "Albuquerque",
          "state": "New Mexico",
          "zip": "87131",
          "country": "United States",
          "contacts": [
            {
              "name": "Atul Kumar",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 35.08449,
            "lon": -106.65114
          }
        },
        {
          "facility": "Perlmutter Cancer Center at NYU Langone Hospital - Long Island",
          "status": "RECRUITING",
          "city": "Mineola",
          "state": "New York",
          "zip": "11501",
          "country": "United States",
          "contacts": [
            {
              "name": "Joshua Sabari",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 40.74927,
            "lon": -73.64068
          }
        },
        {
          "facility": "Laura and Isaac Perlmutter Cancer Center",
          "status": "RECRUITING",
          "city": "New York",
          "state": "New York",
          "zip": "10016",
          "country": "United States",
          "contacts": [
            {
              "name": "Joshua Sabari",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 40.71427,
            "lon": -74.00597
          }
        },
        {
          "facility": "Manhattan Eye, Ear and Throat Hospital",
          "status": "NOT_YET_RECRUITING",
          "city": "New York",
          "state": "New York",
          "zip": "10065",
          "country": "United States",
          "contacts": [
            {
              "name": "Morana Vojnic",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 40.71427,
            "lon": -74.00597
          }
        },
        {
          "facility": "Memorial Sloan Kettering Cancer Center",
          "status": "NOT_YET_RECRUITING",
          "city": "New York",
          "state": "New York",
          "zip": "10065",
          "country": "United States",
          "contacts": [
            {
              "name": "Kathryn Arbour",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 40.71427,
            "lon": -74.00597
          }
        },
        {
          "facility": "Clinical Research Alliance",
          "status": "RECRUITING",
          "city": "Westbury",
          "state": "New York",
          "zip": "11590",
          "country": "United States",
          "contacts": [
            {
              "name": "James T D'Olimpio",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 40.75566,
            "lon": -73.58763
          }
        },
        {
          "facility": "University of North Carolina Medical Center",
          "status": "NOT_YET_RECRUITING",
          "city": "Chapel Hill",
          "state": "North Carolina",
          "zip": "27599",
          "country": "United States",
          "contacts": [
            {
              "name": "Shetal Patel",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 35.9132,
            "lon": -79.05584
          }
        },
        {
          "facility": "Duke Cancer Institute",
          "status": "RECRUITING",
          "city": "Durham",
          "state": "North Carolina",
          "zip": "27710",
          "country": "United States",
          "contacts": [
            {
              "name": "Jeffrey Clarke",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 35.99403,
            "lon": -78.89862
          }
        },
        {
          "facility": "UNC REX Cancer Center",
          "status": "NOT_YET_RECRUITING",
          "city": "Raleigh",
          "state": "North Carolina",
          "zip": "27607",
          "country": "United States",
          "contacts": [
            {
              "name": "Brendan McNulty",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 35.7721,
            "lon": -78.63861
          }
        },
        {
          "facility": "University of Oklahoma Health Sciences Center, Peggy and Charles Stephenson Oklahoma Cancer Center",
          "status": "NOT_YET_RECRUITING",
          "city": "Oklahoma City",
          "state": "Oklahoma",
          "zip": "73104",
          "country": "United States",
          "contacts": [
            {
              "name": "Raid Aljumaily",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 35.46756,
            "lon": -97.51643
          }
        },
        {
          "facility": "Asante Rogue Regional Medical Center",
          "status": "RECRUITING",
          "city": "Medford",
          "state": "Oregon",
          "zip": "97504",
          "country": "United States",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "541-789-5003"
            },
            {
              "name": "Alison Savage",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 42.32652,
            "lon": -122.87559
          }
        },
        {
          "facility": "Providence Portland Medical Center",
          "status": "RECRUITING",
          "city": "Portland",
          "state": "Oregon",
          "zip": "97213",
          "country": "United States",
          "contacts": [
            {
              "name": "Rachel Sanborn",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 45.52345,
            "lon": -122.67621
          }
        },
        {
          "facility": "Providence St. Vincent Medical Center",
          "status": "NOT_YET_RECRUITING",
          "city": "Portland",
          "state": "Oregon",
          "zip": "97225",
          "country": "United States",
          "contacts": [
            {
              "name": "Rachel Sanborn",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 45.52345,
            "lon": -122.67621
          }
        },
        {
          "facility": "Kaiser Permanente Interstate Medical Office Central",
          "status": "NOT_YET_RECRUITING",
          "city": "Portland",
          "state": "Oregon",
          "zip": "97227",
          "country": "United States",
          "contacts": [
            {
              "name": "Sandeep Mashru",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 45.52345,
            "lon": -122.67621
          }
        },
        {
          "facility": "Bryn Mawr Hospital",
          "status": "NOT_YET_RECRUITING",
          "city": "Bryn Mawr",
          "state": "Pennsylvania",
          "zip": "19010",
          "country": "United States",
          "contacts": [
            {
              "name": "Paul Gilman",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 40.30396,
            "lon": -80.08672
          }
        },
        {
          "facility": "Paoli Memorial Hospital",
          "status": "NOT_YET_RECRUITING",
          "city": "Paoli",
          "state": "Pennsylvania",
          "zip": "19301",
          "country": "United States",
          "contacts": [
            {
              "name": "Paul Gilman",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 40.04205,
            "lon": -75.47631
          }
        },
        {
          "facility": "Thomas Jefferson University, Sidney Kimmel Cancer Center - Clinical Trials Office",
          "status": "NOT_YET_RECRUITING",
          "city": "Philadelphia",
          "state": "Pennsylvania",
          "zip": "19107",
          "country": "United States",
          "contacts": [
            {
              "name": "Sarah Gordon",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 39.95233,
            "lon": -75.16379
          }
        },
        {
          "facility": "UPMC Hillman Cancer Center",
          "status": "NOT_YET_RECRUITING",
          "city": "Pittsburgh",
          "state": "Pennsylvania",
          "zip": "15232",
          "country": "United States",
          "contacts": [
            {
              "name": "Timothy Burns",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 40.44062,
            "lon": -79.99589
          }
        },
        {
          "facility": "Lankenau Medical Center",
          "status": "NOT_YET_RECRUITING",
          "city": "Wynnewood",
          "state": "Pennsylvania",
          "zip": "19096",
          "country": "United States",
          "contacts": [
            {
              "name": "Paul Gilman",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 40.00289,
            "lon": -75.27074
          }
        },
        {
          "facility": "Medical University of South Carolina",
          "status": "NOT_YET_RECRUITING",
          "city": "Charleston",
          "state": "South Carolina",
          "zip": "29425",
          "country": "United States",
          "contacts": [
            {
              "name": "Mariam Alexander",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 32.77657,
            "lon": -79.93092
          }
        },
        {
          "facility": "Tidelands Health Oncology",
          "status": "NOT_YET_RECRUITING",
          "city": "Murrells Inlet",
          "state": "South Carolina",
          "zip": "29576",
          "country": "United States",
          "contacts": [
            {
              "name": "David Milling",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 33.551,
            "lon": -79.04143
          }
        },
        {
          "facility": "Baptist Memorial Hospital-Memphis",
          "status": "RECRUITING",
          "city": "Memphis",
          "state": "Tennessee",
          "zip": "38120",
          "country": "United States",
          "contacts": [
            {
              "name": "Osa Ogbeide",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 35.14953,
            "lon": -90.04898
          }
        },
        {
          "facility": "William Beaumont Army Medical Center",
          "status": "RECRUITING",
          "city": "Fort Bliss",
          "state": "Texas",
          "zip": "79918",
          "country": "United States",
          "contacts": [
            {
              "name": "Warren Alexander",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 31.81357,
            "lon": -106.41224
          }
        },
        {
          "facility": "Brooke Army Medical Center",
          "status": "RECRUITING",
          "city": "Fort Sam Houston",
          "state": "Texas",
          "zip": "78234",
          "country": "United States",
          "contacts": [
            {
              "name": "Jason Burris",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 29.45746,
            "lon": -98.4472
          }
        },
        {
          "facility": "Houston Methodist Hospital",
          "status": "NOT_YET_RECRUITING",
          "city": "Houston",
          "state": "Texas",
          "zip": "77030",
          "country": "United States",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "713-441-9948"
            },
            {
              "name": "Jun Zhang",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 29.76328,
            "lon": -95.36327
          }
        },
        {
          "facility": "University of Texas MD Anderson Cancer Center",
          "status": "RECRUITING",
          "city": "Houston",
          "state": "Texas",
          "zip": "77030",
          "country": "United States",
          "contacts": [
            {
              "name": "Marcelo Vailati Negrao",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 29.76328,
            "lon": -95.36327
          }
        },
        {
          "facility": "Baylor Scott & White Medical Center - Temple",
          "status": "RECRUITING",
          "city": "Temple",
          "state": "Texas",
          "zip": "76508",
          "country": "United States",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "254-724-2841"
            },
            {
              "name": "Alan Gowan",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 31.09823,
            "lon": -97.34278
          }
        },
        {
          "facility": "Swedish Medical Center",
          "status": "NOT_YET_RECRUITING",
          "city": "Seattle",
          "state": "Washington",
          "zip": "98104",
          "country": "United States",
          "contacts": [
            {
              "name": "Siddhartha Devarakonda",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 47.60621,
            "lon": -122.33207
          }
        },
        {
          "facility": "Gosford Hospital",
          "status": "RECRUITING",
          "city": "Gosford",
          "state": "New South Wales",
          "zip": "2250",
          "country": "Australia",
          "contacts": [
            {
              "name": "Matthew Ho Fai Wong",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": -33.4244,
            "lon": 151.34399
          }
        },
        {
          "facility": "Icon Cancer Centre Wesley",
          "status": "RECRUITING",
          "city": "Auchenflower",
          "state": "Queensland",
          "zip": "4066",
          "country": "Australia",
          "contacts": [
            {
              "name": "Adam Stirling",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": -27.47443,
            "lon": 152.99213
          }
        },
        {
          "facility": "Sunshine Coast University Hospital",
          "status": "RECRUITING",
          "city": "Birtinya",
          "state": "Queensland",
          "zip": "4575",
          "country": "Australia",
          "contacts": [
            {
              "name": "Bryan Chan",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": -26.74322,
            "lon": 153.11913
          }
        },
        {
          "facility": "Mackay Base Hospital",
          "status": "RECRUITING",
          "city": "Mackay",
          "state": "Queensland",
          "zip": "4740",
          "country": "Australia",
          "contacts": [
            {
              "name": "ZIA UL HAQ ANSARI",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": -21.15345,
            "lon": 149.16554
          }
        },
        {
          "facility": "Gold Coast University Hospital",
          "status": "NOT_YET_RECRUITING",
          "city": "Southport",
          "state": "Queensland",
          "zip": "4215",
          "country": "Australia",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "6175687000"
            },
            {
              "name": "Robert Mason",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": -27.96724,
            "lon": 153.39796
          }
        },
        {
          "facility": "The Townsville Hospital",
          "status": "RECRUITING",
          "city": "Townsville",
          "state": "Queensland",
          "zip": "4814",
          "country": "Australia",
          "contacts": [
            {
              "name": "Abhishek Joshi",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": -19.26639,
            "lon": 146.80569
          }
        },
        {
          "facility": "Royal Adelaide Hospital",
          "status": "RECRUITING",
          "city": "Adelaide",
          "state": "South Australia",
          "zip": "5000",
          "country": "Australia",
          "contacts": [
            {
              "name": "Harminder Takhar",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": -34.92866,
            "lon": 138.59863
          }
        },
        {
          "facility": "Ballarat Health Services",
          "status": "RECRUITING",
          "city": "Ballarat Central",
          "state": "Victoria",
          "zip": "3350",
          "country": "Australia",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "610353208500"
            },
            {
              "name": "Wasek Faisal",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": -37.56206,
            "lon": 143.85082
          }
        },
        {
          "facility": "St Vincent's Hospital",
          "status": "RECRUITING",
          "city": "Melbourne",
          "state": "Victoria",
          "zip": "3065",
          "country": "Australia",
          "contacts": [
            {
              "name": "Melissa Moore",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": -37.814,
            "lon": 144.96332
          }
        },
        {
          "facility": "Goulburn Valley Health",
          "status": "RECRUITING",
          "city": "Shepparton",
          "state": "Victoria",
          "zip": "3630",
          "country": "Australia",
          "contacts": [
            {
              "name": "Myron Klevansky",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": -36.38047,
            "lon": 145.39867
          }
        },
        {
          "facility": "Sir Charles Gairdner Hospital",
          "status": "RECRUITING",
          "city": "Perth",
          "state": "Western Australia",
          "zip": "6009",
          "country": "Australia",
          "contacts": [
            {
              "name": "samantha bowyer",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": -31.95224,
            "lon": 115.8614
          }
        },
        {
          "facility": "Ordensklinikum Linz GmbH Elisabethinen",
          "status": "RECRUITING",
          "city": "Linz",
          "state": "Ober\u00f6sterreich",
          "zip": "4020",
          "country": "Austria",
          "contacts": [
            {
              "name": "Michael Schumacher",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 48.30639,
            "lon": 14.28611
          }
        },
        {
          "facility": "Landeskrankenhaus Feldkirch",
          "status": "NOT_YET_RECRUITING",
          "city": "Feldkirch",
          "state": "Vorarlberg",
          "zip": "6800",
          "country": "Austria",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "4355223032681"
            },
            {
              "name": "Thomas Winder",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 47.23306,
            "lon": 9.6
          }
        },
        {
          "facility": "ZNA Middelheim",
          "status": "NOT_YET_RECRUITING",
          "city": "Antwerp",
          "state": "Antwerpen",
          "zip": "2020",
          "country": "Belgium",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "032803575"
            },
            {
              "name": "Kim De Muynck",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 51.21989,
            "lon": 4.40346
          }
        },
        {
          "facility": "AZ Sint-Maarten, Campus Leopoldstraat 2",
          "status": "RECRUITING",
          "city": "Mechelen",
          "state": "Antwerpen",
          "zip": "2800",
          "country": "Belgium",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "3215892040"
            },
            {
              "name": "Marc Lambrechts",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 51.02574,
            "lon": 4.47762
          }
        },
        {
          "facility": "Universit\u00e9 Catholique de Louvain-Namur - Centre Hospitalier Universitaire Dinant-Godinne - Site Godinne",
          "status": "NOT_YET_RECRUITING",
          "city": "Yvoir",
          "state": "Namur",
          "zip": "5530",
          "country": "Belgium",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "081423351"
            },
            {
              "name": "Sebahat Ocak",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 50.3279,
            "lon": 4.88059
          }
        },
        {
          "facility": "UZ Gent",
          "status": "NOT_YET_RECRUITING",
          "city": "Gent",
          "state": "Oost-Vlaanderen",
          "zip": "9000",
          "country": "Belgium",
          "contacts": [
            {
              "name": "Veerle Surmont",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 51.05,
            "lon": 3.71667
          }
        },
        {
          "facility": "UZ Leuven",
          "status": "RECRUITING",
          "city": "Leuven",
          "state": "Vlaams-Brabant",
          "zip": "3000",
          "country": "Belgium",
          "contacts": [
            {
              "name": "christophe Dooms",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 50.87959,
            "lon": 4.70093
          }
        },
        {
          "facility": "AZ Sint-Jan Brugge-Oostende AV",
          "status": "RECRUITING",
          "city": "Brugge",
          "state": "West-Vlaanderen",
          "zip": "8000",
          "country": "Belgium",
          "contacts": [
            {
              "name": "Lander Van Acker",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 51.20892,
            "lon": 3.22424
          }
        },
        {
          "facility": "AZ Groeninge Campus Kennedylaan",
          "status": "RECRUITING",
          "city": "Kortrijk",
          "state": "West-Vlaanderen",
          "zip": "8500",
          "country": "Belgium",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "056633340"
            },
            {
              "name": "Katrien Ghysen",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 50.82803,
            "lon": 3.26487
          }
        },
        {
          "facility": "Clinique Saint Pierre",
          "status": "RECRUITING",
          "city": "Ottignies",
          "zip": "1340",
          "country": "Belgium",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "003210437298"
            },
            {
              "name": "Luciano Carestia",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 50.66535,
            "lon": 4.56679
          }
        },
        {
          "facility": "AZ Glorieux Ronse",
          "status": "RECRUITING",
          "city": "Ronse",
          "zip": "9600",
          "country": "Belgium",
          "contacts": [
            {
              "name": "Patrick Alexander",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 50.74574,
            "lon": 3.6005
          }
        },
        {
          "facility": "Clinica Amo - Rio Vermelho",
          "status": "NOT_YET_RECRUITING",
          "city": "Salvador",
          "state": "Bahia",
          "zip": "41950-640",
          "country": "Brazil",
          "contacts": [
            {
              "name": "Aknar Calabrich",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": -12.97111,
            "lon": -38.51083
          }
        },
        {
          "facility": "Centro de Pesquisa Cl\u00ednica do Instituto do C\u00e2ncer do Cear\u00e1",
          "status": "NOT_YET_RECRUITING",
          "city": "Fortaleza",
          "state": "Cear\u00e1",
          "zip": "60430235",
          "country": "Brazil",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "558532884576"
            },
            {
              "name": "Fabio Chaves",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": -3.71722,
            "lon": -38.54306
          }
        },
        {
          "facility": "Sirio-Libanes Brasilia - Centro de Oncologia - Asa Sul",
          "status": "NOT_YET_RECRUITING",
          "city": "Brasilia",
          "state": "Distrito Federal",
          "zip": "70200-730",
          "country": "Brazil",
          "contacts": [
            {
              "name": "Luiza Faria",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": -15.77972,
            "lon": -47.92972
          }
        },
        {
          "facility": "Hospital Brasilia",
          "status": "NOT_YET_RECRUITING",
          "city": "Lago sul",
          "state": "Distrito Federal",
          "zip": "71635580",
          "country": "Brazil",
          "contacts": [
            {
              "name": "ROMUALDO BARROSO DE SOUSA",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": -15.90603,
            "lon": -47.86366
          }
        },
        {
          "facility": "Hospital S\u00e3o Domingos",
          "status": "NOT_YET_RECRUITING",
          "city": "Bequimao",
          "state": "Maranh\u00e3o",
          "zip": "65060-645",
          "country": "Brazil",
          "contacts": [
            {
              "name": "Antonio Machado Alencar",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": -2.44889,
            "lon": -44.7825
          }
        },
        {
          "facility": "Oncominas",
          "status": "NOT_YET_RECRUITING",
          "city": "Pouso Alegre",
          "state": "Minas Gerais",
          "zip": "37554-216",
          "country": "Brazil",
          "contacts": [
            {
              "name": "Marina Zorzetto",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": -22.23,
            "lon": -45.93639
          }
        },
        {
          "facility": "Hospital Universit\u00e1rio Evang\u00e9lico Mackenzie",
          "status": "NOT_YET_RECRUITING",
          "city": "Curitiba",
          "state": "Parana",
          "zip": "80730-150",
          "country": "Brazil",
          "contacts": [
            {
              "name": "Fernanda Ronchi",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": -25.42778,
            "lon": -49.27306
          }
        },
        {
          "facility": "Hospital de Cancer de Londrina",
          "status": "NOT_YET_RECRUITING",
          "city": "Londrina",
          "state": "Paran\u00e1",
          "zip": "86015-520",
          "country": "Brazil",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "5541996379769"
            },
            {
              "name": "Mariana Miyasaki Piovesana",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": -23.31028,
            "lon": -51.16278
          }
        },
        {
          "facility": "Liga Norte Riograndense Contra o C\u00e2ncer",
          "status": "NOT_YET_RECRUITING",
          "city": "Natal",
          "state": "Rio Grande Do Norte",
          "zip": "59062-000",
          "country": "Brazil",
          "contacts": [
            {
              "name": "Danielli de Almeida Matias",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": -5.795,
            "lon": -35.20944
          }
        },
        {
          "facility": "Hospital Tacchini",
          "status": "NOT_YET_RECRUITING",
          "city": "Bento Gon\u00e7alves",
          "state": "Rio Grande Do Sul",
          "zip": "95700-084",
          "country": "Brazil",
          "contacts": [
            {
              "name": "ANDRE REIRIZ",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": -29.17139,
            "lon": -51.51917
          }
        },
        {
          "facility": "ONCOSITE - Centro de Pesquisa Clinica em Oncologia",
          "status": "NOT_YET_RECRUITING",
          "city": "Ijui",
          "state": "Rio Grande Do Sul",
          "zip": "98700-000",
          "country": "Brazil",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "55991592101"
            },
            {
              "name": "Fabio Andre Franke",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": -28.38778,
            "lon": -53.91472
          }
        },
        {
          "facility": "Hospital S\u00e3o Lucas da PUCRS",
          "status": "NOT_YET_RECRUITING",
          "city": "Porto Alegre",
          "state": "Rio Grande Do Sul",
          "zip": "90610-000",
          "country": "Brazil",
          "contacts": [
            {
              "name": "Ana Caroline Zimer Gelatti",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": -30.03306,
            "lon": -51.23
          }
        },
        {
          "facility": "Faculdade de Medicina do ABC",
          "status": "NOT_YET_RECRUITING",
          "city": "Santo Andr\u00e9",
          "state": "S\u00e3o Paulo",
          "zip": "09060-650",
          "country": "Brazil",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "551149935497"
            },
            {
              "name": "Claudia Vaz de Melo Sette",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": -23.66389,
            "lon": -46.53833
          }
        },
        {
          "facility": "Hospital BP",
          "status": "NOT_YET_RECRUITING",
          "city": "Sao Paulo",
          "state": "S\u00e3o Paulo",
          "zip": "01321-001",
          "country": "Brazil",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "5511985883170"
            },
            {
              "name": "Marcelo Corassa",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": -23.5475,
            "lon": -46.63611
          }
        },
        {
          "facility": "Hospital Paulistano",
          "status": "NOT_YET_RECRUITING",
          "city": "Sao Paulo",
          "state": "S\u00e3o Paulo",
          "zip": "01321-001",
          "country": "Brazil",
          "contacts": [
            {
              "name": "Emerson Neves dos Santos",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": -23.5475,
            "lon": -46.63611
          }
        },
        {
          "facility": "Instituto D'Or de Pesquisa e Ensino (IDOR)",
          "status": "NOT_YET_RECRUITING",
          "city": "Sao Paulo",
          "state": "S\u00e3o Paulo",
          "zip": "04543-000",
          "country": "Brazil",
          "contacts": [
            {
              "name": "Milena Perez Mak",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": -23.5475,
            "lon": -46.63611
          }
        },
        {
          "facility": "COE Ensino e Pesquisa",
          "status": "NOT_YET_RECRUITING",
          "city": "S\u00e3o Jos\u00e9 dos Campos",
          "state": "S\u00e3o Paulo",
          "zip": "12242-660",
          "country": "Brazil",
          "contacts": [
            {
              "name": "Fabiano de Almeida Costa",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": -23.17944,
            "lon": -45.88694
          }
        },
        {
          "facility": "Instituto Nacional de C\u00e2ncer - INCA",
          "status": "NOT_YET_RECRUITING",
          "city": "Rio de Janeiro",
          "zip": "20231-050",
          "country": "Brazil",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "552132076564"
            },
            {
              "name": "Victor Marcondes Lopes dos Santos",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": -22.90278,
            "lon": -43.2075
          }
        },
        {
          "facility": "Centro de Tratamento de Tumores Botafogo para Oncoclinicas Rio de Janeiro SA",
          "status": "NOT_YET_RECRUITING",
          "city": "Rio de Janeiro",
          "zip": "22250-905",
          "country": "Brazil",
          "contacts": [
            {
              "name": "Pedro Rafael Martins De Marchi",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": -22.90278,
            "lon": -43.2075
          }
        },
        {
          "facility": "Icesp - Instituto Do C\u00e2ncer Do Estado de S\u00e3o Paulo",
          "status": "NOT_YET_RECRUITING",
          "city": "S\u00e3o Paulo",
          "zip": "01246-000",
          "country": "Brazil",
          "contacts": [
            {
              "name": "Gilberto Castro",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": -23.5475,
            "lon": -46.63611
          }
        },
        {
          "facility": "Hospital S\u00edrio Liban\u00eas",
          "status": "NOT_YET_RECRUITING",
          "city": "S\u00e3o Paulo",
          "zip": "01308-060",
          "country": "Brazil",
          "contacts": [
            {
              "name": "Guilherme Harada",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": -23.5475,
            "lon": -46.63611
          }
        },
        {
          "facility": "Centro Paulista de Oncologia Cl\u00ednica",
          "status": "NOT_YET_RECRUITING",
          "city": "S\u00e3o Paulo",
          "zip": "01452-000",
          "country": "Brazil",
          "contacts": [
            {
              "name": "William Nassib William Junior",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": -23.5475,
            "lon": -46.63611
          }
        },
        {
          "facility": "N\u00facleo de Pesquisa Cl\u00ednica da Rede S\u00e3o Camilo",
          "status": "NOT_YET_RECRUITING",
          "city": "S\u00e3o Paulo",
          "zip": "04014-002",
          "country": "Brazil",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "551144500360"
            },
            {
              "name": "Felipe Jos\u00e9 Silva Melo Cruz",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": -23.5475,
            "lon": -46.63611
          }
        },
        {
          "facility": "Instituto de Assist\u251cncia M\u251cdica ao Servidor P",
          "status": "NOT_YET_RECRUITING",
          "city": "S\u00e3o Paulo",
          "zip": "04039-901",
          "country": "Brazil",
          "contacts": [
            {
              "name": "Otavio Gampel",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": -23.5475,
            "lon": -46.63611
          }
        },
        {
          "facility": "BC Cancer Vancouver",
          "status": "NOT_YET_RECRUITING",
          "city": "Vancouver",
          "state": "British Columbia",
          "zip": "V5Z 4E6",
          "country": "Canada",
          "contacts": [
            {
              "name": "Janessa Laskin",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 49.24966,
            "lon": -123.11934
          }
        },
        {
          "facility": "CIUSSS- saguenay-Lac-Saint-Jean",
          "status": "NOT_YET_RECRUITING",
          "city": "Chicoutimi",
          "state": "Quebec",
          "zip": "G7H 5H6",
          "country": "Canada",
          "contacts": [
            {
              "name": "Jose Luiz Miranda Guimaraes",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 48.41963,
            "lon": -71.06369
          }
        },
        {
          "facility": "Unit\u00e9 de Recherche Clinique du CISSS des Laurentides",
          "status": "NOT_YET_RECRUITING",
          "city": "Saint-J\u00e9r\u00f4me",
          "state": "Quebec",
          "zip": "J7Z 2V4",
          "country": "Canada",
          "contacts": [
            {
              "name": "Ghislain Cournoyer",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 45.78036,
            "lon": -74.00365
          }
        },
        {
          "facility": "Wannan Medical College Yijishan Hospital",
          "status": "NOT_YET_RECRUITING",
          "city": "Wuhu",
          "state": "Anhui",
          "zip": "241001",
          "country": "China",
          "contacts": [
            {
              "name": "Xingwu Chen",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 31.33728,
            "lon": 118.37351
          }
        },
        {
          "facility": "Cancer Hospital Chinese Academy of Medical Science",
          "status": "NOT_YET_RECRUITING",
          "city": "Beijing",
          "state": "Beijing",
          "zip": "100021",
          "country": "China",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "8615601395554"
            },
            {
              "name": "Ning Li",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 39.9075,
            "lon": 116.39723
          }
        },
        {
          "facility": "Beijing Cancer hospital",
          "status": "NOT_YET_RECRUITING",
          "city": "Beijing",
          "state": "Beijing",
          "zip": "100142",
          "country": "China",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "8613521469355"
            },
            {
              "name": "Jun Zhao",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 39.9075,
            "lon": 116.39723
          }
        },
        {
          "facility": "The First Affiliated Hospital of the Third Military Medical University",
          "status": "NOT_YET_RECRUITING",
          "city": "Shapingba",
          "state": "Chongqing",
          "zip": "400038",
          "country": "China",
          "contacts": [
            {
              "name": "Xiangdong Zhou",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 29.16792,
            "lon": 109.40029
          }
        },
        {
          "facility": "Fujian Provincial Cancer Hospital",
          "status": "NOT_YET_RECRUITING",
          "city": "Fuzhou",
          "state": "Fujian",
          "zip": "350014",
          "country": "China",
          "contacts": [
            {
              "name": "Gen Lin",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 26.06139,
            "lon": 119.30611
          }
        },
        {
          "facility": "The First Affiliated Hospital of Guangzhou Medical University",
          "status": "NOT_YET_RECRUITING",
          "city": "Guangzhou",
          "state": "Guangdong",
          "zip": "510120",
          "country": "China",
          "contacts": [
            {
              "name": "Chengzhi Zhou",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 23.11667,
            "lon": 113.25
          }
        },
        {
          "facility": "The First Affiliated Hospital, Sun Yat-sen University",
          "status": "NOT_YET_RECRUITING",
          "city": "Guangzhou",
          "state": "Guangdong",
          "country": "China",
          "contacts": [
            {
              "name": "Kejing Tang",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 23.11667,
            "lon": 113.25
          }
        },
        {
          "facility": "Affiliated Hospital of Guangdong Medical University",
          "status": "NOT_YET_RECRUITING",
          "city": "Zhanjiang",
          "state": "Guangdong",
          "zip": "524004",
          "country": "China",
          "contacts": [
            {
              "name": "Shujun Li",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 21.28145,
            "lon": 110.34271
          }
        },
        {
          "facility": "Liuzhou People's Hospital",
          "status": "NOT_YET_RECRUITING",
          "city": "Liuzhou",
          "state": "Guangxi",
          "zip": "545006",
          "country": "China",
          "contacts": [
            {
              "name": "Min Li",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ]
        },
        {
          "facility": "Hainan General Hospital",
          "status": "NOT_YET_RECRUITING",
          "city": "Haikou",
          "state": "Hainan",
          "zip": "570311",
          "country": "China",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "13876825536"
            },
            {
              "name": "yongxing chen",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 20.04583,
            "lon": 110.34167
          }
        },
        {
          "facility": "Harbin Medical University Cancer Hospital",
          "status": "NOT_YET_RECRUITING",
          "city": "Harbin",
          "state": "Heilongjiang",
          "zip": "150081",
          "country": "China",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "13904505825"
            },
            {
              "name": "Yan Yu",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 45.75,
            "lon": 126.65
          }
        },
        {
          "facility": "The First Affiliated Hospital of Xinxiang Medical University",
          "status": "NOT_YET_RECRUITING",
          "city": "Xinxiang",
          "state": "Henan",
          "zip": "453100",
          "country": "China",
          "contacts": [
            {
              "name": "Yinghua Ji",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 35.19033,
            "lon": 113.80151
          }
        },
        {
          "facility": "Wuhan Union Hospital",
          "status": "NOT_YET_RECRUITING",
          "city": "Wuhan",
          "state": "Hubei",
          "zip": "430022",
          "country": "China",
          "contacts": [
            {
              "name": "Xiaorong Dong",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 30.58333,
            "lon": 114.26667
          }
        },
        {
          "facility": "Tongji Hospital Tongji Medical,Science & Technology",
          "status": "NOT_YET_RECRUITING",
          "city": "Wuhan",
          "state": "Hubei",
          "zip": "430030",
          "country": "China",
          "contacts": [
            {
              "name": "Qian Chu",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 30.58333,
            "lon": 114.26667
          }
        },
        {
          "facility": "Renmin Hospital of Wuhan University",
          "status": "NOT_YET_RECRUITING",
          "city": "Wuhan",
          "state": "Hubei",
          "zip": "430060",
          "country": "China",
          "contacts": [
            {
              "name": "Qibin Song",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 30.58333,
            "lon": 114.26667
          }
        },
        {
          "facility": "Xiangyang Central Hospital",
          "status": "NOT_YET_RECRUITING",
          "city": "Xiangyang",
          "state": "Hubei",
          "zip": "441021",
          "country": "China",
          "contacts": [
            {
              "name": "Tienan Yi",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 32.0422,
            "lon": 112.14479
          }
        },
        {
          "facility": "Hunan Cancer Hospital",
          "status": "NOT_YET_RECRUITING",
          "city": "Changsha",
          "state": "Hunan",
          "zip": "410013",
          "country": "China",
          "contacts": [
            {
              "name": "Lin Wu",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 28.19874,
            "lon": 112.97087
          }
        },
        {
          "facility": "Hunan Cancer Hospital",
          "status": "NOT_YET_RECRUITING",
          "city": "Changsha",
          "state": "Hunan",
          "zip": "410013",
          "country": "China",
          "contacts": [
            {
              "name": "Yongchang Zhang",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 28.19874,
            "lon": 112.97087
          }
        },
        {
          "facility": "ZhuZhou Central Hospital",
          "status": "NOT_YET_RECRUITING",
          "city": "Zhuzhou",
          "state": "Hunan",
          "zip": "412007",
          "country": "China",
          "contacts": [
            {
              "name": "Yanchao Liang",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 27.83333,
            "lon": 113.15
          }
        },
        {
          "facility": "The First People's Hospital of Changzhou",
          "status": "NOT_YET_RECRUITING",
          "city": "Changzhou",
          "state": "Jiangsu",
          "zip": "213003",
          "country": "China",
          "contacts": [
            {
              "name": "Mei Ji",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 31.77359,
            "lon": 119.95401
          }
        },
        {
          "facility": "Nanjing First Hospital",
          "status": "NOT_YET_RECRUITING",
          "city": "Nanjing",
          "state": "Jiangsu",
          "zip": "210012",
          "country": "China",
          "contacts": [
            {
              "name": "Surong Fang",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 32.06167,
            "lon": 118.77778
          }
        },
        {
          "facility": "Jiangsu Province Hospital",
          "status": "NOT_YET_RECRUITING",
          "city": "Nanjing",
          "state": "Jiangsu",
          "zip": "210029",
          "country": "China",
          "contacts": [
            {
              "name": "Renhua Guo",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 32.06167,
            "lon": 118.77778
          }
        },
        {
          "facility": "Nantong Tumor Hospital",
          "status": "NOT_YET_RECRUITING",
          "city": "Nantong",
          "state": "Jiangsu",
          "zip": "226361",
          "country": "China",
          "contacts": [
            {
              "name": "Junguo Lu",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 32.03028,
            "lon": 120.87472
          }
        },
        {
          "facility": "The First Affiliated Hospital of Nanchang University",
          "status": "NOT_YET_RECRUITING",
          "city": "Nanchang",
          "state": "Jiangxi",
          "zip": "330006",
          "country": "China",
          "contacts": [
            {
              "name": "Wei Zuo",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 28.68396,
            "lon": 115.85306
          }
        },
        {
          "facility": "Jilin Cancer Hospital",
          "status": "NOT_YET_RECRUITING",
          "city": "Changchun",
          "state": "Jilin",
          "zip": "132000",
          "country": "China",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "043185536383"
            },
            {
              "name": "Ying Cheng",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 43.88,
            "lon": 125.32278
          }
        },
        {
          "facility": "Tangdu Hospital of Fourth Military Medical University of Chinese People's Liberation Army",
          "status": "NOT_YET_RECRUITING",
          "city": "Xi'an",
          "state": "Shaanxi",
          "zip": "710038",
          "country": "China",
          "contacts": [
            {
              "name": "Haichuan Su",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 34.25833,
            "lon": 108.92861
          }
        },
        {
          "facility": "The First Affiliated Hospital of Xi'an Jiaotong University",
          "status": "NOT_YET_RECRUITING",
          "city": "Xi'an",
          "state": "Shaanxi",
          "zip": "710061",
          "country": "China",
          "contacts": [
            {
              "name": "Yu Yao",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 34.25833,
            "lon": 108.92861
          }
        },
        {
          "facility": "Jinan Central Hospital",
          "status": "NOT_YET_RECRUITING",
          "city": "Jinan",
          "state": "Shandong",
          "zip": "250013",
          "country": "China",
          "contacts": [
            {
              "name": "Meili Sun",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 36.66833,
            "lon": 116.99722
          }
        },
        {
          "facility": "Shandong Cancer Hospital",
          "status": "NOT_YET_RECRUITING",
          "city": "Jinan",
          "state": "Shandong",
          "zip": "250117",
          "country": "China",
          "contacts": [
            {
              "name": "Yuping Sun",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 36.66833,
            "lon": 116.99722
          }
        },
        {
          "facility": "LinYi Cancer Hospital",
          "status": "NOT_YET_RECRUITING",
          "city": "Linyi",
          "state": "Shandong",
          "zip": "276001",
          "country": "China",
          "contacts": [
            {
              "name": "Jianhua Shi",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 35.06306,
            "lon": 118.34278
          }
        },
        {
          "facility": "Shanghai Chest Hospital",
          "status": "NOT_YET_RECRUITING",
          "city": "Shanghai",
          "state": "Shanghai",
          "zip": "200030",
          "country": "China",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "8613601813062"
            },
            {
              "name": "Shun Lu",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 31.22222,
            "lon": 121.45806
          }
        },
        {
          "facility": "The Third People's Hospital of Chengdu (CDTPH)",
          "status": "NOT_YET_RECRUITING",
          "city": "Chengdu",
          "state": "Sichuan",
          "zip": "610031",
          "country": "China",
          "contacts": [
            {
              "name": "yi yang",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 30.66667,
            "lon": 104.06667
          }
        },
        {
          "facility": "West China Hospital, Sichuan University",
          "status": "NOT_YET_RECRUITING",
          "city": "ChengDu",
          "state": "Sichuan",
          "zip": "610041",
          "country": "China",
          "contacts": [
            {
              "name": "Yan Zhang",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 30.66667,
            "lon": 104.06667
          }
        },
        {
          "facility": "Tianjin Medical University Cancer Institute and Hospital",
          "status": "NOT_YET_RECRUITING",
          "city": "Tianjin",
          "state": "Tianjin",
          "zip": "300060",
          "country": "China",
          "contacts": [
            {
              "name": "Dingzhi Huang",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 39.14222,
            "lon": 117.17667
          }
        },
        {
          "facility": "The First Affiliated Hospital of Xinjiang Medical University",
          "status": "NOT_YET_RECRUITING",
          "city": "Urumchi",
          "state": "Xinjiang",
          "zip": "830054",
          "country": "China",
          "contacts": [
            {
              "name": "Hua Zhang",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ]
        },
        {
          "facility": "The First Affiliated Hospital, Zhejiang University",
          "status": "NOT_YET_RECRUITING",
          "city": "Hangzhou",
          "state": "Zhejiang",
          "zip": "310003",
          "country": "China",
          "contacts": [
            {
              "name": "Jianying Zhou",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 30.29365,
            "lon": 120.16142
          }
        },
        {
          "facility": "Sir Run Run Shaw Hospital",
          "status": "NOT_YET_RECRUITING",
          "city": "Hangzhou",
          "state": "Zhejiang",
          "zip": "310016",
          "country": "China",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "057186006922"
            },
            {
              "name": "Hongming Pan",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 30.29365,
            "lon": 120.16142
          }
        },
        {
          "facility": "Zhejiang Cancer Hospital",
          "status": "NOT_YET_RECRUITING",
          "city": "Hangzhou",
          "state": "Zhejiang",
          "zip": "310022",
          "country": "China",
          "contacts": [
            {
              "name": "Zhiyu Huang",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 30.29365,
            "lon": 120.16142
          }
        },
        {
          "facility": "Taizhou Hospital of Zhejiang Province",
          "status": "NOT_YET_RECRUITING",
          "city": "Linhai",
          "state": "Zhejiang",
          "zip": "317099",
          "country": "China",
          "contacts": [
            {
              "name": "Dongqing LV",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 28.85535,
            "lon": 121.14469
          }
        },
        {
          "facility": "Hwa Mei Hospital University of Chinese Academy of Sciences",
          "status": "NOT_YET_RECRUITING",
          "city": "Ningbo",
          "state": "Zhejiang",
          "zip": "315099",
          "country": "China",
          "contacts": [
            {
              "name": "Chuangzhou Rao",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 29.87819,
            "lon": 121.54945
          }
        },
        {
          "facility": "Sichuan Cancer hospital",
          "status": "NOT_YET_RECRUITING",
          "city": "Chengdu",
          "zip": "610041",
          "country": "China",
          "contacts": [
            {
              "name": "Wenxiu Yao",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 30.66667,
            "lon": 104.06667
          }
        },
        {
          "facility": "Yichang Central People's Hospital",
          "status": "NOT_YET_RECRUITING",
          "city": "Yichang",
          "zip": "443003",
          "country": "China",
          "contacts": [
            {
              "name": "Xinhua Xu",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 30.71444,
            "lon": 111.28472
          }
        },
        {
          "facility": "Nemocnice AGEL Ostrava - Vitkovice a.s.",
          "status": "RECRUITING",
          "city": "Ostrava",
          "state": "Ostrava M\u011b",
          "zip": "703 84",
          "country": "Czechia",
          "contacts": [
            {
              "name": "Jaromir Roubec",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 49.83465,
            "lon": 18.28204
          }
        },
        {
          "facility": "Fakultni nemocnice Bulovka",
          "status": "RECRUITING",
          "city": "Prague",
          "state": "Praha 8",
          "zip": "180 81",
          "country": "Czechia",
          "contacts": [
            {
              "name": "Jana Krejci",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 50.08804,
            "lon": 14.42076
          }
        },
        {
          "facility": "N\u00e6stved Sygehus",
          "status": "NOT_YET_RECRUITING",
          "city": "N\u00e6stved",
          "state": "Sj\u00e6lland",
          "zip": "4700",
          "country": "Denmark",
          "contacts": [
            {
              "name": "Miroslaw Stelmach",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 55.22992,
            "lon": 11.76092
          }
        },
        {
          "facility": "Roskilde University Hospital",
          "status": "NOT_YET_RECRUITING",
          "city": "Roskilde",
          "state": "Sj\u00e6lland",
          "zip": "4000",
          "country": "Denmark",
          "contacts": [
            {
              "name": "Vladimira Horvat",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 55.64152,
            "lon": 12.08035
          }
        },
        {
          "facility": "Centre Antoine-Lacassagne",
          "status": "NOT_YET_RECRUITING",
          "city": "Nice",
          "state": "Alpes-Maritimes",
          "zip": "06189",
          "country": "France",
          "contacts": [
            {
              "name": "Victoria ferrari",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 43.70313,
            "lon": 7.26608
          }
        },
        {
          "facility": "Nouvel H\u00f4pital Civil (NHC)",
          "status": "NOT_YET_RECRUITING",
          "city": "Strasbourg",
          "state": "Alsace",
          "zip": "67091",
          "country": "France",
          "contacts": [
            {
              "name": "Bertrand Mennecier",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 48.58392,
            "lon": 7.74553
          }
        },
        {
          "facility": "CHU Bordeaux Haut-Leveque",
          "status": "NOT_YET_RECRUITING",
          "city": "Pessac",
          "state": "Aquitaine",
          "zip": "33600",
          "country": "France",
          "contacts": [
            {
              "name": "Remi Veillon",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 44.81011,
            "lon": -0.64129
          }
        },
        {
          "facility": "CHU de Toulouse - Hopital Larrey",
          "status": "NOT_YET_RECRUITING",
          "city": "Toulouse",
          "state": "Haute-Garonne",
          "zip": "31059",
          "country": "France",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "335677718"
            },
            {
              "name": "Julien Mazieres",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 43.60426,
            "lon": 1.44367
          }
        },
        {
          "facility": "H\u00f4pital Foch",
          "status": "NOT_YET_RECRUITING",
          "city": "Suresnes",
          "state": "Hauts-de-Seine",
          "zip": "92151",
          "country": "France",
          "contacts": [
            {
              "name": "Jaafar Bennouna",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 48.87143,
            "lon": 2.22929
          }
        },
        {
          "facility": "Centre Hospitalier Universitaire de Rennes - H\u00f4pital Pontchaillou",
          "status": "NOT_YET_RECRUITING",
          "city": "Rennes",
          "state": "Ille-et-Vilaine",
          "zip": "35033",
          "country": "France",
          "contacts": [
            {
              "name": "Herve Lena",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 48.11198,
            "lon": -1.67429
          }
        },
        {
          "facility": "Centre de Canc\u00e9rologie du Grand Montpellier",
          "status": "NOT_YET_RECRUITING",
          "city": "Montpellier",
          "state": "Languedoc-Roussillon",
          "zip": "34070",
          "country": "France",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "0467926155"
            },
            {
              "name": "Catherine Becht",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 43.61092,
            "lon": 3.87723
          }
        },
        {
          "facility": "Institut de Canc\u00e9rologie de l'Ouest",
          "status": "NOT_YET_RECRUITING",
          "city": "Saint Herblain",
          "state": "Loire-Atlantique",
          "zip": "44805",
          "country": "France",
          "contacts": [
            {
              "name": "Sandrine Hiret",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 47.21765,
            "lon": -1.64841
          }
        },
        {
          "facility": "H\u00f4pital Robert Schuman",
          "status": "NOT_YET_RECRUITING",
          "city": "Vantoux",
          "state": "Lorraine",
          "zip": "57070",
          "country": "France",
          "contacts": [
            {
              "name": "Benoit Godbert",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ]
        },
        {
          "facility": "Institut Jean Godinot",
          "status": "NOT_YET_RECRUITING",
          "city": "Reims",
          "state": "Marne",
          "zip": "51726",
          "country": "France",
          "contacts": [
            {
              "name": "Am\u00e9lie Lemoine",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 49.25,
            "lon": 4.03333
          }
        },
        {
          "facility": "CHU Lille - Institut Coeur Poumon",
          "status": "NOT_YET_RECRUITING",
          "city": "Lille Cedex",
          "state": "Nord",
          "zip": "59037",
          "country": "France",
          "contacts": [
            {
              "name": "Alexis Cortot",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 50.63297,
            "lon": 3.05858
          }
        },
        {
          "facility": "Centre Hospitalier intercommunal de Toulon La Seyne sur Mer",
          "status": "NOT_YET_RECRUITING",
          "city": "Toulon",
          "state": "Provence-Alpes-C\u00f4te-d'Azur",
          "zip": "83100",
          "country": "France",
          "contacts": [
            {
              "name": "Clarisse Audigier-Valette",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 43.12442,
            "lon": 5.92836
          }
        },
        {
          "facility": "Centre Leon Berard",
          "status": "NOT_YET_RECRUITING",
          "city": "Lyon",
          "state": "Rh\u00f4ne-Alpes",
          "zip": "69373",
          "country": "France",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "33426556761"
            },
            {
              "name": "Maurice Perol",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 45.74848,
            "lon": 4.84669
          }
        },
        {
          "facility": "Hospices Civils de Lyon - Hopital Louis Pradel",
          "status": "NOT_YET_RECRUITING",
          "city": "Bron",
          "state": "Rh\u00f4ne",
          "zip": "69677",
          "country": "France",
          "contacts": [
            {
              "name": "Michael Duruisseaux",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 45.73333,
            "lon": 4.91667
          }
        },
        {
          "facility": "Gustave Roussy",
          "status": "NOT_YET_RECRUITING",
          "city": "Villejuif",
          "state": "Val-de-Marne",
          "zip": "94800",
          "country": "France",
          "contacts": [
            {
              "name": "Fabrice Barlesi",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 48.7939,
            "lon": 2.35992
          }
        },
        {
          "facility": "Sainte Catherine Institut du Cancer Avignon Provence",
          "status": "NOT_YET_RECRUITING",
          "city": "Avignon",
          "state": "Vaucluse",
          "zip": "84918",
          "country": "France",
          "contacts": [
            {
              "name": "Magali Ravoire",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 43.94834,
            "lon": 4.80892
          }
        },
        {
          "facility": "Centre Hospitalier Universitaire de Poitiers",
          "status": "NOT_YET_RECRUITING",
          "city": "Poitiers",
          "state": "Vienne",
          "zip": "86021",
          "country": "France",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "33549444538"
            },
            {
              "name": "Corinne Lamour",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 46.58333,
            "lon": 0.33333
          }
        },
        {
          "facility": "Universitaetsklinikum Freiburg",
          "status": "NOT_YET_RECRUITING",
          "city": "Freiburg",
          "state": "Baden-W\u00fcrttemberg",
          "zip": "79106",
          "country": "Germany",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "0049761270366"
            },
            {
              "name": "Justyna Rawluk",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 47.9959,
            "lon": 7.85222
          }
        },
        {
          "facility": "Thoraxklinik-Heidelberg gGmbH",
          "status": "NOT_YET_RECRUITING",
          "city": "Heidelberg",
          "state": "Baden-W\u00fcrttemberg",
          "zip": "69126",
          "country": "Germany",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "4962213968304"
            },
            {
              "name": "Helge Bischoff",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 49.40768,
            "lon": 8.69079
          }
        },
        {
          "facility": "Universitaetsklinikum Tuebingen",
          "status": "RECRUITING",
          "city": "T\u00fcbingen",
          "state": "Baden-W\u00fcrttemberg",
          "zip": "72076",
          "country": "Germany",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "4970712982711"
            },
            {
              "name": "Thorben Gross",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 48.52266,
            "lon": 9.05222
          }
        },
        {
          "facility": "Onkologiezentrum Donauw\u00f6rth",
          "status": "NOT_YET_RECRUITING",
          "city": "Donauw\u00f6rth",
          "state": "Bayern",
          "zip": "86609",
          "country": "Germany",
          "contacts": [
            {
              "name": "Bastian Fleischmann",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 48.71804,
            "lon": 10.7793
          }
        },
        {
          "facility": "Asklepios Fachkliniken M\u00fcnchen-Gauting",
          "status": "RECRUITING",
          "city": "Gauting",
          "state": "Bayern",
          "zip": "82131",
          "country": "Germany",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "004989857914001"
            },
            {
              "name": "Niels Reinmuth",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 48.06919,
            "lon": 11.37703
          }
        },
        {
          "facility": "Klinikum N\u00fcrnberg Nord",
          "status": "NOT_YET_RECRUITING",
          "city": "N\u00fcrnberg",
          "state": "Bayern",
          "zip": "90419",
          "country": "Germany",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "0911398114963"
            },
            {
              "name": "Markus Horneber",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 49.45421,
            "lon": 11.07752
          }
        },
        {
          "facility": "Universit\u00e4tsklinikum M\u00fcnster - Albert Schweitzer Campus",
          "status": "RECRUITING",
          "city": "M\u00fcnster",
          "state": "Nordrhein-Westfalen",
          "zip": "48149",
          "country": "Germany",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "492518352712"
            },
            {
              "name": "Annalen Bleckmann",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 51.96236,
            "lon": 7.62571
          }
        },
        {
          "facility": "Krankenhaus Martha-Maria Halle-D\u00f6lau",
          "status": "RECRUITING",
          "city": "Halle",
          "state": "Sachsen-Anhalt",
          "zip": "06120",
          "country": "Germany",
          "contacts": [
            {
              "name": "Miriam Moeller",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 51.48159,
            "lon": 11.97948
          }
        },
        {
          "facility": "LungenClinic Grosshansdorf",
          "status": "NOT_YET_RECRUITING",
          "city": "Grosshansdorf",
          "state": "Schleswig-Holstein",
          "zip": "22927",
          "country": "Germany",
          "contacts": [
            {
              "name": "Martin Reck",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 53.66667,
            "lon": 10.28333
          }
        },
        {
          "facility": "SRH Wald-Klinikum Gera",
          "status": "NOT_YET_RECRUITING",
          "city": "Gera",
          "state": "Th\u00fcringen",
          "zip": "07548",
          "country": "Germany",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "493658287758"
            },
            {
              "name": "Dagmar T\u00e4uscher",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 50.88029,
            "lon": 12.08187
          }
        },
        {
          "facility": "Evangelische Lungenklinik Berlin",
          "status": "RECRUITING",
          "city": "Berlin",
          "zip": "13125",
          "country": "Germany",
          "contacts": [
            {
              "name": "Christian Grohe",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 52.52437,
            "lon": 13.41053
          }
        },
        {
          "facility": "Charit\u00e9 Campus Virchow-Klinikum",
          "status": "NOT_YET_RECRUITING",
          "city": "Berlin",
          "zip": "13353",
          "country": "Germany",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "4930450665005"
            },
            {
              "name": "Nikolaj Frost",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 52.52437,
            "lon": 13.41053
          }
        },
        {
          "facility": "Helios Klinikum Emil von Behring Berlin-Zehlendorf",
          "status": "NOT_YET_RECRUITING",
          "city": "Berlin",
          "zip": "14165",
          "country": "Germany",
          "contacts": [
            {
              "name": "Jens Kollmeier",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 52.52437,
            "lon": 13.41053
          }
        },
        {
          "facility": "H\u00e4mato-Onkologie Hamburg, Prof. Laack und Partner",
          "status": "RECRUITING",
          "city": "Hamburg",
          "zip": "20251",
          "country": "Germany",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "4940280065620"
            },
            {
              "name": "Eckart Heinz Laack",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 53.57532,
            "lon": 10.01534
          }
        },
        {
          "facility": "University Hospital of Patras",
          "status": "NOT_YET_RECRUITING",
          "city": "Patras",
          "state": "Acha\u1e2fa",
          "zip": "26504",
          "country": "Greece",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "302610999791"
            },
            {
              "name": "Angelos Koutras",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 38.24444,
            "lon": 21.73444
          }
        },
        {
          "facility": "Agios Savvas Regional Cancer Hospital",
          "status": "NOT_YET_RECRUITING",
          "city": "Athens",
          "state": "Attik\u00ed",
          "zip": "115 22",
          "country": "Greece",
          "contacts": [
            {
              "name": "ANASTASIOS GRIVAS",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 37.97945,
            "lon": 23.71622
          }
        },
        {
          "facility": "Errikos Dunant Hospital Center",
          "status": "NOT_YET_RECRUITING",
          "city": "Athens",
          "state": "Attik\u00ed",
          "zip": "115 26",
          "country": "Greece",
          "contacts": [
            {
              "name": "IOANNIS MOUNTZIOS",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 37.97945,
            "lon": 23.71622
          }
        },
        {
          "facility": "Sotiria Thoracic Diseases Hospital of Athens",
          "status": "NOT_YET_RECRUITING",
          "city": "Athens",
          "state": "Attik\u00ed",
          "zip": "115 27",
          "country": "Greece",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "302107700220"
            },
            {
              "name": "Konstantinos Syrigos",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 37.97945,
            "lon": 23.71622
          }
        },
        {
          "facility": "University General Hospital of Heraklion",
          "status": "NOT_YET_RECRUITING",
          "city": "Heraklion",
          "state": "Irakle\u00edo",
          "zip": "715 00",
          "country": "Greece",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "2810392750"
            },
            {
              "name": "Dimitrios Mavroudis",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 35.32787,
            "lon": 25.14341
          }
        },
        {
          "facility": "European Interbalkan Medical Center",
          "status": "NOT_YET_RECRUITING",
          "city": "Thessaloniki",
          "state": "Thessalon\u00edki",
          "zip": "570 01",
          "country": "Greece",
          "contacts": [
            {
              "name": "Sofia Baka",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 40.64361,
            "lon": 22.93086
          }
        },
        {
          "facility": "G. Papanikolaou General Hospital",
          "status": "NOT_YET_RECRUITING",
          "city": "Thessaloniki",
          "state": "Thessalon\u00edki",
          "zip": "570 10",
          "country": "Greece",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "302312307278"
            },
            {
              "name": "Dionisios Gerasimos Spyratos",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 40.64361,
            "lon": 22.93086
          }
        },
        {
          "facility": "Bacs-Kiskun Varmegyei Oktatokorhaz",
          "status": "RECRUITING",
          "city": "Kecskem\u00e9t",
          "state": "B\u00e1cs-Kiskun",
          "zip": "6000",
          "country": "Hungary",
          "contacts": [
            {
              "name": "Zsolt Horvath",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 46.90618,
            "lon": 19.69128
          }
        },
        {
          "facility": "Orsz\u00e1gos Kor\u00e1nyi Pulmonol\u00f3giai Int\u00e9zet",
          "status": "NOT_YET_RECRUITING",
          "city": "Budapest",
          "state": "Pest",
          "zip": "1121",
          "country": "Hungary",
          "contacts": [
            {
              "name": "Szabolcs Soter",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 47.49801,
            "lon": 19.03991
          }
        },
        {
          "facility": "Farkasgyepui Tudogyogyintezet",
          "status": "RECRUITING",
          "city": "Farkasgyep\u0171",
          "state": "Veszpr\u00e9m",
          "zip": "8582",
          "country": "Hungary",
          "contacts": [
            {
              "name": "Zsolt Kiraly",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 47.2,
            "lon": 17.63333
          }
        },
        {
          "facility": "Orsz\u00e1gos Onkol\u00f3giai Int\u00e9zet",
          "status": "RECRUITING",
          "city": "Budapest",
          "zip": "1122",
          "country": "Hungary",
          "contacts": [
            {
              "name": "Tunde Nagy",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 47.49801,
            "lon": 19.03991
          }
        },
        {
          "facility": "Uzsoki Utcai K\u00f3rh\u00e1z",
          "status": "RECRUITING",
          "city": "Budapest",
          "zip": "1145",
          "country": "Hungary",
          "contacts": [
            {
              "name": "Csaba Mathe",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 47.49801,
            "lon": 19.03991
          }
        },
        {
          "facility": "Rajiv Gandhi Cancer Institute And Research Centre",
          "status": "NOT_YET_RECRUITING",
          "city": "New Delhi",
          "state": "Delhi",
          "zip": "110085",
          "country": "India",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "911147022264"
            },
            {
              "name": "Mansi Sharma",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 28.63576,
            "lon": 77.22445
          }
        },
        {
          "facility": "KLES Dr. Prabhakar Kore Hospital & M.R.C",
          "status": "NOT_YET_RECRUITING",
          "city": "Belagave",
          "state": "Karnataka",
          "zip": "590010",
          "country": "India",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "09448111913"
            },
            {
              "name": "Rohan Bhise",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 14.39918,
            "lon": 75.2413
          }
        },
        {
          "facility": "SRV Hospitals",
          "status": "NOT_YET_RECRUITING",
          "city": "Bengaluru",
          "state": "Karnataka",
          "zip": "560027",
          "country": "India",
          "contacts": [
            {
              "name": "lokesh k n",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 12.97194,
            "lon": 77.59369
          }
        },
        {
          "facility": "Regional Cancer Centre - Thiruvananthapuram",
          "status": "NOT_YET_RECRUITING",
          "city": "Thiruvananthapuram",
          "state": "Kerala",
          "zip": "695011",
          "country": "India",
          "contacts": [
            {
              "name": "Anoop Thattungal Manoharan",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 8.4855,
            "lon": 76.94924
          }
        },
        {
          "facility": "Krishna Institute of Medical Sciences - Karad",
          "status": "NOT_YET_RECRUITING",
          "city": "Karad",
          "state": "Maharashtra",
          "zip": "415539",
          "country": "India",
          "contacts": [
            {
              "name": "Rashmi A. Gudur",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 17.28937,
            "lon": 74.18183
          }
        },
        {
          "facility": "Kolhapur Cancer Centre Private Limited",
          "status": "NOT_YET_RECRUITING",
          "city": "Kolh\u0101pur",
          "state": "Maharashtra",
          "zip": "416234",
          "country": "India",
          "contacts": [
            {
              "name": "Nilesh Dhamne",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 16.69563,
            "lon": 74.23167
          }
        },
        {
          "facility": "Tata Memorial Hospital",
          "status": "NOT_YET_RECRUITING",
          "city": "Mumbai",
          "state": "Maharashtra",
          "zip": "400012",
          "country": "India",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "9769331525"
            },
            {
              "name": "Amit Joshi",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 19.07283,
            "lon": 72.88261
          }
        },
        {
          "facility": "HCG Manavata Cancer Centre",
          "status": "NOT_YET_RECRUITING",
          "city": "Nashik",
          "state": "Maharashtra",
          "zip": "422001",
          "country": "India",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "912536661111"
            },
            {
              "name": "Rajnish Vasant Nagarkar",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 19.99727,
            "lon": 73.79096
          }
        },
        {
          "facility": "Grant Medical Foundation - Ruby Hall Clinic",
          "status": "NOT_YET_RECRUITING",
          "city": "Pune",
          "state": "Maharashtra",
          "zip": "411001",
          "country": "India",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "02066455495"
            },
            {
              "name": "Minish mahendra Jain",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 18.51957,
            "lon": 73.85535
          }
        },
        {
          "facility": "Sahyadri Super Speciality Hospital",
          "status": "NOT_YET_RECRUITING",
          "city": "Pune",
          "state": "Maharashtra",
          "zip": "411004",
          "country": "India",
          "contacts": [
            {
              "name": "Tushar Vishvasrao Patil",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 18.51957,
            "lon": 73.85535
          }
        },
        {
          "facility": "All India Institute of Medical Sciences",
          "status": "NOT_YET_RECRUITING",
          "city": "Bhubaneswar",
          "state": "Odisha",
          "zip": "751019",
          "country": "India",
          "contacts": [
            {
              "name": "Sourav Mishra",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 20.27241,
            "lon": 85.83385
          }
        },
        {
          "facility": "Ashwin Hospital",
          "status": "NOT_YET_RECRUITING",
          "city": "Coimbatore",
          "state": "Tamil Nadu",
          "zip": "641012",
          "country": "India",
          "contacts": [
            {
              "name": "Prabagar Manickam",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 11.00555,
            "lon": 76.96612
          }
        },
        {
          "facility": "Nizam's Institute of Medical Sciences",
          "status": "NOT_YET_RECRUITING",
          "city": "Hyderabad",
          "state": "Telangana",
          "zip": "500082",
          "country": "India",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "919440911865"
            },
            {
              "name": "Sadashivudu Gundeti",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 17.38405,
            "lon": 78.45636
          }
        },
        {
          "facility": "Tata Memorial Centre - Homi Bhabha Cancer Hospital",
          "status": "NOT_YET_RECRUITING",
          "city": "Varanasi",
          "state": "Uttar Pradesh",
          "zip": "221002",
          "country": "India",
          "contacts": [
            {
              "name": "Akhil Kapoor",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 25.31668,
            "lon": 83.01041
          }
        },
        {
          "facility": "Banaras Hindu University",
          "status": "NOT_YET_RECRUITING",
          "city": "Varanasi",
          "state": "Uttar Pradesh",
          "zip": "221005",
          "country": "India",
          "contacts": [
            {
              "name": "Sunil Choudhari",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 25.31668,
            "lon": 83.01041
          }
        },
        {
          "facility": "Tata Medical Center",
          "status": "NOT_YET_RECRUITING",
          "city": "Kolkata",
          "state": "West Bengal",
          "zip": "700160",
          "country": "India",
          "contacts": [
            {
              "name": "Bivas Biswas",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 22.56263,
            "lon": 88.36304
          }
        },
        {
          "facility": "Postgraduate Institute of Medical Education & Research",
          "status": "NOT_YET_RECRUITING",
          "city": "Chandigarh",
          "zip": "160012",
          "country": "India",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "9914209678"
            },
            {
              "name": "Gaurav Prakash",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 30.73629,
            "lon": 76.7884
          }
        },
        {
          "facility": "Jawaharlal Institute Of Postgraduate Medical Education And Research",
          "status": "NOT_YET_RECRUITING",
          "city": "Puducherry",
          "zip": "605006",
          "country": "India",
          "contacts": [
            {
              "name": "Prasanth Ganesan",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 11.93381,
            "lon": 79.82979
          }
        },
        {
          "facility": "Istituto Nazionale Tumori IRCCS Fondazione Pascale",
          "status": "RECRUITING",
          "city": "Napoli",
          "state": "Campania",
          "zip": "80131",
          "country": "Italy",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "390817770291"
            },
            {
              "name": "Alessandro Morabito",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 40.85216,
            "lon": 14.26811
          }
        },
        {
          "facility": "Fondazione Policlinico Universitario Agostino Gemelli",
          "status": "NOT_YET_RECRUITING",
          "city": "Roma",
          "state": "Lazio",
          "zip": "00168",
          "country": "Italy",
          "contacts": [
            {
              "name": "Emilio Bria",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 41.89193,
            "lon": 12.51133
          }
        },
        {
          "facility": "Fondazione IRCCS Istituto Nazionale dei Tumori",
          "status": "NOT_YET_RECRUITING",
          "city": "Milan",
          "state": "Lombardia",
          "zip": "20133",
          "country": "Italy",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "390223903829"
            },
            {
              "name": "Giuseppe Lo Russo",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 45.46427,
            "lon": 9.18951
          }
        },
        {
          "facility": "Istituto Nazionale Tumori Regina Elena",
          "status": "RECRUITING",
          "city": "Rome",
          "state": "Roma",
          "zip": "00144",
          "country": "Italy",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "390652666779"
            },
            {
              "name": "Federico Cappuzzo",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 41.89193,
            "lon": 12.51133
          }
        },
        {
          "facility": "Policlinico \"G. Rodolico\"",
          "status": "NOT_YET_RECRUITING",
          "city": "Catania",
          "state": "Sicilia",
          "zip": "95123",
          "country": "Italy",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "390953781496"
            },
            {
              "name": "HECTOR JOSE' SOTO PARRA",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 37.49223,
            "lon": 15.07041
          }
        },
        {
          "facility": "Azienda Ospedaliera Universitaria Integrata Verona - Ospedale Borgo Trento",
          "status": "NOT_YET_RECRUITING",
          "city": "Verona",
          "state": "Veneto",
          "zip": "37126",
          "country": "Italy",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "3904518123515"
            },
            {
              "name": "SARA PILOTTO",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 45.4299,
            "lon": 10.98444
          }
        },
        {
          "facility": "IRCCS - AOU di Bologna",
          "status": "NOT_YET_RECRUITING",
          "city": "Bologna",
          "zip": "40138",
          "country": "Italy",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "390512142204"
            },
            {
              "name": "Andrea Ardizzoni",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 44.49381,
            "lon": 11.33875
          }
        },
        {
          "facility": "Istituto Oncologico Veneto IRCCS",
          "status": "NOT_YET_RECRUITING",
          "city": "Padova",
          "zip": "35128",
          "country": "Italy",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "00390498215608"
            },
            {
              "name": "Giulia Pasello",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 45.40797,
            "lon": 11.88586
          }
        },
        {
          "facility": "Ospedale di Circolo e Fondazione Macchi Varese",
          "status": "RECRUITING",
          "city": "Varese",
          "zip": "21100",
          "country": "Italy",
          "contacts": [
            {
              "name": "Francesco Grossi",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 45.82058,
            "lon": 8.82511
          }
        },
        {
          "facility": "Aichi Cancer Center Hospital",
          "status": "RECRUITING",
          "city": "Nagoya",
          "state": "Aichi",
          "zip": "464-8681",
          "country": "Japan",
          "contacts": [
            {
              "name": "Yutaka Fujiwara",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 35.18147,
            "lon": 136.90641
          }
        },
        {
          "facility": "National Cancer Center Hospital East",
          "status": "RECRUITING",
          "city": "Kashiwa",
          "state": "Chiba",
          "zip": "277-8577",
          "country": "Japan",
          "contacts": [
            {
              "name": "Shigeki Umemura",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 35.86224,
            "lon": 139.97732
          }
        },
        {
          "facility": "National Hospital Organization Shikoku Cancer Center",
          "status": "RECRUITING",
          "city": "Matsuyama",
          "state": "Ehime",
          "zip": "791-0280",
          "country": "Japan",
          "contacts": [
            {
              "name": "TOSHIYUKI KOZUKI",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 33.83916,
            "lon": 132.76574
          }
        },
        {
          "facility": "Hokkaido University Hospital",
          "status": "RECRUITING",
          "city": "Sapporo",
          "state": "Hokkaido",
          "zip": "060-8648",
          "country": "Japan",
          "contacts": [
            {
              "name": "Hidenori Kitai",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 43.06667,
            "lon": 141.35
          }
        },
        {
          "facility": "Himeji Medical Center",
          "status": "RECRUITING",
          "city": "Himeji",
          "state": "Hyogo",
          "zip": "670-8520",
          "country": "Japan",
          "contacts": [
            {
              "name": "Tetsuji Kawamura",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 34.81667,
            "lon": 134.7
          }
        },
        {
          "facility": "Kanagawa Cardiovascular and Respiratory Center",
          "status": "RECRUITING",
          "city": "Yokohama",
          "state": "Kanagawa",
          "zip": "236-0051",
          "country": "Japan",
          "contacts": [
            {
              "name": "Satoshi Ikeda",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 35.43333,
            "lon": 139.65
          }
        },
        {
          "facility": "Kanagawa cancer center",
          "status": "RECRUITING",
          "city": "Yokohama",
          "state": "Kanagawa",
          "zip": "2418515",
          "country": "Japan",
          "contacts": [
            {
              "name": "Seigo Katakura",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 35.43333,
            "lon": 139.65
          }
        },
        {
          "facility": "Miyagi Cancer Center",
          "status": "RECRUITING",
          "city": "Natori",
          "state": "Miyagi",
          "zip": "981-1293",
          "country": "Japan",
          "contacts": [
            {
              "name": "Tatsuro Fukuhara",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 38.16667,
            "lon": 140.88333
          }
        },
        {
          "facility": "Niigata Cancer Center Hospital",
          "status": "RECRUITING",
          "city": "Niigata-shi",
          "state": "Niigata",
          "zip": "951-8566",
          "country": "Japan",
          "contacts": [
            {
              "name": "Satoru Miura",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 37.88637,
            "lon": 139.00589
          }
        },
        {
          "facility": "Kansai Medical University Hospital",
          "status": "RECRUITING",
          "city": "Hirakata",
          "state": "Osaka",
          "zip": "573-1191",
          "country": "Japan",
          "contacts": [
            {
              "name": "Takayasu Kurata",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 34.81352,
            "lon": 135.64914
          }
        },
        {
          "facility": "Kindai University Hospital- Osakasayama Campus",
          "status": "NOT_YET_RECRUITING",
          "city": "Osakasayama",
          "state": "Osaka",
          "zip": "589-8511",
          "country": "Japan",
          "contacts": [
            {
              "name": "Takayuki Takahama",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 34.69374,
            "lon": 135.50218
          }
        },
        {
          "facility": "National Hospital Organization Kinki-chuo Chest Medical Center",
          "status": "RECRUITING",
          "city": "Sakai",
          "state": "Osaka",
          "zip": "591-8555",
          "country": "Japan",
          "contacts": [
            {
              "name": "Kyoichi Okishio",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 34.58333,
            "lon": 135.46667
          }
        },
        {
          "facility": "Tominaga Hospital",
          "status": "RECRUITING",
          "city": "Nagaizumi-cho,Sunto-gun",
          "state": "Shizuoka",
          "zip": "411-8777",
          "country": "Japan",
          "contacts": [
            {
              "name": "Haruki Kobayashi",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ]
        },
        {
          "facility": "Tokyo Metropolitan Komagome Hospital",
          "status": "NOT_YET_RECRUITING",
          "city": "Bunky\u014d-Ku",
          "state": "Tokyo",
          "zip": "113-8677",
          "country": "Japan",
          "contacts": [
            {
              "name": "Kageaki Watanabe",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 35.37517,
            "lon": 139.92991
          }
        },
        {
          "facility": "Japanese Foundation for Cancer Research",
          "status": "RECRUITING",
          "city": "Koto",
          "state": "Tokyo",
          "zip": "135-8550",
          "country": "Japan",
          "contacts": [
            {
              "name": "Ryo Ariyasu",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 35.66667,
            "lon": 139.81718
          }
        },
        {
          "facility": "Tottori University Hospital",
          "status": "RECRUITING",
          "city": "Yonago",
          "state": "Tottori",
          "zip": "683-8504",
          "country": "Japan",
          "contacts": [
            {
              "name": "Tomohiro Sakamoto",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 35.43333,
            "lon": 133.33333
          }
        },
        {
          "facility": "National Hospital Organization Yamaguchi Ube Medical Center",
          "status": "RECRUITING",
          "city": "Ube",
          "state": "Yamaguchi",
          "zip": "755-0241",
          "country": "Japan",
          "contacts": [
            {
              "name": "Keisuke Aoe",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 33.94306,
            "lon": 131.25111
          }
        },
        {
          "facility": "National Hospital Organization Kyushu Cancer Center",
          "status": "RECRUITING",
          "city": "Fukuoka",
          "zip": "811-1395",
          "country": "Japan",
          "contacts": [
            {
              "name": "Masafumi Yamaguchi",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 33.6,
            "lon": 130.41667
          }
        },
        {
          "facility": "Kyushu University Hospital",
          "status": "NOT_YET_RECRUITING",
          "city": "Fukuoka",
          "zip": "812-8582",
          "country": "Japan",
          "contacts": [
            {
              "name": "Isamu Okamoto",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 33.6,
            "lon": 130.41667
          }
        },
        {
          "facility": "University Hospital,Kyoto Prefectural University of Medicine",
          "status": "RECRUITING",
          "city": "Kyoto",
          "zip": "602-8566",
          "country": "Japan",
          "contacts": [
            {
              "name": "Tadaaki Yamada",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 35.02107,
            "lon": 135.75385
          }
        },
        {
          "facility": "Okayama University Hospital",
          "status": "RECRUITING",
          "city": "Okayama",
          "zip": "700-8558",
          "country": "Japan",
          "contacts": [
            {
              "name": "Kadoaki Ohashi",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 34.65,
            "lon": 133.93333
          }
        },
        {
          "facility": "Wakayama Medical University Hospital",
          "status": "NOT_YET_RECRUITING",
          "city": "Wakayama",
          "zip": "641-8510",
          "country": "Japan",
          "contacts": [
            {
              "name": "Hiroaki Akamatsu",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 34.23333,
            "lon": 135.16667
          }
        },
        {
          "facility": "Chungbuk National University Hospital",
          "status": "RECRUITING",
          "city": "Cheongju-si",
          "state": "Chungcheongbuk-do [Chungbuk]",
          "zip": "28644",
          "country": "Korea, Republic of",
          "contacts": [
            {
              "name": "Ki Hyeong Lee",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 36.63722,
            "lon": 127.48972
          }
        },
        {
          "facility": "Chonnam National University Hwasun Hospital",
          "status": "RECRUITING",
          "city": "Hwasun",
          "state": "Jeonranamdo",
          "zip": "58128",
          "country": "Korea, Republic of",
          "contacts": [
            {
              "name": "Young-Chul Kim",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 35.06125,
            "lon": 126.98746
          }
        },
        {
          "facility": "National Cancer Center",
          "status": "RECRUITING",
          "city": "Goyang-si",
          "state": "Ky\u01d2nggi-do",
          "zip": "10408",
          "country": "Korea, Republic of",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "82319201154"
            },
            {
              "name": "Ji-Youn Han",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 37.65639,
            "lon": 126.835
          }
        },
        {
          "facility": "The Catholic University Of Korea St. Vincent's Hospital",
          "status": "RECRUITING",
          "city": "Suwon-si",
          "state": "Ky\u01d2nggi-do",
          "zip": "16247",
          "country": "Korea, Republic of",
          "contacts": [
            {
              "name": "Byoung Yong Shim",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 37.29111,
            "lon": 127.00889
          }
        },
        {
          "facility": "Pusan National University Yangsan Hospital",
          "status": "RECRUITING",
          "city": "Yangsan",
          "state": "Ky\u01d2ngsangnam-do",
          "zip": "KS011",
          "country": "Korea, Republic of",
          "contacts": [
            {
              "name": "Seong Hoon Yoon",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 35.34199,
            "lon": 129.03358
          }
        },
        {
          "facility": "Gangnam Severance Hospital",
          "status": "RECRUITING",
          "city": "Gangnam-gu",
          "state": "Seoul-teukbyeolsi [Seoul]",
          "zip": "06273",
          "country": "Korea, Republic of",
          "contacts": [
            {
              "name": "Yoon Soo Chang",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ]
        },
        {
          "facility": "Korea University Anam Hospital",
          "status": "RECRUITING",
          "city": "Seoul",
          "state": "Seoul-teukbyeolsi [Seoul]",
          "zip": "02841",
          "country": "Korea, Republic of",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "8229206267"
            },
            {
              "name": "Yoon Ji Choi",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 37.566,
            "lon": 126.9784
          }
        },
        {
          "facility": "Severance Hospital, Yonsei University Health System",
          "status": "RECRUITING",
          "city": "Seoul",
          "state": "Seoul-teukbyeolsi [Seoul]",
          "zip": "03722",
          "country": "Korea, Republic of",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "82222284190"
            },
            {
              "name": "Hye Ryun Kim",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 37.566,
            "lon": 126.9784
          }
        },
        {
          "facility": "Asan Medical Center",
          "status": "RECRUITING",
          "city": "Seoul",
          "state": "Seoul-teukbyeolsi [Seoul]",
          "zip": "05505",
          "country": "Korea, Republic of",
          "contacts": [
            {
              "name": "Chang Min Choi",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 37.566,
            "lon": 126.9784
          }
        },
        {
          "facility": "The Catholic University of Korea, Yeouido St. Mary's Hospital",
          "status": "RECRUITING",
          "city": "Seoul",
          "state": "Seoul-teukbyeolsi [Seoul]",
          "zip": "07345",
          "country": "Korea, Republic of",
          "contacts": [
            {
              "name": "Chankwon Park",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 37.566,
            "lon": 126.9784
          }
        },
        {
          "facility": "Korea University Guro Hospital",
          "status": "RECRUITING",
          "city": "Seoul",
          "state": "Seoul-teukbyeolsi [Seoul]",
          "zip": "08308",
          "country": "Korea, Republic of",
          "contacts": [
            {
              "name": "Sung Yong Lee",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 37.566,
            "lon": 126.9784
          }
        },
        {
          "facility": "Hanyang University Seoul Hospital",
          "status": "NOT_YET_RECRUITING",
          "city": "Seoul",
          "state": "Seoul-teukbyeolsi [Seoul]",
          "zip": "4763",
          "country": "Korea, Republic of",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "821052256027"
            },
            {
              "name": "DONG WON PARK",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 37.566,
            "lon": 126.9784
          }
        },
        {
          "facility": "Samsung Medical Center",
          "status": "NOT_YET_RECRUITING",
          "city": "Seoul",
          "state": "Seoul-teukbyeolsi",
          "zip": "06351",
          "country": "Korea, Republic of",
          "contacts": [
            {
              "name": "Se-Hoon Lee",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 37.566,
            "lon": 126.9784
          }
        },
        {
          "facility": "Kyungpook National University Chilgok Hospital",
          "status": "RECRUITING",
          "city": "Daegu",
          "state": "Taegu-Kwangy\u01d2kshi",
          "zip": "41404",
          "country": "Korea, Republic of",
          "contacts": [
            {
              "name": "Shin Yup Lee",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 35.87028,
            "lon": 128.59111
          }
        },
        {
          "facility": "Keimyung University Dongsan Hospital",
          "status": "RECRUITING",
          "city": "Daegu",
          "state": "Taegu-Kwangy\u01d2kshi",
          "zip": "42601",
          "country": "Korea, Republic of",
          "contacts": [
            {
              "name": "Sun Hyo Park",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 35.87028,
            "lon": 128.59111
          }
        },
        {
          "facility": "Health Pharma Professional Research S.A. de C.V:",
          "status": "NOT_YET_RECRUITING",
          "city": "Ciudad de M\u00e9xico",
          "state": "Distrito Federal",
          "zip": "03100",
          "country": "Mexico",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "5215529002732"
            },
            {
              "name": "Jorge Arturo Alatorre Alexander",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 19.42847,
            "lon": -99.12766
          }
        },
        {
          "facility": "Centro Onco-Hematol\u00f3gico Roma (COHR)",
          "status": "NOT_YET_RECRUITING",
          "city": "Mexico City",
          "state": "Distrito Federal",
          "zip": "06700",
          "country": "Mexico",
          "contacts": [
            {
              "name": "Denisse Eugenia Lee Cervantes",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 19.42847,
            "lon": -99.12766
          }
        },
        {
          "facility": "Higiea Oncologia",
          "status": "NOT_YET_RECRUITING",
          "city": "Mexico City",
          "state": "Distrito Federal",
          "zip": "11819",
          "country": "Mexico",
          "contacts": [
            {
              "name": "Manuel Ernesto Magallanes Maciel",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 19.42847,
            "lon": -99.12766
          }
        },
        {
          "facility": "Preparaciones Oncol\u00f3gicas S.C.",
          "status": "NOT_YET_RECRUITING",
          "city": "Le\u00f3n",
          "state": "Guanajuato",
          "zip": "37178",
          "country": "Mexico",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "4777132249"
            },
            {
              "name": "Jose Luis Gonzalez Trujillo",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 21.12908,
            "lon": -101.67374
          }
        },
        {
          "facility": "CIO - Centro de Inmuno-Oncolog\u00eda de Occidente",
          "status": "NOT_YET_RECRUITING",
          "city": "Guadalajara",
          "state": "Jalisco",
          "zip": "44630",
          "country": "Mexico",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "3330447001"
            },
            {
              "name": "Noel Esaul Luna-Romero",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 20.66682,
            "lon": -103.39182
          }
        },
        {
          "facility": "PanAmerican Clinical Research - Guadalajara",
          "status": "NOT_YET_RECRUITING",
          "city": "Guadalajara",
          "state": "Jalisco",
          "zip": "44670",
          "country": "Mexico",
          "contacts": [
            {
              "name": "Emilio Murillo",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 20.66682,
            "lon": -103.39182
          }
        },
        {
          "facility": "Actualidad Basada en la Investigaci\u00f3n del C\u00e1ncer",
          "status": "NOT_YET_RECRUITING",
          "city": "Guadalajara",
          "state": "Jalisco",
          "zip": "44680",
          "country": "Mexico",
          "contacts": [
            {
              "name": "Emmanuel de la Mora Jimenez",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 20.66682,
            "lon": -103.39182
          }
        },
        {
          "facility": "Renati Innovation",
          "status": "NOT_YET_RECRUITING",
          "city": "Guadalajara",
          "state": "Jalisco",
          "zip": "44680",
          "country": "Mexico",
          "contacts": [
            {
              "name": "Carlos Jose Zuloaga Fernandez del Valle",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 20.66682,
            "lon": -103.39182
          }
        },
        {
          "facility": "Dr. Jose Eleuterio Gonzalez",
          "status": "NOT_YET_RECRUITING",
          "city": "Monterrey",
          "state": "Nuevo Le\u00f3n",
          "zip": "64460",
          "country": "Mexico",
          "contacts": [
            {
              "name": "Victor Oyervides Juarez",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 25.67507,
            "lon": -100.31847
          }
        },
        {
          "facility": "Avix Investigaci\u00f3n Clinica, S.C.",
          "status": "NOT_YET_RECRUITING",
          "city": "Monterrey",
          "state": "Nuevo Le\u00f3n",
          "zip": "64710",
          "country": "Mexico",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "528181431112"
            },
            {
              "name": "Julia Angelina Saenz Frias",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 25.67507,
            "lon": -100.31847
          }
        },
        {
          "facility": "Oncare - Unidad Valle",
          "status": "NOT_YET_RECRUITING",
          "city": "San Pedro Garza Garc\u00eda",
          "state": "Nuevo Le\u00f3n",
          "zip": "66220",
          "country": "Mexico",
          "contacts": [
            {
              "name": "Luis Antonio Cancel",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 25.65716,
            "lon": -100.40268
          }
        },
        {
          "facility": "Health Pharma Quer\u00e9taro",
          "status": "NOT_YET_RECRUITING",
          "city": "Juriquilla",
          "state": "Quer\u00e9taro",
          "zip": "76230",
          "country": "Mexico",
          "contacts": [
            {
              "name": "Jordi Guzm\u00e1n Casta",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 20.71277,
            "lon": -100.45568
          }
        },
        {
          "facility": "Centro de Investigacion Clinica de Oaxaca",
          "status": "NOT_YET_RECRUITING",
          "city": "Oaxaca",
          "zip": "68020",
          "country": "Mexico",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "529516035559"
            },
            {
              "name": "Yolanda Lizbeth Bautista Aragon",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 17.06542,
            "lon": -96.72365
          }
        },
        {
          "facility": "Clinica Integral Internacional de Oncolog\u00eda",
          "status": "NOT_YET_RECRUITING",
          "city": "Puebla",
          "zip": "72530",
          "country": "Mexico",
          "contacts": [
            {
              "name": "Ivan Romarico Gonzalez Espinoza",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 19.03793,
            "lon": -98.20346
          }
        },
        {
          "facility": "Ark\u00e9 SMO S.A de C.V",
          "status": "NOT_YET_RECRUITING",
          "city": "Veracruz",
          "zip": "91910",
          "country": "Mexico",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "2299314102"
            },
            {
              "name": "Pedro Arredondo Ruiz",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 19.18095,
            "lon": -96.1429
          }
        },
        {
          "facility": "Medische Centrum Leeuwarden",
          "status": "NOT_YET_RECRUITING",
          "city": "Leeuwarden",
          "state": "Frysl\u00e2n",
          "zip": "8934 AD",
          "country": "Netherlands",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "0031582863103"
            },
            {
              "name": "Rolof Gijtenbeek",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 53.20139,
            "lon": 5.80859
          }
        },
        {
          "facility": "Jeroen Bosch ziekenhuis",
          "status": "NOT_YET_RECRUITING",
          "city": "Den Bosch",
          "state": "Noord-Brabant",
          "zip": "5223 GZ",
          "country": "Netherlands",
          "contacts": [
            {
              "name": "Bianca Veggel",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 51.27,
            "lon": 5.59167
          }
        },
        {
          "facility": "ETZ Elisabeth",
          "status": "NOT_YET_RECRUITING",
          "city": "Tilburg",
          "state": "Noord-Brabant",
          "zip": "5022 GC",
          "country": "Netherlands",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "31132213101"
            },
            {
              "name": "Mart Schiefer",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 51.55551,
            "lon": 5.0913
          }
        },
        {
          "facility": "Medisch Spectrum Twente",
          "status": "NOT_YET_RECRUITING",
          "city": "Enschede",
          "state": "Overijssel",
          "zip": "7512 KZ",
          "country": "Netherlands",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "0534872610"
            },
            {
              "name": "Johan Hugo Schouwink",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 52.21833,
            "lon": 6.89583
          }
        },
        {
          "facility": "Leids Universitair Medisch Centrum",
          "status": "NOT_YET_RECRUITING",
          "city": "Leiden",
          "state": "Zuid-Holland",
          "zip": "2333 ZA",
          "country": "Netherlands",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "31715262950"
            },
            {
              "name": "Egbert F Smit",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 52.15833,
            "lon": 4.49306
          }
        },
        {
          "facility": "Erasmus Medisch Centrum",
          "status": "RECRUITING",
          "city": "Rotterdam",
          "state": "Zuid-Holland",
          "zip": "3015 GD",
          "country": "Netherlands",
          "contacts": [
            {
              "name": "Anne Marie C. Dingemans",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 51.9225,
            "lon": 4.47917
          }
        },
        {
          "facility": "St. Antonius Ziekenhuis, locatie Utrecht",
          "status": "NOT_YET_RECRUITING",
          "city": "Utrecht",
          "zip": "3543 AZ",
          "country": "Netherlands",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "31883201410"
            },
            {
              "name": "Lisanne Kastelijn",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 52.09083,
            "lon": 5.12222
          }
        },
        {
          "facility": "Akershus Universitetssykehus",
          "status": "NOT_YET_RECRUITING",
          "city": "L\u00f8renskog",
          "state": "Akershus",
          "zip": "1478",
          "country": "Norway",
          "contacts": [
            {
              "name": "Kirill Neumann",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 59.92625,
            "lon": 10.95422
          }
        },
        {
          "facility": "Drammen Sykehus, Vestre Viken HF",
          "status": "NOT_YET_RECRUITING",
          "city": "Drammen",
          "state": "Buskerud",
          "zip": "3004",
          "country": "Norway",
          "contacts": [
            {
              "name": "Odd Terje Brustugun",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 59.74389,
            "lon": 10.20449
          }
        },
        {
          "facility": "Haukeland Universitetssjukehus",
          "status": "NOT_YET_RECRUITING",
          "city": "Bergen",
          "state": "Hordaland",
          "zip": "5021",
          "country": "Norway",
          "contacts": [
            {
              "name": "Christina Aamelfot",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 60.39299,
            "lon": 5.32415
          }
        },
        {
          "facility": "Sykehuset Innlandet HF Gj\u00f8vik",
          "status": "NOT_YET_RECRUITING",
          "city": "Gj\u00f8vik",
          "state": "Oppland",
          "zip": "2819",
          "country": "Norway",
          "contacts": [
            {
              "name": "Daniel Heinrich",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 60.79574,
            "lon": 10.69155
          }
        },
        {
          "facility": "Stavanger Universitetssykehus",
          "status": "NOT_YET_RECRUITING",
          "city": "Stavanger",
          "state": "Rogaland",
          "zip": "4011",
          "country": "Norway",
          "contacts": [
            {
              "name": "Tesfaye Madebo",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 58.97005,
            "lon": 5.73332
          }
        },
        {
          "facility": "St. Olavs Hospital",
          "status": "NOT_YET_RECRUITING",
          "city": "Trondheim",
          "state": "S\u00f8r-Tr\u00f8ndelag",
          "zip": "7030",
          "country": "Norway",
          "contacts": [
            {
              "name": "Bj\u00f8rn Gr\u00f8nberg",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 63.43049,
            "lon": 10.39506
          }
        },
        {
          "facility": "Oslo Universitetssykehus Ullev\u00e5l",
          "status": "NOT_YET_RECRUITING",
          "city": "Oslo",
          "zip": "0450",
          "country": "Norway",
          "contacts": [
            {
              "name": "Vilde Drageset Haakensen",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 59.91273,
            "lon": 10.74609
          }
        },
        {
          "facility": "MICS Centrum Medyczne Torun",
          "status": "RECRUITING",
          "city": "Torun",
          "state": "Kujawsko-pomorskie",
          "zip": "87-100",
          "country": "Poland",
          "contacts": [
            {
              "name": "Justyna Wietrzynska",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 53.01375,
            "lon": 18.59814
          }
        },
        {
          "facility": "One Day Med",
          "status": "NOT_YET_RECRUITING",
          "city": "Szczecin",
          "state": "Zachodniopomorskie",
          "zip": "70-419",
          "country": "Poland",
          "contacts": [
            {
              "name": "Piotr Serwatowski",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 53.42894,
            "lon": 14.55302
          }
        },
        {
          "facility": "Swietokrzyskie Centrum Onkologii, Samodzielny Publiczny Zaklad Opieki Zdrowotnej",
          "status": "NOT_YET_RECRUITING",
          "city": "Kielce",
          "state": "\u015awi\u0119tokrzyskie",
          "zip": "25-734",
          "country": "Poland",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "48413674809"
            },
            {
              "name": "Kinga Szydziak-Zwierzynska",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 50.87033,
            "lon": 20.62752
          }
        },
        {
          "facility": "Champalimaud Foundation",
          "status": "NOT_YET_RECRUITING",
          "city": "Lisbon",
          "state": "Lisboa",
          "zip": "1400-038",
          "country": "Portugal",
          "contacts": [
            {
              "name": "Susana Simoes",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 38.71667,
            "lon": -9.13333
          }
        },
        {
          "facility": "Hospital Pulido Valente",
          "status": "NOT_YET_RECRUITING",
          "city": "Lisbon",
          "state": "Lisboa",
          "zip": "1769-001",
          "country": "Portugal",
          "contacts": [
            {
              "name": "Paula Alves",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 38.71667,
            "lon": -9.13333
          }
        },
        {
          "facility": "Centro Hospitalar E Universit\u00e1rio De Coimbra",
          "status": "NOT_YET_RECRUITING",
          "city": "Coimbra",
          "zip": "3040",
          "country": "Portugal",
          "contacts": [
            {
              "name": "Ana Figueiredo",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 40.20564,
            "lon": -8.41955
          }
        },
        {
          "facility": "Hospital da Luz Lisboa",
          "status": "NOT_YET_RECRUITING",
          "city": "Lisboa",
          "zip": "1500-650",
          "country": "Portugal",
          "contacts": [
            {
              "name": "Joao Moreira Pinto",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 38.71667,
            "lon": -9.13333
          }
        },
        {
          "facility": "Centro Hospitalar do Porto - Hospital de Santo Ant\u00f3nio",
          "status": "NOT_YET_RECRUITING",
          "city": "Porto",
          "zip": "4099-001",
          "country": "Portugal",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "222077500"
            },
            {
              "name": "Antonio Araujo",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 41.14961,
            "lon": -8.61099
          }
        },
        {
          "facility": "Hospital CUF Porto",
          "status": "NOT_YET_RECRUITING",
          "city": "Porto",
          "zip": "4100-180",
          "country": "Portugal",
          "contacts": [
            {
              "name": "Barbara Parente",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 41.14961,
            "lon": -8.61099
          }
        },
        {
          "facility": "Instituto Portugu\u00eas de Oncologia do Porto Francisco Gentil, EPE",
          "status": "NOT_YET_RECRUITING",
          "city": "Porto",
          "zip": "4200-072",
          "country": "Portugal",
          "contacts": [
            {
              "name": "Marta Soares",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 41.14961,
            "lon": -8.61099
          }
        },
        {
          "facility": "Lotus-Med",
          "status": "RECRUITING",
          "city": "Bucharest",
          "state": "Bucuresti",
          "zip": "012292",
          "country": "Romania",
          "contacts": [
            {
              "name": "Anca Zgura",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 44.43225,
            "lon": 26.10626
          }
        },
        {
          "facility": "Institutul Oncologic",
          "status": "RECRUITING",
          "city": "Cluj-Napoca",
          "state": "Cluj",
          "zip": "400015",
          "country": "Romania",
          "contacts": [
            {
              "name": "Tudor Ciuleanu",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 46.76667,
            "lon": 23.6
          }
        },
        {
          "facility": "Ovidius Clinical Hospital OCH",
          "status": "RECRUITING",
          "city": "Ovidiu",
          "state": "Constan\u021ba",
          "zip": "905900",
          "country": "Romania",
          "contacts": [
            {
              "name": "Laura Mazilu",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 44.26667,
            "lon": 28.56667
          }
        },
        {
          "facility": "Centrul de Oncologie \"Sf\u00e2ntul Nectarie\"",
          "status": "RECRUITING",
          "city": "Craiova",
          "state": "Dolj",
          "zip": "200542",
          "country": "Romania",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "40727774974"
            },
            {
              "name": "Michael Schenker",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 44.31667,
            "lon": 23.8
          }
        },
        {
          "facility": "S C Oncocenter Oncologie Clinica S R L",
          "status": "RECRUITING",
          "city": "Timi\u0219oara",
          "state": "Timi\u0219",
          "zip": "300166",
          "country": "Romania",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "0040745146020"
            },
            {
              "name": "Roxana Scheusan",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 45.75372,
            "lon": 21.22571
          }
        },
        {
          "facility": "Cabinet Medical Oncomed",
          "status": "RECRUITING",
          "city": "Timi\u0219oara",
          "state": "Timi\u0219",
          "zip": "300239",
          "country": "Romania",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "40723401453"
            },
            {
              "name": "Mihaela Maria Pasca-Fenesan",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 45.75372,
            "lon": 21.22571
          }
        },
        {
          "facility": "Centrul medical Focus",
          "status": "NOT_YET_RECRUITING",
          "city": "Bucure\u0219ti",
          "zip": "022548",
          "country": "Romania",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "40721298677"
            },
            {
              "name": "Ingrid Adriana Iordan",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 44.42802,
            "lon": 26.09665
          }
        },
        {
          "facility": "Gral Medical Diagnostic Center",
          "status": "RECRUITING",
          "city": "Bucure\u0219ti",
          "zip": "031422",
          "country": "Romania",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "40726273762"
            },
            {
              "name": "Cristina Tiut",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 44.42802,
            "lon": 26.09665
          }
        },
        {
          "facility": "CHUS - Hospital Clinico Universitario",
          "status": "RECRUITING",
          "city": "Santiago de Compostela",
          "state": "A Coru\u00f1a [La Coru\u00f1a]",
          "zip": "15706",
          "country": "Spain",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "981950511"
            },
            {
              "name": "Luis Angel Leon Mateos",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 42.88052,
            "lon": -8.54569
          }
        },
        {
          "facility": "CHUAC-Hospital Teresa Herrera",
          "status": "RECRUITING",
          "city": "A Coru\u00f1a",
          "state": "A Coru\u00f1a [",
          "zip": "15006",
          "country": "Spain",
          "contacts": [
            {
              "name": "Maria Rosario Garcia Campelo",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 43.37135,
            "lon": -8.396
          }
        },
        {
          "facility": "Hospital Universitari Son Espases",
          "status": "RECRUITING",
          "city": "Palma De Mallorca",
          "state": "Balears [Baleares]",
          "zip": "07120",
          "country": "Spain",
          "contacts": [
            {
              "name": "Aitor Azkarate Martinez",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 39.56939,
            "lon": 2.65024
          }
        },
        {
          "facility": "Hospital Universitari Vall d'Hebron",
          "status": "RECRUITING",
          "city": "Barcelona",
          "state": "Barcelona [Barcelona]",
          "zip": "8035",
          "country": "Spain",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "34932746085"
            },
            {
              "name": "Enriqueta Felip Font",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 41.38879,
            "lon": 2.15899
          }
        },
        {
          "facility": "Instituto Catalan de Oncologia - Hospital Duran i Reynals",
          "status": "NOT_YET_RECRUITING",
          "city": "Hospitalet de Llobregat",
          "state": "Barcelona [Barcelona]",
          "zip": "08907",
          "country": "Spain",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "932607744"
            },
            {
              "name": "Ernest Nadal Alforja",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 41.35967,
            "lon": 2.10028
          }
        },
        {
          "facility": "Complejo Asistencial Universitario de Le\u00f3n - Hospital de Le\u00f3n",
          "status": "RECRUITING",
          "city": "Le\u00f3n",
          "state": "Castilla Y Le\u00f3n",
          "zip": "24071",
          "country": "Spain",
          "contacts": [
            {
              "name": "Blanca T\u00e1vara",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 42.60003,
            "lon": -5.57032
          }
        },
        {
          "facility": "Hospital Universitari Dexeusa",
          "status": "RECRUITING",
          "city": "Barcelona",
          "state": "Catalunya [Catalu\u00f1a]",
          "zip": "08028",
          "country": "Spain",
          "contacts": [
            {
              "name": "ANDRES AGUILAR",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 41.38879,
            "lon": 2.15899
          }
        },
        {
          "facility": "Hospital Jerez de la Frontera",
          "status": "RECRUITING",
          "city": "Jerez De La Frontera",
          "state": "C\u00e1diz",
          "zip": "11407",
          "country": "Spain",
          "contacts": [
            {
              "name": "Jesus Corral Jaime",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 36.68645,
            "lon": -6.13606
          }
        },
        {
          "facility": "Hospital Insular de Gran Canaria",
          "status": "RECRUITING",
          "city": "Las Palmas de Gran Canaria",
          "state": "Las Palmas",
          "zip": "35016",
          "country": "Spain",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "34928441738"
            },
            {
              "name": "DELVYS RODRIGUEZ ABREU",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 28.09973,
            "lon": -15.41343
          }
        },
        {
          "facility": "Hospital Universitario 12 de Octubre",
          "status": "RECRUITING",
          "city": "Madrid",
          "state": "Madrid, Comunidad De",
          "zip": "28041",
          "country": "Spain",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "0034913908000"
            },
            {
              "name": "Luis Paz-Ares Rodriguez",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 40.4165,
            "lon": -3.70256
          }
        },
        {
          "facility": "Hospital Universitario Quironsalud Madrid",
          "status": "RECRUITING",
          "city": "Pozuelo de Alarcon",
          "state": "Madrid",
          "zip": "28223",
          "country": "Spain",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "34914521987"
            },
            {
              "name": "Belen Rubio Viqueira",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 40.43293,
            "lon": -3.81338
          }
        },
        {
          "facility": "Complejo Hospitalario de Navarra",
          "status": "RECRUITING",
          "city": "Pamplona",
          "state": "Navarra",
          "zip": "31009",
          "country": "Spain",
          "contacts": [
            {
              "name": "Maite Martinez Aguillo",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 42.81687,
            "lon": -1.64323
          }
        },
        {
          "facility": "Hospital Clinico de Valencia",
          "status": "RECRUITING",
          "city": "Valencia",
          "state": "Valenciana, Comunitat",
          "zip": "46010",
          "country": "Spain",
          "contacts": [
            {
              "name": "Amelia Insa Molla",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 39.46975,
            "lon": -0.37739
          }
        },
        {
          "facility": "Hospital Infanta Cristina",
          "status": "RECRUITING",
          "city": "Badajoz",
          "zip": "06006",
          "country": "Spain",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "924218040"
            },
            {
              "name": "Marta Gonzalez Cordero",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 38.87789,
            "lon": -6.97061
          }
        },
        {
          "facility": "Hospital Regional Universitario",
          "status": "RECRUITING",
          "city": "M\u00e1laga",
          "zip": "29011",
          "country": "Spain",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "34951308130"
            },
            {
              "name": "Mar\u00eda Vanesa Gutierrez Calderon",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 36.72016,
            "lon": -4.42034
          }
        },
        {
          "facility": "Hospital Universitario Virgen Del Rocio",
          "status": "RECRUITING",
          "city": "Sevilla",
          "zip": "41013",
          "country": "Spain",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "955013068"
            },
            {
              "name": "Reyes Bernabe Caro",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 37.38283,
            "lon": -5.97317
          }
        },
        {
          "facility": "V\u00e4stmanlands Sjukhus V\u00e4ster\u00e5s",
          "status": "NOT_YET_RECRUITING",
          "city": "V\u00e4ster\u00e5s",
          "state": "V\u00e4stmanlands L\u00e4n [se-19]",
          "zip": "721 89",
          "country": "Sweden",
          "contacts": [
            {
              "name": "Andreea Sima",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 59.61617,
            "lon": 16.55276
          }
        },
        {
          "facility": "CHUV (centre hospitalier universitaire vaudois)",
          "status": "NOT_YET_RECRUITING",
          "city": "Lausanne",
          "state": "Vaud",
          "zip": "1011",
          "country": "Switzerland",
          "contacts": [
            {
              "name": "Solange Peters",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 46.516,
            "lon": 6.63282
          }
        },
        {
          "facility": "Kantonsspital Winterthur",
          "status": "NOT_YET_RECRUITING",
          "city": "Winterthur",
          "zip": "8401",
          "country": "Switzerland",
          "contacts": [
            {
              "name": "Laetitia Mauti",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 47.50564,
            "lon": 8.72413
          }
        },
        {
          "facility": "Universit\u00e4tsSpital Z\u00fcrich",
          "status": "NOT_YET_RECRUITING",
          "city": "Z\u00fcrich",
          "zip": "8091",
          "country": "Switzerland",
          "contacts": [
            {
              "name": "Ulrich Richter",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 47.36667,
            "lon": 8.54999
          }
        },
        {
          "facility": "Changhua Christian Hospital",
          "status": "RECRUITING",
          "city": "Changhua County",
          "state": "Changhua",
          "zip": "50006",
          "country": "Taiwan",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "88647238595"
            },
            {
              "name": "Sheng-Hao Lin",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ]
        },
        {
          "facility": "Hualien Tzu Chi Medical Center",
          "status": "NOT_YET_RECRUITING",
          "city": "Hualien City",
          "state": "Hualien",
          "zip": "970",
          "country": "Taiwan",
          "contacts": [
            {
              "name": "Chih-Bin Lin",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 23.97694,
            "lon": 121.60444
          }
        },
        {
          "facility": "Chung Shan Medical University Hospital",
          "status": "RECRUITING",
          "city": "Taichung City",
          "state": "Taichung",
          "zip": "402",
          "country": "Taiwan",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "0424739595"
            },
            {
              "name": "Gee-Chen Chang",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 24.1469,
            "lon": 120.6839
          }
        },
        {
          "facility": "Chi Mei Hospital - Liouying Branch",
          "status": "RECRUITING",
          "city": "Tainan City",
          "state": "Tainan",
          "zip": "73657",
          "country": "Taiwan",
          "contacts": [
            {
              "name": "Wen-Tsung Huang",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 22.99083,
            "lon": 120.21333
          }
        },
        {
          "facility": "National Taiwan University Cancer Center (NTUCC)",
          "status": "RECRUITING",
          "city": "Taipei City",
          "state": "Taipei",
          "zip": "106",
          "country": "Taiwan",
          "contacts": [
            {
              "name": "Chih-Hsin Yang",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 25.04776,
            "lon": 121.53185
          }
        },
        {
          "facility": "National Taiwan University Hospital Yun-Lin Branch Dou-Liou Region",
          "status": "RECRUITING",
          "city": "Douliu City",
          "state": "Yunlin",
          "zip": "640",
          "country": "Taiwan",
          "contacts": [
            {
              "name": "Chung-Yu Chen",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ]
        },
        {
          "facility": "Buddhist Dalin Tzu Chi General Hospital",
          "status": "RECRUITING",
          "city": "Chiayi",
          "zip": "622",
          "country": "Taiwan",
          "contacts": [
            {
              "name": "Chun-Liang Lai",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ]
        },
        {
          "facility": "Kaohsiung Medical University Hospital",
          "status": "RECRUITING",
          "city": "Kaohsiung",
          "zip": "807",
          "country": "Taiwan",
          "contacts": [
            {
              "name": "Jen-Yu Hung",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 22.61626,
            "lon": 120.31333
          }
        },
        {
          "facility": "Chang Gung Memorial Hospital at Kaohsiung",
          "status": "RECRUITING",
          "city": "Kaohsiung",
          "zip": "83301",
          "country": "Taiwan",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "88677317123"
            },
            {
              "name": "Chin-Chou Wang",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 22.61626,
            "lon": 120.31333
          }
        },
        {
          "facility": "Taichung Veterans General Hospital",
          "status": "RECRUITING",
          "city": "Taichung",
          "zip": "407",
          "country": "Taiwan",
          "contacts": [
            {
              "name": "Tsung-Ying Yang",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 24.1469,
            "lon": 120.6839
          }
        },
        {
          "facility": "National Cheng Kung University Hospital",
          "status": "RECRUITING",
          "city": "Tainan",
          "zip": "704",
          "country": "Taiwan",
          "contacts": [
            {
              "name": "Chien-Chung Lin",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 22.99083,
            "lon": 120.21333
          }
        },
        {
          "facility": "National Taiwan University Hospital",
          "status": "RECRUITING",
          "city": "Taipei",
          "zip": "10002",
          "country": "Taiwan",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "886223123456"
            },
            {
              "name": "Chia-Chi Lin",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 25.04776,
            "lon": 121.53185
          }
        },
        {
          "facility": "Taipei Veterans General Hospital",
          "status": "RECRUITING",
          "city": "Taipei",
          "zip": "11217",
          "country": "Taiwan",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "886228757865"
            },
            {
              "name": "Yuh-Min Chen",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 25.04776,
            "lon": 121.53185
          }
        },
        {
          "facility": "Chang Gung Medical Foundation-Linkou Branch",
          "status": "RECRUITING",
          "city": "Taoyuan",
          "zip": "333",
          "country": "Taiwan",
          "contacts": [
            {
              "name": "Cheng-Ta Yang",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 24.95233,
            "lon": 121.20193
          }
        },
        {
          "facility": "Adana Medical Park Seyhan Hastanesi",
          "status": "RECRUITING",
          "city": "Adana",
          "zip": "01140",
          "country": "Turkey",
          "contacts": [
            {
              "name": "Ahmet Sezer",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 37.00167,
            "lon": 35.32889
          }
        },
        {
          "facility": "Adana City Hospital",
          "status": "RECRUITING",
          "city": "Adana",
          "zip": "01370",
          "country": "Turkey",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "905386099202"
            },
            {
              "name": "Timucin Cil",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 37.00167,
            "lon": 35.32889
          }
        },
        {
          "facility": "Ankara Etlik City Hospital",
          "status": "RECRUITING",
          "city": "Ankara",
          "zip": "06170",
          "country": "Turkey",
          "contacts": [
            {
              "name": "Berna Oksuzoglu",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 39.91987,
            "lon": 32.85427
          }
        },
        {
          "facility": "Dr. Abdurrahman Yurtaslan Ankara Onkoloji Egitim ve Arast\u0131rma Hastanesi",
          "status": "RECRUITING",
          "city": "Ankara",
          "zip": "06200",
          "country": "Turkey",
          "contacts": [
            {
              "name": "Cengiz Karacin",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 39.91987,
            "lon": 32.85427
          }
        },
        {
          "facility": "Ankara City Hospital",
          "status": "NOT_YET_RECRUITING",
          "city": "Ankara",
          "zip": "06800",
          "country": "Turkey",
          "contacts": [
            {
              "name": "Mehmet Ali Nahit Sendur",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 39.91987,
            "lon": 32.85427
          }
        },
        {
          "facility": "Akdeniz Universitesi Hastanesi",
          "status": "RECRUITING",
          "city": "Antalya",
          "zip": "07059",
          "country": "Turkey",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "05052312377"
            },
            {
              "name": "Sema Sezgin Goksu",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 36.90812,
            "lon": 30.69556
          }
        },
        {
          "facility": "Memorial Antalya Hospital",
          "status": "RECRUITING",
          "city": "Antalya",
          "zip": "07090",
          "country": "Turkey",
          "contacts": [
            {
              "name": "Mustafa Ozdogan",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 36.90812,
            "lon": 30.69556
          }
        },
        {
          "facility": "Uludag Universitesi",
          "status": "RECRUITING",
          "city": "Bursa",
          "zip": "16059",
          "country": "Turkey",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "905336460546"
            },
            {
              "name": "Turkkan Evrensel",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 40.19559,
            "lon": 29.06013
          }
        },
        {
          "facility": "Dicle \u00dcniversitesi",
          "status": "RECRUITING",
          "city": "Diyarbakir",
          "zip": "21200",
          "country": "Turkey",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "905337677131"
            },
            {
              "name": "Muhammet Ali kaplan",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 37.91363,
            "lon": 40.21721
          }
        },
        {
          "facility": "Bezmialem Vakf \u00dcniversitesi",
          "status": "RECRUITING",
          "city": "Istanbul",
          "zip": "34093",
          "country": "Turkey",
          "contacts": [
            {
              "name": "Haci Mehmet Turk",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 41.01384,
            "lon": 28.94966
          }
        },
        {
          "facility": "\u0130.A.\u00dc VM Medical Park Florya Hastanesi",
          "status": "NOT_YET_RECRUITING",
          "city": "Istanbul",
          "zip": "34295",
          "country": "Turkey",
          "contacts": [
            {
              "name": "Irfan Cicin",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 41.01384,
            "lon": 28.94966
          }
        },
        {
          "facility": "TC Saglik Bakanligi Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi",
          "status": "RECRUITING",
          "city": "Istanbul",
          "zip": "34722",
          "country": "Turkey",
          "contacts": [
            {
              "name": "Mahmut Gumus",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 41.01384,
            "lon": 28.94966
          }
        },
        {
          "facility": "Ege Universitesi Hastanesi",
          "status": "RECRUITING",
          "city": "Izmir",
          "zip": "35100",
          "country": "Turkey",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "05322202675"
            },
            {
              "name": "Tuncay Goksel",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 38.41273,
            "lon": 27.13838
          }
        },
        {
          "facility": "zmir Katip \u00c7elebi \u00dcniversitesi Atat\u00fcrk Eitim Ve Aratrma Hastanesi",
          "status": "RECRUITING",
          "city": "Izmir",
          "zip": "35360",
          "country": "Turkey",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "905324078648"
            },
            {
              "name": "Ahmet Alacacioglu",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 38.41273,
            "lon": 27.13838
          }
        },
        {
          "facility": "Ondokuz May\u0131s Universitesi",
          "status": "RECRUITING",
          "city": "Samsun",
          "zip": "55139",
          "country": "Turkey",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "90532599282"
            },
            {
              "name": "Bahiddin Yilmaz",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 41.27976,
            "lon": 36.3361
          }
        },
        {
          "facility": "Aberdeen Royal Infirmary",
          "status": "NOT_YET_RECRUITING",
          "city": "Aberdeen",
          "state": "Aberdeen City",
          "zip": "AB25 2ZN",
          "country": "United Kingdom",
          "contacts": [
            {
              "name": "Andrew Duncan",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 57.14369,
            "lon": -2.09814
          }
        },
        {
          "facility": "Ninewells Hospital and Medical School",
          "status": "NOT_YET_RECRUITING",
          "city": "Dundee",
          "state": "Angus",
          "zip": "DD1 9SY",
          "country": "United Kingdom",
          "contacts": [
            {
              "name": "Hannah Lord",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 56.46913,
            "lon": -2.97489
          }
        },
        {
          "facility": "Weston Park Hospital",
          "status": "NOT_YET_RECRUITING",
          "city": "Sheffield",
          "state": "England",
          "zip": "S10 2SJ",
          "country": "United Kingdom",
          "contacts": [
            {
              "name": "Tathagata Das",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 53.38297,
            "lon": -1.4659
          }
        },
        {
          "facility": "Cheltenham General Hospital",
          "status": "NOT_YET_RECRUITING",
          "city": "Cheltenham",
          "state": "Gloucestershire",
          "zip": "GL53 7AN",
          "country": "United Kingdom",
          "contacts": [
            {
              "name": "Sean Brown",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 51.90006,
            "lon": -2.07972
          }
        },
        {
          "facility": "Mount Vernon Hospital",
          "status": "NOT_YET_RECRUITING",
          "city": "Northwood",
          "state": "Hillingdon",
          "zip": "HA6 2RN",
          "country": "United Kingdom",
          "contacts": [
            {
              "name": "Andreas Polychronis",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ]
        },
        {
          "facility": "The Christie NHS Foundation Trust",
          "status": "NOT_YET_RECRUITING",
          "city": "Manchester",
          "state": "Withington",
          "zip": "M20 4 BX",
          "country": "United Kingdom",
          "contacts": [
            {
              "name": "Colin Lindsay",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 53.48095,
            "lon": -2.23743
          }
        },
        {
          "facility": "St James's University Hospital",
          "status": "NOT_YET_RECRUITING",
          "city": "Leeds",
          "zip": "LS9 7TF",
          "country": "United Kingdom",
          "contacts": [
            {
              "name": "Katy Clarke",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 53.79648,
            "lon": -1.54785
          }
        },
        {
          "facility": "New Cross Hospital",
          "status": "NOT_YET_RECRUITING",
          "city": "Wolverhampton",
          "zip": "WV10 0QP",
          "country": "United Kingdom",
          "contacts": [
            {
              "role": "CONTACT",
              "phone": "07859065070"
            },
            {
              "name": "Ankit Jain",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 52.58547,
            "lon": -2.12296
          }
        }
      ],
      "eligibilityModule": {
        "eligibilityCriteria": "Inclusion Criteria:\n\n* Histologically or cytologically confirmed NSCLC with Stage IIIB-IIIC or Stage IV disease, not suitable for curative intent radical surgery or radiation therapy.\n* Part B and Safety Lead-In Part B: the histology of the tumor must be predominantly non-squamous (in line with pemetrexed label).\n* Must have disease with evidence of KRAS G12C mutation.\n* Must have known programmed death-ligand 1 (PD-L1) expression\n\n  * Part A: Greater than or equal to (\u2265)50 percent (%).\n  * Part B: 0% to 100%.\n* Must have measurable disease per RECIST v1.1.\n* Must have an ECOG performance status of 0 or 1.\n* Estimated life expectancy \u226512 weeks.\n* Ability to swallow capsules.\n* Must have adequate laboratory parameters.\n* Contraceptive use should be consistent with local regulations for those participating in clinical studies.\n* Women of childbearing potential must\n\n  * Have a negative pregnancy test.\n  * Not be breastfeeding during treatment and after study intervention for at least 180 days.\n\nExclusion Criteria:\n\n* Have a documented additional validated targetable oncogenic driver mutation or alteration in genes such as epidermal growth factor receptor (EGFR), anaplastic lymphoma kinase (ALK), BRAF (V600E), human epidermal growth factor receptor 2 (HER2), MET (exon 14), ROS1, rearranged during transfection (RET), or neurotrophic tyrosine receptor kinase (NTRK)1/2/3.\n* Have had any of the following prior to randomization:\n\n  -- Prior systemic therapy (chemotherapy, immunotherapy, targeted therapy, or biological therapy) for advanced or metastatic NSCLC.\n\n  --- 1 cycle of standard-of-care treatment prior to study enrollment will be allowed for cases where immediate treatment is clinically indicated:\n* Have known active central nervous system metastases and/or carcinomatous meningitis.\n\nExclusion Criteria for Participants receiving Pemetrexed and Platinum (Part B and Safety Lead-In Part B)\n\n* Squamous cell and/or mixed small cell/nonsmall cell histology is not permitted.\n* Is unable to interrupt aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs)\n* Is unable or unwilling to take folic acid or vitamin B12 supplementation.",
        "healthyVolunteers": false,
        "sex": "ALL",
        "minimumAge": "18 Years",
        "stdAges": [
          "ADULT",
          "OLDER_ADULT"
        ]
      },
      "studyType": "INTERVENTIONAL",
      "phases": [
        "PHASE3"
      ]
    },
    "structured_criteria": {
      "inclusion": {
        "Inclusion Criteria:": [
          "Patients who meet all of the following criteria are eligible for trial participation: ",
          [
            "* Histologically or cytologically confirmed NSCLC with Stage IIIB-IIIC or Stage IV disease, not suitable for curative intent radical surgery or radiation therapy.",
            "* Part B and Safety Lead-In Part B: the histology of the tumor must be predominantly non-squamous (in line with pemetrexed label).",
            "* Must have disease with evidence of KRAS G12C mutation.",
            [
              "* Must have known programmed death-ligand 1 (PD-L1) expression",
              "  * Part A: Greater than or equal to (\u2265)50 percent (%).",
              "  * Part B: 0% to 100%."
            ],
            "* Must have measurable disease per RECIST v1.1.",
            "* Must have an ECOG performance status of 0 or 1.",
            "* Estimated life expectancy \u226512 weeks.",
            "* Ability to swallow capsules.",
            "* Must have adequate laboratory parameters.",
            "* Contraceptive use should be consistent with local regulations for those participating in clinical studies.",
            [
              "* Women of childbearing potential must",
              "  * Have a negative pregnancy test.",
              "  * Not be breastfeeding during treatment and after study intervention for at least 180 days."
            ]
          ]
        ]
      },
      "exclusion": {
        "Exclusion Criteria:": [
          "Patients who meet any of the following criteria are not eligible for trial participation: ",
          [
            "* Have a documented additional validated targetable oncogenic driver mutation or alteration in genes such as epidermal growth factor receptor (EGFR), anaplastic lymphoma kinase (ALK), BRAF (V600E), human epidermal growth factor receptor 2 (HER2), MET (exon 14), ROS1, rearranged during transfection (RET), or neurotrophic tyrosine receptor kinase (NTRK)1/2/3.",
            [
              "* Have had any of the following prior to randomization:",
              "  -- Prior systemic therapy (chemotherapy, immunotherapy, targeted therapy, or biological therapy) for advanced or metastatic NSCLC.",
              "  --- 1 cycle of standard-of-care treatment prior to study enrollment will be allowed for cases where immediate treatment is clinically indicated:"
            ],
            "* Have known active central nervous system metastases and/or carcinomatous meningitis."
          ]
        ],
        "Exclusion Criteria for Participants receiving Pemetrexed and Platinum (Part B and Safety Lead-In Part B)": [
          "Patients who meet any of the following criteria are not eligible for trial participation: ",
          [
            "* Squamous cell and/or mixed small cell/nonsmall cell histology is not permitted.",
            "* Is unable to interrupt aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs)",
            "* Is unable or unwilling to take folic acid or vitamin B12 supplementation."
          ]
        ]
      }
    },
    "results_inclusion": [
      [
        "Inclusion Criteria:",
        "Patients who meet all of the following criteria are eligible for trial participation: ",
        [
          "* Histologically or cytologically confirmed NSCLC with Stage IIIB-IIIC or Stage IV disease, not suitable for curative intent radical surgery or radiation therapy.",
          "* Part B and Safety Lead-In Part B: the histology of the tumor must be predominantly non-squamous (in line with pemetrexed label).",
          "* Must have disease with evidence of KRAS G12C mutation.",
          "* Must have measurable disease per RECIST v1.1.",
          "* Must have an ECOG performance status of 0 or 1."
        ],
        {
          "reasoning": "Reasoning: Let's think step by step in order to produce the criteria_decision. We will evaluate each criterion based on the patient information provided.\n\n1. \u00ab* Histologically or cytologically confirmed NSCLC with Stage IIIB-IIIC or Stage IV disease, not suitable for curative intent radical surgery or radiation therapy.\u00bb\n   - The patient has lung adenocarcinoma, stage 4, which is a type of NSCLC and is not suitable for curative intent radical surgery or radiation therapy.\n   - Decision: True\n\n2. \u00ab* Part B and Safety Lead-In Part B: the histology of the tumor must be predominantly non-squamous (in line with pemetrexed label).\u00bb\n   - The patient has lung adenocarcinoma, which is a non-squamous histology.\n   - Decision: True\n\n3. \u00ab* Must have disease with evidence of KRAS G12C mutation.\u00bb\n   - The patient has a KRAS p.G12C mutation.\n   - Decision: True\n\n4. \u00ab* Must have measurable disease per RECIST v1.1.\u00bb\n   - There is no information provided about whether the disease is measurable per RECIST v1.1.\n   - Decision: ?\n\n5. \u00ab* Must have an ECOG performance status of 0 or 1.\u00bb\n   - There is no information provided about the patient's ECOG performance status.\n   - Decision: ?",
          "criteria_decision": {
            "explanation": [
              "The patient has lung adenocarcinoma, stage 4, which is a type of NSCLC and is not suitable for curative intent radical surgery or radiation therapy.",
              "The patient has lung adenocarcinoma, which is a non-squamous histology.",
              "The patient has a KRAS p.G12C mutation.",
              "There is no information provided about whether the disease is measurable per RECIST v1.1.",
              "There is no information provided about the patient's ECOG performance status."
            ],
            "criteria_decision": [
              true,
              true,
              true,
              "?",
              "?"
            ]
          }
        }
      ],
      [
        "Inclusion Criteria:",
        "Patients who meet all of the following criteria are eligible for trial participation: ",
        [
          "* Estimated life expectancy \u226512 weeks.",
          "* Ability to swallow capsules.",
          "* Must have adequate laboratory parameters.",
          "* Contraceptive use should be consistent with local regulations for those participating in clinical studies."
        ],
        {
          "reasoning": "Reasoning: Let's think step by step in order to produce the criteria_decision. We will evaluate each criterion based on the provided patient information.\n\n1. **Estimated life expectancy \u226512 weeks.**\n   - The patient information does not provide any details about the estimated life expectancy.\n   - Decision: `?`\n\n2. **Ability to swallow capsules.**\n   - The patient information does not mention anything about the patient's ability to swallow capsules.\n   - Decision: `?`\n\n3. **Must have adequate laboratory parameters.**\n   - The patient information does not provide any laboratory parameters.\n   - Decision: `?`\n\n4. **Contraceptive use should be consistent with local regulations for those participating in clinical studies.**\n   - The patient information does not mention anything about contraceptive use.\n   - Decision: `?`",
          "criteria_decision": {
            "explanation": [
              "The patient information does not provide any details about the estimated life expectancy.",
              "The patient information does not mention anything about the patient's ability to swallow capsules.",
              "The patient information does not provide any laboratory parameters.",
              "The patient information does not mention anything about contraceptive use."
            ],
            "criteria_decision": [
              "?",
              "?",
              "?",
              "?"
            ]
          }
        }
      ],
      [
        "Inclusion Criteria:",
        "Patients who meet all of the following criteria are eligible for trial participation: ",
        [
          "* Must have known programmed death-ligand 1 (PD-L1) expression",
          "  * Part A: Greater than or equal to (\u2265)50 percent (%).",
          "  * Part B: 0% to 100%."
        ],
        {
          "reasoning": "Reasoning: Let's think step by step in order to produce the criteria decision. We need to evaluate each inclusion criterion based on the patient information provided.\n\n1. **Must have known programmed death-ligand 1 (PD-L1) expression**:\n   - The patient information does not mention PD-L1 expression.\n   - Therefore, we cannot determine if the patient meets this criterion.\n   - Decision: `?`\n\n2. **Part A: Greater than or equal to (\u2265)50 percent (%)**:\n   - This criterion is a subcriterion of the first one.\n   - Since we do not have information about PD-L1 expression, we cannot determine if the patient meets this criterion.\n   - Decision: `?`\n\n3. **Part B: 0% to 100%**:\n   - This criterion is also a subcriterion of the first one.\n   - Since we do not have information about PD-L1 expression, we cannot determine if the patient meets this criterion.\n   - Decision: `?`\n\nSince the global condition is based on the subcriteria, and we do not have sufficient information to determine the patient's eligibility for any of the subcriteria, the global result is also `?`.",
          "criteria_decision": {
            "criteria_result": {
              "explanation": [
                "The patient information does not mention PD-L1 expression, so we cannot determine if the patient meets this criterion.",
                "This criterion is a subcriterion of the first one. Since we do not have information about PD-L1 expression, we cannot determine if the patient meets this criterion.",
                "This criterion is also a subcriterion of the first one. Since we do not have information about PD-L1 expression, we cannot determine if the patient meets this criterion."
              ],
              "criteria_decision": [
                "?",
                "?",
                "?"
              ]
            },
            "global_result": "?"
          }
        }
      ],
      [
        "Inclusion Criteria:",
        "Patients who meet all of the following criteria are eligible for trial participation: ",
        [
          "* Women of childbearing potential must",
          "  * Have a negative pregnancy test.",
          "  * Not be breastfeeding during treatment and after study intervention for at least 180 days."
        ],
        {
          "reasoning": "Reasoning: Let's think step by step in order to produce the criteria decision. We need to evaluate each inclusion criterion based on the patient information provided.\n\n1. The global condition is \"Women of childbearing potential must\".\n   - The patient is a 59-year-old male, so this global condition does not apply to him. Therefore, he effectively passes this criterion.\n\n2. Subcriteria:\n   - \"Have a negative pregnancy test.\"\n     - Since the patient is male, this criterion is not applicable. Decision: True.\n   - \"Not be breastfeeding during treatment and after study intervention for at least 180 days.\"\n     - Again, since the patient is male, this criterion is not applicable. Decision: True.\n\nSince the global condition does not apply to the patient, he effectively passes all the subcriteria.",
          "criteria_decision": {
            "criteria_result": {
              "explanation": [
                "The patient is male, so the global condition 'Women of childbearing potential must' does not apply.",
                "The patient is male, so the criterion 'Have a negative pregnancy test' does not apply.",
                "The patient is male, so the criterion 'Not be breastfeeding during treatment and after study intervention for at least 180 days' does not apply."
              ],
              "criteria_decision": [
                true,
                true,
                true
              ]
            },
            "global_result": true
          }
        }
      ]
    ],
    "results_exclusion": [
      [
        "Exclusion Criteria:",
        "Patients who meet any of the following criteria are not eligible for trial participation: ",
        [
          "* Have a documented additional validated targetable oncogenic driver mutation or alteration in genes such as epidermal growth factor receptor (EGFR), anaplastic lymphoma kinase (ALK), BRAF (V600E), human epidermal growth factor receptor 2 (HER2), MET (exon 14), ROS1, rearranged during transfection (RET), or neurotrophic tyrosine receptor kinase (NTRK)1/2/3.",
          "* Have known active central nervous system metastases and/or carcinomatous meningitis."
        ],
        {
          "reasoning": "Reasoning: Let's think step by step in order to produce the criteria_decision. We will evaluate each exclusion criterion based on the patient information provided.\n\n1. **Criterion 1**: \"Have a documented additional validated targetable oncogenic driver mutation or alteration in genes such as epidermal growth factor receptor (EGFR), anaplastic lymphoma kinase (ALK), BRAF (V600E), human epidermal growth factor receptor 2 (HER2), MET (exon 14), ROS1, rearranged during transfection (RET), or neurotrophic tyrosine receptor kinase (NTRK)1/2/3.\"\n   - The patient information lists molecular alterations: KRAS p.G12C, KEAP1 p.L276F, and STK11 p.K83Tfs*13.\n   - None of these alterations are in the genes mentioned in the exclusion criterion (EGFR, ALK, BRAF, HER2, MET, ROS1, RET, NTRK1/2/3).\n   - Therefore, the patient does not have any of the specified targetable oncogenic driver mutations.\n   - **Decision**: True (The patient is eligible based on this criterion).\n\n2. **Criterion 2**: \"Have known active central nervous system metastases and/or carcinomatous meningitis.\"\n   - The patient information does not mention any central nervous system (CNS) metastases or carcinomatous meningitis.\n   - According to the guardrails, if a condition is not explicitly mentioned, we assume it is not present.\n   - **Decision**: True (The patient is eligible based on this criterion).",
          "criteria_decision": {
            "explanation": [
              "The patient does not have any of the specified targetable oncogenic driver mutations (EGFR, ALK, BRAF, HER2, MET, ROS1, RET, NTRK1/2/3).",
              "The patient information does not mention any central nervous system metastases or carcinomatous meningitis, so we assume these conditions are not present."
            ],
            "criteria_decision": [
              true,
              true
            ]
          }
        }
      ],
      [
        "Exclusion Criteria:",
        "Patients who meet any of the following criteria are not eligible for trial participation: ",
        [
          "* Have had any of the following prior to randomization:",
          "  -- Prior systemic therapy (chemotherapy, immunotherapy, targeted therapy, or biological therapy) for advanced or metastatic NSCLC.",
          "  --- 1 cycle of standard-of-care treatment prior to study enrollment will be allowed for cases where immediate treatment is clinically indicated:"
        ],
        {
          "reasoning": "```json\n{\n  \"criteria_result\": {\n    \"explanation\": [\n      \"The patient information does not mention any prior systemic therapy for advanced or metastatic NSCLC. Therefore, we assume the patient has not had any prior systemic therapy.\",\n      \"The patient information does not mention any prior systemic therapy for advanced or metastatic NSCLC. Therefore, we assume the patient has not had any prior systemic therapy.\",\n      \"The patient information does not mention any prior systemic therapy for advanced or metastatic NSCLC. Therefore, we assume the patient has not had any prior systemic therapy.\"\n    ],\n    \"criteria_decision\": [\n      true,\n      true,\n      true\n    ]\n  },\n  \"global_result\": true\n}\n```",
          "criteria_decision": {
            "criteria_result": {
              "explanation": [
                "The patient information does not mention any prior systemic therapy for advanced or metastatic NSCLC. Therefore, we assume the patient has not had any prior systemic therapy.",
                "The patient information does not mention any prior systemic therapy for advanced or metastatic NSCLC. Therefore, we assume the patient has not had any prior systemic therapy.",
                "The patient information does not mention any prior systemic therapy for advanced or metastatic NSCLC. Therefore, we assume the patient has not had any prior systemic therapy."
              ],
              "criteria_decision": [
                true,
                true,
                true
              ]
            },
            "global_result": true
          }
        }
      ],
      [
        "Exclusion Criteria for Participants receiving Pemetrexed and Platinum (Part B and Safety Lead-In Part B)",
        "Patients who meet any of the following criteria are not eligible for trial participation: ",
        [
          "* Squamous cell and/or mixed small cell/nonsmall cell histology is not permitted.",
          "* Is unable to interrupt aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs)",
          "* Is unable or unwilling to take folic acid or vitamin B12 supplementation."
        ],
        {
          "reasoning": "Reasoning: Let's think step by step in order to produce the criteria_decision. We will evaluate each exclusion criterion based on the provided patient information.\n\n1. **Criterion 1: Squamous cell and/or mixed small cell/nonsmall cell histology is not permitted.**\n   - The patient has lung adenocarcinoma, which is a type of non-small cell lung cancer but not squamous cell or mixed small cell/nonsmall cell histology.\n   - Decision: True (The patient is eligible as the exclusion criterion is not met).\n\n2. **Criterion 2: Is unable to interrupt aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs).**\n   - There is no information provided about the patient's ability to interrupt aspirin or NSAIDs.\n   - Decision: ? (The information is not sufficient to make a decision).\n\n3. **Criterion 3: Is unable or unwilling to take folic acid or vitamin B12 supplementation.**\n   - There is no information provided about the patient's willingness or ability to take folic acid or vitamin B12 supplementation.\n   - Decision: ? (The information is not sufficient to make a decision).",
          "criteria_decision": {
            "explanation": [
              "The patient has lung adenocarcinoma, which is not squamous cell or mixed small cell/nonsmall cell histology. Therefore, the patient is eligible.",
              "There is no information provided about the patient's ability to interrupt aspirin or NSAIDs. Therefore, the decision is '?'.",
              "There is no information provided about the patient's willingness or ability to take folic acid or vitamin B12 supplementation. Therefore, the decision is '?'."
            ],
            "criteria_decision": [
              true,
              "?",
              "?"
            ]
          }
        }
      ]
    ],
    "subinstruction": "metastatic lung adenocarcinoma, KRAS p.G12C mutation",
    "patient_id": "p6",
    "patient_info": "\nPatient Information\n    Name: Doe, John\n    born: 18.08.1968\n    Address: Main Street 1, Berlin\n\nOverview of Tumor Diagnosis and Therapy\n    Tumor Diagnosis\n    Diagnosis: Metastatic KRAS G12C mutant non-small cell lung cancer (NSCLC)\n    Initial Detection: March 22, 2023, following symptoms of persistent cough and weight loss\n    Biopsy Date: April 15, 2023, adenocarcinoma of the lung\n    Molecular Profile: KRAS p.G12C (AF 18%), KEAP1 p.L276F (AF 45%), STK11 p.K83Tfs*13 (AF 38%).\n\nTherapy Overview\n    Initial Treatment:\n    Chemotherapy: Began May 5, 2022 in Berlin, with a platinum-based regimen (Cisplatin and\n    Pemetrexed), partial response noted after initial chemotherapy cycle completed by August 10, 2022, contunuation of therapy until october 2023 (progressive disease)\n    Subsequent Treatment: Immunotherapy with Prembolizumab at Charit\u00e9 Berlin initiated on October 25, 2023, with Pembrolizumab, staging CT shows disease progression after 3 months\n    Current Status:\n    Health Condition: Stable with an ECOG performance status of 1\n    Comorbidities: Well-managed and not contraindicating further treatment\n \nComorbidities\n    Former Smoker: 40py\n    Hypertension: Controlled with medication (Lisinopril 20 mg daily), current blood pressure 130/90mmHg\n    Type 2 Diabetes Mellitus: Controlled with Metformin 1000 mg twice daily\n    Hyperlipidemia: Managed with Atorvastatin 40 mg daily\n    Osteoarthritis: Managed with over-the-counter NSAIDs as needed\n    Chronic Obstructive Pulmonary Disease (COPD): Mild, managed with inhalers (Tiotropium)\n    Gastroesophageal Reflux Disease (GERD): Managed with Omeprazole 20 mg daily\n    Benign Prostatic Hyperplasia (BPH): Treated with Tamsulosin 0.4 mg daily\n\nPerformance Status: ECOG Performance Status 1\n \nChronological Medical Findings:\n    January 10, 2018: Routine annual physical examination. Blood pressure elevated, diagnosed with hypertension. Prescribed Lisinopril 10 mg daily.\n    March 15, 2018: Complained of heartburn and acid reflux. Diagnosed with GERD. Prescribed Omeprazole 20 mg daily.\n    February 25, 2019: Annual follow-up for hypertension. Blood pressure well-controlled. Lisinopril dosage maintained.\n    May 20, 2019: Complained of knee pain. Diagnosed with osteoarthritis. Recommended over-the-counter NSAIDs for pain management.\n    April 5, 2020: Routine check-up. Elevated blood glucose levels. Diagnosed with Type 2 Diabetes Mellitus. Prescribed Metformin 500 mg twice daily.\n    August 30, 2020: Routine cholesterol check. Diagnosed with hyperlipidemia. Prescribed Atorvastatin 20 mg daily.\n    November 10, 2020: Follow-up for diabetes and hyperlipidemia. Dosages adjusted: Metformin increased to 1000 mg twice daily, Atorvastatin increased to 40 mg daily.\n    February 12, 2021: Complained of shortness of breath and chronic cough. Diagnosed with mild COPD. Prescribed Tiotropium inhaler.\n    July 18, 2021: Routine follow-up. Stable condition with controlled comorbidities. Blood pressure, blood sugar, and cholesterol levels within target ranges.\n    March 22, 2023: Experienced persistent cough and weight loss. Chest X-ray and CT scan revealed a mass in the left lung. Referred to oncologist. CT Angiography, Pulmonary Arteries: Tumor Size: Approximately 4.5 cm in diameter. Bronchial Obstruction: Partial obstruction of the left main bronchus leading to atelectasis of the left upper lobe.\n    Urgent suspicion of a tumor-atelectasis complex in the left upper lobe of the lung. Mucus present in the lower lobe bronchi on the left. Suspicion of mediastinal lymph node metastases. No evidence of pulmonary artery embolism. Thrombus in the left atrium at the transition to the auricle. Emphysematous and fibrotic changes in the lung parenchyma. \n    Lymph Nodes: Enlarged, FDG-positive lymph nodes in the mediastinum, particularly in regions 4R and infracarinal. \n    April 15, 2023: Lung biopsy via bronchoscopy: Endobronchial tumor manifestation in the distal left main bronchus extending to the upper lobe. Acute and chronic atrophic tracheobronchitis. Collapsed bronchial system in the affected area. Biopsy taken. Diagnosed with non-small cell lung cancer (NSCLC), molecular diagnostics: KRAS G12C mutant. \n    April 27, 2022: Ventilation: Moderate obstruction, no restriction. Increased airway resistance and slight hyperinflation. Tiffeneau index (FEV1/FVC) at 42.34%, z-score -3.32. FEV1: 0.93 L (42% predicted), z-score -2.89.Total lung capacity (TLC): 5.86 L (103% predicted), z-score 0.22. Forced vital capacity (FVC): 2.19 L, z-score -1.5. Residual volume (RV): 3.67 L, z-score 2.44. RV/TLC: 62.68%, z-score -1.18.\n    May 5, 2022: Initiated on platinum-based chemotherapy regimen (Cisplatin and Pemetrexed).\n    August 10, 2023: Completed initial chemotherapy cycle. Partial response noted. \n    August-October: Continued chemotherapy with Cisplatin/Pemetrexed.\n    October 13, 2023: Follow-up CT (chest + abdomen): Moderate disease progression. New nodule in the right lung (1cm). Slight increase in the size of previously noted FDG-positive lymph nodes in the mediastinum. No additional metastatic lesions were detected. The patient has continued to tolerate the current treatment regimen well, with no significant adverse effects reported.\n    October 25, 2023: Started immune checkpoint inhibitor therapy (Pembrolizumab), good tolerability, no signs of autoimmunity.\n    March 12, 2024: Follow-up CT scan abdomen/lung: Progressive Disease with three new metastases in the right lung and additional enlarged FDG-positive lymph nodes in the mediastinum. MRI scan of the brain conducted; no evidence of metastatic disease. Incidental findings included mild age-related cerebral atrophy and scattered white matter hyperintensities consistent with chronic microvascular ischemic changes.\n    March 17, 2024: Tumorboard recommends considering clinical trial options due to limited response to standard therapies.\n    April 20, 2024: Detailed assessment of health status. ECOG performance status 1. All routine labs, including liver and renal function tests, within normal limits.\n",
    "instruction": "Please find a clincial trial targeting the patients tumor and alterations in Germany."
  },
  {
    "nctId": "NCT04699188",
    "avg_inclusion_score": 0.5,
    "avg_exclusion_score": 0.875,
    "avg_overall_score": 0.6875,
    "trial": {
      "clean_text": "#briefTitle\nStudy of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation\n\n#officialTitle\nA Phase Ib/II Open-label, Multi-center Dose Escalation Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation\n\n#briefSummary\nThis is a phase Ib/II open label study. The escalation part will characterize the safety and tolerability of JDQ443 single agent and JDQ443 in combination with the other study treatments (TNO155 and tislelizumab) in advanced solid tumor patients. After the determination of the maximum tolerated dose / recommended dose for a particular treatment arm, dose expansion will assess the anti-tumor activity and further assess the safety, tolerability, and PK/PD of each regimen at the maximum tolerated dose / recommended dose or lower dose.\n\n#conditions\nKRAS G12C Mutant Solid Tumors\nCarcinoma, Non-Small-Cell Lung\nCarcinoma, Colorectal\nCancer of Lung\nCancer of the Lung\nLung Cancer\nNeoplasms, Lung\nNeoplasms, Pulmonary\nPulmonary Cancer\nPulmonary Neoplasms\n\n",
      "briefTitle": "Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation",
      "officialTitle": "A Phase Ib/II Open-label, Multi-center Dose Escalation Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation",
      "briefSummary": "This is a phase Ib/II open label study. The escalation part will characterize the safety and tolerability of JDQ443 single agent and JDQ443 in combination with the other study treatments (TNO155 and tislelizumab) in advanced solid tumor patients. After the determination of the maximum tolerated dose / recommended dose for a particular treatment arm, dose expansion will assess the anti-tumor activity and further assess the safety, tolerability, and PK/PD of each regimen at the maximum tolerated dose / recommended dose or lower dose.",
      "detailedDescription": null,
      "conditions": [
        "KRAS G12C Mutant Solid Tumors",
        "Carcinoma, Non-Small-Cell Lung",
        "Carcinoma, Colorectal",
        "Cancer of Lung",
        "Cancer of the Lung",
        "Lung Cancer",
        "Neoplasms, Lung",
        "Neoplasms, Pulmonary",
        "Pulmonary Cancer",
        "Pulmonary Neoplasms"
      ],
      "armGroups": [
        {
          "label": "Arm A",
          "type": "EXPERIMENTAL",
          "description": "JDQ443",
          "interventionNames": [
            "Drug: JDQ443"
          ]
        },
        {
          "label": "Arm B",
          "type": "EXPERIMENTAL",
          "description": "JDQ443 in combination with TNO155",
          "interventionNames": [
            "Drug: JDQ443",
            "Drug: TNO155"
          ]
        },
        {
          "label": "Arm C",
          "type": "EXPERIMENTAL",
          "description": "JDQ443 in combination with tislelizumab",
          "interventionNames": [
            "Drug: JDQ443",
            "Biological: tislelizumab"
          ]
        },
        {
          "label": "Arm D",
          "type": "EXPERIMENTAL",
          "description": "JDQ443 in combination with TNO155 and tislelizumab",
          "interventionNames": [
            "Drug: JDQ443",
            "Drug: TNO155",
            "Biological: tislelizumab"
          ]
        }
      ],
      "interventions": [
        {
          "type": "DRUG",
          "name": "JDQ443",
          "description": "KRAS G12C inhibitor",
          "armGroupLabels": [
            "Arm A",
            "Arm B",
            "Arm C",
            "Arm D"
          ]
        },
        {
          "type": "DRUG",
          "name": "TNO155",
          "description": "SHP2 inhibitor",
          "armGroupLabels": [
            "Arm B",
            "Arm D"
          ]
        },
        {
          "type": "BIOLOGICAL",
          "name": "tislelizumab",
          "description": "Anti PD1 antibody",
          "armGroupLabels": [
            "Arm C",
            "Arm D"
          ]
        }
      ],
      "primaryOutcomes": [
        {
          "measure": "Dose Escalation: Incidence and severity of dose limiting toxicities (DLTs) during the first cycle of monotherapy or combination treatment",
          "description": "A dose-limiting toxicity (DLT) is defined as an adverse event or abnormal laboratory value assessed as having a suspected relationship to study drug, and unrelated to disease, disease progression, inter-current illness, or concomitant medications that occurs within the first cycle of treatment",
          "timeFrame": "21 days"
        },
        {
          "measure": "Dose Escalation: Incidence and severity of adverse events (AEs) and serious adverse events (SAEs)",
          "description": "All information obtained on AE will be displayed by treatment group. Summary tables will include only AEs that started/worsened during the cycles of treatment (treatment-emergent AEs).",
          "timeFrame": "24 months"
        },
        {
          "measure": "Dose Escalation: Frequency of dose interruptions and reductions, by treatment",
          "description": "Tolerability of study drug will be assessed by summarizing the number of and reason for dose delays and dose reductions.",
          "timeFrame": "24 months"
        },
        {
          "measure": "Dose Escalation: Dose intensity by treatment",
          "description": "Dose intensity is defined as the ratio of actual cumulative dose received and actual duration of treatment.",
          "timeFrame": "24 months"
        },
        {
          "measure": "Dose Expansion: Overall response rate (ORR) per RECIST v1.1, by treatment",
          "description": "Overall response rate is defined as the proportion of patients with a BOR of CR or PR according to RECIST 1.1, and will be summarized along with the corresponding 95% exact binomial confidence interval (CI). Applies to all groups except the brain metastasis group.",
          "timeFrame": "24 months"
        },
        {
          "measure": "Dose expansion: Overall intracranial response rate (OIRR) per mRANO-BM",
          "description": "OIRR per mRANO-BM is defined as the proportion of participants with a best overall intracranial response (BOIR) of CR or PR according to mRANO-BM criteria, and will be summarized along with the corresponding 90% and 95% exact CI. Applies to brain metastasis group only.",
          "timeFrame": "24 months"
        },
        {
          "measure": "Dose expansion: Incidence and severity of AEs and SAEs",
          "description": "All information obtained on AE will be displayed by treatment group. Summary tables will include only AEs that started/worsened during the cycles of treatment (treatment-emergent AEs). Applies to JDQ443 dose randomization group only.",
          "timeFrame": "24 months"
        },
        {
          "measure": "Dose expansion: frequency of dose interruptions and reductions, by treatment",
          "description": "Tolerability of study drug will be assessed by summarizing the number of and reason for dose delays and dose reductions. Applies to JDQ443 dose randomization group only.",
          "timeFrame": "24 months"
        },
        {
          "measure": "Dose expansion: Dose intensity by treatment",
          "description": "Dose intensity is defined as the ratio of actual cumulative dose received and actual duration of treatment. Applies to JDQ443 dose randomization group only",
          "timeFrame": "24 months"
        },
        {
          "measure": "Dose expansion: ORR per RECIST 1.1 of JDQ443 single agent in patients with non-small cell lung cancer (JDQ443 dose randomization group only)",
          "description": "Overall response rate is defined as the proportion of patients with BOR of CR or PR according to RECIST 1.1, and will be summarized along with the corresponding 95% exact binomial confidence interval (CI). Applies to JDQ443 dose randomization group only",
          "timeFrame": "24 months"
        }
      ],
      "secondaryOutcomes": [
        {
          "measure": "Dose Escalation and Expansion: ORR per RECIST v1.1",
          "description": "Overall response rate is defined as the proportion of patients with a BOR of CR or PR according to RECIST 1.1, and will be summarized along with the corresponding 95% exact binomial confidence interval (CI)",
          "timeFrame": "24 months"
        },
        {
          "measure": "Dose Escalation and Expansion: Best Overall Response (BOR) per RECIST v1.1",
          "description": "BOR is defined as the best overall confirmed response recorded from the start of the treatment until disease progression/recurrence.",
          "timeFrame": "24 months"
        },
        {
          "measure": "Dose Escalation and Expansion: Progression-free survival (PFS) per RECIST v1.1, Overall Survival (OS)",
          "description": "Per RECIST 1.1, PFS is defined as the time from the date of start of treatment to the date of the first documented progression, or death. If patient has not had an event, PFS will be censored at the date of last adequate tumor assessment. PFS will be summarized using the Kaplan-Meier method, along with 95% CI",
          "timeFrame": "24 months"
        },
        {
          "measure": "Dose Escalation and Expansion: Duration of Response (DOR) per RECIST v1.1",
          "description": "Duration of response is defined as the time from the date of the first documented response (CR or PR), to the date of first documented progression, or death due any cause. Estimates will use Kaplan-Meier method, and median DOR and corresponding 95% CI will be presented.",
          "timeFrame": "24 months"
        },
        {
          "measure": "Dose Escalation and Expansion: Disease Control Rate (DCR) per RECIST v1.1",
          "description": "The disease control rate is calculated as the percentage of patients with advanced or metastatic cancer who have achieved complete response, partial response and stable disease. It will be summarized along with the corresponding 95% exact CI",
          "timeFrame": "24 months"
        },
        {
          "measure": "Dose Escalation and Expansion: Plasma or serum concentration vs time profiles (AUC) by treatment",
          "description": "AUC is defined as area under the plasma or serum concentration versus time curve after a dose of JDQ443, TNO155 and tislelizumab",
          "timeFrame": "Up to 24 months"
        },
        {
          "measure": "Dose Escalation and Expansion: Plasma concentration (Cmax) by treatment",
          "description": "Cmax is defined as the maximum observed plasma or serum drug concentration after single dose administration.",
          "timeFrame": "Up to 24 months"
        },
        {
          "measure": "Dose Escalation and Expansion: Time to achieve Cmax (Tmax) by treatment",
          "description": "Tmax is defined as the time to reach maximum plasma or serum drug concentration after single dose administration.",
          "timeFrame": "Up to 24 months"
        },
        {
          "measure": "Dose Escalation and Expansion: Antidrug antibody (ADA) incidence by treatment",
          "description": "To evaluate the immunogenicity of tislelizumab when dosed in combination with JDQ443 and/or TNO155 - only applicable to Arms C and D",
          "timeFrame": "Up to 24 months"
        },
        {
          "measure": "Dose Expansion: Dose intensity by treatment",
          "timeFrame": "24 months"
        },
        {
          "measure": "Dose Expansion: Frequency of dose interruptions and reductions, by treatment",
          "description": "Tolerability of study drug will be assessed by summarizing the number of and reason for dose delays and dose reductions.",
          "timeFrame": "24 months"
        },
        {
          "measure": "Dose Expansion: Incidence and severity of dose limiting toxicities (DLTs) during the first cycle of monotherapy or combination treatment",
          "description": "A dose-limiting toxicity (DLT) is defined as an adverse event or abnormal laboratory value assessed as having a suspected relationship to study drug, and unrelated to disease, disease progression, inter-current illness, or concomitant medications that occurs within the first cycle of treatment",
          "timeFrame": "21 days"
        },
        {
          "measure": "Dose Expansion: Incidence and severity of AEs and SAEs by treatment",
          "timeFrame": "24 months"
        },
        {
          "measure": "Dose expansion: Intracranial disease control rate (IDCR) per mRANO-BM",
          "description": "IDCR is the proportion of participants with a confirmed BOIR of CR or PR or SD (or non-CR/non-PD) per mRANO-BM criteria. It will be summarized along with the corresponding 90% and 95% CI. Applies to the brain metastasis group only.",
          "timeFrame": "24 months"
        },
        {
          "measure": "Dose expansion: Best overall intracranial response (BOIR) per mRANO-BM",
          "description": "BOIR is defined as the best overall confirmed response recorded from the start of the treatment until disease progression/recurrence per mRANO-BM, or until patient comes off study, whichever comes first. BOIR will be summarized along with the corresponding 95% exact CI. Applies to the brain metastasis group only.",
          "timeFrame": "24 months"
        },
        {
          "measure": "Dose expansion: Intracranial progression free survival (IPFS) per mRANO-BM",
          "description": "IPFS is defined as the time from the date of start of treatment to the date of the first documented progression per mRANO-BM, or death due to any cause. If a patient has not had an event, IPFS will be censored at the date of last adequate tumor assessment. IPFS will be summarized using the Kaplan-Meier method. Median IPFS and IPFS probability at pre specified time-points will be presented along with 95% CI. Applies to the brain metastasis group only.",
          "timeFrame": "24 months"
        },
        {
          "measure": "Dose expansion: Duration of intracranial response (DOIR) per mRANO-BM",
          "description": "DOIR is defined as the time from the date of first documented intracranial response of either CR or PR to the date of the first documented intracranial progression as per mRANO-BM criteria as assessed by central review or date of death due to underlying cause of cancer. DOIR will be summarized using the KM method if data permit. Median DOIR, with corresponding 95% CI. KM estimates for DOIR proportions at specific time points, along with 95% CI will also be provided. Applies to the brain metastasis group only.",
          "timeFrame": "24 months"
        }
      ],
      "eligibilityCriteria": "Inclusion Criteria:\n\n* Adult patients with advanced (metastatic or unresectable) KRAS G12C mutant solid tumors who have received standard of care or are intolerant or ineligible to approved therapies\n* ECOG Performance Status of 0 or 1\n* At least one measurable lesion as defined by RECIST 1.1\n* Prior treatment with a KRAS G12C inhibitor may be allowed for dose escalations of combinations and a subset of groups in dose expansion\n\nExclusion Criteria:\n\n* Tumors harboring driver mutations that have approved targeted therapies, with the exception of KRAS G12C mutations\n* Symptomatic brain metastases or known leptomeningeal disease. Patients with asymptomatic treated or untreated brain metastases may be eligible\n* Clinically significant cardiac disease or risk factors at screening\n* A medical condition that results in increased photosensitivity Other protocol-defined inclusion/exclusion criteria may apply.",
      "nctId": "NCT04699188",
      "overallStatus": "RECRUITING",
      "keywords": [
        "KRAS",
        "KRAS G12C",
        "Metastatic cancer",
        "Advanced cancer",
        "Enzyme inhibitor",
        "PD-1",
        "SHP2",
        "Targeted therapy",
        "Non-small-cell lung cancer",
        "colorectal cancer",
        "Molecular mechanisms of pharmacological action"
      ],
      "locations": [
        {
          "facility": "Emory University School of Medicine/Winship Cancer Institute Winship Cancer Center",
          "status": "RECRUITING",
          "city": "Atlanta",
          "state": "Georgia",
          "zip": "30322",
          "country": "United States",
          "contacts": [
            {
              "name": "Obi Okafor",
              "role": "CONTACT",
              "email": "aookafo@emory.edu"
            },
            {
              "name": "Conor E. Steuer",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 33.749,
            "lon": -84.38798
          }
        },
        {
          "facility": "Massachusetts General Hospital Cancer Center",
          "status": "RECRUITING",
          "city": "Boston",
          "state": "Massachusetts",
          "zip": "02114",
          "country": "United States",
          "contacts": [
            {
              "name": "Rebecca Heist",
              "role": "CONTACT",
              "email": "rheist@partners.org"
            },
            {
              "name": "Rebecca Heist",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 42.35843,
            "lon": -71.05977
          }
        },
        {
          "facility": "Washington Uni School of Med .",
          "status": "WITHDRAWN",
          "city": "Saint Louis",
          "state": "Missouri",
          "zip": "63110",
          "country": "United States",
          "geoPoint": {
            "lat": 38.62727,
            "lon": -90.19789
          }
        },
        {
          "facility": "Providence Cancer Center",
          "status": "RECRUITING",
          "city": "Portland",
          "state": "Oregon",
          "zip": "97213",
          "country": "United States",
          "contacts": [
            {
              "name": "Teresa Song",
              "role": "CONTACT",
              "phone": "503-215-2691",
              "email": "teresa.song@providence.org"
            },
            {
              "name": "Rachel Sanborn",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 45.52345,
            "lon": -122.67621
          }
        },
        {
          "facility": "Hillman Cancer Center",
          "status": "RECRUITING",
          "city": "Pittsburgh",
          "state": "Pennsylvania",
          "zip": "15232",
          "country": "United States",
          "contacts": [
            {
              "name": "Lorenzo Sellitto",
              "role": "CONTACT",
              "phone": "412-647-8569",
              "email": "sellittol@upmc.edu"
            },
            {
              "name": "Timothy Burns",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 40.44062,
            "lon": -79.99589
          }
        },
        {
          "facility": "Uni of TX MD Anderson Cancer Cntr Dept of MD Anderson CancerCent",
          "status": "RECRUITING",
          "city": "Houston",
          "state": "Texas",
          "zip": "77030",
          "country": "United States",
          "contacts": [
            {
              "name": "Rebecca Okumah",
              "role": "CONTACT",
              "phone": "+1 713 745 3039",
              "email": "rokumah@mdanderson.org"
            },
            {
              "name": "Marcelo Vailati Negrao",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 29.76328,
            "lon": -95.36327
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Melbourne",
          "state": "Victoria",
          "zip": "3000",
          "country": "Australia",
          "geoPoint": {
            "lat": -37.814,
            "lon": 144.96332
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Leuven",
          "zip": "3000",
          "country": "Belgium",
          "geoPoint": {
            "lat": 50.87959,
            "lon": 4.70093
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Montreal",
          "state": "Quebec",
          "zip": "H2W 1T8",
          "country": "Canada",
          "geoPoint": {
            "lat": 45.50884,
            "lon": -73.58781
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Fuzhou",
          "state": "Fujian",
          "zip": "350014",
          "country": "China",
          "geoPoint": {
            "lat": 26.06139,
            "lon": 119.30611
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Guangzhou",
          "state": "Guangdong",
          "zip": "51000",
          "country": "China",
          "geoPoint": {
            "lat": 23.11667,
            "lon": 113.25
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Nanchang",
          "state": "Jiangxi",
          "zip": "330006",
          "country": "China",
          "geoPoint": {
            "lat": 28.68396,
            "lon": 115.85306
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Beijing",
          "zip": "100036",
          "country": "China",
          "geoPoint": {
            "lat": 39.9075,
            "lon": 116.39723
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Copenhagen",
          "zip": "DK-2100",
          "country": "Denmark",
          "geoPoint": {
            "lat": 55.67594,
            "lon": 12.56553
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Lyon",
          "zip": "69373",
          "country": "France",
          "geoPoint": {
            "lat": 45.74848,
            "lon": 4.84669
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Marseille",
          "zip": "13273",
          "country": "France",
          "geoPoint": {
            "lat": 43.29551,
            "lon": 5.38958
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Villejuif",
          "zip": "94800",
          "country": "France",
          "geoPoint": {
            "lat": 48.7939,
            "lon": 2.35992
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Dresden",
          "zip": "01307",
          "country": "Germany",
          "geoPoint": {
            "lat": 51.05089,
            "lon": 13.73832
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Essen",
          "zip": "45147",
          "country": "Germany",
          "geoPoint": {
            "lat": 51.45657,
            "lon": 7.01228
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Freiburg",
          "zip": "79106",
          "country": "Germany",
          "geoPoint": {
            "lat": 47.9959,
            "lon": 7.85222
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Koeln",
          "zip": "50937",
          "country": "Germany",
          "geoPoint": {
            "lat": 50.93333,
            "lon": 6.95
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Hong Kong",
          "country": "Hong Kong",
          "geoPoint": {
            "lat": 22.27832,
            "lon": 114.17469
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Brescia",
          "state": "BS",
          "zip": "25123",
          "country": "Italy",
          "geoPoint": {
            "lat": 45.53558,
            "lon": 10.21472
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Milano",
          "state": "MI",
          "zip": "20133",
          "country": "Italy",
          "geoPoint": {
            "lat": 45.46427,
            "lon": 9.18951
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Milano",
          "state": "MI",
          "zip": "20162",
          "country": "Italy",
          "geoPoint": {
            "lat": 45.46427,
            "lon": 9.18951
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Nagoya",
          "state": "Aichi",
          "zip": "466 8560",
          "country": "Japan",
          "geoPoint": {
            "lat": 35.18147,
            "lon": 136.90641
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Kashiwa",
          "state": "Chiba",
          "zip": "277 8577",
          "country": "Japan",
          "geoPoint": {
            "lat": 35.86224,
            "lon": 139.97732
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Yokohama-city",
          "state": "Kanagawa",
          "zip": "241-8515",
          "country": "Japan",
          "geoPoint": {
            "lat": 35.43333,
            "lon": 139.65
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Osaka-city",
          "state": "Osaka",
          "zip": "541-8567",
          "country": "Japan",
          "geoPoint": {
            "lat": 34.69374,
            "lon": 135.50218
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Chuo ku",
          "state": "Tokyo",
          "zip": "104 0045",
          "country": "Japan",
          "geoPoint": {
            "lat": 35.57779,
            "lon": 139.71685
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Koto ku",
          "state": "Tokyo",
          "zip": "135 8550",
          "country": "Japan",
          "geoPoint": {
            "lat": 35.66667,
            "lon": 139.81718
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Osaka",
          "zip": "545-8586",
          "country": "Japan",
          "geoPoint": {
            "lat": 34.69374,
            "lon": 135.50218
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Seoul",
          "zip": "03722",
          "country": "Korea, Republic of",
          "geoPoint": {
            "lat": 37.566,
            "lon": 126.9784
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Amsterdam",
          "zip": "1066 CX",
          "country": "Netherlands",
          "geoPoint": {
            "lat": 52.37403,
            "lon": 4.88969
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Singapore",
          "zip": "119074",
          "country": "Singapore",
          "geoPoint": {
            "lat": 1.28967,
            "lon": 103.85007
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Singapore",
          "zip": "168583",
          "country": "Singapore",
          "geoPoint": {
            "lat": 1.28967,
            "lon": 103.85007
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Malaga",
          "state": "Andalucia",
          "zip": "29010",
          "country": "Spain",
          "geoPoint": {
            "lat": 36.72016,
            "lon": -4.42034
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Barcelona",
          "state": "Catalunya",
          "zip": "08035",
          "country": "Spain",
          "geoPoint": {
            "lat": 41.38879,
            "lon": 2.15899
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Hospitalet de LLobregat",
          "state": "Catalunya",
          "zip": "08907",
          "country": "Spain",
          "geoPoint": {
            "lat": 41.35967,
            "lon": 2.10028
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Valencia",
          "state": "Comunidad Valenciana",
          "zip": "46010",
          "country": "Spain",
          "geoPoint": {
            "lat": 39.46975,
            "lon": -0.37739
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Santiago De Compostela",
          "state": "Galicia",
          "zip": "15706",
          "country": "Spain",
          "geoPoint": {
            "lat": 42.88052,
            "lon": -8.54569
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Madrid",
          "zip": "28050",
          "country": "Spain",
          "geoPoint": {
            "lat": 40.4165,
            "lon": -3.70256
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Tainan",
          "zip": "70403",
          "country": "Taiwan",
          "geoPoint": {
            "lat": 22.99083,
            "lon": 120.21333
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Taipei",
          "zip": "10002",
          "country": "Taiwan",
          "geoPoint": {
            "lat": 25.04776,
            "lon": 121.53185
          }
        }
      ],
      "eligibilityModule": {
        "eligibilityCriteria": "Inclusion Criteria:\n\n* Adult patients with advanced (metastatic or unresectable) KRAS G12C mutant solid tumors who have received standard of care or are intolerant or ineligible to approved therapies\n* ECOG Performance Status of 0 or 1\n* At least one measurable lesion as defined by RECIST 1.1\n* Prior treatment with a KRAS G12C inhibitor may be allowed for dose escalations of combinations and a subset of groups in dose expansion\n\nExclusion Criteria:\n\n* Tumors harboring driver mutations that have approved targeted therapies, with the exception of KRAS G12C mutations\n* Symptomatic brain metastases or known leptomeningeal disease. Patients with asymptomatic treated or untreated brain metastases may be eligible\n* Clinically significant cardiac disease or risk factors at screening\n* A medical condition that results in increased photosensitivity Other protocol-defined inclusion/exclusion criteria may apply.",
        "healthyVolunteers": false,
        "sex": "ALL",
        "minimumAge": "18 Years",
        "stdAges": [
          "ADULT",
          "OLDER_ADULT"
        ]
      },
      "studyType": "INTERVENTIONAL",
      "phases": [
        "PHASE1",
        "PHASE2"
      ]
    },
    "structured_criteria": {
      "inclusion": {
        "Inclusion Criteria:": [
          "Patients who meet all of the following criteria are eligible for trial participation: ",
          [
            "* Adult patients with advanced (metastatic or unresectable) KRAS G12C mutant solid tumors who have received standard of care or are intolerant or ineligible to approved therapies",
            "* ECOG Performance Status of 0 or 1",
            "* At least one measurable lesion as defined by RECIST 1.1",
            "* Prior treatment with a KRAS G12C inhibitor may be allowed for dose escalations of combinations and a subset of groups in dose expansion"
          ]
        ]
      },
      "exclusion": {
        "Exclusion Criteria:": [
          "Patients who meet any of the following criteria are not eligible for trial participation: ",
          [
            "* Tumors harboring driver mutations that have approved targeted therapies, with the exception of KRAS G12C mutations",
            "* Symptomatic brain metastases or known leptomeningeal disease. Patients with asymptomatic treated or untreated brain metastases may be eligible",
            "* Clinically significant cardiac disease or risk factors at screening",
            "* A medical condition that results in increased photosensitivity Other protocol-defined inclusion/exclusion criteria may apply."
          ]
        ]
      }
    },
    "results_inclusion": [
      [
        "Inclusion Criteria:",
        "Patients who meet all of the following criteria are eligible for trial participation: ",
        [
          "* Adult patients with advanced (metastatic or unresectable) KRAS G12C mutant solid tumors who have received standard of care or are intolerant or ineligible to approved therapies",
          "* ECOG Performance Status of 0 or 1",
          "* At least one measurable lesion as defined by RECIST 1.1",
          "* Prior treatment with a KRAS G12C inhibitor may be allowed for dose escalations of combinations and a subset of groups in dose expansion"
        ],
        {
          "reasoning": "Reasoning: Let's think step by step in order to produce the criteria_decision. We will evaluate each criterion based on the patient information provided.\n\n1. **Criterion 1**: \"Adult patients with advanced (metastatic or unresectable) KRAS G12C mutant solid tumors who have received standard of care or are intolerant or ineligible to approved therapies\"\n   - The patient is a 59-year-old male with stage 4 lung adenocarcinoma, which is advanced and metastatic.\n   - The patient has a KRAS p.G12C mutation.\n   - There is no information on whether the patient has received standard of care or is intolerant or ineligible to approved therapies.\n   - **Decision**: `?` (Insufficient information about standard of care or intolerance/ineligibility to approved therapies)\n\n2. **Criterion 2**: \"ECOG Performance Status of 0 or 1\"\n   - There is no information provided about the patient's ECOG Performance Status.\n   - **Decision**: `?` (Insufficient information about ECOG Performance Status)\n\n3. **Criterion 3**: \"At least one measurable lesion as defined by RECIST 1.1\"\n   - There is no information provided about measurable lesions as defined by RECIST 1.1.\n   - **Decision**: `?` (Insufficient information about measurable lesions)\n\n4. **Criterion 4**: \"Prior treatment with a KRAS G12C inhibitor may be allowed for dose escalations of combinations and a subset of groups in dose expansion\"\n   - There is no information provided about prior treatment with a KRAS G12C inhibitor.\n   - **Decision**: `?` (Insufficient information about prior treatment with a KRAS G12C inhibitor)",
          "criteria_decision": {
            "explanation": [
              "Insufficient information about standard of care or intolerance/ineligibility to approved therapies",
              "Insufficient information about ECOG Performance Status",
              "Insufficient information about measurable lesions",
              "Insufficient information about prior treatment with a KRAS G12C inhibitor"
            ],
            "criteria_decision": [
              "?",
              "?",
              "?",
              "?"
            ]
          }
        }
      ]
    ],
    "results_exclusion": [
      [
        "Exclusion Criteria:",
        "Patients who meet any of the following criteria are not eligible for trial participation: ",
        [
          "* Tumors harboring driver mutations that have approved targeted therapies, with the exception of KRAS G12C mutations",
          "* Symptomatic brain metastases or known leptomeningeal disease. Patients with asymptomatic treated or untreated brain metastases may be eligible",
          "* Clinically significant cardiac disease or risk factors at screening",
          "* A medical condition that results in increased photosensitivity Other protocol-defined inclusion/exclusion criteria may apply."
        ],
        {
          "reasoning": "Reasoning: Let's think step by step in order to produce the criteria_decision. We will evaluate each exclusion criterion based on the patient information provided.\n\n1. **Tumors harboring driver mutations that have approved targeted therapies, with the exception of KRAS G12C mutations**:\n   - The patient has a KRAS p.G12C mutation, which is explicitly mentioned as an exception in the exclusion criteria.\n   - Decision: True (The patient is eligible based on this criterion).\n\n2. **Symptomatic brain metastases or known leptomeningeal disease. Patients with asymptomatic treated or untreated brain metastases may be eligible**:\n   - There is no mention of brain metastases or leptomeningeal disease in the patient information.\n   - Decision: True (Assume the patient does not have symptomatic brain metastases or leptomeningeal disease).\n\n3. **Clinically significant cardiac disease or risk factors at screening**:\n   - There is no information provided about the patient's cardiac health or risk factors.\n   - Decision: ? (Insufficient information to determine eligibility).\n\n4. **A medical condition that results in increased photosensitivity. Other protocol-defined inclusion/exclusion criteria may apply**:\n   - There is no mention of any medical condition that results in increased photosensitivity in the patient information.\n   - Decision: True (Assume the patient does not have a condition that results in increased photosensitivity).",
          "criteria_decision": {
            "explanation": [
              "The patient has a KRAS p.G12C mutation, which is explicitly mentioned as an exception in the exclusion criteria.",
              "There is no mention of brain metastases or leptomeningeal disease in the patient information.",
              "There is no information provided about the patient's cardiac health or risk factors.",
              "There is no mention of any medical condition that results in increased photosensitivity in the patient information."
            ],
            "criteria_decision": [
              true,
              true,
              "?",
              true
            ]
          }
        }
      ]
    ],
    "subinstruction": "metastatic lung adenocarcinoma, KRAS p.G12C mutation",
    "patient_id": "p6",
    "patient_info": "\nPatient Information\n    Name: Doe, John\n    born: 18.08.1968\n    Address: Main Street 1, Berlin\n\nOverview of Tumor Diagnosis and Therapy\n    Tumor Diagnosis\n    Diagnosis: Metastatic KRAS G12C mutant non-small cell lung cancer (NSCLC)\n    Initial Detection: March 22, 2023, following symptoms of persistent cough and weight loss\n    Biopsy Date: April 15, 2023, adenocarcinoma of the lung\n    Molecular Profile: KRAS p.G12C (AF 18%), KEAP1 p.L276F (AF 45%), STK11 p.K83Tfs*13 (AF 38%).\n\nTherapy Overview\n    Initial Treatment:\n    Chemotherapy: Began May 5, 2022 in Berlin, with a platinum-based regimen (Cisplatin and\n    Pemetrexed), partial response noted after initial chemotherapy cycle completed by August 10, 2022, contunuation of therapy until october 2023 (progressive disease)\n    Subsequent Treatment: Immunotherapy with Prembolizumab at Charit\u00e9 Berlin initiated on October 25, 2023, with Pembrolizumab, staging CT shows disease progression after 3 months\n    Current Status:\n    Health Condition: Stable with an ECOG performance status of 1\n    Comorbidities: Well-managed and not contraindicating further treatment\n \nComorbidities\n    Former Smoker: 40py\n    Hypertension: Controlled with medication (Lisinopril 20 mg daily), current blood pressure 130/90mmHg\n    Type 2 Diabetes Mellitus: Controlled with Metformin 1000 mg twice daily\n    Hyperlipidemia: Managed with Atorvastatin 40 mg daily\n    Osteoarthritis: Managed with over-the-counter NSAIDs as needed\n    Chronic Obstructive Pulmonary Disease (COPD): Mild, managed with inhalers (Tiotropium)\n    Gastroesophageal Reflux Disease (GERD): Managed with Omeprazole 20 mg daily\n    Benign Prostatic Hyperplasia (BPH): Treated with Tamsulosin 0.4 mg daily\n\nPerformance Status: ECOG Performance Status 1\n \nChronological Medical Findings:\n    January 10, 2018: Routine annual physical examination. Blood pressure elevated, diagnosed with hypertension. Prescribed Lisinopril 10 mg daily.\n    March 15, 2018: Complained of heartburn and acid reflux. Diagnosed with GERD. Prescribed Omeprazole 20 mg daily.\n    February 25, 2019: Annual follow-up for hypertension. Blood pressure well-controlled. Lisinopril dosage maintained.\n    May 20, 2019: Complained of knee pain. Diagnosed with osteoarthritis. Recommended over-the-counter NSAIDs for pain management.\n    April 5, 2020: Routine check-up. Elevated blood glucose levels. Diagnosed with Type 2 Diabetes Mellitus. Prescribed Metformin 500 mg twice daily.\n    August 30, 2020: Routine cholesterol check. Diagnosed with hyperlipidemia. Prescribed Atorvastatin 20 mg daily.\n    November 10, 2020: Follow-up for diabetes and hyperlipidemia. Dosages adjusted: Metformin increased to 1000 mg twice daily, Atorvastatin increased to 40 mg daily.\n    February 12, 2021: Complained of shortness of breath and chronic cough. Diagnosed with mild COPD. Prescribed Tiotropium inhaler.\n    July 18, 2021: Routine follow-up. Stable condition with controlled comorbidities. Blood pressure, blood sugar, and cholesterol levels within target ranges.\n    March 22, 2023: Experienced persistent cough and weight loss. Chest X-ray and CT scan revealed a mass in the left lung. Referred to oncologist. CT Angiography, Pulmonary Arteries: Tumor Size: Approximately 4.5 cm in diameter. Bronchial Obstruction: Partial obstruction of the left main bronchus leading to atelectasis of the left upper lobe.\n    Urgent suspicion of a tumor-atelectasis complex in the left upper lobe of the lung. Mucus present in the lower lobe bronchi on the left. Suspicion of mediastinal lymph node metastases. No evidence of pulmonary artery embolism. Thrombus in the left atrium at the transition to the auricle. Emphysematous and fibrotic changes in the lung parenchyma. \n    Lymph Nodes: Enlarged, FDG-positive lymph nodes in the mediastinum, particularly in regions 4R and infracarinal. \n    April 15, 2023: Lung biopsy via bronchoscopy: Endobronchial tumor manifestation in the distal left main bronchus extending to the upper lobe. Acute and chronic atrophic tracheobronchitis. Collapsed bronchial system in the affected area. Biopsy taken. Diagnosed with non-small cell lung cancer (NSCLC), molecular diagnostics: KRAS G12C mutant. \n    April 27, 2022: Ventilation: Moderate obstruction, no restriction. Increased airway resistance and slight hyperinflation. Tiffeneau index (FEV1/FVC) at 42.34%, z-score -3.32. FEV1: 0.93 L (42% predicted), z-score -2.89.Total lung capacity (TLC): 5.86 L (103% predicted), z-score 0.22. Forced vital capacity (FVC): 2.19 L, z-score -1.5. Residual volume (RV): 3.67 L, z-score 2.44. RV/TLC: 62.68%, z-score -1.18.\n    May 5, 2022: Initiated on platinum-based chemotherapy regimen (Cisplatin and Pemetrexed).\n    August 10, 2023: Completed initial chemotherapy cycle. Partial response noted. \n    August-October: Continued chemotherapy with Cisplatin/Pemetrexed.\n    October 13, 2023: Follow-up CT (chest + abdomen): Moderate disease progression. New nodule in the right lung (1cm). Slight increase in the size of previously noted FDG-positive lymph nodes in the mediastinum. No additional metastatic lesions were detected. The patient has continued to tolerate the current treatment regimen well, with no significant adverse effects reported.\n    October 25, 2023: Started immune checkpoint inhibitor therapy (Pembrolizumab), good tolerability, no signs of autoimmunity.\n    March 12, 2024: Follow-up CT scan abdomen/lung: Progressive Disease with three new metastases in the right lung and additional enlarged FDG-positive lymph nodes in the mediastinum. MRI scan of the brain conducted; no evidence of metastatic disease. Incidental findings included mild age-related cerebral atrophy and scattered white matter hyperintensities consistent with chronic microvascular ischemic changes.\n    March 17, 2024: Tumorboard recommends considering clinical trial options due to limited response to standard therapies.\n    April 20, 2024: Detailed assessment of health status. ECOG performance status 1. All routine labs, including liver and renal function tests, within normal limits.\n",
    "instruction": "Please find a clincial trial targeting the patients tumor and alterations in Germany."
  },
  {
    "nctId": "NCT05445843",
    "avg_inclusion_score": 0.5,
    "avg_exclusion_score": 0.8333333333333334,
    "avg_overall_score": 0.6818181818181818,
    "trial": {
      "clean_text": "#briefTitle\nStudy of Efficacy and Safety of JDQ443 Single-agent as First-line Treatment for Patients With Locally Advanced or Metastatic KRAS G12C- Mutated Non-small Cell Lung Cancer With a PD-L1 Expression < 1% or a PD-L1 Expression \u2265 1% and an STK11 Co-mutation.\n\n#officialTitle\nKontRASt-06: An Open-label Phase II Trial Evaluating the Activity and Safety of JDQ443 Single-agent as First-line Treatment for Patients With Locally Advanced or Metastatic KRAS G12C-mutated Non-small Cell Lung Cancer With a PD-L1 Expression < 1% or a PD-L1 Expression \u2265 1% and an STK11 Co-mutation.\n\n#briefSummary\nThis study aims to assess the antitumor activity and safety of JDQ443 single-agent as first-line treatment for participants with locally advanced or metastatic non-small cell lung cancer (NSCLC) whose tumors harbor a KRAS G12C mutation and a PD-L1 expression \\< 1% regardless of STK11 mutation status (cohort A), or a PD-L1 expression \u2265 1% and an STK11 co-mutation (cohort B).\n\n#detailedDescription\nThis is a non-randomized, open-label, single arm, multicenter, phase II study evaluating the antitumor activity and safety of JDQ443 single agent as first-line treatment for participants with locally advanced or metastatic KRAS G12C-mutated NSCLC. The study will have 2 non-comparative cohorts (Cohort A and B) that will recruit participants in parallel.\n\nThe study treatment begins on Cycle 1 Day 1 (C1D1) with the first administration of JDQ443. Each cycle is 21 days.\n\nStudy completion is defined as the earliest occurrence of one of the following:\n\n* The last participant completes last study visit (and the assessments associated with this visit have been documented and followed-up appropriately by the Investigator), dies, withdraws consent or is lost to follow-up, whichever comes first.\n* In the event of an early study termination decision, the date of that decision.\n* Another clinical study becomes available that can continue to provide JDQ443 to study participants and all participants with ongoing treatment are transferred to that clinical study.\n\n#conditions\nLocally Advanced or Metastatic KRAS G12C-mutated NSCLC With a PD-L1 Expression <1% or a PD-L1 Expression \u2265 1% and an STK11 Co-mutation\n\n",
      "briefTitle": "Study of Efficacy and Safety of JDQ443 Single-agent as First-line Treatment for Patients With Locally Advanced or Metastatic KRAS G12C- Mutated Non-small Cell Lung Cancer With a PD-L1 Expression < 1% or a PD-L1 Expression \u2265 1% and an STK11 Co-mutation.",
      "officialTitle": "KontRASt-06: An Open-label Phase II Trial Evaluating the Activity and Safety of JDQ443 Single-agent as First-line Treatment for Patients With Locally Advanced or Metastatic KRAS G12C-mutated Non-small Cell Lung Cancer With a PD-L1 Expression < 1% or a PD-L1 Expression \u2265 1% and an STK11 Co-mutation.",
      "briefSummary": "This study aims to assess the antitumor activity and safety of JDQ443 single-agent as first-line treatment for participants with locally advanced or metastatic non-small cell lung cancer (NSCLC) whose tumors harbor a KRAS G12C mutation and a PD-L1 expression \\< 1% regardless of STK11 mutation status (cohort A), or a PD-L1 expression \u2265 1% and an STK11 co-mutation (cohort B).",
      "detailedDescription": "This is a non-randomized, open-label, single arm, multicenter, phase II study evaluating the antitumor activity and safety of JDQ443 single agent as first-line treatment for participants with locally advanced or metastatic KRAS G12C-mutated NSCLC. The study will have 2 non-comparative cohorts (Cohort A and B) that will recruit participants in parallel.\n\nThe study treatment begins on Cycle 1 Day 1 (C1D1) with the first administration of JDQ443. Each cycle is 21 days.\n\nStudy completion is defined as the earliest occurrence of one of the following:\n\n* The last participant completes last study visit (and the assessments associated with this visit have been documented and followed-up appropriately by the Investigator), dies, withdraws consent or is lost to follow-up, whichever comes first.\n* In the event of an early study termination decision, the date of that decision.\n* Another clinical study becomes available that can continue to provide JDQ443 to study participants and all participants with ongoing treatment are transferred to that clinical study.",
      "conditions": [
        "Locally Advanced or Metastatic KRAS G12C-mutated NSCLC With a PD-L1 Expression <1% or a PD-L1 Expression \u2265 1% and an STK11 Co-mutation"
      ],
      "armGroups": [
        {
          "label": "Cohort A- PD-L1<1%",
          "type": "EXPERIMENTAL",
          "description": "Participants whose tumors harbor a KRAS G12C mutation and a PD-L1 expression \\<1%, regardless of STK11 mutation status.",
          "interventionNames": [
            "Drug: JDQ443"
          ]
        },
        {
          "label": "Cohort B- PD-L1\u2265 1% and STK11 mutation",
          "type": "EXPERIMENTAL",
          "description": "Participants whose tumors harbor a KRAS G12C mutation, a PD-L1 expression \u2265 1% and an STK11 co-mutation.",
          "interventionNames": [
            "Drug: JDQ443"
          ]
        }
      ],
      "interventions": [
        {
          "type": "DRUG",
          "name": "JDQ443",
          "description": "JDQ443 orally administered",
          "armGroupLabels": [
            "Cohort A- PD-L1<1%",
            "Cohort B- PD-L1\u2265 1% and STK11 mutation"
          ]
        }
      ],
      "primaryOutcomes": [
        {
          "measure": "Overall response rate (ORR) by blinded independent review committee (BIRC) in cohort A",
          "description": "ORR is defined as the percentage of participants with a confirmed complete response (CR) or partial response (PR) as best overall response (BOR) per response evaluation criteria in solid tumors (RECIST) version 1.1 by BIRC in cohort A",
          "timeFrame": "Up to approximately 24 months"
        }
      ],
      "secondaryOutcomes": [
        {
          "measure": "ORR by BIRC in cohort B",
          "description": "ORR is defined as the percentage of participants with a CR or PR as BOR per RECIST 1.1 by BIRC in cohort B",
          "timeFrame": "Up to approximately 24 months"
        },
        {
          "measure": "Duration of response (DOR) by BIRC in both cohorts",
          "description": "DOR is defined as the time from the first occurrence of a PR or a CR per RECIST 1.1 by BIRC to the occurrence of disease progression or death due to any cause. DOR will be calculated separately for each of the two cohorts.",
          "timeFrame": "From first documented response to disease progression or death, up to approximately 24 months"
        },
        {
          "measure": "Progression Free Survival (PFS) by BIRC in both cohorts",
          "description": "PFS is defined as the time from the date of first dose of study treatment to the date of the first documented disease progression per RECIST 1.1 by BIRC or date of death due to any cause. PFS will be calculated separately for each of the two cohorts.",
          "timeFrame": "From first study treatment to first documented progression or death, up to approximately 24 months"
        },
        {
          "measure": "Overall survival (OS) in both cohorts",
          "description": "OS is defined as the time from the date of enrollment to the date of death due to any cause. OS will be calculated separately for each of the two cohorts.",
          "timeFrame": "From enrollment to death, up to approximately 36 months"
        },
        {
          "measure": "Disease control rate (DCR) by BIRC in both cohorts",
          "description": "DCR is defined as the percentage of participants with a BOR of confirmed CR, PR and stable disease (SD) per RECIST 1.1 by BIRC. DCR will be calculated separately for each of the two cohorts.",
          "timeFrame": "Up to approximately 24 months"
        },
        {
          "measure": "Time to response (TTR) by BIRC in both cohorts",
          "description": "TTR is defined as the time from the date of enrollment to the date of first documented response of either CR or PR per RECIST 1.1 by BIRC. TTR will be calculated separately for each of the two cohorts.",
          "timeFrame": "From enrollment to first documented response, up to approximately 24 months"
        },
        {
          "measure": "ORR by local radiology assessment in both cohorts",
          "description": "ORR is defined as the percentage of participants with a CR or PR as BOR per RECIST 1.1 by local review assessment. ORR will be calculated separately for each of the two cohorts.",
          "timeFrame": "Up to approximately 24 months"
        },
        {
          "measure": "DOR by local review assessment in both cohorts",
          "description": "DOR is defined as the time from the first occurrence of a PR or a CR per RECIST 1.1 by local review assessment to the occurrence of disease progression or death due to any cause. DOR will be calculated separately for each of the two cohorts.",
          "timeFrame": "From first documented response to disease progression or death, up to approximately 24 months"
        },
        {
          "measure": "DCR by local review assessment in both cohorts",
          "description": "DCR is defined as the percentage of participants with a BOR of confirmed CR, PR and SD per RECIST 1.1 by local review assessment. DCR will be calculated separately for each of the two cohorts.",
          "timeFrame": "Up to approximately 24 months"
        },
        {
          "measure": "TTR by local review assessment in both cohorts",
          "description": "TTR is defined as the time from the date of enrollment to the date of first documented response of either CR or PR per RECIST 1.1 by local review assessment. TTR will be calculated separately for each of the two cohorts.",
          "timeFrame": "From enrollment to first documented response, up to approximately 24 months"
        },
        {
          "measure": "PFS by local review assessment in both cohorts",
          "description": "PFS is defined as the time from the date of first dose of study treatment to the date of the first documented disease progression per RECIST 1.1 by local review assessment or date of death due to any cause. PFS will be calculated separately for each of the two cohorts.",
          "timeFrame": "From first study treatment to first documented progression or death, up to approximately 24 months"
        },
        {
          "measure": "ORR by BIRC and local radiology assessment for participants whose tumors harbor an STK11 mutation regardless of PD-L1 expression status (pooled from both cohorts)",
          "description": "ORR is defined as the percentage of participants with a confirmed complete response (CR) or partial response (PR) as best overall response (BOR) per RECIST 1.1 by local review assessment and by BIRC. ORR will be calculated for all participants whose tumors harbor an STK11 mutation by pooling participants from both cohorts",
          "timeFrame": "Up to approximately 24 months"
        },
        {
          "measure": "DOR by BIRC and local radiology assessment for participants whose tumors harbor an STK11 mutation regardless of PD-L1 expression status (pooled from both cohorts)",
          "description": "DOR is defined as the time from the first occurrence of a PR or a CR per RECIST 1.1 by local review assessment and by BIRC to the occurrence of disease progression or death due to any cause. DOR will be calculated for all participants whose tumors harbor an STK11 mutation by pooling participants from both cohorts.",
          "timeFrame": "From first documented response to disease progression or death, up to approximately 24 months"
        },
        {
          "measure": "DCR by BIRC and local radiology assessment for participants whose tumors harbor an STK11 mutation regardless of PD-L1 expression status (pooled from both cohorts)",
          "description": "DCR is defined as the percentage of participants with a BOR of confirmed CR, PR and stable disease (SD) per RECIST 1.1 by local review assessment and by BIRC. DCR will be calculated for all participants whose tumors harbor an STK11 mutation by pooling participants from both cohorts",
          "timeFrame": "Up to approximately 24 months"
        },
        {
          "measure": "TTR by BIRC and local radiology assessment for participants whose tumors harbor an STK11 mutation regardless of PD-L1 expression status (pooled from both cohorts)",
          "description": "TTR is defined as the time from the date of enrollment to the date of first documented response of either CR or PR per RECIST 1.1 by local review assessment and by BIRC. TTR will be calculated for all participants whose tumors harbor an STK11 mutation by pooling participants from both cohorts",
          "timeFrame": "From enrollment to first documented response, up to approximately 24 months"
        },
        {
          "measure": "PFS by BIRC and local radiology assessment for participants whose tumors harbor an STK11 mutation regardless of PD-L1 expression status (pooled from both cohorts)",
          "description": "PFS is defined as the time from the date of first dose of study treatment to the date of the first documented disease progression per RECIST 1.1 by local review assessment and BIRC or date of death due to any cause. PFS will be calculated for all participants whose tumors harbor an STK11 mutation by pooling participants from both cohorts",
          "timeFrame": "From first study treatment to first documented progression or death, up to 24 months"
        },
        {
          "measure": "OS for participants whose tumors harbor an STK11 mutation regardless of PD-L1 expression status (pooled from both cohorts)",
          "description": "OS is defined as the time from the date of enrollment to the date of death due to any cause. OS will be calculated for all participants whose tumors harbor an STK11 mutation by pooling participants from both cohorts",
          "timeFrame": "From enrollment to death, up to approximately 36 months"
        },
        {
          "measure": "Maximum concentration (Cmax) of JDQ443 in plasma",
          "description": "Blood samples will be collected for pharmacokinetics characterization.",
          "timeFrame": "Up to approximately 24 months"
        },
        {
          "measure": "Time to reach maximum concentration at steady-state (Tmax,ss) of JDQ443 in plasma",
          "description": "Blood samples will be collected for pharmacokinetics characterization.",
          "timeFrame": "Up to approximately 24 months"
        },
        {
          "measure": "Area Under the Curve From Time Zero to End of Dosing Interval (AUCtau) of JDQ443 in plasma",
          "description": "Blood samples will be collected for pharmacokinetics characterization.",
          "timeFrame": "Up to approximately 24 months"
        },
        {
          "measure": "Area Under the Curve From Time Zero to the last measurable concentration sampling time at steady-state (AUClastss) of JDQ443 in plasma",
          "description": "Blood samples will be collected for pharmacokinetics characterization.",
          "timeFrame": "Up to approximately 24 months"
        },
        {
          "measure": "Observed concentration at the end of a dosing interval at steady-state (Cmin,ss) of JDQ443 in plasma",
          "description": "Blood samples will be collected for pharmacokinetics characterization.",
          "timeFrame": "Up to approximately 24 months"
        },
        {
          "measure": "Total body clearance (CL/F) of JDQ443 from the plasma",
          "description": "Blood samples will be collected for pharmacokinetics characterization.",
          "timeFrame": "Up to approximately 24 months"
        },
        {
          "measure": "Time to definitive deterioration (TTDD) in NSCLC-SAQ total score",
          "description": "The Non-Small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ) is a 7-item, patient-reported outcome measure which assess patient-reported symptoms associated with advanced NSCLC: cough, pain, dyspnea, fatigue, and appetite.",
          "timeFrame": "From baseline up to approximately 24 months"
        },
        {
          "measure": "TTDD in the physical functioning scale of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ) C30",
          "description": "The EORTC QLQ-C30 includes 5 functional scales (physical, role, cognitive, emotional and social functioning), 3 symptom scales (fatigue, pain and nausea/vomiting), a GHS/QoL scale, and six single items (constipation, diarrhea, insomnia, shortness of breath, appetite loss and financial difficulties).",
          "timeFrame": "From baseline up to approximately 24 months"
        },
        {
          "measure": "Chain from baseline in NSCLC-SAQ",
          "description": "The NSCLC-SAQ is a 7-item, patient-reported outcome measure which assess patient-reported symptoms associated with advanced NSCLC: cough, pain, dyspnea, fatigue, and appetite.",
          "timeFrame": "From baseline up to approximately 24 months"
        },
        {
          "measure": "Change from baseline in EORTC QLQ-C30",
          "description": "The EORTC QLQ-C30 includes 5 functional scales (physical, role, cognitive, emotional and social functioning), 3 symptom scales (fatigue, pain and nausea/vomiting), a GHS/QoL scale, and six single items (constipation, diarrhea, insomnia, shortness of breath, appetite loss and financial difficulties).",
          "timeFrame": "From baseline up to approximately 24 months"
        }
      ],
      "eligibilityCriteria": "Key Inclusion criteria\n\n* Histologically confirmed locally advanced (stage IIIb/IIIc not eligible for definitive chemoradiation or surgical resection with curative intent) or metastatic (stage IV) NSCLC without previous systemic treatment for metastatic disease. Prior (neo)adjuvant treatment with chemotherapy and/or immunotherapy, or prior radiotherapy administered sequentially or concomitantly with chemotherapy and/or immunotherapy for localized or locally advanced disease are accepted if the time between therapy completion and enrollment is \\> 12 months.\n* Presence of a KRAS G12C mutation (all participants) and:\n* Cohort A: PD-L1 expression \\< 1%, regardless of STK11 mutation status\n* Cohort B: PD-L1 expression \u2265 1% and an STK11 co-mutation\n* At least one measurable lesion per RECIST 1.1.\n* ECOG performance status \u2264 1.\n* Participants capable of swallowing study medication.\n\nKey Exclusion criteria\n\n* Participants whose tumors harbor an EGFR-sensitizing mutation and/or ALK rearrangement by local laboratory testing. Participants with other known druggable alterations will be excluded, if required by local guidelines\n* Previous use of a KRAS G12C inhibitor or previous systemic treatment for metastatic NSCLC.\n* A medical condition that results in increased photosensitivity (i.e. solar urticaria, lupus erythematosus, etc).\n* Know active (unstable/symptomatic) central nervous system (CNS) metastases and/or carcinomatous meningitis\n* Participants who are taking a prohibited medication (strong CYP3A inducers) that cannot be discontinued at least seven days prior to the first dose of study treatment and for the duration of the study\n\nOther inclusion/exclusion criteria may apply",
      "nctId": "NCT05445843",
      "overallStatus": "RECRUITING",
      "keywords": [
        "Lung cancer",
        "NSCLC",
        "KRAS G12C",
        "STK11",
        "PD-L1",
        "JDQ443"
      ],
      "locations": [
        {
          "facility": "Hartford Hospital",
          "status": "RECRUITING",
          "city": "Hartford",
          "state": "Connecticut",
          "zip": "06102",
          "country": "United States",
          "contacts": [
            {
              "name": "Joshua Lopez",
              "role": "CONTACT",
              "phone": "860-545-5000",
              "email": "Joshua.lopez@hhchealth.org"
            },
            {
              "name": "Wylie Hosmer",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 41.76371,
            "lon": -72.68509
          }
        },
        {
          "facility": "University of Toledo Precision Oncology",
          "status": "RECRUITING",
          "city": "Toledo",
          "state": "Ohio",
          "zip": "43606",
          "country": "United States",
          "contacts": [
            {
              "name": "Katherine Behrens",
              "role": "CONTACT",
              "email": "Katherine.Behrens@utoledo.edu"
            },
            {
              "name": "Danae Hamouda",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 41.66394,
            "lon": -83.55521
          }
        },
        {
          "facility": "The Brown University Oncology Group",
          "status": "RECRUITING",
          "city": "Providence",
          "state": "Rhode Island",
          "zip": "02903",
          "country": "United States",
          "contacts": [
            {
              "name": "Robert Jarbadan",
              "role": "CONTACT",
              "phone": "401-444-5435",
              "email": "rjarbadan@lifespan.org"
            },
            {
              "name": "Christopher Azzoli",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 41.82399,
            "lon": -71.41283
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Pilar",
          "state": "Buenos Aires",
          "zip": "B1629AHJ",
          "country": "Argentina",
          "geoPoint": {
            "lat": -31.6789,
            "lon": -63.87964
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Buenos Aires",
          "state": "Caba",
          "zip": "C1431FWO",
          "country": "Argentina",
          "geoPoint": {
            "lat": -34.61315,
            "lon": -58.37723
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Rosario",
          "state": "Santa Fe",
          "zip": "S2000DSV",
          "country": "Argentina",
          "geoPoint": {
            "lat": -32.94682,
            "lon": -60.63932
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Buenos Aires",
          "zip": "C1426AGE",
          "country": "Argentina",
          "geoPoint": {
            "lat": -34.61315,
            "lon": -58.37723
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Cordoba",
          "zip": "X5000JHQ",
          "country": "Argentina",
          "geoPoint": {
            "lat": -31.4135,
            "lon": -64.18105
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Cordoba",
          "zip": "X5016KEH",
          "country": "Argentina",
          "geoPoint": {
            "lat": -31.4135,
            "lon": -64.18105
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Feldkirch",
          "zip": "A 6807",
          "country": "Austria",
          "geoPoint": {
            "lat": 47.23306,
            "lon": 9.6
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Klagenfurt",
          "zip": "9020",
          "country": "Austria",
          "geoPoint": {
            "lat": 46.62472,
            "lon": 14.30528
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Wels",
          "zip": "A-4600",
          "country": "Austria",
          "geoPoint": {
            "lat": 48.16667,
            "lon": 14.03333
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Sint Niklaas",
          "state": "Oost Vlaanderen",
          "zip": "9100",
          "country": "Belgium",
          "geoPoint": {
            "lat": 51.16509,
            "lon": 4.1437
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Roeselare",
          "zip": "8800",
          "country": "Belgium",
          "geoPoint": {
            "lat": 50.94653,
            "lon": 3.12269
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Salvador",
          "state": "BA",
          "zip": "41825-010",
          "country": "Brazil",
          "geoPoint": {
            "lat": -12.97111,
            "lon": -38.51083
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Belo Horizonte",
          "zip": "30360 680",
          "country": "Brazil",
          "geoPoint": {
            "lat": -19.92083,
            "lon": -43.93778
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Rio de Janeiro",
          "zip": "22271-110",
          "country": "Brazil",
          "geoPoint": {
            "lat": -22.90278,
            "lon": -43.2075
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Rio Grande Do Sul",
          "zip": "90035-001",
          "country": "Brazil"
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Branipole",
          "zip": "4109",
          "country": "Bulgaria",
          "geoPoint": {
            "lat": 42.08333,
            "lon": 24.75
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Plovdiv",
          "zip": "4004",
          "country": "Bulgaria",
          "geoPoint": {
            "lat": 42.15,
            "lon": 24.75
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Sofia",
          "zip": "1303",
          "country": "Bulgaria",
          "geoPoint": {
            "lat": 42.69751,
            "lon": 23.32415
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "WITHDRAWN",
          "city": "Guang Zhou",
          "state": "Guang Dong Province",
          "zip": "510120",
          "country": "China"
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Wuhan",
          "state": "Hubei",
          "zip": "430022",
          "country": "China",
          "geoPoint": {
            "lat": 30.58333,
            "lon": 114.26667
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Wuhan",
          "state": "Hubei",
          "zip": "430030",
          "country": "China",
          "geoPoint": {
            "lat": 30.58333,
            "lon": 114.26667
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Changsha",
          "state": "Hunan",
          "zip": "410013",
          "country": "China",
          "geoPoint": {
            "lat": 28.19874,
            "lon": 112.97087
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Xian",
          "state": "Shanxi",
          "zip": "710061",
          "country": "China",
          "geoPoint": {
            "lat": 34.25833,
            "lon": 108.92861
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Beijing",
          "zip": "100021",
          "country": "China",
          "geoPoint": {
            "lat": 39.9075,
            "lon": 116.39723
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Beijing",
          "zip": "100036",
          "country": "China",
          "geoPoint": {
            "lat": 39.9075,
            "lon": 116.39723
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Shanyang",
          "zip": "110005",
          "country": "China",
          "geoPoint": {
            "lat": 26.67019,
            "lon": 119.20509
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Zhengzhou",
          "zip": "450008",
          "country": "China",
          "geoPoint": {
            "lat": 34.75778,
            "lon": 113.64861
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Marseille cedex 20",
          "state": "Bouches Du Rhone",
          "zip": "13915",
          "country": "France",
          "geoPoint": {
            "lat": 43.29551,
            "lon": 5.38958
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Bron",
          "zip": "69677",
          "country": "France",
          "geoPoint": {
            "lat": 45.73333,
            "lon": 4.91667
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Montpellier",
          "zip": "34070",
          "country": "France",
          "geoPoint": {
            "lat": 43.61092,
            "lon": 3.87723
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Paris",
          "zip": "75014",
          "country": "France",
          "geoPoint": {
            "lat": 48.85341,
            "lon": 2.3488
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Paris",
          "zip": "75970",
          "country": "France",
          "geoPoint": {
            "lat": 48.85341,
            "lon": 2.3488
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Saint Herblain",
          "zip": "44805",
          "country": "France",
          "geoPoint": {
            "lat": 47.21765,
            "lon": -1.64841
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Strasbourg Cedex",
          "zip": "67091",
          "country": "France",
          "geoPoint": {
            "lat": 48.58392,
            "lon": 7.74553
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Berlin",
          "zip": "13125",
          "country": "Germany",
          "geoPoint": {
            "lat": 52.52437,
            "lon": 13.41053
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Halle (Saale)",
          "zip": "06120",
          "country": "Germany",
          "geoPoint": {
            "lat": 51.48159,
            "lon": 11.97948
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Harburg",
          "zip": "31787",
          "country": "Germany",
          "geoPoint": {
            "lat": 53.46057,
            "lon": 9.98388
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Hemer",
          "zip": "58675",
          "country": "Germany",
          "geoPoint": {
            "lat": 51.38707,
            "lon": 7.77019
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Kempten",
          "zip": "87439",
          "country": "Germany",
          "geoPoint": {
            "lat": 47.72674,
            "lon": 10.31389
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Oldenburg",
          "zip": "26121",
          "country": "Germany",
          "geoPoint": {
            "lat": 53.14118,
            "lon": 8.21467
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Tuebingen",
          "zip": "72076",
          "country": "Germany",
          "geoPoint": {
            "lat": 48.52266,
            "lon": 9.05222
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Athens",
          "state": "GR",
          "zip": "115 27",
          "country": "Greece",
          "geoPoint": {
            "lat": 37.97945,
            "lon": 23.71622
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Athens",
          "zip": "11526",
          "country": "Greece",
          "geoPoint": {
            "lat": 37.97945,
            "lon": 23.71622
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Torokbalint",
          "state": "Pest",
          "zip": "2045",
          "country": "Hungary",
          "geoPoint": {
            "lat": 47.42931,
            "lon": 18.91356
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Matrahaza",
          "zip": "3200",
          "country": "Hungary",
          "geoPoint": {
            "lat": 47.87124,
            "lon": 19.97981
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Varanasi",
          "state": "Uttarpradesh",
          "zip": "221005",
          "country": "India",
          "geoPoint": {
            "lat": 25.31668,
            "lon": 83.01041
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Kolkata",
          "state": "West Bengal",
          "zip": "700160",
          "country": "India",
          "geoPoint": {
            "lat": 22.56263,
            "lon": 88.36304
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Puducherry",
          "zip": "605006",
          "country": "India",
          "geoPoint": {
            "lat": 11.93381,
            "lon": 79.82979
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Bari",
          "state": "BA",
          "zip": "70124",
          "country": "Italy",
          "geoPoint": {
            "lat": 41.11148,
            "lon": 16.8554
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Rozzano",
          "state": "MI",
          "zip": "20089",
          "country": "Italy",
          "geoPoint": {
            "lat": 45.38193,
            "lon": 9.1559
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Roma",
          "state": "RM",
          "zip": "00128",
          "country": "Italy",
          "geoPoint": {
            "lat": 41.89193,
            "lon": 12.51133
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Orbassano",
          "state": "TO",
          "zip": "10043",
          "country": "Italy",
          "geoPoint": {
            "lat": 45.00547,
            "lon": 7.53813
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Varese",
          "state": "VA",
          "zip": "21100",
          "country": "Italy",
          "geoPoint": {
            "lat": 45.82058,
            "lon": 8.82511
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Alor Setar",
          "state": "Kedah",
          "zip": "05460",
          "country": "Malaysia",
          "geoPoint": {
            "lat": 6.12104,
            "lon": 100.36014
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Kuantan",
          "state": "Pahang",
          "zip": "25200",
          "country": "Malaysia",
          "geoPoint": {
            "lat": 3.8077,
            "lon": 103.326
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Kuching",
          "state": "Sarawak",
          "zip": "93586",
          "country": "Malaysia",
          "geoPoint": {
            "lat": 1.54999,
            "lon": 110.33333
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Pulau Pinang",
          "zip": "10990",
          "country": "Malaysia",
          "geoPoint": {
            "lat": 3.55,
            "lon": 102.56667
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Breda",
          "zip": "4818 CK",
          "country": "Netherlands",
          "geoPoint": {
            "lat": 51.58656,
            "lon": 4.77596
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Leeuwarden",
          "zip": "8934 AD",
          "country": "Netherlands",
          "geoPoint": {
            "lat": 53.20139,
            "lon": 5.80859
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Lisboa",
          "zip": "1998-018",
          "country": "Portugal",
          "geoPoint": {
            "lat": 38.71667,
            "lon": -9.13333
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Porto",
          "zip": "4100-180",
          "country": "Portugal",
          "geoPoint": {
            "lat": 41.14961,
            "lon": -8.61099
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Singapore",
          "zip": "168583",
          "country": "Singapore",
          "geoPoint": {
            "lat": 1.28967,
            "lon": 103.85007
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Sevilla",
          "state": "Andalucia",
          "zip": "41013",
          "country": "Spain",
          "geoPoint": {
            "lat": 37.38283,
            "lon": -5.97317
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Santander",
          "state": "Cantabria",
          "zip": "39008",
          "country": "Spain",
          "geoPoint": {
            "lat": 43.46472,
            "lon": -3.80444
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Barcelona",
          "state": "Catalunya",
          "zip": "08035",
          "country": "Spain",
          "geoPoint": {
            "lat": 41.38879,
            "lon": 2.15899
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Madrid",
          "zip": "28041",
          "country": "Spain",
          "geoPoint": {
            "lat": 40.4165,
            "lon": -3.70256
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Songkhla",
          "state": "Hat Yai",
          "zip": "90110",
          "country": "Thailand",
          "geoPoint": {
            "lat": 7.19882,
            "lon": 100.5951
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Bangkok",
          "zip": "10400",
          "country": "Thailand",
          "geoPoint": {
            "lat": 13.75398,
            "lon": 100.50144
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Bangkok",
          "zip": "10700",
          "country": "Thailand",
          "geoPoint": {
            "lat": 13.75398,
            "lon": 100.50144
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Adana",
          "zip": "01140",
          "country": "Turkey",
          "geoPoint": {
            "lat": 37.00167,
            "lon": 35.32889
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Ankara",
          "zip": "06560",
          "country": "Turkey",
          "geoPoint": {
            "lat": 39.91987,
            "lon": 32.85427
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Diyarbakir",
          "zip": "21000",
          "country": "Turkey",
          "geoPoint": {
            "lat": 37.91363,
            "lon": 40.21721
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Edirne",
          "zip": "22030",
          "country": "Turkey",
          "geoPoint": {
            "lat": 41.67719,
            "lon": 26.55597
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Istanbul",
          "zip": "34214",
          "country": "Turkey",
          "geoPoint": {
            "lat": 41.01384,
            "lon": 28.94966
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Izmir",
          "zip": "35575",
          "country": "Turkey",
          "geoPoint": {
            "lat": 38.41273,
            "lon": 27.13838
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Torquay",
          "state": "Devon",
          "zip": "TQ2 7AA",
          "country": "United Kingdom",
          "geoPoint": {
            "lat": 50.46198,
            "lon": -3.5252
          }
        }
      ],
      "eligibilityModule": {
        "eligibilityCriteria": "Key Inclusion criteria\n\n* Histologically confirmed locally advanced (stage IIIb/IIIc not eligible for definitive chemoradiation or surgical resection with curative intent) or metastatic (stage IV) NSCLC without previous systemic treatment for metastatic disease. Prior (neo)adjuvant treatment with chemotherapy and/or immunotherapy, or prior radiotherapy administered sequentially or concomitantly with chemotherapy and/or immunotherapy for localized or locally advanced disease are accepted if the time between therapy completion and enrollment is \\> 12 months.\n* Presence of a KRAS G12C mutation (all participants) and:\n* Cohort A: PD-L1 expression \\< 1%, regardless of STK11 mutation status\n* Cohort B: PD-L1 expression \u2265 1% and an STK11 co-mutation\n* At least one measurable lesion per RECIST 1.1.\n* ECOG performance status \u2264 1.\n* Participants capable of swallowing study medication.\n\nKey Exclusion criteria\n\n* Participants whose tumors harbor an EGFR-sensitizing mutation and/or ALK rearrangement by local laboratory testing. Participants with other known druggable alterations will be excluded, if required by local guidelines\n* Previous use of a KRAS G12C inhibitor or previous systemic treatment for metastatic NSCLC.\n* A medical condition that results in increased photosensitivity (i.e. solar urticaria, lupus erythematosus, etc).\n* Know active (unstable/symptomatic) central nervous system (CNS) metastases and/or carcinomatous meningitis\n* Participants who are taking a prohibited medication (strong CYP3A inducers) that cannot be discontinued at least seven days prior to the first dose of study treatment and for the duration of the study\n\nOther inclusion/exclusion criteria may apply",
        "healthyVolunteers": false,
        "sex": "ALL",
        "minimumAge": "18 Years",
        "stdAges": [
          "ADULT",
          "OLDER_ADULT"
        ]
      },
      "studyType": "INTERVENTIONAL",
      "phases": [
        "PHASE2"
      ]
    },
    "structured_criteria": {
      "inclusion": {
        "Key Inclusion criteria": [
          "Patients who meet all of the following criteria are eligible for trial participation: ",
          [
            "* Histologically confirmed locally advanced (stage IIIb/IIIc not eligible for definitive chemoradiation or surgical resection with curative intent) or metastatic (stage IV) NSCLC without previous systemic treatment for metastatic disease. Prior (neo)adjuvant treatment with chemotherapy and/or immunotherapy, or prior radiotherapy administered sequentially or concomitantly with chemotherapy and/or immunotherapy for localized or locally advanced disease are accepted if the time between therapy completion and enrollment is \\> 12 months.",
            [
              "* Presence of a KRAS G12C mutation (all participants) and:",
              "* Cohort A: PD-L1 expression \\< 1%, regardless of STK11 mutation status",
              "* Cohort B: PD-L1 expression \u2265 1% and an STK11 co-mutation"
            ],
            "* At least one measurable lesion per RECIST 1.1.",
            "* ECOG performance status \u2264 1.",
            "* Participants capable of swallowing study medication."
          ]
        ]
      },
      "exclusion": {
        "Key Exclusion criteria": [
          "Patients who meet any of the following criteria are not eligible for trial participation: ",
          [
            "* Participants whose tumors harbor an EGFR-sensitizing mutation and/or ALK rearrangement by local laboratory testing. Participants with other known druggable alterations will be excluded, if required by local guidelines",
            "* Previous use of a KRAS G12C inhibitor or previous systemic treatment for metastatic NSCLC.",
            "* A medical condition that results in increased photosensitivity (i.e. solar urticaria, lupus erythematosus, etc).",
            "* Know active (unstable/symptomatic) central nervous system (CNS) metastases and/or carcinomatous meningitis",
            "* Participants who are taking a prohibited medication (strong CYP3A inducers) that cannot be discontinued at least seven days prior to the first dose of study treatment and for the duration of the study",
            "Other inclusion/exclusion criteria may apply"
          ]
        ]
      }
    },
    "results_inclusion": [
      [
        "Key Inclusion criteria",
        "Patients who meet all of the following criteria are eligible for trial participation: ",
        [
          "* Histologically confirmed locally advanced (stage IIIb/IIIc not eligible for definitive chemoradiation or surgical resection with curative intent) or metastatic (stage IV) NSCLC without previous systemic treatment for metastatic disease. Prior (neo)adjuvant treatment with chemotherapy and/or immunotherapy, or prior radiotherapy administered sequentially or concomitantly with chemotherapy and/or immunotherapy for localized or locally advanced disease are accepted if the time between therapy completion and enrollment is \\> 12 months.",
          "* At least one measurable lesion per RECIST 1.1.",
          "* ECOG performance status \u2264 1.",
          "* Participants capable of swallowing study medication."
        ],
        {
          "reasoning": "Reasoning: Let's think step by step in order to produce the criteria_decision. We will evaluate each criterion based on the provided patient information.\n\n1. **Criterion 1**: The patient has histologically confirmed stage 4 lung adenocarcinoma, which is metastatic NSCLC. There is no mention of previous systemic treatment for metastatic disease, so we assume the patient has not received it. The criterion also allows prior (neo)adjuvant treatment if the time between therapy completion and enrollment is > 12 months, but this information is not provided. Therefore, we decide `?` for this criterion.\n   \n2. **Criterion 2**: There is no information provided about measurable lesions per RECIST 1.1 in the patient information. Therefore, we decide `?` for this criterion.\n\n3. **Criterion 3**: There is no information provided about the patient's ECOG performance status. Therefore, we decide `?` for this criterion.\n\n4. **Criterion 4**: There is no information provided about the patient's capability of swallowing study medication. Therefore, we decide `?` for this criterion.",
          "criteria_decision": {
            "explanation": [
              "The patient has stage 4 lung adenocarcinoma, but there is no information about previous systemic treatment for metastatic disease or the time between therapy completion and enrollment.",
              "There is no information about measurable lesions per RECIST 1.1.",
              "There is no information about the patient's ECOG performance status.",
              "There is no information about the patient's capability of swallowing study medication."
            ],
            "criteria_decision": [
              "?",
              "?",
              "?",
              "?"
            ]
          }
        }
      ],
      [
        "Key Inclusion criteria",
        "Patients who meet all of the following criteria are eligible for trial participation: ",
        [
          "* Presence of a KRAS G12C mutation (all participants) and:",
          "* Cohort A: PD-L1 expression \\< 1%, regardless of STK11 mutation status",
          "* Cohort B: PD-L1 expression \u2265 1% and an STK11 co-mutation"
        ],
        {
          "reasoning": "Reasoning: Let's think step by step in order to produce the criteria decision. We need to evaluate each criterion based on the patient information provided.\n\n1. **Presence of a KRAS G12C mutation (all participants)**:\n   - The patient has a KRAS p.G12C mutation.\n   - Decision: True\n\n2. **Cohort A: PD-L1 expression < 1%, regardless of STK11 mutation status**:\n   - There is no information about the PD-L1 expression in the patient information.\n   - Decision: ?\n\n3. **Cohort B: PD-L1 expression \u2265 1% and an STK11 co-mutation**:\n   - The patient has an STK11 p.K83Tfs*13 mutation.\n   - There is no information about the PD-L1 expression in the patient information.\n   - Decision: ?\n\nNow, let's determine the global result based on the overall logic of the criteria. The global condition requires the presence of a KRAS G12C mutation and then evaluates the patient for either Cohort A or Cohort B based on PD-L1 expression and STK11 mutation status.\n\nSince the patient meets the first criterion (KRAS G12C mutation), but we do not have sufficient information to determine eligibility for either Cohort A or Cohort B due to the lack of PD-L1 expression data, the global result is '?'.",
          "criteria_decision": {
            "criteria_result": {
              "explanation": [
                "The patient has a KRAS p.G12C mutation, so this criterion is met.",
                "There is no information about the PD-L1 expression in the patient information, so we cannot determine eligibility for Cohort A.",
                "The patient has an STK11 p.K83Tfs*13 mutation, but there is no information about the PD-L1 expression in the patient information, so we cannot determine eligibility for Cohort B."
              ],
              "criteria_decision": [
                true,
                "?",
                "?"
              ]
            },
            "global_result": "?"
          }
        }
      ]
    ],
    "results_exclusion": [
      [
        "Key Exclusion criteria",
        "Patients who meet any of the following criteria are not eligible for trial participation: ",
        [
          "* Participants whose tumors harbor an EGFR-sensitizing mutation and/or ALK rearrangement by local laboratory testing. Participants with other known druggable alterations will be excluded, if required by local guidelines",
          "* Previous use of a KRAS G12C inhibitor or previous systemic treatment for metastatic NSCLC.",
          "* A medical condition that results in increased photosensitivity (i.e. solar urticaria, lupus erythematosus, etc).",
          "* Know active (unstable/symptomatic) central nervous system (CNS) metastases and/or carcinomatous meningitis",
          "* Participants who are taking a prohibited medication (strong CYP3A inducers) that cannot be discontinued at least seven days prior to the first dose of study treatment and for the duration of the study"
        ],
        {
          "reasoning": "Reasoning: Let's think step by step in order to produce the criteria_decision. We will evaluate each exclusion criterion based on the provided patient information.\n\n1. **Participants whose tumors harbor an EGFR-sensitizing mutation and/or ALK rearrangement by local laboratory testing. Participants with other known druggable alterations will be excluded, if required by local guidelines.**\n   - The patient information does not mention EGFR-sensitizing mutations or ALK rearrangements. Therefore, we assume these are not present.\n   - The patient has KRAS p.G12C, KEAP1 p.L276F, and STK11 p.K83Tfs*13 mutations. The criterion mentions exclusion for other known druggable alterations if required by local guidelines, but it is not specified if these particular mutations are excluded by local guidelines.\n   - Decision: `?` (Insufficient information about local guidelines regarding these specific mutations).\n\n2. **Previous use of a KRAS G12C inhibitor or previous systemic treatment for metastatic NSCLC.**\n   - The patient information does not mention any previous use of a KRAS G12C inhibitor or previous systemic treatment for metastatic NSCLC.\n   - Decision: `True` (Assume no previous use or treatment).\n\n3. **A medical condition that results in increased photosensitivity (i.e. solar urticaria, lupus erythematosus, etc).**\n   - The patient information does not mention any medical condition that results in increased photosensitivity.\n   - Decision: `True` (Assume no such medical condition).\n\n4. **Know active (unstable/symptomatic) central nervous system (CNS) metastases and/or carcinomatous meningitis.**\n   - The patient information does not mention CNS metastases or carcinomatous meningitis.\n   - Decision: `True` (Assume no CNS metastases or carcinomatous meningitis).\n\n5. **Participants who are taking a prohibited medication (strong CYP3A inducers) that cannot be discontinued at least seven days prior to the first dose of study treatment and for the duration of the study.**\n   - The patient information does not mention any medications, including strong CYP3A inducers.\n   - Decision: `True` (Assume no prohibited medication).",
          "criteria_decision": {
            "explanation": [
              "The patient has KRAS p.G12C, KEAP1 p.L276F, and STK11 p.K83Tfs*13 mutations, but it is not specified if these are excluded by local guidelines.",
              "The patient information does not mention any previous use of a KRAS G12C inhibitor or previous systemic treatment for metastatic NSCLC.",
              "The patient information does not mention any medical condition that results in increased photosensitivity.",
              "The patient information does not mention CNS metastases or carcinomatous meningitis.",
              "The patient information does not mention any medications, including strong CYP3A inducers."
            ],
            "criteria_decision": [
              "?",
              true,
              true,
              true,
              true
            ]
          }
        }
      ],
      [
        "Key Exclusion criteria",
        "Patients who meet any of the following criteria are not eligible for trial participation: ",
        [
          "Other inclusion/exclusion criteria may apply"
        ],
        {
          "reasoning": "```json\n{\n  \"explanation\": [\n    \"The exclusion criteria provided is too vague ('Other inclusion/exclusion criteria may apply') and does not specify any particular condition or disease. Therefore, it is not possible to determine the eligibility of the patient based on this criterion.\"\n  ],\n  \"criteria_decision\": [\"?\"]\n}\n```",
          "criteria_decision": {
            "explanation": [
              "The exclusion criteria provided is too vague ('Other inclusion/exclusion criteria may apply') and does not specify any particular condition or disease. Therefore, it is not possible to determine the eligibility of the patient based on this criterion."
            ],
            "criteria_decision": [
              "?"
            ]
          }
        }
      ]
    ],
    "subinstruction": "metastatic lung adenocarcinoma, KRAS p.G12C mutation",
    "patient_id": "p6",
    "patient_info": "\nPatient Information\n    Name: Doe, John\n    born: 18.08.1968\n    Address: Main Street 1, Berlin\n\nOverview of Tumor Diagnosis and Therapy\n    Tumor Diagnosis\n    Diagnosis: Metastatic KRAS G12C mutant non-small cell lung cancer (NSCLC)\n    Initial Detection: March 22, 2023, following symptoms of persistent cough and weight loss\n    Biopsy Date: April 15, 2023, adenocarcinoma of the lung\n    Molecular Profile: KRAS p.G12C (AF 18%), KEAP1 p.L276F (AF 45%), STK11 p.K83Tfs*13 (AF 38%).\n\nTherapy Overview\n    Initial Treatment:\n    Chemotherapy: Began May 5, 2022 in Berlin, with a platinum-based regimen (Cisplatin and\n    Pemetrexed), partial response noted after initial chemotherapy cycle completed by August 10, 2022, contunuation of therapy until october 2023 (progressive disease)\n    Subsequent Treatment: Immunotherapy with Prembolizumab at Charit\u00e9 Berlin initiated on October 25, 2023, with Pembrolizumab, staging CT shows disease progression after 3 months\n    Current Status:\n    Health Condition: Stable with an ECOG performance status of 1\n    Comorbidities: Well-managed and not contraindicating further treatment\n \nComorbidities\n    Former Smoker: 40py\n    Hypertension: Controlled with medication (Lisinopril 20 mg daily), current blood pressure 130/90mmHg\n    Type 2 Diabetes Mellitus: Controlled with Metformin 1000 mg twice daily\n    Hyperlipidemia: Managed with Atorvastatin 40 mg daily\n    Osteoarthritis: Managed with over-the-counter NSAIDs as needed\n    Chronic Obstructive Pulmonary Disease (COPD): Mild, managed with inhalers (Tiotropium)\n    Gastroesophageal Reflux Disease (GERD): Managed with Omeprazole 20 mg daily\n    Benign Prostatic Hyperplasia (BPH): Treated with Tamsulosin 0.4 mg daily\n\nPerformance Status: ECOG Performance Status 1\n \nChronological Medical Findings:\n    January 10, 2018: Routine annual physical examination. Blood pressure elevated, diagnosed with hypertension. Prescribed Lisinopril 10 mg daily.\n    March 15, 2018: Complained of heartburn and acid reflux. Diagnosed with GERD. Prescribed Omeprazole 20 mg daily.\n    February 25, 2019: Annual follow-up for hypertension. Blood pressure well-controlled. Lisinopril dosage maintained.\n    May 20, 2019: Complained of knee pain. Diagnosed with osteoarthritis. Recommended over-the-counter NSAIDs for pain management.\n    April 5, 2020: Routine check-up. Elevated blood glucose levels. Diagnosed with Type 2 Diabetes Mellitus. Prescribed Metformin 500 mg twice daily.\n    August 30, 2020: Routine cholesterol check. Diagnosed with hyperlipidemia. Prescribed Atorvastatin 20 mg daily.\n    November 10, 2020: Follow-up for diabetes and hyperlipidemia. Dosages adjusted: Metformin increased to 1000 mg twice daily, Atorvastatin increased to 40 mg daily.\n    February 12, 2021: Complained of shortness of breath and chronic cough. Diagnosed with mild COPD. Prescribed Tiotropium inhaler.\n    July 18, 2021: Routine follow-up. Stable condition with controlled comorbidities. Blood pressure, blood sugar, and cholesterol levels within target ranges.\n    March 22, 2023: Experienced persistent cough and weight loss. Chest X-ray and CT scan revealed a mass in the left lung. Referred to oncologist. CT Angiography, Pulmonary Arteries: Tumor Size: Approximately 4.5 cm in diameter. Bronchial Obstruction: Partial obstruction of the left main bronchus leading to atelectasis of the left upper lobe.\n    Urgent suspicion of a tumor-atelectasis complex in the left upper lobe of the lung. Mucus present in the lower lobe bronchi on the left. Suspicion of mediastinal lymph node metastases. No evidence of pulmonary artery embolism. Thrombus in the left atrium at the transition to the auricle. Emphysematous and fibrotic changes in the lung parenchyma. \n    Lymph Nodes: Enlarged, FDG-positive lymph nodes in the mediastinum, particularly in regions 4R and infracarinal. \n    April 15, 2023: Lung biopsy via bronchoscopy: Endobronchial tumor manifestation in the distal left main bronchus extending to the upper lobe. Acute and chronic atrophic tracheobronchitis. Collapsed bronchial system in the affected area. Biopsy taken. Diagnosed with non-small cell lung cancer (NSCLC), molecular diagnostics: KRAS G12C mutant. \n    April 27, 2022: Ventilation: Moderate obstruction, no restriction. Increased airway resistance and slight hyperinflation. Tiffeneau index (FEV1/FVC) at 42.34%, z-score -3.32. FEV1: 0.93 L (42% predicted), z-score -2.89.Total lung capacity (TLC): 5.86 L (103% predicted), z-score 0.22. Forced vital capacity (FVC): 2.19 L, z-score -1.5. Residual volume (RV): 3.67 L, z-score 2.44. RV/TLC: 62.68%, z-score -1.18.\n    May 5, 2022: Initiated on platinum-based chemotherapy regimen (Cisplatin and Pemetrexed).\n    August 10, 2023: Completed initial chemotherapy cycle. Partial response noted. \n    August-October: Continued chemotherapy with Cisplatin/Pemetrexed.\n    October 13, 2023: Follow-up CT (chest + abdomen): Moderate disease progression. New nodule in the right lung (1cm). Slight increase in the size of previously noted FDG-positive lymph nodes in the mediastinum. No additional metastatic lesions were detected. The patient has continued to tolerate the current treatment regimen well, with no significant adverse effects reported.\n    October 25, 2023: Started immune checkpoint inhibitor therapy (Pembrolizumab), good tolerability, no signs of autoimmunity.\n    March 12, 2024: Follow-up CT scan abdomen/lung: Progressive Disease with three new metastases in the right lung and additional enlarged FDG-positive lymph nodes in the mediastinum. MRI scan of the brain conducted; no evidence of metastatic disease. Incidental findings included mild age-related cerebral atrophy and scattered white matter hyperintensities consistent with chronic microvascular ischemic changes.\n    March 17, 2024: Tumorboard recommends considering clinical trial options due to limited response to standard therapies.\n    April 20, 2024: Detailed assessment of health status. ECOG performance status 1. All routine labs, including liver and renal function tests, within normal limits.\n",
    "instruction": "Please find a clincial trial targeting the patients tumor and alterations in Germany."
  },
  {
    "nctId": "NCT05358249",
    "avg_inclusion_score": 0.5,
    "avg_exclusion_score": 0.7,
    "avg_overall_score": 0.625,
    "trial": {
      "clean_text": "#briefTitle\nPlatform Study of JDQ443 in Combinations in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation\n\n#officialTitle\nKontRASt-03: A Phase Ib/II, Multicenter, Open-label Platform Study of JDQ443 With Select Combinations in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation\n\n#briefSummary\nThis is Phase Ib/II, multicenter, open-label adaptive platform study of JDQ443 with select therapies in patients with advanced solid tumors harboring the KRAS G12C mutation.\n\n#detailedDescription\nJDQ443 will be considered \"backbone\" treatment in this trial and combined with selected therapies, or \"partner(s)\". The combination of a backbone and a partner will constitute a treatment arm. After dose escalation, treatment arms that reach a maximum tolerated dose /recommended dose and are determined to be safe may, but are not required to, proceed to Phase II to further explore safety, tolerability, and anti-tumor activity.\n\n#conditions\nKRAS G12C Mutant Solid Tumors\nCarcinoma, Non-Small Cell Lung\nCarcinoma, Non-Small-Cell Lung\nNon-Small Cell Lung Cancer\nNon-Small Cell Lung Carcinoma\nNonsmall Cell Lung Cancer\nColorectal Cancer\nColorectal Carcinoma\nColorectal Neoplasms\nColorectal Tumors\nNeoplasms, Colorectal\n\n",
      "briefTitle": "Platform Study of JDQ443 in Combinations in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation",
      "officialTitle": "KontRASt-03: A Phase Ib/II, Multicenter, Open-label Platform Study of JDQ443 With Select Combinations in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation",
      "briefSummary": "This is Phase Ib/II, multicenter, open-label adaptive platform study of JDQ443 with select therapies in patients with advanced solid tumors harboring the KRAS G12C mutation.",
      "detailedDescription": "JDQ443 will be considered \"backbone\" treatment in this trial and combined with selected therapies, or \"partner(s)\". The combination of a backbone and a partner will constitute a treatment arm. After dose escalation, treatment arms that reach a maximum tolerated dose /recommended dose and are determined to be safe may, but are not required to, proceed to Phase II to further explore safety, tolerability, and anti-tumor activity.",
      "conditions": [
        "KRAS G12C Mutant Solid Tumors",
        "Carcinoma, Non-Small Cell Lung",
        "Carcinoma, Non-Small-Cell Lung",
        "Non-Small Cell Lung Cancer",
        "Non-Small Cell Lung Carcinoma",
        "Nonsmall Cell Lung Cancer",
        "Colorectal Cancer",
        "Colorectal Carcinoma",
        "Colorectal Neoplasms",
        "Colorectal Tumors",
        "Neoplasms, Colorectal"
      ],
      "armGroups": [
        {
          "label": "JDQ443+trametinib",
          "type": "EXPERIMENTAL",
          "description": "JDQ443 in combination with trametinib",
          "interventionNames": [
            "Drug: JDQ443",
            "Drug: trametinib"
          ]
        },
        {
          "label": "JDQ443+ribociclib",
          "type": "EXPERIMENTAL",
          "description": "JDQ443 in combination with ribociclib",
          "interventionNames": [
            "Drug: JDQ443",
            "Drug: Ribociclib"
          ]
        },
        {
          "label": "JDQ443+cetuximab",
          "type": "EXPERIMENTAL",
          "description": "JDQ443 in combination with cetuximab",
          "interventionNames": [
            "Drug: JDQ443",
            "Biological: cetuximab"
          ]
        }
      ],
      "interventions": [
        {
          "type": "DRUG",
          "name": "JDQ443",
          "description": "KRAS G12C inhibitor, oral",
          "armGroupLabels": [
            "JDQ443+cetuximab",
            "JDQ443+ribociclib",
            "JDQ443+trametinib"
          ]
        },
        {
          "type": "DRUG",
          "name": "trametinib",
          "description": "MEK inhibitor, oral",
          "armGroupLabels": [
            "JDQ443+trametinib"
          ],
          "otherNames": [
            "TMT212"
          ]
        },
        {
          "type": "DRUG",
          "name": "Ribociclib",
          "description": "CDK4/6 inhibitor, oral",
          "armGroupLabels": [
            "JDQ443+ribociclib"
          ],
          "otherNames": [
            "LEE011"
          ]
        },
        {
          "type": "BIOLOGICAL",
          "name": "cetuximab",
          "description": "EGFR inhibitor, intravenous",
          "armGroupLabels": [
            "JDQ443+cetuximab"
          ]
        }
      ],
      "primaryOutcomes": [
        {
          "measure": "Dose escalation: Incidence and severity of dose limiting toxicities (DLTs) of each combination treatment.",
          "description": "A dose-limiting toxicity (DLT) is defined as an adverse event or abnormal laboratory value that is not primarily related to disease, disease progression, intercurrent illness/injury, or concomitant medications that occurs within the first 28 days of study treatment and meets a defined criteria.",
          "timeFrame": "28 days"
        },
        {
          "measure": "Dose escalation: Incidence and severity of adverse events (AEs) and serious adverse events (SAEs) by treatment",
          "description": "All information obtained on AE will be displayed by treatment group. Summary tables will include only AEs that started/worsened during the cycles of treatment (treatment-emergent AEs).",
          "timeFrame": "24 months"
        },
        {
          "measure": "Dose escalation: Frequency of dose interruptions and reductions, by treatment",
          "description": "The number of patients with dose adjustments (reductions and interruptions) will be summarized by treatment group.",
          "timeFrame": "24 months"
        },
        {
          "measure": "Dose Escalation: Dose intensity by treatment",
          "description": "Dose intensity is defined as the ratio of actual cumulative dose received and actual duration of response.",
          "timeFrame": "24 months"
        },
        {
          "measure": "PhaseII: Overall Response Rate by Blinded Independent Review Committee (BIRC) per RECIST 1.1",
          "description": "ORR is the proportion of patients with a best overall response (BOR) of Complete Response (CR) or Partial Response (PR).",
          "timeFrame": "24 months"
        }
      ],
      "secondaryOutcomes": [
        {
          "measure": "Dose escalation and Phase II: ORR by local review per RECIST 1.1",
          "description": "ORR is the proportion of patients with a BOR of CR or PR.",
          "timeFrame": "24 months"
        },
        {
          "measure": "Dose escalation and Phase II: Disease Control Rate (DCR) by local review per RECIST 1.1",
          "description": "DCR is the proportion of patients with a BOR of CR or PR or Stable Disease (SD). The objective of this endpoint is to summarize patients with signs of \"activity\" defined as either shrinkage of tumor (regardless of duration) or slowing down of tumor growth.",
          "timeFrame": "24 months"
        },
        {
          "measure": "Dose escalation and Phase II: Duration of Response (DoR) by local review per RECIST 1.1",
          "description": "Duration of response is defined as the time from the date of the first documented response (CR or PR), to the date of first documented progression, or death due any cause.",
          "timeFrame": "24 months"
        },
        {
          "measure": "Dose escalation and Phase II: Progression-Free Survival (PFS) by local review per RECIST 1.1",
          "description": "PFS is defined as the time from the date of start of treatment to the date of the first documented progression, or death due to any cause. If a patient has not had an event, progression-free survival is censored at the date of last adequate tumor assessment.",
          "timeFrame": "24 months"
        },
        {
          "measure": "Phase II: DCR by BIRC per RECIST 1.1",
          "description": "DCR is the proportion of patients with a BOR of CR or PR or SD. The objective of this endpoint is to summarize patients with signs of \"activity\" defined as either shrinkage of tumor (regardless of duration) or slowing down of tumor growth.",
          "timeFrame": "24 months"
        },
        {
          "measure": "Phase II: DoR by BIRC per RECIST 1.1",
          "description": "Duration of response is defined as the time from the date of the first documented response (CR or PR), to the date of first documented progression, or death due any cause.",
          "timeFrame": "24 months"
        },
        {
          "measure": "Phase II: PFS by BIRC per RECIST 1.1",
          "description": "PFS is defined as the time from the date of start of treatment to the date of the first documented progression, or death due to any cause. If a patient has not had an event, progression-free survival is censored at the date of last adequate tumor assessment.",
          "timeFrame": "24 months"
        },
        {
          "measure": "Phase II: Overall survival (OS)",
          "description": "OS is defined as the time from date of randomization/start of treatment to date of death due to any cause. If a patient is not known to have died, survival will be censored at the date of last known date patient alive.",
          "timeFrame": "24 months"
        },
        {
          "measure": "Dose escalation and Phase II: PK parameters - Maximum Concentration (Cmax), as applicable per arm",
          "description": "The maximum (peak) observed plasma, blood, serum, or other body fluid drug concentration after single dose administration (mass x volume-1)",
          "timeFrame": "5 months"
        },
        {
          "measure": "Dose escalation and Phase II: PK parameters - Minimum Concentration (Cmin), as applicable per arm",
          "description": "Observed concentration at the end of a dosing interval (taken directly before next administration)",
          "timeFrame": "5 months"
        },
        {
          "measure": "Dose escalation: Time to achieve Cmax - Tmax, as applicable per arm",
          "description": "The time to reach maximum (peak) plasma, blood, serum, or other body fluid drug concentration after single dose administration (time)",
          "timeFrame": "5 months"
        },
        {
          "measure": "Dose escalation and Phase II: Plasma or serum concentration vs time profiles - AUCtau, as applicable per arm",
          "description": "The Area under curve calculated to the end of a dosing interval (tau) at steady-state (amount x time x volume-1)",
          "timeFrame": "5 months"
        },
        {
          "measure": "Dose escalation and Phase II: Plasma or serum concentration vs time profiles - AUCinf, as applicable per arm",
          "description": "The AUC from time zero to infinity (mass x time x volume-1)",
          "timeFrame": "5 months"
        },
        {
          "measure": "Phase II: Incidence and severity of adverse events (AEs) and serious adverse events (SAEs) by treatment",
          "description": "All information obtained on AE will be displayed by treatment group. Summary tables will include only AEs that started/worsened during the cycles of treatment (treatment-emergent AEs).",
          "timeFrame": "24 months"
        },
        {
          "measure": "Phase II: Frequency of dose interruptions and reductions, by treatment",
          "description": "The number of patients with dose adjustments (reductions and interruptions) will be summarized by treatment group.",
          "timeFrame": "24 months"
        },
        {
          "measure": "Phase II: Dose intensity by treatment",
          "description": "Dose intensity is defined as the ratio of actual cumulative dose received and actual duration of response.",
          "timeFrame": "24 months"
        }
      ],
      "eligibilityCriteria": "Inclusion Criteria:\n\nDose Escalation:\n\n- Patients with advanced (metastatic or unresectable) KRAS G12C mutant solid tumors who have received standard of care therapy or are ineligible to receive such therapy.\n\nPhase II:\n\n* Patients with advanced (metastatic or unresectable) KRAS G12C mutant non-small cell lung cancer who have received platinum-based chemotherapy regimen and immune checkpoint inhibitor therapy, unless patient was ineligible to receive such therapy\n* Patients with advanced (metastatic or unresectable) KRAS G12C mutant colorectal cancer who have received fluropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy, unless patient was ineligible to such therapy.\n\nAll patients:\n\n* ECOG performance status of 0 or 1.\n* Patients must have a site of disease amenable to biopsy and be a candidate for tumor biopsy according to the treating institution's guidelines.\n\nExclusion Criteria:\n\n* Tumors harboring driver mutations that have approved targeted therapies, with the exception of KRAS G12C mutations\n* Prior treatment with a KRAS G12C inhibitor is excluded for patients in a subset of groups in Phase II.\n* Active brain metastases, including symptomatic brain metastases or known leptomeningeal disease\n* Clinically significant cardiac disease or risk factors at screening\n* Insufficient bone marrow, hepatic or renal function at screening Other protocol-defined inclusion/exclusion criteria may apply",
      "nctId": "NCT05358249",
      "overallStatus": "RECRUITING",
      "keywords": [
        "KRAS G12C",
        "targeted therapy",
        "NSCLC",
        "CRC",
        "advanced solid tumors",
        "JDQ443",
        "trametinib",
        "ribociclib",
        "cetuximab"
      ],
      "locations": [
        {
          "facility": "Massachusetts General Hospital .",
          "status": "RECRUITING",
          "city": "Boston",
          "state": "Massachusetts",
          "zip": "02114",
          "country": "United States",
          "contacts": [
            {
              "name": "Aaron Paul Doss",
              "role": "CONTACT",
              "email": "APAULDOSS@mgh.harvard.edu"
            },
            {
              "name": "Rebecca Heist",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 42.35843,
            "lon": -71.05977
          }
        },
        {
          "facility": "Dana Farber Cancer Institute Dept.of DFCI",
          "status": "RECRUITING",
          "city": "Boston",
          "state": "Massachusetts",
          "zip": "02215",
          "country": "United States",
          "contacts": [
            {
              "name": "Brian Schwalm",
              "role": "CONTACT",
              "email": "brian_schwalm@dfci.harvard.edu"
            },
            {
              "name": "Jia Luo",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 42.35843,
            "lon": -71.05977
          }
        },
        {
          "facility": "NYU School of Medicine Langone Health",
          "status": "RECRUITING",
          "city": "New York",
          "state": "New York",
          "zip": "10015",
          "country": "United States",
          "contacts": [
            {
              "name": "Sasha Richardson",
              "role": "CONTACT",
              "phone": "212-731-5662",
              "email": "sasha.richardson@nyulangone.org"
            },
            {
              "name": "Janice Mehnert",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 40.71427,
            "lon": -74.00597
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Leuven",
          "zip": "3000",
          "country": "Belgium",
          "geoPoint": {
            "lat": 50.87959,
            "lon": 4.70093
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Bordeaux",
          "zip": "33076",
          "country": "France",
          "geoPoint": {
            "lat": 44.84044,
            "lon": -0.5805
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Lyon",
          "zip": "69373",
          "country": "France",
          "geoPoint": {
            "lat": 45.74848,
            "lon": 4.84669
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Freiburg",
          "zip": "79106",
          "country": "Germany",
          "geoPoint": {
            "lat": 47.9959,
            "lon": 7.85222
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Ulm",
          "zip": "89081",
          "country": "Germany",
          "geoPoint": {
            "lat": 48.39841,
            "lon": 9.99155
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Milano",
          "state": "MI",
          "zip": "20162",
          "country": "Italy",
          "geoPoint": {
            "lat": 45.46427,
            "lon": 9.18951
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Seoul",
          "zip": "03080",
          "country": "Korea, Republic of",
          "geoPoint": {
            "lat": 37.566,
            "lon": 126.9784
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Singapore",
          "zip": "168583",
          "country": "Singapore",
          "geoPoint": {
            "lat": 1.28967,
            "lon": 103.85007
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Barcelona",
          "state": "Catalunya",
          "zip": "08036",
          "country": "Spain",
          "geoPoint": {
            "lat": 41.38879,
            "lon": 2.15899
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Madrid",
          "zip": "28034",
          "country": "Spain",
          "geoPoint": {
            "lat": 40.4165,
            "lon": -3.70256
          }
        },
        {
          "facility": "Novartis Investigative Site",
          "status": "RECRUITING",
          "city": "Madrid",
          "zip": "28050",
          "country": "Spain",
          "geoPoint": {
            "lat": 40.4165,
            "lon": -3.70256
          }
        }
      ],
      "eligibilityModule": {
        "eligibilityCriteria": "Inclusion Criteria:\n\nDose Escalation:\n\n- Patients with advanced (metastatic or unresectable) KRAS G12C mutant solid tumors who have received standard of care therapy or are ineligible to receive such therapy.\n\nPhase II:\n\n* Patients with advanced (metastatic or unresectable) KRAS G12C mutant non-small cell lung cancer who have received platinum-based chemotherapy regimen and immune checkpoint inhibitor therapy, unless patient was ineligible to receive such therapy\n* Patients with advanced (metastatic or unresectable) KRAS G12C mutant colorectal cancer who have received fluropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy, unless patient was ineligible to such therapy.\n\nAll patients:\n\n* ECOG performance status of 0 or 1.\n* Patients must have a site of disease amenable to biopsy and be a candidate for tumor biopsy according to the treating institution's guidelines.\n\nExclusion Criteria:\n\n* Tumors harboring driver mutations that have approved targeted therapies, with the exception of KRAS G12C mutations\n* Prior treatment with a KRAS G12C inhibitor is excluded for patients in a subset of groups in Phase II.\n* Active brain metastases, including symptomatic brain metastases or known leptomeningeal disease\n* Clinically significant cardiac disease or risk factors at screening\n* Insufficient bone marrow, hepatic or renal function at screening Other protocol-defined inclusion/exclusion criteria may apply",
        "healthyVolunteers": false,
        "sex": "ALL",
        "minimumAge": "18 Years",
        "stdAges": [
          "ADULT",
          "OLDER_ADULT"
        ]
      },
      "studyType": "INTERVENTIONAL",
      "phases": [
        "PHASE1",
        "PHASE2"
      ]
    },
    "structured_criteria": {
      "inclusion": {
        "Inclusion Criteria:": [
          "Patients who meet all of the following criteria are eligible for trial participation: ",
          [
            [
              "Dose Escalation:",
              "- Patients with advanced (metastatic or unresectable) KRAS G12C mutant solid tumors who have received standard of care therapy or are ineligible to receive such therapy."
            ],
            [
              "Phase II:",
              "* Patients with advanced (metastatic or unresectable) KRAS G12C mutant non-small cell lung cancer who have received platinum-based chemotherapy regimen and immune checkpoint inhibitor therapy, unless patient was ineligible to receive such therapy",
              "* Patients with advanced (metastatic or unresectable) KRAS G12C mutant colorectal cancer who have received fluropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy, unless patient was ineligible to such therapy."
            ],
            [
              "All patients:",
              "* ECOG performance status of 0 or 1.",
              "* Patients must have a site of disease amenable to biopsy and be a candidate for tumor biopsy according to the treating institution's guidelines."
            ]
          ]
        ]
      },
      "exclusion": {
        "Exclusion Criteria:": [
          "Patients who meet any of the following criteria are not eligible for trial participation: ",
          [
            "* Tumors harboring driver mutations that have approved targeted therapies, with the exception of KRAS G12C mutations",
            "* Prior treatment with a KRAS G12C inhibitor is excluded for patients in a subset of groups in Phase II.",
            "* Active brain metastases, including symptomatic brain metastases or known leptomeningeal disease",
            "* Clinically significant cardiac disease or risk factors at screening",
            "* Insufficient bone marrow, hepatic or renal function at screening Other protocol-defined inclusion/exclusion criteria may apply"
          ]
        ]
      }
    },
    "results_inclusion": [
      [
        "Inclusion Criteria:",
        "Patients who meet all of the following criteria are eligible for trial participation: ",
        [
          "Dose Escalation:",
          "- Patients with advanced (metastatic or unresectable) KRAS G12C mutant solid tumors who have received standard of care therapy or are ineligible to receive such therapy."
        ],
        {
          "reasoning": "Reasoning: Let's think step by step in order to produce the criteria_decision. We need to evaluate each subcriterion and then decide if the global condition is met.\n\n1. The global condition is \"Dose Escalation\".\n2. The subcriterion is: \"Patients with advanced (metastatic or unresectable) KRAS G12C mutant solid tumors who have received standard of care therapy or are ineligible to receive such therapy.\"\n\nLet's evaluate the subcriterion:\n- The patient has lung adenocarcinoma, stage 4, which is an advanced (metastatic) condition.\n- The patient has a KRAS p.G12C mutation.\n- There is no information provided about whether the patient has received standard of care therapy or is ineligible to receive such therapy.\n\nBased on this information:\n- The patient meets the condition of having an advanced KRAS G12C mutant solid tumor.\n- However, we do not have sufficient information to determine if the patient has received standard of care therapy or is ineligible to receive such therapy.",
          "criteria_decision": {
            "criteria_result": {
              "explanation": [
                "The patient has an advanced (metastatic) KRAS G12C mutant solid tumor.",
                "It is not clear if the patient has received standard of care therapy or is ineligible to receive such therapy."
              ],
              "criteria_decision": [
                true,
                "?"
              ]
            },
            "global_result": "?"
          }
        }
      ],
      [
        "Inclusion Criteria:",
        "Patients who meet all of the following criteria are eligible for trial participation: ",
        [
          "Phase II:",
          "* Patients with advanced (metastatic or unresectable) KRAS G12C mutant non-small cell lung cancer who have received platinum-based chemotherapy regimen and immune checkpoint inhibitor therapy, unless patient was ineligible to receive such therapy",
          "* Patients with advanced (metastatic or unresectable) KRAS G12C mutant colorectal cancer who have received fluropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy, unless patient was ineligible to such therapy."
        ],
        {
          "reasoning": "Let's analyze the patient information and the inclusion criteria step by step to determine the eligibility of the patient for the clinical trial.\n\n### Patient Info:\n- 59-year-old male\n- Lung adenocarcinoma, stage 4\n- Molecular alterations: KRAS p.G12C (AF 18%), KEAP1 p.L276F (AF 45%), STK11 p.K83Tfs*13 (AF 38%)\n\n### Inclusion Criteria:\n1. Phase II:\n2. Patients with advanced (metastatic or unresectable) KRAS G12C mutant non-small cell lung cancer who have received platinum-based chemotherapy regimen and immune checkpoint inhibitor therapy, unless patient was ineligible to receive such therapy.\n3. Patients with advanced (metastatic or unresectable) KRAS G12C mutant colorectal cancer who have received fluropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy, unless patient was ineligible to such therapy.\n\n### Reasoning:\n1. **Phase II:**\n   - This is a general statement indicating the phase of the trial. It does not provide any specific inclusion criteria. Therefore, it does not affect the eligibility decision.\n   - Decision: `?` (Not sufficient information to make a decision)\n\n2. **Patients with advanced (metastatic or unresectable) KRAS G12C mutant non-small cell lung cancer who have received platinum-based chemotherapy regimen and immune checkpoint inhibitor therapy, unless patient was ineligible to receive such therapy:**\n   - The patient has advanced (stage 4) lung adenocarcinoma, which is a type of non-small cell lung cancer.\n   - The patient has a KRAS p.G12C mutation.\n   - There is no information provided about whether the patient has received platinum-based chemotherapy and immune checkpoint inhibitor therapy.\n   - Decision: `?` (Not sufficient information to make a decision)\n\n3. **Patients with advanced (metastatic or unresectable) KRAS G12C mutant colorectal cancer who have received fluropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy, unless patient was ineligible to such therapy:**\n   - The patient has lung adenocarcinoma, not colorectal cancer.\n   - Decision: False (The patient does not meet this criterion)\n\n### Criteria Decision:\nBased on the above reasoning, the decisions for each criterion are as follows:\n\n```json\n{\n  \"criteria_result\": {\n    \"explanation\": [\n      \"Phase II is a general statement and does not provide specific inclusion criteria.\",\n      \"The patient has advanced lung adenocarcinoma with KRAS G12C mutation, but there is no information about prior treatments.\",\n      \"The patient has lung adenocarcinoma, not colorectal cancer.\"\n    ],\n    \"criteria_decision\": [\"?\", \"?\", false]\n  },\n  \"global_result\": \"?\"\n}\n```\n\n### Global Result:\n- Since the global condition is not explicitly stated, we assume that all criteria must be met for the patient to be eligible.\n- Given that one of the criteria is `False` and the others are `?`, the overall eligibility cannot be determined with the given information.\n- Therefore, the global result is `?`.\n\nThis JSON object provides a clear decision for each criterion and the overall eligibility based on the given patient information and inclusion criteria.",
          "criteria_decision": {
            "criteria_result": {
              "explanation": [
                "Phase II is a general statement and does not provide specific inclusion criteria.",
                "The patient has advanced lung adenocarcinoma with KRAS G12C mutation, but there is no information about prior treatments.",
                "The patient has lung adenocarcinoma, not colorectal cancer."
              ],
              "criteria_decision": [
                "?",
                "?",
                false
              ]
            },
            "global_result": "?"
          }
        }
      ],
      [
        "Inclusion Criteria:",
        "Patients who meet all of the following criteria are eligible for trial participation: ",
        [
          "All patients:",
          "* ECOG performance status of 0 or 1.",
          "* Patients must have a site of disease amenable to biopsy and be a candidate for tumor biopsy according to the treating institution's guidelines."
        ],
        {
          "reasoning": "Reasoning: Let's think step by step in order to produce the criteria_decision. We need to evaluate each subcriterion individually and then decide the global result based on the overall logic.\n\n1. **Global Condition**: \"All patients:\"\n   - This is a general statement indicating that the following criteria apply to all patients. It does not require a specific decision.\n\n2. **Subcriterion 1**: \"* ECOG performance status of 0 or 1.\"\n   - The patient information does not mention the ECOG performance status. Therefore, we cannot determine if the patient meets this criterion.\n   - Decision: \"?\"\n\n3. **Subcriterion 2**: \"* Patients must have a site of disease amenable to biopsy and be a candidate for tumor biopsy according to the treating institution's guidelines.\"\n   - The patient information does not provide details about the site of disease or biopsy candidacy. Therefore, we cannot determine if the patient meets this criterion.\n   - Decision: \"?\"\n\nSince the global condition is \"All patients:\", we need to ensure that all subcriteria are met for the patient to be eligible. Given that we have insufficient information for both subcriteria, the global result will be \"?\".",
          "criteria_decision": {
            "criteria_result": {
              "explanation": [
                "The global condition 'All patients:' does not require a specific decision.",
                "The patient information does not mention the ECOG performance status, so we cannot determine if the patient meets this criterion.",
                "The patient information does not provide details about the site of disease or biopsy candidacy, so we cannot determine if the patient meets this criterion."
              ],
              "criteria_decision": [
                "?",
                "?",
                "?"
              ]
            },
            "global_result": "?"
          }
        }
      ]
    ],
    "results_exclusion": [
      [
        "Exclusion Criteria:",
        "Patients who meet any of the following criteria are not eligible for trial participation: ",
        [
          "* Tumors harboring driver mutations that have approved targeted therapies, with the exception of KRAS G12C mutations",
          "* Prior treatment with a KRAS G12C inhibitor is excluded for patients in a subset of groups in Phase II.",
          "* Active brain metastases, including symptomatic brain metastases or known leptomeningeal disease",
          "* Clinically significant cardiac disease or risk factors at screening",
          "* Insufficient bone marrow, hepatic or renal function at screening Other protocol-defined inclusion/exclusion criteria may apply"
        ],
        {
          "reasoning": "Let's think step by step in order to produce the criteria_decision. We will evaluate each exclusion criterion based on the patient information provided.\n\n1. **Criterion 1**: \u00ab* Tumors harboring driver mutations that have approved targeted therapies, with the exception of KRAS G12C mutations\u00bb\n   - The patient has a KRAS G12C mutation, which is explicitly mentioned as an exception. Therefore, the patient is eligible based on this criterion.\n   - **Decision**: True\n\n2. **Criterion 2**: \u00ab* Prior treatment with a KRAS G12C inhibitor is excluded for patients in a subset of groups in Phase II.\u00bb\n   - There is no information provided about prior treatment with a KRAS G12C inhibitor. Therefore, we cannot determine eligibility based on this criterion.\n   - **Decision**: ?\n\n3. **Criterion 3**: \u00ab* Active brain metastases, including symptomatic brain metastases or known leptomeningeal disease\u00bb\n   - There is no mention of brain metastases or leptomeningeal disease in the patient information. We assume the patient does not have these conditions.\n   - **Decision**: True\n\n4. **Criterion 4**: \u00ab* Clinically significant cardiac disease or risk factors at screening\u00bb\n   - There is no information provided about cardiac disease or risk factors. Therefore, we cannot determine eligibility based on this criterion.\n   - **Decision**: ?\n\n5. **Criterion 5**: \u00ab* Insufficient bone marrow, hepatic or renal function at screening Other protocol-defined inclusion/exclusion criteria may apply\u00bb\n   - There is no information provided about bone marrow, hepatic, or renal function. Therefore, we cannot determine eligibility based on this criterion.\n   - **Decision**: ?\n\nBased on the above reasoning, here is the JSON output:\n\n```json\n{\n  \"explanation\": [\n    \"The patient has a KRAS G12C mutation, which is explicitly mentioned as an exception. Therefore, the patient is eligible based on this criterion.\",\n    \"There is no information provided about prior treatment with a KRAS G12C inhibitor. Therefore, we cannot determine eligibility based on this criterion.\",\n    \"There is no mention of brain metastases or leptomeningeal disease in the patient information. We assume the patient does not have these conditions.\",\n    \"There is no information provided about cardiac disease or risk factors. Therefore, we cannot determine eligibility based on this criterion.\",\n    \"There is no information provided about bone marrow, hepatic, or renal function. Therefore, we cannot determine eligibility based on this criterion.\"\n  ],\n  \"criteria_decision\": [\n    true,\n    \"?\",\n    true,\n    \"?\",\n    \"?\"\n  ]\n}\n```",
          "criteria_decision": {
            "explanation": [
              "The patient has a KRAS G12C mutation, which is explicitly mentioned as an exception. Therefore, the patient is eligible based on this criterion.",
              "There is no information provided about prior treatment with a KRAS G12C inhibitor. Therefore, we cannot determine eligibility based on this criterion.",
              "There is no mention of brain metastases or leptomeningeal disease in the patient information. We assume the patient does not have these conditions.",
              "There is no information provided about cardiac disease or risk factors. Therefore, we cannot determine eligibility based on this criterion.",
              "There is no information provided about bone marrow, hepatic, or renal function. Therefore, we cannot determine eligibility based on this criterion."
            ],
            "criteria_decision": [
              true,
              "?",
              true,
              "?",
              "?"
            ]
          }
        }
      ]
    ],
    "subinstruction": "metastatic lung adenocarcinoma, KRAS p.G12C mutation",
    "patient_id": "p6",
    "patient_info": "\nPatient Information\n    Name: Doe, John\n    born: 18.08.1968\n    Address: Main Street 1, Berlin\n\nOverview of Tumor Diagnosis and Therapy\n    Tumor Diagnosis\n    Diagnosis: Metastatic KRAS G12C mutant non-small cell lung cancer (NSCLC)\n    Initial Detection: March 22, 2023, following symptoms of persistent cough and weight loss\n    Biopsy Date: April 15, 2023, adenocarcinoma of the lung\n    Molecular Profile: KRAS p.G12C (AF 18%), KEAP1 p.L276F (AF 45%), STK11 p.K83Tfs*13 (AF 38%).\n\nTherapy Overview\n    Initial Treatment:\n    Chemotherapy: Began May 5, 2022 in Berlin, with a platinum-based regimen (Cisplatin and\n    Pemetrexed), partial response noted after initial chemotherapy cycle completed by August 10, 2022, contunuation of therapy until october 2023 (progressive disease)\n    Subsequent Treatment: Immunotherapy with Prembolizumab at Charit\u00e9 Berlin initiated on October 25, 2023, with Pembrolizumab, staging CT shows disease progression after 3 months\n    Current Status:\n    Health Condition: Stable with an ECOG performance status of 1\n    Comorbidities: Well-managed and not contraindicating further treatment\n \nComorbidities\n    Former Smoker: 40py\n    Hypertension: Controlled with medication (Lisinopril 20 mg daily), current blood pressure 130/90mmHg\n    Type 2 Diabetes Mellitus: Controlled with Metformin 1000 mg twice daily\n    Hyperlipidemia: Managed with Atorvastatin 40 mg daily\n    Osteoarthritis: Managed with over-the-counter NSAIDs as needed\n    Chronic Obstructive Pulmonary Disease (COPD): Mild, managed with inhalers (Tiotropium)\n    Gastroesophageal Reflux Disease (GERD): Managed with Omeprazole 20 mg daily\n    Benign Prostatic Hyperplasia (BPH): Treated with Tamsulosin 0.4 mg daily\n\nPerformance Status: ECOG Performance Status 1\n \nChronological Medical Findings:\n    January 10, 2018: Routine annual physical examination. Blood pressure elevated, diagnosed with hypertension. Prescribed Lisinopril 10 mg daily.\n    March 15, 2018: Complained of heartburn and acid reflux. Diagnosed with GERD. Prescribed Omeprazole 20 mg daily.\n    February 25, 2019: Annual follow-up for hypertension. Blood pressure well-controlled. Lisinopril dosage maintained.\n    May 20, 2019: Complained of knee pain. Diagnosed with osteoarthritis. Recommended over-the-counter NSAIDs for pain management.\n    April 5, 2020: Routine check-up. Elevated blood glucose levels. Diagnosed with Type 2 Diabetes Mellitus. Prescribed Metformin 500 mg twice daily.\n    August 30, 2020: Routine cholesterol check. Diagnosed with hyperlipidemia. Prescribed Atorvastatin 20 mg daily.\n    November 10, 2020: Follow-up for diabetes and hyperlipidemia. Dosages adjusted: Metformin increased to 1000 mg twice daily, Atorvastatin increased to 40 mg daily.\n    February 12, 2021: Complained of shortness of breath and chronic cough. Diagnosed with mild COPD. Prescribed Tiotropium inhaler.\n    July 18, 2021: Routine follow-up. Stable condition with controlled comorbidities. Blood pressure, blood sugar, and cholesterol levels within target ranges.\n    March 22, 2023: Experienced persistent cough and weight loss. Chest X-ray and CT scan revealed a mass in the left lung. Referred to oncologist. CT Angiography, Pulmonary Arteries: Tumor Size: Approximately 4.5 cm in diameter. Bronchial Obstruction: Partial obstruction of the left main bronchus leading to atelectasis of the left upper lobe.\n    Urgent suspicion of a tumor-atelectasis complex in the left upper lobe of the lung. Mucus present in the lower lobe bronchi on the left. Suspicion of mediastinal lymph node metastases. No evidence of pulmonary artery embolism. Thrombus in the left atrium at the transition to the auricle. Emphysematous and fibrotic changes in the lung parenchyma. \n    Lymph Nodes: Enlarged, FDG-positive lymph nodes in the mediastinum, particularly in regions 4R and infracarinal. \n    April 15, 2023: Lung biopsy via bronchoscopy: Endobronchial tumor manifestation in the distal left main bronchus extending to the upper lobe. Acute and chronic atrophic tracheobronchitis. Collapsed bronchial system in the affected area. Biopsy taken. Diagnosed with non-small cell lung cancer (NSCLC), molecular diagnostics: KRAS G12C mutant. \n    April 27, 2022: Ventilation: Moderate obstruction, no restriction. Increased airway resistance and slight hyperinflation. Tiffeneau index (FEV1/FVC) at 42.34%, z-score -3.32. FEV1: 0.93 L (42% predicted), z-score -2.89.Total lung capacity (TLC): 5.86 L (103% predicted), z-score 0.22. Forced vital capacity (FVC): 2.19 L, z-score -1.5. Residual volume (RV): 3.67 L, z-score 2.44. RV/TLC: 62.68%, z-score -1.18.\n    May 5, 2022: Initiated on platinum-based chemotherapy regimen (Cisplatin and Pemetrexed).\n    August 10, 2023: Completed initial chemotherapy cycle. Partial response noted. \n    August-October: Continued chemotherapy with Cisplatin/Pemetrexed.\n    October 13, 2023: Follow-up CT (chest + abdomen): Moderate disease progression. New nodule in the right lung (1cm). Slight increase in the size of previously noted FDG-positive lymph nodes in the mediastinum. No additional metastatic lesions were detected. The patient has continued to tolerate the current treatment regimen well, with no significant adverse effects reported.\n    October 25, 2023: Started immune checkpoint inhibitor therapy (Pembrolizumab), good tolerability, no signs of autoimmunity.\n    March 12, 2024: Follow-up CT scan abdomen/lung: Progressive Disease with three new metastases in the right lung and additional enlarged FDG-positive lymph nodes in the mediastinum. MRI scan of the brain conducted; no evidence of metastatic disease. Incidental findings included mild age-related cerebral atrophy and scattered white matter hyperintensities consistent with chronic microvascular ischemic changes.\n    March 17, 2024: Tumorboard recommends considering clinical trial options due to limited response to standard therapies.\n    April 20, 2024: Detailed assessment of health status. ECOG performance status 1. All routine labs, including liver and renal function tests, within normal limits.\n",
    "instruction": "Please find a clincial trial targeting the patients tumor and alterations in Germany."
  }
]